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Abstract 
Dietary fibre is believed to protect against the development of a number of western 
diseases including colorectal cancer. The aim of this study was to investigate 
whether dietary fibres exert a chemopreventative effect in respect of colorectal 
neoplasia using the 1,2-dimethylhydrazine (DMH) mouse model, and to elucidate 
their biological mechanism of action focusing on the cadherin/catenin complex. 
Examination of DMH-induced adenomas revealed alterations in the cadherin/catenin 
complex. Within the dysplastic epithelium there was an increase in cytoplasmic 
localisation of P-catenin, cc-catenin, p120 and E-cadherin. This was accompanied by 
nuclear localisation of P-catenin and the possible overexpression of all components 
of the cadherin/catenin complex. Within the feeding study which examined the 
effects of dietary fibre supplementation on DMH-induced mouse colonic tumours the 
dietary fibre pectin was found to significantly increase tumour incidence. This was 
accompanied by a possible increase in tumour development and an increase in 
colonic cells undergoing DNA replication as assessed by flash labelling experiments 
with the thymidine analogue bromodeoxyuridine. On examination of the 
cadherin/catenin complex there was no apparent difference in the pattern of 
expression, within the non-dysplastic and dysplastic epithelium, between the 
different fibre-supplemented diets. In in-vitro studies the dietary fibres did not affect 
total cell number or P-catenin expression, although the SCFAs butyrate and 
propionate, products associated with fibre fermentation, were shown to result in a 
decreased total cell number. Within the cell line HCT1 16, butyrate was also shown 
to result in the redistribution of P-catenin from the cell membrane to the cytoplasm. 
In summary, these studies have shown that dietary fibre may not account for the 
chemopreventive actions of fruit and vegetables, although the production of butyrate 
from the fermentation of fibre may elicit some protective effects. This is in keeping 
with the hypothesis that the chemopreventive biological effects for fibre are mediated 
via short chain fatty acids. 
i 
To my husband Tim 
Without whom this would not have been completed, 
But without whom this would have been completed 12 months ago! 
"You are one in a million. I love you7' 
and 
to all my family and friends. 
Acknowledgements 
Firstly I would like to thank my supervisor Professor Massimo Pignatelli who gave me the 
opportunity to undertake this challenge and provided encouragement throughout the duration. I 
particularly would like to thank Dr Moorghen for his enormous help with the feeding study, 
particularly the work up in the roof - unfortunately it gave us both nightmares - so I am forever 
indebted to him and the final stages of writing up. I would also like to thank Dr Joyti Gupta for her 
help during the feeding study. I would like to thank those at Reckittl3enckiser, particularly Professor 
Peter Dettmarr for all his words of encouragement and by giving me the chance to attend and present 
at numerous conferences where I gained an immense amount of experience and a wealth of 
knowledge. I would also like to thank Mike Havler for helping me enormously by producing the 
protocols for the modified Englyst technique and the fermentation analysis but most significantly by 
keeping a smile on my face when I was up and down with his amazing sense of hurnour and his words 
of encouragement. 
I would like to thank my group, particularly Raff who helped me settle in to London, Emma for her 
friendship, words of encouragement and support through every step of the Phl), along with our coffee 
mornings! I would also like to thank Andrea who guided me through immunofluoresence and 
encouraged me especially through the last few weeks of the write up process. I would also like to 
thank Nari for showing me the ropes in PCR and SSCP techniques, Jenny and Joy for their help in 
processing and sectioning of the 100s of turnours derived from the feeding study. I would also like to 
thank everyone in CPs group for their support and encouragement particularly David for reading 
through a couple of my chapters in his spare time. I also would like to thank Angela Wells for all her 
help in setting up the lab when we first arrived, for her continual support thereafter and our friendship. 
This would have not have been possible without the support of my friends particularly Zoe, Katie, 
Emma, Chris and Julian, Jo, Claire, Erin, Helena, Diane and the others - you know who you are - for 
keeping me sane, constant encouragement and understanding. I would particularly like to thank Zoe 
for being a complete star! I would like to thank all mine and Tim's family for all their support, 
encouragement and providing a sanctuary when I needed one, particularly I would like to thank my 
mum and dad who have made this possible and Dad and Laurie for help in proof reading my English. 
I would like to thank my husband Tim for all his love, support, encouragement and his ability to help 
me through the most stressful of times - lots of big hugs and cups of tea. 
Financial support was provided by ReckittBenckiser Healthcare Limited, Hull and BBSRC, Swindon. 




WiJnhoven, B. P. L., Tucker, E. L., Dinjen, W. N. M, Tialanus, H. W., Pignatelli, M. 
Biochemical analysis and subcellular distribution of the E-cadherin-catenin complex 
in adenocarcinomas of the gastric oesophageal junction. Submitted. 
Tucker, E. L, Pignatelli, M. (2000) Catenins and their associated proteins in 
colorectal cancer. Histol Histopathol. 15: 251-260. 
Tucker, E., Buda, A., Janghra, N., Baker, J., Code, J., Moorghan, M., Havler, M., 
Dettmar, P., Pignatelli, M. (2003) Abnormalities of the cadherin/catenin complex in 
chemically induced colorectal. carcinogenesis. Proc Nut Soc. 62: 229-236 
iv 
Declaration 
I declare that the work in this dissertation was carried out in accordance with the 
Regulations of the University of Bristol. The work is original except where indicated 
by special reference in the text and no part of this dissertation has been submitted for 
any other degree. 
Any views expressed in the dissertation are those of the author and in no way 
represent those of the University of Bristol. 
The dissertation has not been presented to any other University for examination 
either in the United Kingdom or overseas. 
SIGNED: DATE: 









List of Figures xi 
List of Tables xvil 
Abbreviations xviii 
Chapter I Introduction 1 
1.1 The Large Intestine I 
1.1.1 The physiology of the large intestine 1 
1.1.2 The colonic epithelium 4 
1.2 Colorectal Cancer 7 
1.2.1 The role of genetics in colorectal cancer development 8 
1.2.2 Environmental factors in the development of colorectal cancer 8 
1.3 The role of Genetics in the development of colorectal 10 
cancer 
1.3.1 Adenomatous polyposis coli (APQ 10 
1.3.2 The catenin family 14 
1.3.3 The catenin family (a-, 0-, y- ), p120 and E-cadherin In cell 17 
adhesion 
1.3.4 Cell signaling and the regulation of the catenin family 21 
1.3.5 The catenins (cc-, 0-, y- ), p120 and E-cadherin in colon cancer 25 
1.4 Environment 30 
1.4.1 Environmental factors involved In the aetiology of colorectal 
cancer development 30 
1.5 Dietary Fibre 32 
1.5.1 Definition of dietary fibre 32 
1.5.2 Quantification of dietary fibre 33 
1.5.3 The physiochemical properties of dietary fibres 34 
1.5.4 Fermentation of dietary fibre 38 
1.5.5 Physiological significance of SCFA production 43 
1.5.5.1 Acetate 44 
1.5.5.2 Propionate 44 
1.5.5.3 Butyrate 45 
1.5.6 Health benefits of dietary fibre and their use In disease states 50 
1.5.6.1 Large bowel disorders 50 
1.5.6.2 Colorectal. cancer 50 
1.5.6.3 Possible protective mechanisms of dietary fibres 52 
V1 
1.6 Models of colorectal cancer 55 
1.6.1 Animal studies -In F71vo models of colorectal cancer 55 1.6.2 Multiple intestinal neoplastic mouse 57 
1.6.3 1,2-dimethylhydrazine mouse (DMED model 57 
1.7 Aims 60 
Chapter 2 Materials and Methods 62 
2.1 Fiber characterisation 62 
2.1.1 Fermentation study using faecal slurries under anaerobic 62 
conditions. 
2.1.2 Non-starch polysaccharide analysis using the Englyst technique 66 2.1.3 Solubility of the fibres as determined by image analysis 71 
2.2 1,2-dimethylhydrazine mouse model 72 
2.2.1 Housekeeping 72 
2.2.2 Treatment with 1,2-dimethylhydrazine 74 2.2.3 Bromodeoxyuridine (BrdU) as a measurement of proliferation 74 2.2.4 Bromodeoxyuridine (BrdU)-Labelling index 76 
2.2.5 Tumour burden 76 
2.3 1,2-dimethylhydrazine mouse model characterization 77 
2.3.1 Histopathology 77 
2.3.2 Immunobistochernistry 77 
2.3.3 Tissue lysates for varifying specificity of antibodies in mouse 78 
tissues. 
2.3.4 Protein extract analysis to determine equal loading 79 
2.4 Mutational Analysis 80 
2.4.1 Primer design 80 
2.4.2 Polymerase Chain Reaction (PCR) for P-catenin gene amplification 80 2.4.3 Single Strand Conformational Polymorphism (SSCP) 81 
2.4.4 Sequencing 81 
2.5 In Nitro Cell Culture 83 
2.5.1 Cell Lines 83 
2.5.1.1 Maintenance of cell cultures 83 2.5.1.2 Subculturing cells 83 2.5.1.3 Storage and Retrieval 84 
2.6 Cell line characterisation and protein expression 86 
2.6.1 Primers/PCR/SSCP/Sequencing 86 2.6.2 SDS-PAGE western blotting 86 
2.6.2.1 Cell lysates 86 2.6.2.2 SDS-PAGE 87 2.6.2.3 SCFA and Fibres 90 
2.6.3 Immunocytochernistry (ICC) 90 
vii 
2.6.4 Cell Proliferation 91 
2.6.5 3D-Collagen Gel Protocol 91 
2.6.6 Immunoflourescence using confocal microscopy 92 
2.7 Statistical Analysis 95 
2.7.1 Anova 95 
2.7.2 Student t Test 95 
Chapter 3 The characterisation of the fibres Ispaghula 
husk, Pectin, Cellulose, Rice starch and 
resistant starch and their associated diets 96 
3.1 Introduction 96 
3.2 Aim 98 
3.3 Objectives 98 
3.4 Methodology 99 
3.5 Results 100 
3.5.1 Solubility of NSP content of the fibres Ispaghula husk, Pectin , Cellulose, Rice starch, Resistant starch and their associated diets 100 
3.5.1.1 Ispaghula husk 100 
3.5.1.2 Pectin 103 
3.5.1.3 Cellulose 103 
3.5.1.4 Rice and Resistant Starch 104 
3.5.2 Constituent NSP sugars within the total, insoluble and soluble 
fractions of the fibres Ispaghula husk, Pectin, Cellulose, Rice 
starch, Resistant starch and their associated diets 105 
3.5.2.1 Ispaghula husk 105 
3.5.2.2 Pectin 107 
3.5.2.3 Cellulose 109 
3.5.2.4 Rice and Resistant starch 109 
3.5.3 Fermentation characteristics of the fibres Ispaghula husk, 
Pectin, Cellulose, Rice starch and Resistant starch 112 
3.5.3.1 pH changes 112 
3.5.3.2 Total Short chain fatty acid production 114 
3.5.3.3 Acetate production 118 
3.5.3A Butyrate production 120 
3.5.3.5 Propionate production 123 
3.5.4 SCFA profiles for the fibres Ispaghula husk, Pectin, Cellulose, 
Rice starch and Resistant starch 128 
3.5.5 Fermentation characteristics of the basal and fibre supplemented 
diets Ispaghula husk, Pectin and Cellulose 129 
3.5.5.1 pH changes 129 
3.5.5.2 Total short chain fatty acid production 131 
3.5.5.3 Acetate production 131 
3.5.5.4 Propionate production 134 
3.5.5.5 Butyrate production 136 
3.5.5.6 Rate of fermentation 136 
viii 
3.5.6 Comparison of fermentation characteristics of the fibres Ispaghula 
husk, Pectin, Cellulose, Rice starch, Resistant starch and their 
associated diets 136 
3.6 Discussion 141 
3.6.1 The physiochemical properties of dietary fibres 142 
3.6.1.1 Ispaghula husk 142 
3.6.1.2 Pectin 144 
3.6.1.3 Cellulose 145 
3.6.1.4 Starch 147 
3.6.2 Health benefits of Dietry Fibres and their use in disease states 148 
3.6.2.1 Weight Management 148 
3.6.2.2 Cardiovascular Disease - Cholesterol metabolism 149 
3.6.2.3 Diabetes - Glucose metabolism and Insulin response 151 
3.6.2.4 Large Bowel Disorders 153 
Chapter 4 Characterisation of the 1,2-dimethylhydrazine 
balb/c mouse model 159 
4.1 Introduction 159 
4.2 Aim 161 
4.3 Objectives 161 
4.4 Methodology 162 
4.5 Results 164 
4.5.1 Examination of the expression and cellular localisation of the E- 
cadherin and catenin complex by immunohistochemistry 164 
4.5.1.1 Increase in cytoplasmic expression and nuclear localisation in 
catenin in dysplastic mucosa 164 
4.5.1.2 Cytoplasmic E-cadherin cellular localisation is not associated with 
reduced membranous expression on dysplastic mucosa 164 
4.5.1.3 Increase in cc-catenin and p120 cytoplasmic expression in dysplastic 
mucosa is not associated with nuclear localization 166 
4.5.1.4 y-catenin is not expressed in Balb/c mice exposed to the carcinogen 
1,2-dimethylhydrazine 171 
4.5.2 Expression of P- and a-catenin by western blotting 171 
4.5.3 Mutation analysis of exon 3 of the P-catenin gene 173 
4.6 Discussion 176 
4.7 Conclusion 183 
Chapter 5 The effects of dietary flibre on the development 
of 1,2-dimethylhydrazine induced colorectal 
tumours in female Balb/c mice 185 
5.1 Introduction 185 
5.2 Aim 186 
5.3 Objectives 187 
ix 
5.4 Study Design 187 
5.5 Results 189 
5.5.1 Monitoring of Feeding Study 189 
5.5.2 Macroscopic analysis of nodules induced by the administration of 
1,2-dimethylhydrazine.... 194 
5.5.3 Microscopic analysis of tumours induced by the administration of 
1,2-dimethylhydrazine within the colonic tissues of Balb/c mice... 194 
5.5.4 Addition of dietary fibres to the basal diet increased the number of 
cells undergoing DNA replication suggesting an increase 
in cell proliferation.... 207 
5.5.5 The Basal diet that was deficient in fibre resulted in the lowest 
tumour Incidence, tuniour number and tuniour burden induced by 1,2- 
dimethylhydrazine.... 207 
5.5.6 Dietary fibres appear to have no significant effect on 0-catenin, a- 
catenin, P120 and E-cadherin expression... 211 
5.6 Discussion 213 
5.6.1 The potential protective or causative mechanisms of dietary 
fibres on colon cancer development 213 
5.6.1.1 Bulking effects of Fibres 213 
5.6.1.2 Fermentation 214 
5.6.1.3 Microflora 216 
5.6.1.4 Bile Acids 217 
5.6.1.5 Colonic homeostasis 218 
5.6.1.6 Changes in gene or protein expression 219 
5.6.1.7 Immune responses 221 
5.6.2 Other dietary Intervention studies and biological effects 221 
5.6.3 Animal studies 223 
Chapter 6 Examination of the effects of SCFAs and dietary 
fibres on colonic cell homeostasis and the 
expression and cellular localization of 
P-catenin 225 
6.1 Introduction 225 
6.2 Aims 226 
63 Methodology 227 
6.4 Results 229 
6.4.1 The effects of SCFAs (butyrate, acetete, propionate) and fibres 
(ispaghula husk, pectin, cellulose and rice starch) on cell numbers.. 229 6.4.2 The characterization of the cell lines LS I 74T and RG/C2 for a exon 
3 P-catenin gene mutation 238 
6.4.3 The effects of SCFAs acetate, propionate and butyrate on P-catenin 
protein expression 243 
6.5 Discussion 258 
Chapter 7 Concluding remarks 266 
Chapter 8 Bibliography 277 
x 
List of Figures. 
Fig 1.1 The Gastrointestinal tract. 2 
Fig 1.2 The colonic mucosa. 5 
Fig 1.3 The colonic crypt. 6 
Fig 1.4 Environmental and Genetic factors associated with the 9 adenoma to carcinoma sequence. 
Fig 1.5 The structure and molecular interactions of (A) APC and (B) 12 P-catenin. 
Fig 1.6 Catenins and their associated proteins. 
is 
Fig 1.7 The Wnt-1 signalling pathway. 
23 
Fig 1.8 Metabolism of DMH. 59 
Fig 2.1 Representative of the colon revealing the colonic divisions 75 made when locating the distribution of nodules and turnours. 
Fig 2.2 Representative nodules. 75 
Fig 2.3 A diagrammatic representation of single strand 82 conformational polymorphisms. 
Fig 2.4 Representative negative controls for immunocytochemistry, 93 immunohistochernistry and immunofluoresence. 
Fig 2.5 Immunoflouresence using confocal microscopy. 94 
Fig 3.1 Solubility of the dietary fibres; ispaghula husk, pectin, 101 cellulose, rice starch and resistant starch ........... 
Fig 3.2 pH changes within human faecal homogenates supplemented 
with the dietary fibres; ispaghula husk, pectin, cellulose, rice and 
resistant starch ......... 
113 
Fig 3.3 Total short chain fatty acid production from the fermentation 
of the dietary fibres ispaghula husk, pectin, cellulose, rice and 115 resistant starch. 
Fig 3.4 Rate of total SCFA production by the dietary fibres ispaghula 
husk, pectin, cellulose, rice starch and resistant starch. 117 
Fig 3.5 Total acetate production from the fermentation of the dietary 
fibres ispaghula husk, pectin, cellulose, rice and resistant starch. 119 
xi 
Fig 3.6 Rate of acetate production by the fibres ispaghula husk, 
pectin, cellulose, rice and starch and resistant starch. 121 
Fig 3.7(a) Total butyrate production (b) Ratio of butyrate from the 
fermentation of the dietary fibres; ispaghula husk, pectin, cellulose, 
rice and resistant starch. 122 
Fig 3.8 Rate of butyrate production by the dietary fibres ispaghula 
husk, pectin, cellulose, rice starch and resistant starch. 124 
Fig 3.9(a) Total propionate (b) Ratio of propionate from the 
fermentation of dietary fibres; ispaghula Husk, pectin, cellulose, rice 
and resistant starch. 125 
Fig 3.10 Rate of propionate production by the dietary fibres ispaghula 
husk, pectin, cellulose, rice starch and resistant starch. 127 
Fig 3.11 pH changes within human faecal homogenates supplemented 
with the basal diet and the basal diet .......... 
130 
Fig 3.12 Total short chain fatty acid production from the fermentation 
of the dietary fibre supplemented diets. 132 
Fig 3.13 Total acetate production from the fermentation of dietary 
fibre supplemented diets. 133 
Fig 3.14a) Total propionate production (b) Ratio of propionate from 
the fermentation of dietary fibre. 135 
Fig 3.15a) Total butyrate production (b) Ratio of butyrate from the 
fermentation of dietary fibre supplemented diets. 137 
Fig 3.16 Rate of SCFA production by dietary fibre supplemented 
diets. 138 
Fig 3.17 Diagrammatic representation of diet in health and disease. 158 
Fig 4. IA. Representative 1,2-dimethylhydrazine mouse colonic tissue 
section showing P-catenin localisation ........... 
165 
Fig 4.2 A. Representative 1,2 -dimethylhydrazine mouse colonic 
tissue section showing E-cadherin localisation .......... 
167 
Fig 4.3A. Representative 1,2-dimethylhydrazine treated mouse 
colonic tissue section showing a-catenin localisation ............ 
168 
X11 
Fig 4.4A. Representative 1,2-dimethylhydrazine treated mouse 
colonic tissue section showing p 120 localisation ............ 
169 
Fig 4.5 Expression of a-, P-catenins, p 120(") and E-cadherin within 
the 1,2-dimethyl-hydrazine mouse colonic tissues as determined by 
immunohistochernistry. 170 
Fig 4.6 Expression of a- and P- catenin by western blotting. 172 
Fig 4.7 PCR amplification of P-catnin from frozen distal colonic 174 tissue samples of DMH treated Balb/c mice. 
Fig 4.8 SSCP revealing possible P-catenin mutations in 3 of the 4 174 DMH treated Balb/c mice. 
Fig 4.9 DNA sequences 175 
Fig 4.10 Proposed 1,2-dimethlydrazine adenoma to carcinoma 184 
sequence. 
Fig 5.1 Average weight gain in female Balb/c mice fed various 190 dietary fibre supplemented diets .......... 
Fig 5.2 Faecal matter obtained from female Balb/c mice fed on the 191 different diets, basal and basal diet ........ 
Fig 5.3 Incidence of nodule development in 1,2-dimethylhdrazine 195 female Balb/c mice fed on various diets ........... 
Fig 5.4 Total number of macroscopic nodules found within the colons 196 of 1,2-dimethylhydrazine treated female Balb/c mice .......... 
Fig 5.5 Total macroscopic nodule burden fortned within the colons of 
1,2-dimethylhdrazine treated female Balb/c mice ........... 
197 
Fig 5.6 Represents the nodule distribution within the colon in 1,2 
dimethy1hydrazine female Balb/c mice fed on various dietary fibre- 198 supplemented diets. 
Fig 5.7 Percentage of macroscopic confirmed nodules as microscopic 199 turnours ....... . 
Fig 5.8 Classification of the macroscopic nodules formed in the 1,2 
dimethy1hydrazine female Balb/c mice on various dietary fibre 200 supplemented diets. 
X111 
Fig 5.9 Percentage of female Balb/c mice that developed 1,2 
dimethy1hydrazine induced turnours fed on various dietary fibre 
supplemented diets. 202 
Fig 5.10 Total number of tumours induced by 1,2-dimethylhydrazine 
in female Balb/c mice on various dietary fibre supplement diets. 203 
Fig 5.11 Total tumour burden found in 1,2-dimethylhydrazine treated 
female Balb/c mice on various dietary fibre supplemented diets. 204 
Fig 5.12 Tumour distribution within 1,2-dimethylhydrazine treated 
female Balb/c mice fed on various dietary fibre supplemented diets. 205 
Fig 5.13 Average microadenoma number in 1,2-dimethylhydrazine 
treated female Balb/c mice fed on different dietary fibre 
supplemented diets. 206 
Fig 5.14 The effects of various fibre-supplemented diets on the 
average colonic crypt length in 1,2-dimethylhydrazine treated female 
Balb/c mice. 208 
Figure 5.15a Effects of various fibre supplemented diets on the 
number of colonic cells in S phase ............ 209 
Fig S. I 5b Representative light micrographs of colonic 
epithelium ...... 210 
Fig 5.16 The effect of the dietary fibres Ispaghula husk, Pectin and 
cellulose on (A) P-catenin, (B) E-cadherin, (C) cc-catenin and (D) 
p120 expression. 212 
Fig 6.1 The SCFAs Butyrate and propionate reduced total cell 
number in the colonic epithelial cell line HCTI 16.230 
Fig 6.2 The SCFAs butyrate and propionate reduced total cell 
numbers in the colonic epithelial cell line HT29 231 
Fig 6.3 The SCFAs butyrate and propionate reduced total cell number 
in the colonic epithelial cell line SW1222 232 
Fig 6.4 The SCFAs butyrate and propionate reduced total cell 
numbers inthe colonic epithelial cell line LS174T 233 
Fig 6.5 The SCFAs butyrate and propionate reduced total cell 
numbers in the colonic epithelial cell line RG/C2 234 
Fig 6.6 The SCFAs butyrate and propionate reduced total cell number 
inthe colonic epithelail cell line CMT-93 235 
xiv 
Fig 6.7 Histograms showing the effects of SCFA treatment on 
cellular proliferation as determined by ......... 236 
Fig 6.8 Histograms showing the effects of SCFA treatment on 
cellular proliferation as determined by ......... 237 
Fig 6.9 Expression of P-catenin in LS 174T (p 18) and RG/C2 (p46) 
growing as a monolayer (1) and in 3D collagen gel (2). 239 
Fig 6.10 SSCP on four different cell lines revealing a P-catenin 
240 mutation in LS I 74T cell line. 
Fig 6.11 Sequence analysis of LS 174T (p2 1) for exon 3 of the 
catenin gene. 241 
Fig 6.12 Sequence analysis of RG/C2 (p46) PCR product of exon 3 of 242 the fl-catenin gene. 
Fig 6.13 Effect of varying concentrations o butyrate on fl-catenin 
total protein expression in HT29 (pI 85), SW1222 (p 115) and 244 HCTI 16 (p34) cell lines. 
Fig 6.14 The effects of varying concentrations of the SCFAS 
propionate and acetate on P-catenin protein expression in the cell 245 lines HT29 (p 18 0) and SW 1222 (p 113). 
Fig 6.15 Butyrate treatment of colonic carcinoma derived HCTI 16 
(p23) cell line results in the relocalisation of P-catenin from the cell 246 
membrane. 
Fig 6.16 The SCFAs, butyrate, propionate and acetate, had no 
obvious effect on the localisation of P-catenin localisation in the cell 247 line HT29. 
Fig 6.17 The SCFAs, butyrate, propionate and acetate, had no 
obvious effect on the localisation of P-catenin localisation in the cell 248 line SW1222. 
Fig 6.18 Butyrate treatment of colonic carcinoma-derived HCTI 16 
cell line results in the relocalisation of p-catenin from the cell 249 
membrane to the cytoplasm. 
Fig 6.19 Butyrate treatment of colonic carcinoma-derived HT29 cell 
line has no effect on the localisation of P-catenin. 251 
xv 
Fig 6.20 Western blot showing an increase in soluble P-catenin after 
treatment with 4mM Butyrate ........ 253 
Fig 6.21 The luminal factors pectin and ispaghula husk had no 
obvious effect on the localisation of P-catenin ....... 
255 
Fig 6.22 The effect of butyrate, ispahula husk and pectin on the 
cellular localisation of 0-catenin in the cells HM 16 during growth 
in collagen. 256 
Fig 6.23 Treatment of SW1222 collagen gels with butyrate, ispaghula 
257 husk and pectin. 
xvi 
List of Tables. 
Table 2.1 Dietary fibres. 62 
Table 2.2a Mineral Salts Media. 65 
Table 2.2b Vitamin mix. 65 
Table 2.3 Englyst solutions 70 
Table 2.4 Composition of the diets used in the maintenance of 
Balb/C mice. 73 
Table 2.5 Antibodies. 78 
Table 2.6 Cell lines. 85 
Table 2.7 Acrylamide gels. 88 
Table 2.8 Western blotting solutions. - 89 
Table 2.9 Western blotting and immunocytochernistry antibodies. 90 
Table 3.1 Total, soluble and insoluble NSP content of (a) ispaghula 
husk, pectin, cellulose, rice and resistant starch (b) basal diet and 
basal diets ............ 
102 
Table 3.2 Constituent NSP sugars within total, insoluble and 
soluble fractions of (a) ispaghula husk (b) ispaghula husk 
supplemented basal diet ........... 
106 
Table 3.3 Constituent NSP sugars within total, insoluble and 
soluble fractions of (a) pectin and (b) pectin supplemented basal 
diet ......... 
108 
Table 3.4 Constituent NSP sugars within total, insoluble and 
soluble fractions of (a) cellulose and (b) cellulose supplemented 
basal diet .... 
110 
Tables 3.5 Constituent NSP sugars within total, insoluble and 
soluble fractions of (a) resistant starch, (b) rice starch and (c) basal 
diet ........ 
ill 
Table 5.1 A) Fibre content B) Energy content of the Basal diet 
192 (fibre Deficient diet) ........................ 
Table 5.2 Formulation of the different fibre supplemented diets 





aa Amino acid 
ACF Aberrant Crypt Foci 
ANOVA Analysis of Variance 
AOM Azoxymethane 
APC Adenomatous Polyposis Coli 
B Butyrate 
BrdU Bromodeoxyuridine 
BrdU-LI Bromodeoxyuridine-labeling index 





CRC Cancer Research Campaign 
DAB Diaminobenzidine 
DM Diabetes Mellitus 
DMEM Dulbecco's Modified Eagles Medium 
DMH 1,2-dimethylhydrazine 
DMSO Dimethylsulphoxide 
DoH Department of Health 
ECL Enhanced Chemiluminescence 
ECM Extracellular matrix 
EDTA Ethylenediamine tetra-acetic acid 
EGF Epidermal growth factor 
EGFR Epidermal growth factor receptor 
ELISA Enzyme-linked immunosorbant assay 
FCS Foetal. calf serum 
FH Faecal homogenate 
FITC Fluorescein isothiocyanate, 





HDL High Density Lipoprotein 
HDLG Human discs large 
HGF Hepatocyte growth factor HMG-CoA 3-hydroxy-3methylglutary coenzyme A 
HRP Horseradish Peroxidase 
IGF Insulin growth factor IgG Immunoglobulin G 
IH Ispaghula husk 
IP Intraperitoneal 
kD Kilodalton 







MMP Matrix Metalloproteinase 
mRNA Messenger ribonucleic acid 
MSM Mineral salts media 
MW Molecular weight 
Na/K Sodium/potassium 
NIDDM Non-insulin dependent diabetes mellitus 
NSAID Non-steroidal anti-inflammatory drugs 
NSP Non-starch polysaccharide 
N-terminal Amino-terminal 
OD Optical density at wavelength 
P Probability 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PCNA-LI Proliferating cell nuclear antigen - Labeling index. 
PKC Protein kinase C 
Prop Propionate 
PTP Protein tyrosine phosphatase 
RBI Retinoblastoma 
SCFA Short chain fatty acids 
SDS Sodium dodecyl sulphate 
TBS Tris-buffered saline 
TBST 0.5% Tween 20/TBS buffer 
TCF/LEF-1 T cell factor/lymphoid-enhancer-binding factor-I 
V Volt 
W11C Water holding capacity 








1.1 The Large Intestine. 
1.1.1 The physiology ofthe Large Intestine. 
The human large intestine (colon) is over 1.5 meters long and is made up of the 
caecum, vermiform appendix, ascending colon, transverse colon, descending colon, 
sigmoid colon, rectum and anal canal (Fig 1.1) (Reviewed Davies and Davies, 1962; 
Reviewed by Moore and Agur, 1995; Reviewed by Ross et al., 1995). The large 
intestine can 
' 
be regarded as two organs; the right side, which consists of the caecum, 
a fermenter where bacteria metabolise materials including bile passing from the 
ileum of the small intestine (Reviewed by Brydon, 1995), and the ascending 
(proximal) colon where most water absorption occurs (Reviewed by Moore and 
Agur, 1995), and the left side consists of the descending and sigmoid (distal) colon 
which are areas primarily involved in stool formation (Reviewed by Brydon, 1995). 
The large intestine innervature is supplied by parasympathetic and sympathetic 
nerves of the mesenteric ganglia (Superior and Inferior) with blood supply via the 
mesenteric artery and removal via the mesenteric vein (Reviewed Davies and Davies, 
1962; Reviewed by Moore and Agur, 1995; Reviewed by Ross et al., 1995). 
Secretion and absorption are important processes in the colon with numerous 
proteins being involved (Reviewed by Sellin, 1993). Chloride secretion and 
absorption is facilitated by three main types of channel; calcium mediated, cyclic- 
AMP-mediated and volume-induced channels, the latter two bearing some 
resemblance to the cystic fibrosis transmembrane conductance regulator (CFTR) 
receptor, a target for both protein kinase A (PKA) and protein kinase C (PKC) 
(Reviewed by Sellin, 1993). CFTR is itself shown to form a small chloride channel 
exchanging for bicarbonate being linked to sodium-hydrogen exchange (Reviewed 
by Sellin, 1993). There is a family of sodium and hydrogen exchangers located on 
both the apical (vectorial transport) and basolateral (housekeeping, maintaining pH) 
i 
































membrane (Reviewed by Sellin, 1993). Short chain fatty acids (SCFAs) produced 
from the fermentation of dietary fibre and protein are absorbed in the colon but the 
precise mechanism is not known (Reviewed by Rombeau and Roth, 1995). SCFA 
absorption is shown to be associated with luminal alkalinization (helping to maintain 
the lumen at around pH 6), bicarbonate secretion (Reviewed by Sellin, 1993) and 
sodium-hydrogen exchange with the SCFAs crossing the apical membrane 
transcellularly (Reviewed by Rombeau and Roth, 1995). Sellin and Soignie (1998) 
found that a physiological gradient of SCFAs across the colonic epithelium elicits 
polarized effects on both pH and Ne absorption, this in turn may affect fluid 
transport. Schr6der et al. (2000) found that the absorption of SCFAs in apical 
membranes is mediated by a SCFA bicarbonate (HCOD exchange mechanism in rat 
distal colon. The transduction of extracellular signals into changes in cellular 
function of colonocytes generally involves second messengers including cyclic 
AMP, cyclic GMP and calcium (diacylglycerol, inositol triphosphate and 
intracellular calcium activities) (Reviewed by Sellin, 1993). An example of this is 
protein kinase C, which activates diacylglycerol regulating chloride secretion 
possibly via CFTR like receptors (Reviewed by Sellin, 1993). A number of factors 
may influence absorption including oxygen metabolites produced via the immune 
system affecting the secretory response in the colon neuronally (Reviewed by Sellin, 
1993). 
Mammalian species can be classified into several groups based on characteristics of 
their respective digestive tracts. Colonic digesters, sacculated digesters such as man, 
do not have much caecal capacity whereas caecal fermenters such as the mouse 
exhibit large caeca and unsacculated colons (Reviewed by Van Soest, 1995). The 
large intestine is host to a large and diverse commensal microflora, consisting of 50 
different genera/families with over 400 different species, at a level of approximately 
1011 (1010 Tannock) cells (Reviewed by Bingham, 1990; Reviewed by Tannock, 
1994; Reviewed by Hill, 1995a). These bacteria tend to be anaerobes, such as 
Bacteriodes and Bifidobacter, with few facultative anaerobes such as Ecoli and 
eubacteria (Reviewed by Tannock, 1994). There is site specificity for bacteria within 
the large intestine with anaerobes persisting in the proximal colon and numbers of 
facultative anaerobes increasing in the distal colon. This variation of bacteria affects 




of non-starch polysaccharides (NSP) in an anaerobic environment leads to the 
production of short chain fatty acids (SCFAs), carbon dioxide (C02). methane (CH4) 
and hydrogen (112) (Reviewed by Macfarlane and Gibson, 1994; Reviewed Rombeau 
and Roth, 1995). 
The acquisition of the gastrointestinal microflora has been studied in the mouse 
(Reviewed by Tannock, 1994). Neonatal mice have environmentally derived 
bacteria, ten days after birth the numbers of environmentally derived bacteria 
decrease dramatically, lactobacilli flourish in the proximal colon and enterococci and 
E-coli flourish in the distal colon (Reviewed by Tannock, 1994). Obligate anaerobic 
bacteria (bacteriodes andfusiform) become established in the gastrointestinal tract at 
infancy leading to marked reduction in facultative anaerobes (enterococcal and 
E-coh) (Reviewed by Tannock, 1994). Genetics and the environment play a role in 
determining predominant species within' the large intestine. The effect of the 
environment and genetics on microflora colonisation of the gastrointestinal tract can 
be demonstrated by the colonisation of the colon by methogenic bacteria. 
Methogenic bacterial colonisation varies not only by geography but also race. An 
example of this being the higher incidence of methogenic bacterial colonisation in 
black South Africans when compared to white South Africans, and again a higher 
rate of colonisation in those black South Africans living within rural rather than 
urban areas (Reviewed by Walker, 1995). 
1.1.2. The Colonic Epithelium. 
The wall of the colon (large intestine) and rectum is made up of four distinct layers; 
the mucosa, an epithelial lining with underlying connective tissue (lamina propria) 
and muscularis mucosae (smooth muscle), the submucosa (connective tissue), 
muscularis extema, and the serosa (Figure 1.2) (Reviewed by Ross et al., 1995). 
The colonic epithelium is a rapidly proliferating tissue with a high turn over of cells 
(Reviewed by Goodlad and Wright, 1990; Reviewed by Cassidy and Fitzpatrick, 
1995; Tappenden and McBurney, 1998). The epithelium is arranged in test-tube 
shaped invaginations known as colonic crypts (crypts of lieberkuhn), which have a 
defined spatial organisation (Fig 1.3) (Reviewed by Williams et al., 1996; Reviewed 
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. 7. ' 
(Reviewed by Ross et al., 1995). 
Key. M, Mucosa; LP, Lamina Propria; MM, Muscularis Mucosa; SubM, Sub 
Mucosa;. ME, Muscularis externa; ME(c), circular layer of muscularis extema; ME(l), 
longitudinal layer of muscularis externa; S, Serosa; BV, blood vessels. 
Figure 1.2 A. A cross section of the large intestine from monkey (00). 
The wall of the colon (large intestine) and rectum is made up of four 
distinct layers; the mucosa (M), an epithelial lining with underlying 
connective tissue (lamina propria) and muscularis mucosae (MM) (smooth 
muscle), the submucosa (SubM) (connective tissue), muscularis externa 
(ME), and the serosa (S) (Reviewed by Ross et al., 1995). B. The mucosa 
(x140) contains straight, unbranched, tubular glands (crypts of lieberkuhn) 
that extend to the musularis mucosae (MM). Between the glands (GL) is a 
lamina propria (LP) that contains cells of the immune system. The colonic 
crypt lies within the pericryptal sheath and undergoes cross talk with the 
surrounding fibroblasts (Reviewed by Ross et al., 1995) . 
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(Reviewed by Williams et al., 1996) 
Key: MM, Muscularis Mucosa; LP, Lamina Propria; M, Mitosis; GC, Goblet Cells; AC, 
Absorbative cells. 
Fig 1.3 The cells within the crypt originate from a single stem cell, these 
cells migrate up to the luminal surface of the crypt, as they migrate they start 
to differentiate forming absorptive (AC), goblet (GC) or enteroendocrine 
cells. At the mouth of the crypt the cells become terminally differentiated, 
undergoing apoptosis being sloughed off into the lumen (Reviewed by 
Williams et al., 1996; Reviewed by Ross et al., 1995). 
(Reviewed by Ross et al., 1995). 
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by Roncucci et al., 2000). The bottom third of the crypt consists of the proliferating 
cells (proliferative compartment), each progeny being derived from a precursor stem 
cell. The cells migrate up the crypt, as they migrate they lose their ability to 
proliferate and thus start to differentiate (transitional zone) (Reviewed by Williams et 
al., 1996; Reviewed by Roncucci et al., 2000). The cells differentiate into 
absorptive, goblet or enteroendocrine cells (Reviewed by Cassidy and Fitzpatrick, 
1995; Reviewed by Williams et al., 1996). When the cells finally reach the mouth of 
the crypt at the luminal surface they begin to undergo apoptosis (terminally 
differentiated zone) seen as cell shedding (Reviewed by Williams et al., 1996; 
Reviewed by Roncucci et al., 2000). Each crypt is surrounded by the pericryptal 
sheath and subepithelial fibroblasts. The subepithelial fibroblasts synthesise 
components of the extracellular matrix, secrete growth factors, and are important 
components of the neuroimmunohormonal system that regulates secretion (Reviewed 
by Sellin, 1993). * Epithelial cell function is governed by a large number'of signalling 
pathways that include hormonal, neuronal, subepithelial and cytoskeletal molecules 
(Reviewed by Goodlad and Wright, 1990; Reviewed by Sellin, 1993). 
1.2 Colorectal Cancer 
Colorectal Cancer is the second biggest cause of cancer mortality in the western 
world (Reviewed by Mason, 1998) resulting in 17000 deaths in England and Wales 
each year (DoH, 1998). The majority of colorectal cancers originate from the 
epithelial cells lining the colon and rectum (Reviewed by Alberts et al., 1994). 
Colorectal cancer development is the consequence of a number of abnormalities 
resulting in a loss of colonic cell homeostasis, allowing tumour formation through 
excessive cell proliferation and/or a lack of differentiation (Reviewed by Bingham, 
1999). Mutations in four or five genes are thought to be required for the 
development of a malignant tumour, although fewer may lead to the formation of 
benign tumours (Reviewed by Fearon, 1991). There are two main types of colon 
cancer; those inherited including familial adenomatous polyposis (FAP) and 
hereditary non polyposis colorectal cancer (HNPCC), accounting for approximately 
15% of all colorectal cancer; and those which sporadically appear accounting for 




1996). Cancer develops along a three step process; firstly initiation, secondly 
promotion and thirdly progression (Reviewed by Bingham, 1999), genes and the 
environment are tightly linked to each stage (Fig 1.4) (Reviewed by Hill, 2001). 
Thus the development of colorectal cancer is thought to arise from the interaction of 
genes and their environment (Reviewed by Bingham, 1990; Reviewed by Hill, 
1997d). 
1.2.1 The role ofgenetics in colorectal cancer development. 
The genetic steps involved in the development of colorectal cancer have been well 
studied and the adenoma to carcinoma sequence has been well elucidated (Figure 
1.4) (Fearon and Vogelstein, 1990; Reviewed by Kinzler and Vogelstein, 1996; 
Reviewed Gryfe et al., 1997; Reviewed by White, 1998). The first genetic alteration 
in the multistep process, in inherited and sporadic tumours, is the loss of the APC 
tumour suppressor gene (Reviewed by Kinzler and Vogelstein, 1996). Other genetic 
changes are also surnmarised in Fig 1.4, revealing the role of loss of a number of 
turnour suppressor genes, the induction of a number of oncogenes and the acetylation 
of DNA (Fearon and Vogelstein, 1990; Reviewed by Kinzler and Vogelstein, 1996; 
Reviewed Gryfe et al., 1997; Reviewed by White, 1998). This helped to elucidate 
that colon cancer provides a clear example of tumour progression where 
adenomatous polyps are believed to be the precursors of colorectal cancers 
(Reviewed by Alberts et al., 1994). Other genetic factors may also play a role in 
influencing an individuals' cancer risk, with individuals inheriting different 
enzymatic capacities to detoxify or activate carcinogens (Reviewed by Bingham, 
1999). 
1.2.2 Environmentalfactors in the development ofcolorectal cancer 
The majority of major cancers; breast, colon, lung, prostate and oesophageal, occur 
in epithelial tissues (Reviewed by Alberts et al., 1994; Reviewed by Bingham, 1999), 
and appear to be influenced by environmental factors (Reviewed by Bingham, 1999). 
The environmental factors for colon cancer include a number of socio-economic 
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activity, diet, alcohol consumption, tobacco smoke and obesity along with 
psychological variables such as stress (Jarosz and Perczynska, 2001). 
The work on the relationship between diet and cancer was prompted by the studies of 
Armstrong and Doll (1975) who showed strong international associations between 
rates of cancer and intakes of foods (Reviewed Hill, 1997c; Reviewed by Bingham, 
1999). There are two main examples of dietary influences involving migration 
studies and marked trends with time within countries (Reviewed by Key et al., 
2002). The incidence rate for colorectal cancer varies considerably geographically, 
in the USA incidence rates for colorectal cancer in men are 34.1%, whereas in India 
men have a much lower incidence rate of 1.8% (Weisburger et al., 1977; Reviewed 
by Bingham, 1990; CRC, 1993), with colon cancer incidence rates varying 20 fold 
between countries (Reviewed by Bingham, 1999). There is a strong positive 
association between fat, meat, refined carbohydrates and alcohol consumption along 
with a strong negative association with vegetable, fruit, vitamins and calcium 
consumption and the incidence of large bowel cancer (Reviewed by Kim, 2000). 
Epidemiological estimates suggest that up to 80% of breast, bowel and prostate 
cancer is attributable to diet (Reviewed by Cummings and Bingham, 1998) with the 
European Prospective Investigation into Cancer (EPIC) indicating that 9 out of 10 
colon cancer deaths might be prevented by dietary change (Reviewed by Mason, 
1998). It has been proposed that diets rich in fruit and vegetables may decrease the 
risk of many of these cancers (Reviewed by Harris and Ferguson, 1993; Reviewed by 
Kim, 2000). It is therefore important to identify which, if any, of these dietary 
factors contribute to this protective effect and elucidating their mechanism of action 
(Reviewed by Harris and Ferguson, 1993). 
1.3 The role of Genetics in the development of colorectal cancer 
1.3.1 Adenomatouspolyposis coli (APQ 
Inherited forms of colorectal cancer have provided insight into the genetic changes 
associated with disease development. Familial Adenomatous Polyposis (FAP) is an 
inherited autosomal dominant disease resulting in the inheritance of a mutant APC 
10 
Cis apter I 
Introduction 
gene, followed by a second somatic mutation, leading to the early onset of colorectal 
cancer (Levy et al., 1994; Reviewed by Kinzler and Vogelstein, 1996; Reviewed 
Gryfe et al., 1997; Reviewed by Fearnhead et al., 2001). Studies into FAP led to the 
identification of the APC gene and was shown to be the first genetic alteration in the 
development of colorectal cancer (Reviewed by Kinzler and Vogelstein, 1996; 
Reviewed Ilyas and Thomlinson, 1997; Reviewed by White, 1998; Reviewed by 
Goss and Groden, 2000) with up to 95% of patients with FAP carrying inactivating 
mutations in APC (Larken et al., 1999). 80-85% of sporadic adenomas are thought 
to carry an APC mutation, resulting in loss of protein function (Reviewed by 
Nakamura, 1997). APC has been described as a gatekeeper or turnour suppressor 
gene regulating growth of turnours through the regulation of colonic homeostasis by 
inhibiting cell growth and/or promoting cell death (Reviewed by Kinzler and 
Vogelstein, 1996; Morin et al., 1997a; Reviewed by Morin et al., 1997b; Reviewed 
by Kinzler and Vogelstein, 1998; Mulkens et al., 1998) with APC mutations being 
associated with increased proliferation within adenomas (Mulkens et al., 1998). The 
APC protein also has a number of functional roles in cell signalling, intercellular 
adhesion, migration and apoptosis (Vleminckx et al., 1997; Reviewed by Fearnhead 
et al., 2001). 
The APC gene has been mapped to chromosome 5q2I and shown to consist of 8535 
base pairs spanning 21 exons encoding for a 2843 amino acid protein (Reviewed by 
Morin et al., 1997; Reviewed by Feamhead et al., 2001). A homologue of APC, 
APC2, has also been described and is thought to have functions comparable to that of 
APC (van Es et al., 1999). The APC protein consists of a large number of domains 
(Figure 1.5); including oligomerisation, armadillo region (Arm), 15 amino acid 
(aa)repeat region that binds P-catenin, 20 aa repeat motif TPXXFSXXXSL that also 
binds P-catenin, basic domain, EB1 domain and HDLG (human discs large) domain 
(Reviewed by Fearnhead et al., 2001) that binds HDLG (Matsumine et al., 1996). 
APC is a cytoplasmic protein found in association with y- and P-catenin (Rubinfeld 
et al., 1993; Su et al., 1993; Reviewed Jawhari et al., 1997a; Reviewed by Moon and 
Miller, 1997) and is thought to function by controlling the cytoplasmic and nuclear 
levels of P-catenin (Reviewed by Moon and Miller, 1997; Reviewed by Morin et al., 
1997b; Reviewed by Ben-Ze'ev and Geiger, 1998; Reviewed by Gordon, 1998; 
11 
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Reviewed by White, 1998). The stabilisation and accumulation of cytoplasmic 0- 
catenin, resulting from 'loss of function' mutations in APC, or 'gain of function' 
mutations in fl-catenin gene have been found to be associated with colon 
carcinogenesis (Takahashi et al., 1998; Rubinfeld et al., 1996; MUller et al., 1998; 
Lamlurn et al., 2000; Reviewed by Fearrifead et al., 2001) and is coupled to the 
activation of P-catenin-TCF signaling (Morin et al., 1997a). 
Ninety five percent of germline mutations in the APC gene of FAP patients are 
nonsense or frameshift mutations that result in a truncated APC protein with an 
abnormal function (Reviewed by Fearnhead et al., 2001). The most common 
germline mutations occur in codons; 1061 and 1309, the mutational cluster region 
(MCR). Exon 15 is found within the MCF, Exon 15 contains more than 75% of 
APC genes coding sequence, possibly explaining why it is the most common target 
for both germline and somatic mutations (Reviewed by Fearnhead et al., 2001). 
These mutations within the MCR have been associated with an increase in the 
occurrence of adenomas and these tend to be larger in size (Mulkens et al., 1998). 
The majority of APC mutants lack part, if not all, the 20-aa repeats. These amino 
acid repeats are involved in the binding and regulation of P-catenin protein levels 
suggesting that this function is targeted for elimination during turnourigenesis 
(Reviewed Moon and Miller, 1997; Reviewed Fearnhead et al., 2001). 
There is a marked variation in phenotype of FAP depending on the position of the 
mutation within the APC gene (Reviewed by Fearnhead et al., 2001; Reviewed 
Houlston et al., 2001; Crabtree et al., 2002). Phenotypic variations of FAP include 
attenuated FAP, congenital hypertrophy of the retinal pigment epithelium (CHRPE), 
upper gastrointestinal turnours (periampullary carcinoma), Gardner's syndrome, 
Turcot syndrome and papillary carcinoma of the thyroid and adrenocortical turnours 
(Dietrich et al., 1993; Reviewed by Fearnhead et al., 200 1; Reviewed Houlston et al., 
200 1). This vast variation in germline APC gene mutations and the phenotype of the 
disease has led to the search for modifier genes that may be involved in this 
phenotypic variation, for example mom-1 (Dietrich et al., 1993; Reviewed by 




1.3.2 The Catenin Family. 
The catenins are a family of cytoplasmic proteins involved in a number of cellular 
processes including cell adhesion and signal transduction (figure 1.6). The multigene 
family comprises of a- (102Kda), fl- (92Kd), * (Plakoglobin) (83Kd) catenin, and 
p, 120(CAS'c'"), and are found on chromosomes 5q2l-q22,3p (3p22-p2l. 3), l7q21 and 
11 qII respectively (Peifer et al., 1992; McPherson et al., 1994; van Hengel et al., 
1995; Reynolds et al., 1996; Liu et al., 1997; Reviewed by Smith and Pignatelli, 
1997; Aono et al., 1999; Liang and Goltesman, 2003). 0-catenin is also homologous 
to the armadillo protein found in Drosophila, suggesting that the catenins have been 
evolutionarily conserved (Reviewed by Gumbiner, 1995; Reviewed by Ilyas and 
Thomlinson, 1997). The catenin proteins have three structurally distinct regions; an 
amino and carboxyl terminal domain together with a hydrophobic region comprising 
of arm repeats, each repeat consisting of 42 amino acids. The number of arm repeats 
vary between the catenins with both P- and y-cateniri having 13 arm repeats, whereas 
p120 has 11 (Reynolds et al., 1994; Ruiz et al., 1996; Troyanosky et al., 1996; 
Reviewed by Ilyas and Thomlinson, 1997). Of the catenins, 7-catenin and P-catenin 
share the greatest homology, with the y-catenin arm repeat region being 85% 
homologous to P-catenin (Troyanosky et al., 1996). The catenins have been found to 
be associated with a large number of proteins namely APC, cadherins (in adhesive 
junctions), epidermal growth factor receptor (EGFR), C-erbB2, Tyrosine Kinases (v- 
src) and Phosphatases (Vandate and PTPli), vinculin, a-actinin, fascin, paxillin, axin, 
GSK-3p and the transcription factors TCF (T cell Factor) and LEF (Leukocyte 
enhancing factor) (Brady-Kalnay et al, 1995; Reviewed by Nakamura, 1997; Hiscox 
and Jiang, 1998a; Ikeda et al., 1998; Reviewed by Pignatelli, 1998; Reviewed by 
Hirohashi, 2000). 
P-catenin (Fig 1.5) is the most widely studied, having diverse binding specificities 
and as a consequence functionality. Many of the activities of P-catenin are regulated 
through the formation of functional complexes with other molecules such as APC, 
GSK-3p, axin, E-cadherin, a-catenin and hLEF-hTCF, or the phosphorylation of P- 
catenin by tyrosine kinases such as EGFR, ErbB, c-MET and Src (Shibamoto et al, 
1995; Reviewed by Ilyas and Thomlinson, 1997; Reviewed Yamada and Geiger, 
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(A) E-Cadherin forms calcium dependent homotypic interactions with adjacent cells. The 
cytoplasmic domain of E-Cadherin forms a complex with either P-catenin/cc-catenin or y-catenin/a- 
catenin, with cc-catenin linking it to the actin cytoskeleton via interactions with oc-actinin, vinculin or 
fascin (V) (Nathke et al., 1994; Barth et al., 1997a; Hulsken et al, 1994; Imamura et al., 1999). (B) 
Wnt-I pathway leading to the inhibition of GSK-3P which leads to the stabilisation and 
accumulation of O-catenin within the cytoplasm. (C) Cytoplasmic accumulation of P-catenin can 
result its association with the transcription factors hTCF-4/hLEF-1, resulting in translocation into the 
nucleus (Reviewed by Nusse, 1997; Maller et al., 1999; Reviewed by Ilyas and Thomlinson, 1997; 
Reviewed Yamada and Geiger, 1997). (D) In the nucleus P-catenin/Tcf complex binds to the DNA 
resulting in gene expression, targets include c-Myc (He et al., 1998) and CyclinDl (Shtutman et al., 
1999) . (E) P-catenin is phosphorylated by a complex consisting of APC, GSK-30 and Axin resulting in the targeting of O-catenin for ubiquitin dependent proteosomal degradation, and (F) tyrosine 
kinases and phosphatases including c-Src and EGFR (Sakanaka et al., 1998; Ikeda et al., 1998; 




1997; Hart et al., 1998; Hiscox and Jiang, 1999b). Both E-cadherin and APC 
compete for binding to P-catenin and this interaction is mediated by the internal Arm 
repeats (HUlsken et al., 1994). P-catenin plays a role in cell adhesion via binding to 
E-cadherin (Peifer et al., 1992; Nagafuchi et al., 1994; Reviewed by Pignatelli, 1998), 
and cell signalling via the wingless-Wnt pathway associating with LEF/TCF 
transcription factors altering gene transcription and also receptor and non-receptor 
tyrosine kinases (Reviewed by Nusse, 1997; Reviewed by Ilyas and Thomlinson, 
1997; Reviewed Yamada and Geiger, 1997; MUller et al., 1999). P-catenin is 
phosphorylated by the APC/Axin/GSK-3P complex targeting it for ubiquitin 
mediated proteolysis, with FWDI acting as a receptor for the phosphorylated P- 
catenin, and is phosphorylated by both receptor tyrosine kinases and non-receptor 
tyrosine kinases (Reviewed by Yamada and Geiger, 1997; Sakanaka et al., 1998; 
Ikeda et al., 1998; Kishida et al., 1998; Kitagawa et al., 1999). A further protein, 
Axil, has been shown to bind to GSK3P and enhances the GSK-3P dependent 
phosphorylation of P-catenin (Yamamoto et al., 1998). P-catenin has also been 
described as an oncogene as it has been shown to promote the GI to S phase of the 
cell cycle and has been shown to protect cells from anoikis (Orford et al., 1999). 
y-catenin (plakoglobin) like P-catenin plays a role in cell adhesion by binding to E- 
cadherin in the absence of P-catenin, and cell signalling by binding to the TCF/LEF 
transcription factors (Reviewed by Ben Ze'ev and Geiger, 1998, Reviewed by Barker 
and Clevers, 2000). Unlike P-catenin, y-catenin is also found associated with the 
desmosomal proteins desmoglein and desmocollin and is crucial for organisation 
desmosomal junctions (Birchmeier et al., 1996; Troyanosky et al., 1996; Ruiz et al., 
1996). 
a-catenin has two isoforms of the protein, a-E which is found in epithelial tissue and 
a-N which is found in neuronal tissues (Hirano et al., 1992; Hoschuetzky et al., 
1994). a-catenin binds directly to a number of proteins, including y-catenin and 0- 
catenin, APC, vinculin, ot-actinin and v-src. It has also been shown to bind indirectly 
to E-cadherin via y-catenin and p-catenin, having an essential role in cell adhesion 
(Oyama et al., 1994; Reviewed by Barth et al., 1997b; Weiss et al., 1998; Reviewed 




vinculin complexes have also been shown to play a fundamental role in the assembly 
of apical junctional complex (tight junctions) (Watabe-Uchida et al., 1998). cc- 
catenin and the actin cytoskeleton has been shown to be essential for the strong state 
of the E-cadherin adhesion system (Imamura et al., 1999). 
p120 (Cas, cadherin-associated src substrate, ctn, catenin) was originally identified as 
one of several substrates of the tyrosine kinase pp60src (Reynolds et al., 1994; Liu et 
al., 1997). Subsequently pl20('-"') was shown to associate with P-catenin and E- 
cadherin in cell adhesive complexes (Shibarnoto et al., 1995; Liu et al., 1997) but its 
role in cell adhesion still remains to be elucidated. Unlike P- and Y- catenins, p120 
has been shown to have at least 4 different isoforms, which are expressed 
differentially in a variety of cell types (Reynolds et al., 1994). 
1.3.3 The Cateninfamily (a-, fl-, s-), p120 andE-Cadherin in CellAdhesion. 
Cell adhesion to neighbouring cells, via cadherin-catenin interactions plays an 
important role in cell motility, growth, differentiation and survival (Pignatelli et al., 
1992; Watabe et al., 1994; Reviewed by Ben-Ze'ev and Geiger, 1998; Reviewed by 
Efstathiou and Pignatelli, 1998a; Reviewed by Pignatelli, 1998). Perturbation of any 
of these interactions results in changes in intercellular adhesion and cell 
transformation (Pignatelli et al., 1992; Valizadeh et al., 1997; Guilford et al., 1998). 
The cadherins are a family of transmembrane glycoproteins that mediate calcium 
dependent adhesion (Gagliardi et al., 1995; Chitaev and Troyanovsky, 1998), sharing 
common amino acid sequences. They have been divided up into more than 10 
subclasses dependent on their tissue distribution, including E- (Epithelial), N- 
(Neuronal) and P- (Placental) cadherin (Shiozaki et al., 1994; Reviewed by Smith 
and Pignatelli, 1997), with Fat a protein homologous to cadherin, found in 
Drosophila, suggesting evolutionary conservation (Mahoney et al., 1991). 
The E-cadherin gene (CDH 1), found on chromosome 16q22.1, was first isolated by 
Berx et al. (1995), and was found to span 10OKb consisting of 16 exons (Berx et al., 




al., 1995) is located at zipper like adherens junctions forming calcium dependent 
homophilic interactions between cells (Shiozaki et al., 1994; Gagliardi et al., 1995; 
Reviewed by Smith and Pignatelli, 1997) tending to concentrate at the apical 
membrane (Nathke et al., 1994). E-cadherin homotypic dimer formation at the cell 
membrane is promoted by calcium (Nagar et al., 1996). E-cadherin functional 
adhesive complexes are linked to the actin cytoskeleton via interactions with P- or y- 
catenin and p120 and indirectly by a-catenin, a- actinin, vinculin, IQGAP and 
calmodulin (figure 1.6) (HUlsken et al, 1994; Nathke et al., 1994; Barth et al., 1997a; 
Imamura et al., 1999). Changes in the expression levels of cadherins and catenins 
have been shown to affect cell-cell adhesion (Reviewed by Adams and Nelson, 
1998). Catenins are thought to mediate E-cadherin adhesive functions (Reviewed by 
Kemler, 1993; Reviewed by Smith and Pignatelli, 1997) and in the absence of 0- 
catenin the E-cadherin cytoplasmic domain becomes unstructured (Huber et al., 
2001). 
P-catenin has been shown to mediate epithelial cell adhesion by binding to the 
cytoplasmic domain of E-cadherin (Jou et al., 1995), subsequently linking E- 
cadherin to the actin cytoskeleton by binding to a-catenin via its amino terminal 
(Reviewed by Yamada and Geiger, 1997), or directly associating with vinculin, a- 
actinin or fascin (an actin bundling protein) (Reviewed by Smith and Pignatelli, 
1997; Reviewed by Polakis, 1998). y-catenin has also been shown to bind to E- 
cadherin (Knudsen and Wheelock, 1992; Troyanosky et al., 1996; Reviewed by 
Barth et al., 1997b; Reviewed Ben Ze'ev and Geiger, 1998), with evidence pointing 
to P-catenin and y-catenin forming mutually exclusive complexes (Reviewed by 
Barth et al., 1997b). The domains of y-catenin and P-catenin, which associate with 
cadherins and the cytoskeleton, have been mapped. It was found that while the 
central arm repeats of catenins interact with cadherins, the amino terminal domain, as 
well as the first arm repeat bind to cc-catenin (Ruiz et al., 1996). Unlike P-catenin, y. - 
catenin is also found associated with desmosomal cadherins, mainly desmoglein 
(Dsg) and desmocollin (Dsc) (Troyanosky et al., 1996; Reviewed by Barth et al., 
1997b) in desmosomes. y-catenin functions to sort and assemble desmosomal 
junctional components (Reviewed by Barth et al., 1997b; Lewis et al., 1997) with the 




(Ruiz et al.; 1996). Troyanosky et al. (1996) suggested that it is the Arm repeat 
region of plakoglobin that mediates these functions. The Arm repeat region was 
shown to comprise of two functionally distinct regions, with the first 5 Arm repeats 
involved in specific binding of E-cadherin and desmoglein, with the remaining arm 
repeats being involved in targeting plakoglobin/cadherin complexes to junctional 
structures (Troyanosky et al., 1996). 
cc-catenin, an actin bundling protein in vitro, is involved in adhesion by indirectly 
linking cadherin to the actin cytoskeleton (Reviewed by Adams and Nelson, 1998). 
a-catenin mediates the connection between the cadherin-catenin complex with the 
actin filaments (Hoschuetzky et al., 1994; Reviewed by Efstashiou et al, 1998a; 
Reviewed by Hirohashi, 1998). Furthermore cffl-catenin has been shown, in 
association with vinculin, to play a role in the assembly of apical junctional complex 
within the epithelium (Watabe-Uchida et al, 1998). Adams and Nelson (1998) have 
suggested that vinculin, a protein homologous to a-catenin, may bind to the 
cadherin/p-catenin or cadherin/y-catenin complex in the absence ct-catenin as a form 
of compensation (Shiozaki et al., 1994; Nagafuchi et al, 1994; Reviewed by Adams 
and Nelson, 1998). p120, like P- and yýcatenin, has been shown to bind directly to E- 
cadherin, and is found associated with both the E-cadherin/p-catenin and the E- 
cadherin/ý-catenin complexes (Jou et al., 1995; Shibamoto et al, 1995; Troyanosky et 
al., 1996; Reviewed by Barth et al., 1997b). Unlike P- and y-catenin p120 does not 
bind cE-catenin (Jou et al., 1995). Skoudy et al (1996) results suggest that p120 plays 
a role in regulating E-cadherin, although the exact role remains a matter of debate 
(Skoudy et al., 1996; Reviewed by Adams and Nelson, 1998). It has been suggested 
that p120 plays a role in blocking cellular adhesion (Aono et al., 1999). Cadherin- 
p120 complex maybe formed initially to increase the rates of homotypic recognition 
and binding between cadherin molecules on two adjacent cells. Subsequently cc- 
catenin, P-catenin and the actin cytoskeleton may associate with and stabilize the 
cadherin-p120 cluster and, thereby, strengthen the cell-cell adhesion. This 
interpretation of Skoudy et al (1996) results would explain why cells that 
overexpress cadherin with an intact p-catenin binding region, but lacking the p120 
binding region, adhere very slowly (Reviewed Adams and Nelson, 1998). 




ligand stimulation of receptor tyrosine kinases (Reynolds et al., 1994; Liu et al., 
1997; Valizadeh et al., 1997) it may act to mediate the regulation of cadherin 
adhesion by these signalling pathways (Reynolds et al., 1994; Hoschuetzky et al, 
1994; Reviewed by Barth et al., 1997b; Ozawa and Ohkubo, 2001). The proposed 
role for p120 in cellular adhesion is that it couples the formation and disruption of 
cadherin mediated cell to cell contacts during cell motility by triggering signalling 
pathways that involve the Rho family of GTPases (Grosheva et al., 2001). 
A number of other proteins have been shown to be associated with the E- 
cadherin/catenin complex. Catenins are involved in tyrosine kinases and 
phosphatase signalling pathways that regulate cell adhesion (Reviewed by Barth et 
al., 1997b). A number of non-receptor and receptor tyrosine kinases, including small 
G proteins, Ras, cdc42 and Rac-1, involved in cell survival, death and the 
remodelling of the actin cytoskel6ton (Reviewed by Braga, 2000), EGFR, and 
receptor tyrosine phosphatase, protein-tyrosine phosphatases (PTPIA and PT? IB), 
alter the phosphorylation status of components of the cadherin-catenin complex 
(Hoschvetzky et al, 1994; Brady-Kalnoy et al., 1995; Liu et al., 1997; Balsamo et al., 
1998). Each of the different kinases/phosphatases has a different specificity for 
cadherin/catenin complex components. For example TFF3 (Trefoil factor 3) has 
been shown to cause rapid and specific tyrosine phosphorylation of P-catenin and 
epidermal growth factor receptor, but not E-cadherin or a-catenin (Liu et al., 1997). 
Hepatocyte growth factor/scatter factor (HGF/SF) has been shown to induce the 
phosphorylation of p120, P- and y- catenin (Shibamoto et al, 1995). The adaptor 
protein Shc has been shown to bind to and phosphorylate E-cadherin inhibiting the 
binding of P-catenin (Xu and Carpenter, 1999). Hoschuetzky et al. (1994) clearly 
demonstrated that EGF results in the tyrosine phosphorylation of P- and Y- catenin, 
whereas with v-src the primary targets are cc-, p- catenin and p120(c") (Hoschuetzky 
et al., 1994; Liu et al., 1997; Valizadeh et al., 1997). Hoschuetzky et al. (1994) also 
demonstrated that this is also cell type specific. Tyrosine phosphorylation of P- 
catenin results in cytoplasmic accumulation and cellular migration, expression of 
PTP LAR (protein tyrosine phosphatase leukocyte common antigen) has been shown 
to inhibit this migration, colocalising with E-cadherin-catenin complex regulating 




P-catenin protein was observed in mammalian fibroblasts transduced with v-src, 
where src was shown to accumulate at adherens junctions and increase tyrosine 
phophorylation levels (Tsukita et al 1991). The precise biological consequence of 
tyrosine phosphorylation of the catenins is unknown. It has been suggested that it 
inactivates cadherin-mediated adhesion, with phosphorylated P-catenin being 
exclusively found in detergent soluble fractions, suggesting that tyrosine 
phosphorylation induces disassembly of the cadherin-catenin complex from the actin 
filament network, although other explanations are possible (Hoschuetzky et al., 
1994; Reviewed by Barth et al, 1997b; Liu et al., 1997). This loss of cadherin- 
mediated adhesion, through tyrosine phosphorylation, resulting in destabilisation of 
the adherens junctions, was shown to induce cell dispersion/migration (Liu et al., 
1997) and is an important factor in determining the biological properties of human 
cancers (Reviewed by Hirohashi, 2000). 
1.3.4 Cell Signalling and the regulation ofthe cateninfamily. 
Studies in Drosophila revealed the role for armadillo in the wingless-wnt pathway 
that mediates cell fate determination (Reviewed by Barth et al., 1997b). The WNT 
(wnt-1, wnt-2 and wnt-3) pathway has been shown to be involved in a number of 
cellular processes including cell polarity, growth, proliferation, differentiation and 
apoptosis (Reviewed by Gumbiner, 1995; Reviewed Gordon, 1998). As P-catenin is 
highly homologous to the armadillo protein it was proposed that P-catenin would 
play a part in the vertebrate wingless-wnt pathway (Reviewed by Gumbiner, 1995; 
Reviewed by Nusse, 1997; Reviewed by Ilyas and Thomlinson, 1997), subsequently 
revealing the importance of P-catenin in embryogenesis (Reviewed by Barth et al., 
1997b). P-catenin is a major player in the Wnt/wingless signalling pathway, Hinck 
et al. (1994a) showed that Wnt-I expression resulted in the accumulation of 0- 
catenin and y-catenin in the cytoplasm. This cytoplasmic accumulation was coupled 
with an increase in cellular adhesion due to increased stability between the cadherins 
and catenins and increased E-cadherin expression (Bradley et al., 1993; Hinck et al., 
1994a), and an increase in the stability between APC and the catenins (Papkoff et al., 
1996). E-cadherin has been shown to prevent P-catenin nuclear localisation coupled 




Stockinger et al., 2001). Casein kinase II and GSK-30 have been shown to result in 
the phosphorylation of E-cadherin increasing the E-cadherin/0-catenin interaction in 
cell to cell adhesion, thus fin-ther regulating P-catenin (Lickert et al., 2000). 
The Wnt-1 pathway has been fairly well elucidated (figure 1.7), Cook et al. (1996) 
used 10TI/2 fibroblasts to show that Writ acted through the wingless pathway to 
inhibit serine threonine glycogen kinase (GSK-3). Wnt-1 binds to its receptor 
frizzled, which in turn activates the vertebrate homologue of dishevelled (Holmen et 
al., 2002). Activated dishevelled (dvl, dsh, Dvl, Dsh) inactivates GSK-30 through 
phosphorylation. GSK-30 is a serine/threonine kinase that negatively regulates P- 
catenin, when P-catenin levels increase to excess (Rubinfeld et al., 1996; Reviewed 
by Jankowski et al., 1997; Morin et al., 1997a; Reviewed by Peifer, 1997). GSK-3 
is, involved in the phosphorylation of both APC (increasing APCs affinity for 
catenin) and P-catenin (on the N-terminal region) resulting in the degradation of P- 
catenin (Rubinfeld et al., 1996; Reviewed by Moon and Miller, 1997) via ubiquitin 
dependent proteolysis (Aberle et al., 1997). Inhibition of GSK-30 results in 
increased stability of P-catenin resulting in its cytoplasmic accumulation. GSK-3P 
and APC may regulate P-catenin independently of each other (Reviewed by Moon 
and Miller, 1997), or work in a complex comprising axin (conductin) (Reviewed by 
Gordon, 1998; Hart et al., 1998). A ftu-ther protein, casein kinase I is involved in 
targeting P-catenin for degredation, by phosphorylating P-catenin which then allows 
GSK-3P to phosphorylate P-catenin (Ding and Dale, 2002) and axin may mediate the 
interaction netween Dvl-2 and GSK-3P (Smalley et al., 1999). Other studies have 
also suggested that other serine kinases may be involved in P-catenin degradation, 
when GSK-3P is inhibited (Easwaran et al., 1999). Axin also aids in P-catenin 
degradation in cells lacking the axin binding sites within APC (Hart et al., 1998). 
This increase in cytoplasmic P-catenin leads to translocation of P-catenin into the 
nucleus where it associates with the transcription factors LEF and TCF (Reviewed by 
22 












Wnt/Wg signaling pathway (A) Wnt binds to its receptor frizzled activating Dishevelled (dsh); 
(B) Activated dsh inhibits GSK-30 from phosphorylating P-catenin preventing 0- or y-catenin 
degradation; (C) This leads to an increase in cytoplasmic P-catenin leaving it free to associate 
with the transcription factors TCF/LEF, in the nucleus this complex binds to the DNA 
(Reviewed by Barth et al., 1997b; Reviewed by Jankowski et al., 1997; Korinek et al., 1997; 
Reviewed by Nusse, 1997; Behrens et al., 1996; Morin et al., 1997); (D) This results in the 
expression of a number of target genes including C-Myc (He et al., 1998), Cyclin DI (Shtutman 
et al., 1999), MMP-7 (Brabletz et al., 1999), CD44 (Wielenga et al., 1999) and AP-1 (Mann et 




Barth et al., 1997b; Behrens et al., 1996; Reviewed by Jankowski et al., 1997; 
Korinek et al., 1997; Reviewed by Nusse, 1997; Morin et al., 1997) and pontin52 
subsequently displacing Groucho-related gene or CREB-binding protein corepressors 
from LEF or TCF consequently altering gene transcription (Reviewed by Roose and 
Clevers, 1999; Reviewed by Novak and Dedhar, 1999). P-catenin consists of 
transactivation domains which recruit the basal transcription machinery to promoter 
regions of Wnt target genes (Hecht et al., 1999; Vlemincks et al., 1999). P-catenin 
translocates into the nucleus through the nuclear pore in a Ran-unassisted manner 
(Yokoya et al., 1999). LEF and TCF are members of the high mobility group sex 
determining (sry) family of transcription factors that induce bends in the DNA helix 
on binding. These transcription factors, LEF and TCF, by themselves are poor 
promoters of transcription. However when P-catenin is complexed with these 
transcription factors the DNA bend produced by these transcription factors is thought 
to enhance and alter gene transcription (Behrens et al., 1996; Reviewed by Nusse, 
1997; Reviewed by Moon and Miller, 1997). p-catenin, plakoglobin and armadillo 
have different transactivation capacities that may explain their distinct signalling 
properties (Hecht et al., 1999). p120 has also been shown to enter the nucleus and 
interact with transcription factors (van Hengel et al., 1999; Reviewed by Nollet et al., 
1999) with E-cadherin being shown to down-regulate nuclear p120 (van Hengel et 
al., 1999). The target genes of P-catenin-TCF-4/LEF-I have long been sort after, but 
are thought to be involved in inhibiting apoptosis or promoting cellular proliferation. 
He et al. (1998) have shown that one of the target genes of TCF-4 is c-myc a known 
oncogene over expressed in colon cancer. There have been a number of other target 
genes isolated including Cyclin D1 (Shtutman et al., 1999), MMP-7 (Matrix 
metalloproteinase-7) (Brabletz et al., 1999), Matrilysin (Crawford et al., 1999), 
CD44 (Wielenga et al., 1999), AP-1 (c-jun andfta-1) and indirectly uPAR along with 
a reduction in ZO-I a protein involved in epithelial polarization (Mann et al., 1999). 
C-myc has been shown to be more efficiently activated by plakoglobin than P- 
catenin, further supporting the theory that plakoglobin and P-catenin have different 
roles during Wnt signalling targeting different genes (Reviewed by Barker and 
Clevers, 2000). Wnt-1 activation has also been shown to result in elevated 
expression of E-cadherin and increased cell-cell adhesion (Bradley et al., 1993). The 




cadherin gene suggesting that this signalling pathway can modulate E-cadherin 
expression and subsequently cell adhesion (Reviewed by Ben-Ze've, 1997). Cell- 
cell adhesion in turn is thought to play a major role in the transduction of 
transmembrane signals (Reviewed by Ben-Ze'ev, 1997). Simcha et al. (1998) 
showed that cc-catenin, along with cadherins, sequester P-catenin to the cytoplasm 
inhibiting its transcriptional activity. Whether tyrosine phosphorylation of P-catenin 
is involved in the wingless-Wnt signalling pathway has not been clarified (Reviewed 
by Nakamura, 1997). LEF-I/P-catenin complex and activation of specific LEF-I 
target genes is thought to be critical for tumourigenesis (Aoki et al., 1999), although 
it has been suggested that a ftu-ther component is required for gene activation (Prieve 
and Waterman, 1999). Increased expression of P-catenin and subsequent nuclear 
translocation has been shown to result in cellular hyperproliferation within a murine 
model of colonic hyperplasia (Sellin et al., 2001). 
y-catenin has also been shown to enter the nucleus and interact with these 
transcription factors, thus suggesting some functional homology between the two 
proteins, P-catenin and y-catenin. Simcha et al., 1998 have shown that y-catenin and 
P-catenin differ in their nuclear translocation and their association with the 
transcription factor LEF-1, with transcription being preferentially driven by 
catenin, with P-catenin binding to LEF- I in association with vinculin. 
1.3.5 The Catenins ( a-, A, ý, ), p. 120 and E-Cadherin in colon cancer. 
Stabilization and accumulation of cytoplasmic P-catenin as a result of mutations in 
either the APC or fl-catenin genes are causatively associated with colon 
carcinogenesis (Rubenfeld et al, 1996; Iwao et al., 1998; Takahashi et al, 1998; 
Milller et al., 1998; Herter et al., 1999). As discussed in section 1.3.1, '4PC 
mutations usually involve at least one of the P-catenin binding sites, thus resulting in 
increased stability of the P-catenin protein (Reviewed by Moon and Miller, 1997). 
This is shown in cells expressing mutant APC, as they possess an abnormally large 
pool of monomeric P-catenin (Reviewed by Moon and Miller, 1997). But where no 
APC mutations are observed there are a number of other possible candidate genes, 




catenins. Somatic P-catenin activating mutations contribute to a small number of 
human colorectal cancer (MUller et al., 1998). 
Using immunohistochernical techniques Hao et al. (1997) showed that in normal 
tissues P-catenin was located at the cell membranes, but in the adenoma and 
carcinoma tissues there was a relocalisation of P-catenin resulting in reduced 
membranous staining which was accompanied with an increase in cytoplasmic and 
nuclear staining (Hao et al., 1997; Hugh et al., 1999). The redistribution of P-catenin 
appears to occur early in sporadic colorectal turnourigenesis (Herter et al., 1999). 
This redistribution of P-cateninwas also found to correlate with the progression from 
adenomas to carcinomas (Hao et al., 1997), and serves as a criteria for estimating 
malignant potential of colonic turnours (Herter et al., 1999). A further study 
revealed that P-catenin was not homogenously expressed within dysplastic tissues 
with strong nuclear expression being predominantly localised at the invasion front 
(Brabletz et al., 1998). P-catenin mutations are also usually found within small 
colorectal adenomas rather than the larger adenomas and invasive carcinomas 
(Samowitz et al., 1999). fl-catenin mutations have been found within primary 
colorectal cancers involving exon 3, the absence of exon 3 has been shown to result 
in a stabilized protein which has a dominant oncogenic effect on colorectal 
turnourigenesis (Iwao et al., 1998). Takahashi et al (1998) showed that in AMO 
(azoxymethane) treated rats there was an increase in both cytoplasmic and nuclear P- 
catenin. Further analysis of &atenin revealed that in this model a mutation in the 
GSK-3P consensus motif resulted in the increased P-catenin stability due to 
decreased degradation. There are a number of other possible mutation sites in fl- 
catenin, i. e. tyrosine phosphorylation due to a mutation in the coding sequences of 
the serine residues (Reviewed by Jankowski et al., 1997), and an amino terminal 
deletion results in stabilisation of the protein along with hyperphosphorylation of 
APC (Munemitsu et al, 1996). Activating mutations in the fl-catenin gene is thought 
to be responsible for the excessive P-catenin signalling involved in the majority of 
carcinogen induced colonic carcinomas (Yamada et al., 2000). Yamada et al. (2000) 
found that P-catenin signalling may be involved in the initial stage, aberrant crypt 
foci, of colon carcinogenesis in azoxymethane treated male F344 rats. A further 




lesions of colon cancer, and are independent of aberrant crypt foci (ACF) (Yamada et 
al., 2001a). Further support for P-catenin mutations being involved in colon cancer 
was provided by Romagnolo et al. (1999) where transgenic mice containing a NH2- 
terminally truncated mutant Acatenin resulted in multifocal dysplastic lesions within 
the small intestine (Romagnolo et al., 1999). P-catenin is expressed at epithelial cell 
membranes, except during cell signalling or disruptions in its regulation (i. e. 
mutations) where it is found in the cytoplasm and nucleus. 
The increase of free P-catenin results in increased and inappropriate transcription of 
hLEF- I and hTCF-4 (Reviewed by Moon and Miller, 1997) resulting in altered gene 
transcription such as c-myc expression (He et al., 1998), this could be one cause of c- 
myc being overexpressed in colorectal. turnours (Refer to section 1.3.4, page 24, for 
other target genes). The transcription factor TCF-4 has also been shown to maintain 
crypt stem cells of the small intestine, suggesting that when APC or p-catenin are 
mutated in human epithelial cells, these cells may regain stem cell characteristics 
thus resulting in malignant transformation (Korinek et al., 1998). LEF-1/0-catenin 
complex formation resulting in the activation of LEF-I target genes has also been 
implicated in turnourigenesis (Aoki et al., 1999). 
y-catenin has also been shown to associate with APC and TCF/LEF entering the 
nucleus, suggesting there may be further functional homology with P-catenin. P- 
catenin mutations, with oncogenic activity, are found in many human tumours, 
whereas mutations in y-catenin are rarely found, subsequently the suggestion that 
plakoglobin may act as a tumour suppressor gene was proposed (Williams et al., 
2000). However plakoglobin in the absence of stabilising mutations has been shown 
to induce neoplastic transformation of rat epithelial cells (Reviewed by Barker and 
Clevers, 2000). Plakoglobin has been shown to have a role in apoptosis by 
regulating the expression of the anti-apoptotic protein Bcl-2, with increases in 
plakoglobin expression correlating with increases in Bcl-2 protein (Hakimelahi et al., 
2000). Mutations in plakoglobin have failed to enhance its stability possibly 




In normal colorectal epithelium E-cadherin is found associated with the cell 
membrane. In intestinal turnours, from transgenic mice and FAP patients, E- 
cadherin is located into the cytoplasm (Sloncova et al., 2001). As early as 1989, 
Behrens et al. (1989) suggested that the loss of adhesive function of E-cadherin 
(uvomorulin) is a critical step in the promotion of the malignant phenotype of 
epithelial cells. E-cadherin is essential for the formation and maintenance of 
epithelia, and any perturbation of the adhesive complex leads to increased 
invasiveness and decreased differentiation (Vleminckx et al., 1991; Frixen et al., 
1991; Pignatelli et al., 1992; Berx et al., 1995; Reviewed by Shiozaki et al., 1996; 
Guilford et al., 1998) a fundamental aspect of the neoplastic process (Reviewed by 
Jawhari et al., 1999a). E-cadherin has been proposed as a turnour suppressor gene 
with the possibility that loss of cell-cell adhesion may convey signals that actively 
induce invasion and metastasis (Reviewed by Semb and Christofori, 1998; Reviewed 
by Christofori and Semb, 1999), along with an increase'in genomic instability 
(Reviewed by Tisty, 1998). Mutations in E-cadherin itself, P-catenin, a-catenin and 
y- catenin have all been shown to result in the perturbation of cellular adhesion 
(Gagliardi et al., 1995). Gagliardi et al. (1995) used immunohistochernical 
techniques to look at the expression of E-cadherin in normal and cancerous tissues. 
They found that in normal colorectal epithelial cells there was typical membranous 
staining at the adherens junctions, but in the adenoma and carcinoma tissues there 
were changes in the immunoreactivity and cellular localisation. These changes 
correlating with turnour size, histopathology, growth patterns and degree of dysplasia 
(Dorudi et al., 1993; Gagliardi et al., 1995). Poorly differentiated adenocarcinomas 
and adenomas revealed a decrease in the expression of E-cadherin (Nigarn et al., 
1993; Valizadeh et al., 1997). Loss of E-cadherin mediated cell-cell adhesion could 
allow cells to escape normal growth control signals resulting in cell proliferation. 
Alternatively Guilford suggests that the cytoplasmic domain of E-cadherin may 
modulate the Wnt signalling pathway by inhibiting the availability of free P-catenin, 
similarly to APC (Guilford et al., 1998). It has also been shown that there is an 
increase in the activation of several receptor tyrosine kinases, i. e. EGFR, v-src and c- 
MET in cancer cells, resulting in tyrosine phosphorylation of the catenin molecules, 
thus disrupting cellular adhesion (Behrens et al, 1993; Reviewed by Jankowski et al., 




Yoshiura et al (1995) who showed that methylation on CpG islands near the 
promoter region also inactivated E-cadherin at least in ovarian, breast and prostate 
carcinomas. With hypermethylation of the promoter region of E-cadherin gene also 
found in sporadic colorectal cancer (Wheeler et al., 2001). 
Shiozaki et al. (1994) looked at whether the possible down regulation of a-catenin 
expression played a role in tumour invasion and metastasis through E-cadherin 
dysfunction. They found that normal epithelium expressed cc-catenin strongly, 
without exception. However, cc-catenin was reduced or absent in a number of 
primary tumours of the oesophagus, stomach and colon, thus suggesting that E- 
cadherin mediated adhesion may be abrogated by downregulation of a-catenin 
(Shiozaki et al., 1994). An investigation into patients with colorectal cancer coupled 
with liver metastasis were examined for E-cadherin and a-catenin expression, cc- 
catenin expression was found to be reduced and significantly correlated to invasion 
of the turnour whereas E-cadherin was downregulated in fewer cases and did not 
correlate to invasion (Goffiku et al., 1999) suggesting that there may be ftu-ther 
disruption of a-catenin at the cell membrane. Loss of ct-catenin expression has been 
shown to significantly correlate with tumour de-differentiation (Hugh et al., 1999). 
Down regulation of a-catenin has also been observed in cell lines, HCT-8, which 
have a more invasive phenotype (Vermeulen et al., 1995). 
Skoudy et aL (1996) also reported altered p120 expression in colorectal cancer. 
Skoudy et aL (1996) demonstrated that in the normal colon, p120-catenin was 
present in the crypt and surface epithelium, the cells showed reactivity in both the 
membrane and cytosol, with Valizadeh et al (1997) showing that the staining 
intensity was greatest in the proliferating crypt cells. Reduced expression of p120 
was observed in 20% of adenomatous polyps, with loss of membranous p120 
expression correlating with reduced E-cadherin expression. Decreased expression of 
p120 was also found to correlate with the larger size turnour (Skoudy et al, 1996). 
These findings are difficult to explain as the physiological role of p 120 is unknown, 
but Skoudy et aL results suggest that changes in p120 catenin levels are a common 
event in colorectal turnours, and suggest that the distribution of this protein and E- 





1.4.1 Environmental Factors involved in the aetiology of colorectal cancer 
development. 
A number of studies have revealed the importance of environmental factors in the 
aetiology of a vast majority of human cancers, further diet has been considered as 
important as tobacco smoking (Reviewed by Hill, 1997a). There are number of 
methods for determining the role of environmental factors in human cancer including 
epidemiological studies, animal models, in vitro studies and human intervention 
studies (Reviewed by Hill, 1997a). The strongest evidence for the role of diet in the 
aetiology of colon cancer has been provided by numerous epidemiological studies. 
These studies have identified potential promoters of colon cancer; including meat 
and fat intake, tobacco smoke, alcohol intake, lack of physical exercise, obesity (due 
to an energy imbalance), low intake of fruit, vegetables and whole grain cereals; with 
potential protectors including dietary fibre, antioxidants provided by fruits and 
vegetables, cereals and physical activity (Reviewed by Bingham, 1990; Reviewed 
Hill, 1997a; Reviewed Hill, 1997b, Reviewed Hill, 1997c; Reviewed by Cummings 
and Bingham, 1998). There are a number of human intervention trials that have been 
undertaken. These trials include the ECP trial involving 21 centres from 10 
countries, which found that supplementation of a diet with ispaghula husk may have 
adverse effects on colorectal adenoma recurrence especially in patients with high 
calcium intake (Bonithon-Kopp et al., 2000). Calcium on the other hand was shown 
to be associated with a small but not significant reduction in adenoma recurrence 
(Bonithon-Kopp et al., 2000). Other trials include a study on wheat bran fibre and 
the polyp prevention trial (low fat, high fibre diet) both revealed that diet had no 
effect on the incidence of new colorectal adenomas (Reviewed by Byers, 2000). A 
prospective study of 88,757 women with no history of any bowel disease over a 16 
year follow up period again revealed no association with fibre intake and colorectal 
cancer (Fuchs et al., 1999). The Toronto polyp prevention trial found that high fibre 
low fat diets reduced the risk of neoplastic polyp recurrence in women with this 
being associated with a reduction in faecal bile acids. However this same diet 




that there may be a gender-specific association with diet and colorectal cancer 
recurrence (McKeown-Eyssen et al., 1994). Experiments using rodents also 
indicated the importance of diet in cancer development, including early work carried 
out by Tannenbaum and Silverstone (Reviewed by Hill, 1997a). In vitro methods 
reveal possible biological mechanisms behind dietary factors, including the potential 
role of short chain fatty acids (SCFAs, products of fibre fermentation), particularly 
butyrate, and a number of antioxidants and their role in colorectal cancer 
development or prevention (Reviewed by Hill, 1997a). 
Denis Burkitt and Hugh Trowell hypothesised that dietary fibre could have a 
protective effect against a range of diseases that are prevalent in the western world 
(Reviewed Kritchevsky, 2001). Healthy image fibre-rich food products are now 
mainstream, with over 80% of American adults concerned about the effects of diet, 
especially dietary fibre, on their health (Reviewed by Dreher, 1995). One way to 
increase fibre intake is to eat fibre rich foods, and a second alternative way is to 
develop fibre rich processed foods (Reviewed by Dreher, 1995). Fibre has a number 
of health benefits and prophylactic uses including the lowering of cholesterol 
(Reviewed by Reiser, 1987), improvement of the glycaemic control of diabetes 
(Reviewed by Reiser, 1987; Reviewed by Spiller, 1994; Reviewed by Spiller, 1999), 
the relief of constipation (Reviewed Dwyer et al., 1978; Reviewed by Spiller, 1994), 
diarrhoea (Reviewed by Spiller, 1994; Reviewed by Spiller, 1999) and a number of 
other large bowel disorders (Reviewed by Dwyer et al., 1978; Reviewed by 
Kritchevsky, 2001). Dietary fibre had also been proposed to protect against colonic 
cancer with fibre subsequently becoming the health panacea of the 1980's. 
Subsequent reports have suggested that 'fibre supplemented foods may damage your 
health' (Reviewed by Wasan and Goodlad, 1996) with some fibres potentially 
increasing the risk of colon cancer development. A number of epidemiological 
studies examining the relationship between colon cancer and fibre intake have 
revealed that fibre has a protective role in colorectal cancer development (Reviewed 
by Bingham, 1990; Reviewed by Byers, 1995; Reviewed by Hill, 1997a; Reviewed 
by Hill, 1997b, Reviewed by Hill, 1997c; Reviewed by Cummings and Bingham, 
1998). Fibre studies in animals have had varying results ranging from protection, no 
effect, to enhancement of colorectal cancer (Jacobs and Lupton, 1986; Reviewed by 




Ferguson, 1999). On balance soluble fibre appears to be less protective than the 
insoluble fibres (Reviewed by Harris and Ferguson, 1993). 
1.5 Dietary Fibre 
1.5.1 Definition ofDietary Fibre 
Dietary fibre is, as an entity, hard to define. There have been a number of attempts at 
a definition over the years. The initial definition being coined by Hipsley (1953), 
with further definitions by Cleave (1956), but the first definition accepted by 
scientists world-wide was that proposed by Huge Trowell in 1976 (Reviewed by 
Prosky, 2001; Reviewed by McCleary, 2001; Reviewed by Kritchevsky, 2001), 
'dietary fibre is composed of the remnants of plant cells resistant to hydrolysis by 
human alimentary enzymes including all indigestible polysaccharides (cellulose, 
hemicellulose, oligosaccharides, pectins, gums, and algal polysaccharides) plus 
waxes and lignin' (Reviewed by Dreher, 1995; Reviewed by Lembo, 1998; 
Reviewed by Prosky, 2001; Reviewed by Kritchevsky, 2001). This definition was 
based not only his own observations but also those of Walker and Burkitt and 
reinforced by work of Cowgill and Anderson (1932), Williams and Olmstead (1936) 
and Dimock (1937) (Reviewed by Kritchevsky, 2001). Subsequent definitions 
referred to dietary fibre as 'non-starch polysaccharides' (Englyst et al., 1994), 
'ingested plant wall material and any non-starch polysaccharide not degraded by 
endogenous mammalian enzymes (Goodlad et al., 1989; Ghatei et al., 1997). 
Observations by Stephens (1983) revealed that this did not cover all the material 
available in the colon (Reviewed Hill, 1997b) as it did not include resistant starch 
polysaccharides which behaves physiologically as if NSP (Englyst et al., 1996; 
Reviewed by Hill, 1997b; Reviewed by McCleary, 2001). Later studies revealed that 
resistant starch is a primary food source for colonic microflora (Reviewed by 
Blackwood et al., 2000) with three times more starch possibly reaching the colon 
than NSP (Reviewed by Hill, 1997b). Thus if dietary fibre is not simply seen as 
residual plant cell wall material but all plant-derived carbohydrate entering the colon, 
then resistant starch is part of dietary fibre (Reviewed by Jenkins and Kendall, 2000). 




starch. It has been suggested that the definition of dietary fibre should be replaced 
with the term complex carbohydrate (CC) (Reviewed by Hill, 1997b). There are a 
number of other dietary and host components that resist digestion in the small bowel 
entering the colon thus acting as a microbial food source. These dietary and host 
components include other plant materials, including oligosaccharides (some being 
used a prebiotics such as fructooligosaccharides), proteins, sloughed cells and mucin 
(Reviewed by Rombeau and Roth, 1995). Consumption of dietary fibre has been 
shown to have a number of physiological effects on the gastrointestinal tract 
including increasing stool weight, altering gut transit time, altering the activity of the 
colonic microflora, modifying the absorption of fats, sugars, minerals and bile acids, 
influencing appetite, and absorbing toxins (Reviewed by Blackwood et al., 2000). 
The Food and Agricultural Organisation (FAO) of the United Nation World Health 
Organisation (WHO) has also recognised that dietary fibre has not only constituents 
of plant origins but also animal origin, basically those resistant to enzyme attack 
through the alimentary canal (Reviewed by Prosky, 2001). The definition was 
subsequently extended, to not only include some of these new dietary fibres but also 
the health benefits associated with these dietary fibres; 
'Dietary Fibre is the edible parts of plants or analogous carbohydrates that are 
resistant to digestion and absorption in the small intestine with complete or partial 
fermentation in the large intestine. Dietary fibre includes polysaccharides, 
oligosaccharides, lignin and associated plant substances. Dietary fibre promotes 
beneficial physiological effects, such as laxation, and/or blood cholesterol 
attenuation, and/or blood glucose attenuation' (Reviewed by Prosky, 2001) 
1.5.2 Quantification ofDietary Fibre. 
A number of methods have been devised to not only determine the dietary fibre 
contents of food but as an aid in defining dietary fibre and its structure (Reviewed by 
Prosky, 2001). Methods can be classified as either chemical (Southgate, 1969; 
Theander and Aman, 1979; Englyst et al., 1992), gravimetric (Asp et al., 1983; 
Mongeau and Brassard, 1986), Neutral detergent fibre (Van Soest and Wine, 1967) 
or fall into the AOAC method (Prosky et al., 1984) (Reviewed by Marlett, 1995). 




(1935), Southgate (1969,1982), Englyst and Cummings (1984,1988), Prosky 
(AOAC) and methods for determining dietary fibre structure include Englyst (1983) 
(Reviewed by Prosky, 2001), methylation analysis (Edwards et al., 2001) coupled 
with specific enzyme degradation (Blackwood and Chaplin, 2001). All methods 
have been extensively modified over the years, provide a crude measurement of 
dietary fibre content with the main aim to provide as much information about the 
fibre source to understand basis for the effect of fibre (Reviewed by Marlett, 1995). 
The procedures result in the removal of the digestible portion of the food using 
enzymes leaving an indigestible portion, mimicking the dietary fibre that enters the 
colon (Reviewed by Prosky, 2001). The determining factor for which procedure is 
preferentially used is not only time, modification but also geography (Reviewed by 
Prosky, 2001). The US Food and Drug Administration (1993) and the US 
Department of Agriculture (1993) and the WHO in America generally accepted the 
AOAC method for determining dietary fibre content of foodstuff (Reviewed by 
Prosky, 2001). In the UK, however, the Ministry of Agriculture, Fisheries and Food 
(MAFF) adopted the Englyst and Cummings method which determines the NSP 
content of foods (Reviewed by McCleary, 2001) thus adopting the term NSP to refer 
to dietary fibre (Reviewed by Prosky, 2001). The Englyst procedure has not received 
widespread adoption because, from a physiological point of view, NSP is less 
relevant than total dietary fibre (determined using the AOAC method) (Reviewed by 
McCleary, 2001). 
1.5.3 The Physicochemical properties ofD! eta? y Fibres. 
Dietary fibre is heterogeneous in both structure and function having a wide variety of 
chemical and physiological (physical and metabolic) properties. The physiological 
effects of dietary fibres are partly predictable on the basis of their physicochernical 
properties (Reviewed by Blackwood et al., 2000). These properties of dietary fibre 
are dependent on a number of factors not only intrinsic to the fibre and the host but 
also a number of extrinsic factors. intrinsic factors include the dietary fibres 
conformation (branching, flexibility), monosaccharide content, monosaccharide 
availability, water holding capacity, solubility and subsequent viscosity (which in 
turn all affects molecular weight), level of exposed hydrophobic surfaces, particle 




level of protein intake (Weisburger et al, 1977; Reviewed by Blackwood et al., 2000; 
Reviewed by Morris, 2001; Reviewed by Kritchevsky, 2001). The conformation of 
dieary fibre affects the rate and extent of its fermentation with soluble fibres being 
more readily fermented and earlier in the colon, than insoluble fibres (Reviewed by 
Blackwood et al., 2000). The monsaccharide composition also affects the rate of 
fermentation with polysaccharide chains being fermented at the terminal region first, 
and carbohydrates containing a-arabinose (pectin and ispaghula husk) and (x- 
galacturonic acid (pectin) residues are more susceptible (Reviewed by Blackwood et 
al., 2000). The site, rate and extent to which the fibres are fermented and absorbed 
in the colon and the type of products produced during this fermentation all affect the 
physiological properties of the fibre (Reviewed by Blackwood et al., 2000). Host- 
derived factors affecting the physiological properties of the fibre include the colonic 
microflora, the pH of lumen, metabolic rate and genetic background. Extrinsic 
factors affecting dietary fibres physicochernical properties include pancreaticobiliary 
secretions, bacterial flora, and gastrointestinal hormones (Reviewed by Cassidy and 
Fitzpatrick, 1995), the extent of mastication, the extent of preparation (cooking, 
heating, processing) and the form of fibre (whole foods verses individual fibres) 
(Reviewed by Eastwood, 1995). Food preparation, in terms of processing and 
heating will also affect dietary fibres structure. Food processing will affect dietary 
fibre in terms of particle size and viscosity, for example sterilisation by gamma 
irradiation has been shown to affect ispaghula husks viscosity (M. Havler, personal 
communication). 
Vast arrays of dietary fibres exist but the entire principal component are the non- 
starch polysaccharides and lignin (Reviewed by Blackwood et al., 2000). Non-starch 
polysaccharides are composed of various structural polysaccharides including 
cellulose, hemicellulose (including arabinoxylans), and non-structural 
polysaccharides such as pectins, gums and mucilages (Reviewed by Dreher, 1995; 
Reviewed by Lembo, 1998; Reviewed by Blackwood et al., 2000). Dietary fibre can 
also be sub-divided fairly crudely into soluble (non-structural polysaccharides such 
as pectin, ispaghula) verses insoluble (structural polysaccharides such as cellulose) 




combination of soluble (approximately 10%) and insoluble dietary fibre (Reviewed 
by Dreher, 1995). 
Fibre structures can have very different geonometries ranging from flat ribbon 
assemblies (cellulose fibrils), double helices (starch) to buckled chains containing 
cavities that are occupied by bound ions (pectin) (Reviewed by Morris, 1995). Most 
polysaccharides of greatest importance are built up of six-membered, pyranose rings 
in a chair shaped conformation; for example, cellulose is made up of glucose chains 
of poly-0(1-4)-D-anhydroglucose (Reviewed by McCleary, 2001). The differences 
in the fermentation of cellulose, poly- P-D-Glucose, and resistant starch, poly-a-D- 
Glucose, is its conformation, axial versus equatorial, and due to its packing; for 
example, cellulose has a more ordered packing making it more resistant to enzymatic 
attack resulting in limited degradation during fermentation (Reviewed by Morris, 
2001). 
Water binding and viscosity are physical manifestations of fibre action and influence 
gastric emptying, faecal flow and absorption of nutrients (Reviewed by Eastwood, 
1995; Reviewed by Blackwood et al., 2000; Reviewed by Kritchevsky, 2001), 
enzyme activity, stool weight and facilitates fermentation (Reviewed by Eastwood, 
1995). This also affects intestinal and colonic muscle activity, metabolic turnover 
rate of absorbed nutrients and endocrine hormone activity (Reviewed by Eastwood, 
1995). The Blythe technique in humans, showed that there was an inverse 
relationship between water holding capacity (WHQ and stool weight providing 
evidence that fibre did not increase faecal weight by simply retaining water but that 
faeces also contained bacteria (Reviewed by Brydon, 1995). Thus fibre provides an 
energy source for bacteria through fermentation, resulting in their proliferation and 
subsequent increase in biomass (Reviewed by Brydon, 1995; Reviewed Lembo, 
1998). An increase in stool mass is accompanied by a decrease in colonic transit 
time (Reviewed by Lembo, 1998). 
Diet gives clues to the aetiology of many of the life style diseases, such as colon 
cancer and heart disease, which themselves have a large number of risk factors 




binding of bile acids and inorganic ions and potential carcinogens (Reviewed by 
Blackwood et al., 2000; Reviewed by Kritchevsky, 2001). Bulking may increase the 
excretion of those substances trapped in the faecal mass (Reviewed by Kritchevsky, 
2001). The mechanical action of dietary fibre, influencing stool weight, results in the 
relief of constipation and diverticular disease (Reviewed Dwyer et al., 1978; 
Reviewed by Kritchevsky, 2001). There are a number of metabolic effects 
associated with fibres: these include reducing obesity; gallstones (through reducing 
cholesterol saturation and possibly affecting the bile acid pool); diabetes (found to 
help alleviate symptoms by normalising glucose tolerance and plasma insulin levels); 
coronary heart disease and colon cancer (Reviewed by Kritchevsky, 2001; Marcil et 
al., 2002). It is now established that insoluble fibres (cellulose) do not influence 
serum lipids, whereas soluble fibres (pectin and psyllium due to their viscous nature) 
exert a hypocholesterolaernic effect (Reviewed by Reiser, 1987; Reviewed by 
Kritchevsky, 2001). 
Fibrous carbohydrates are digested symbiotically by colonic microorganisms in all 
higher animals that have not evolved cellulases, hemi-cellulases or pectinases 
(Reviewed by Sakata and Yajima, 1984; Reviewed by Van Soest, 1995). Fibre is 
fermented by the microflora in the large intestine, to produce a number of metabolic 
by-products, particularly the short chain fatty acids (SCFAs) such as butyrate, acetate 
and propionate (Goodlad et al., 1989; Reviewed by Mortensen and Nordgaard, 1995; 
Wang and Friedman, 1998). This can be shown by the administration of antibiotics, 
which was associated with a decrease in SCFA production highlighting the role of 
the microflora in their production (Reviewed by Sellin, 1993). Different fibres 
produce different levels of SCFAs, a wheat bran diet results in a colonic contents rich 
in butyrate with less propionate, whereas an oat bran diet yielded half as much 
butyrate but with a similar amount of propionate (Wang and Friedman, 1998). 
An increase in colonic dietary fibre (NSP) also results in increased carbohydrate 
fermentation thus resulting in a decrease in protein metabolism and thus a reduction 
in ammonia formation (Reviewed by Macfarlane and Gibson, 1994; Reviewed by 
Eggum, 1995). Ammonia formation from colonic bacteria is of physiological 
significance to the host since concentrations as low as lOmM can alter the 




and increase their lifespan (Reviewed by Macfarlane and Gibson, 1994). Thus the 
colonic microflora influences colonic mucosal architecture, mucosal cell turnover 
and intestinal motility (Reviewed by Salyers, 1995). SCFA production, e. g. butyrate, 
has been shown to affect mucosal cell turnover thus an indirect way that the 
microflora affects the mucosa (section 1.5.5) (Goodlad et al., 1989; Reviewed by 
Salyers, 1995; Goodlad et al, 1995). Diet has been shown to stimulate ornithine 
decarboxylase (ODC) intestinal activity, which is one of the earliest biochemical 
parameters associated with cellular turnover and development (Reviewed by Cassidy 
and Fitzpatrick, 1995). Diet has been shown to influence colonic morphology in rats, 
resulting in a physiological adaptation of the colonic epithelium and is essential for 
the maintenance of normal small and large intestinal mucosal structure and function 
(Reviewed by Cassidy and Fitzpatrick, 1995). 
1.5.4 Fermentation ofDietary Fibre. 
Fermentation is an important parameter of dietary fibre characterisation, in terms of 
the types of products formed, the rate at which they are formed and the site at which 
they are formed within the large intestine. The majority of fermentation occurs in the 
caecurn (Reviewed by Lembo, 1998), which corresponds to the veriform appendix in 
humans (fig. 1.1) (Reviewed Eastwood, 1995). The abundance of anaerobic, 
saccharolytic bacteria in the human colon provides an important milieu for the 
fermentation process (Reviewed by Rombeau and Roth, 1995). The majority of the 
carbohydrates entering the large bowel are polysaccharide chains (such as dietary 
fibres) and are fermented by the anaerobic bacteria using a series of energy-yielding 
reactions (Reviewed by Macfarlane and Gibson, 1994). With the exception of 
bifidobacter, the majority of saccharolytic anaerobes use the Embden-Meyerhoff. 
Parnas pathway (of anaerobic glycolysis) to ferment carbohydrates producing SCFA 
(Reviewed by Macfarlane and Gibson, 1994; Reviewed by Rombeau and Roth, 
1995). Together with the other metabolites lactate, ethanol, hydrogen and succinate, 
they are produced to provide electron sinks to maintain a redox balance within the 
colonic lumen as fermentation results in the lowering of intraluminal pH (Reviewed 
by Macfarlane and Gibson, 1994; Reviewed by Lembo, 1998). The intermediates of 
fermentation such as lactic acid can also be utilised by other bacteria resulting in 




The major SCFAs produced from fermentation are butyrate, acetate and propionate 
(Walter, 1986; McBumey, 1991; Reviewed by Cummings, 1994; Reviewed by 
Livesey, 1995). Dietary fibre (NSP) is thought to be the largest contributor to SCFA 
production with the type of dietary fibre (NSP) influencing the pattern of SCFA 
production (McBurney, 1991; Edwards and Eastwood, 1992; Reviewed by 
Macfarlane and Gibson, 1994; Reviewed by Brydon, 1995; Reviewed by Rombeau 
and Roth, 1995; Wang and Friedman, 1998). The rate, site and extent of 
carbohydrate fermentation in the gut is also dependent on a number of factors 
associated with the fibre including solubility, chemical structure, availability of other 
more readily fermentable substrates (Reviewed by Blackwood et al., 2000). SCFA 
production is dependent on a number of other factors including substrate precursors, 
composition of the microflora, and a number of other host factors (Reviewed by 
Rombeau and Roth, 1995). Different dietary fibres are fermented to varying degrees, 
differing between whole foods and purified fibres (Reviewed by Wolever, 1995). 
SCFAs are usually absorbed directly across the wall of the colon into the blood in the 
form of free acids (Reviewed by Van Soest, 1995) with absorption occurring to a 
much greater extent in the ascending (proximal) colon than the descending (distal) 
colon (Reviewed by Rombeau and Roth, 1995). The exact absorptive mechanism is 
unknown although SCFAs tend to move transcellularly across the apical membrane 
being dependent on sodium-hydrogen exchange and is associated with colonic 
alkalinisation (Reviewed by Rombeau and Roth, 1995). McNeil et al. (1978) 
suggested that SCFAs are absorbed by the large intestine with Sellin and De Soignie 
(1998) showing that SCFA affected pH and Ne absorption. The transport of 
butyrate across the luminal pole of the colon possibly involves a carrier protein, in 
the form of a pH activated anion exchange process/ anion exchanger (Ritzhaupt et 
al., 1998). A broad range of anions are shown to exchange for butyrate, although its 
transport involves a single saturable transport protein (Ritzhaupt et al., 1998). There 
is substantial evidence that transcellular flux of SCFA absorption is mediated by an 
anion exchange process with bicarbonate (Schr6der et al., 2000). SCFAs are rapidly 
absorbed as water and sodium are absorbed and bicarbonate is secreted in the colon 
(Review Cook and Sellin, 1998). The absorption of SCFAs maintains the pH of the 
colon above 6, which is required by the normal fibre-digesting bacteria (Reviewed by 




by the colonic wall (colonocytes) as a maintenance source of energy (Reviewed by 
Van Soest, 1995; Reviewed by Behall, 1997; Reviewed by Lembo, 1998; Ritzhaupt 
et al., 1998), and are used over and above other energy sources such as glucose and 
glutamine (Reviewed by Burrin and Reeds, 1997; Avivi-Green et al., 2000b). Thus 
butyrate is essential for the maintenance of a healthy colon (Avivi-Green et al., 
2000b). This is reflected by the pattern of SCFA metabolism within different tissues 
of the body, acetate is largely metabolised by peripheral tissues (liver and muscles), 
propionate is mainly metabolised in the liver and butyrate by the colonic tissues 
(rumen epithelium) (Reviewed by Cummings, 1994; Reviewed by Van Soest, 1995, 
Reviewed by Cummings, 1997). 
The colonic microflora, has a symbiotic role in carbohydrate and protein metabolism, 
where the host provides dietary residues or endogenous substrates, for the bacteria 
which in turn supply metabolites such as short chain fatty acids for utilisation by the 
host (Reviewed Macfarlane and Gibson, 1994). Bacterial activities include 
breakdown of dietary and host polysaccharides, the breakdown of proteins, the 
modification of xenobiotic compounds, modification of bile salts and sterols, the 
production of faecal mutagens and the synthesis of many enzymes (Reviewed by 
Salyers, 1995). Changes in the microflora are seen due to influences of endogenous 
or exogenous; origin. The substrate precursors include not only type and volume of 
unabsorbable carbohydrate (NSP and resistant starch), protein, nitrogen and 
endogenous/host polysaccharide sources including sloughed cells and mucus 
(Reviewed by Rombeau and Roth, 1995). Prebiotics are non-digestible food 
ingredients, such as oligosaccharides and dietary fibres, that selectively stimulates 
the growth and or activity of one or a number of limited bacteria in the colon that are 
beneficial to the hosts health (Reviewed by Gibson and Roberfroid, 1995). 
Acquisition of the microflora influences host biochemistry such as enzymatic activity 
of the intestinal contents (e. g. P-D-Glucuronidase, azoreductase, bile salt 
hydrolyase), SCFA concentrations, oxidation-reduction potential, host physiology 
(e. g. rate of replacement of enterocytes), immunology (stimulation of 
reticuloendothelial tissues) and the modification of host-synthesized molecules (e. g. 




form secondary bile acids, mucin degradation) (Reviewed by Tannock, 1994). The 
colonic microflora influences colonic mucosal architecture, mucosal cell turnover 
and intestinal motility (Reviewed by Salyers, 1995). SCFA production, for example 
butyrate, affects mucosal cell turnover providing an indirect way that the microflora 
affects the mucosa (Reviewed by Salyers, 1995). SCFA production from fibres 
results in an increase in colonic cell proliferation (Goodlad et al., 1989; Goodlad et 
al., 1995). Stability in species composition of the normal microflora may be 
common, stability at the level of bacterial strains may be less common (Reviewed by 
Tannock, 1994). Colonic bacteria are very versatile and adaptable, changing to a 
constantly changing environment including changes in substrate availability 
(Reviewed by Salyers, 1995). The volume of substrate present is also important, 
increased substrate results in more bacteria having access, which will subsequently 
increase and alter the type of fermentation product formed (Reviewed by Macfarlane 
and Gibson, 1994). Increasing carbohydrate availability also affects bacterial growth 
rates resulting in an increase in bacterial biomass which can in turn influence the 
actions of the microflora such as depolymerising enzymes (Reviewed by Macfarlane 
and Gibson, 1994). The rate at which any fermentable substrate becomes available 
for assimilation by the bacteria along with substrate preferences will affect the type 
of fermentation products produced (Reviewed by Macfarlane and Gibson, 1994). 
There are a number of possible ways fibres interact with the colonic microflora 
changing total numbers, changing species and changes in bacterial products and 
activities (Reviewed by Salyers, 1995). For example C. perfilngens has been shown to 
increase lactate production and decreases acetate production, thereby enabling the 
bacteria to maximise their energy (Reviewed by Macfarlane and Gibson, 1994; 
Reviewed by Rombeau and Roth, 1995). The production of these substances in 
fermentation therefore contributes to the diversity of bacteria found in the colon 
(Reviewed by Macfarlane and Gibson, 1994). There are marked differences of levels 
of bacterial metabolites, i. e. SCFAs and methane in different regions of the colon, 
along with a variation in species, and obligate versus facultative anaerobes. Edwards 
and Eastwood (1992) demonstrated that fibres were fermented at different sites 
within the colon they showed that wheat bran was mainly fermented in the caecurn 
whereas ispaghula husk was fermented throughout the colon (Edwards and 
Eastwood, 1992; Reviewed by Brydon, 1995). 
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There are variations in the metabolic capacity of bacteria from colon to colon this 
may explain the differential response to non-absorbable carbohydrates from 
individual to individual (Reviewed by Sellin, 1993). The availability of inorganic 
electron acceptors, such as N03- will affect the ratio or type of SCFA produced 
(Reviewed by Macfarlane and Gibson, 1994). Interestingly butyrate highlights 
another factor that must influence fermentation in that butyrate makes up 20% of the 
total SCFA pool but the level of butyrate producing bacteria in the faeces is very low 
(<l%). This suggests that they are very metabolically active, so numbers may not be 
the only important criterion (Reviewed by Macfarlane and Gibson, 1994). 
The metabolism of proteins produces a number of by-products including ammonia, 
urea and free amino acids providing nitrogen for growth of saccharolytic bacteria and 
amino acids for fermentation by assaccharilytic species. Fermentation of amino 
acids also results in a wide spectrum of by products including ammonia, amines, 
phenols, indoles, organic acids (e. g. SCFAs mentioned earlier plus the branched 
SCFAs isobutyrate and isovalerate), alcohols and the gases H2 and C02 (Reviewed 
by Macfarlane and Gibson, 1994; Reviewed by Rombeau and Roth, 1995). Some of 
these by-products are toxic to the host and are thus excreted in the faeces or 
transported to the liver where they are converted into urea and excreted in the urine 
(Reviewed by Macfarlane and Gibson, 1994). The more dietary fibre (NSP or 
starch) available in the colon the smaller the volume of protein metabolised by the 
colonic microflora (Reviewed by Eggum, 1995). Fibre affects protein/amino acid 
metabolism by decreasing transit, with an increase in transit time increasing phenol 
production by faecal bacteria, suggesting the breakdown of protein rather than 
carbohydrate (Reviewed by Macfarlane and Gibson, 1994). Some bacterial by- 
products are toxic and potentially carcinogenic, for example faecapentaenes 
produced by Bacterlodes from plasminogen precursor have been shown to cause 
mutations in DNA (Reviewed by Salyers, 1995). There are also potentially 
beneficial bacteria such as Bifidobacteria in the gut (Reviewed by Blackwood et al., 
2000). Rycroft et al. (2001) looked at the fermentation of some prebiotic 
oligosaccharides in 24 hour batch cultures. All prebiotics increased the numbers of 
Bifidobacteria and most decreased Clostridia, but different oligosaccharides affects 
these numbers to different extents and resulting in different fermentation profiles 




1.5.5 Physiological significance ofSCFA production 
SCFAs are the predominant luminal anion (Reviewed by Sellin, 1993) with acetate, 
propionate and butyrate predominating, contributing to about 50%, 20% and 20% of 
the total SCFA (Reviewed by Macfarlane and Gibson, 1994). In humans 
approximately 200mMol of SCFAs are produced daily but is dependent on 
polysaccharide consumption (Reviewed by Rombeau and Roth, 1995). SCFA are 
rapidly absorbed through the colonic epithelium (Reviewed by Macfarlane and 
Gibson, 1994; Reviewed by Van Soest, 1995; Reviewed by Behall, 1997; Reviewed 
by Cook and Sellin, 1998; Ritzhaupt et al., 1998; Schr6der et al., 2000). Acetate is 
metabolised in the brain, heart and peripheral tissues, whereas propionate appears to 
be mainly cleared by the liver (Reviewed by Macfarlane and Gibson, 1994; 
Reviewed by Rombeau. and Roth, 1995). Butyrate formation by intestinal bacteria is 
of particular interest, because this SCFA is an essential fuel for the colonic 
epithelium particularly in the distal gut (Reviewed by Macfarlane and Gibson, 1994). 
Clinically, SCFAs have been studied as possible therapeutic agents in diversion 
colitis, ulcerative colitis, radiation proctitis, pouchitis and antibiotic associated 
diarrhoea (Review Cook and Sellin, 1998). SCFAs may be the effector of the 
beneficial role of fibre in prevention of colon cancer (Review Cook and Sellin, 
1998). 
The SCFAs profoundly alter the milieu of the colon and have a wide range of 
biological effects. The physiological effects of SCFA production include the 
enhancement of sodium absorption, stimulation of blood flow improving peripheral 
artery dilation (mainly by acetate), and helps regulate carbohydrate and lipid 
metabolism (Reviewed by Sakata and Yajima, 1984; Reviewed by Rombeau and 
Roth, 1995). SCFAs have been implicated in water retention in faecal matter 
(Reviewed by Brydon, 1995) and electrolyte absorption (Reviewed by Lembo, 
1998). The fermentation of fibre also results an increase in bacterial biomass 
(Reviewed by Topping, 1995) by stimulating bacterial growth and this stimulation of 
biomass leads to increased faecal bulk and bacterial protein synthesis. In vitro these 
SCFAs, particularly butyrate, have been shown to be powerful promoters of 
differentiation, apoptosis and cell migration (Hague et al., 1995; Wilson and Gibson, 




Siavoshian et al, 2000), inhibition of growth (Archer et al., 1998a; Archer et al., 
1998b; Basson et al., 1998), membrane synthesis and sodium absorption of 
colonocytes (Schwartz et al. 1998) and changes in protein and gene expression 
(Archer et al., 1998; Tappenden and McBurney, 1998; Coradini et al., 2000; Buecher 
et al., 2001). In vivo Behall et al (1997) reviewed that SCFAs change intestinal 
morphology of rats. Colonic infusion of SCFAs resulted in greater mucosal height 
and DNA synthesis, but no change in absorption of water, electrolytes, or butyrate 
(Reviewed by Sellin, 1993). There is now evidence that these SCFAs can stimulate 
intestinal cell proliferation in vivo (Goodlad et al., 1989; Goodlad et al., 1995; 
Ichikawa and Sakata, 1998). The ratio of SCFA production is very important 
(Reviewed Eastwood, 1995), with different fibres producing different levels of these 
SCFAs (Edwards and Eastwood, 1992; Reviewed Rombeau and Roth, 1995; Wang 
and Friedman, 1998). 
1.5.5.1 Acetate. 
Acetate enters the portal system, is mainly metabolised in the liver into long-chain 
fatty acids and ketone bodies providing energy for the periphery (Reviewed by 
Rombeau and Roth, 1995). Acetate may be an important precursor for lipogenesis in 
the absence of adequate carbohydrate intake (Reviewed by Rombeau and Roth, 
1995). The minimal metabolism of acetate by colonocytes suggests it will have little 
biological influence directly on them. Acetate has been shown to have some 
immunomodulatory effects, increasing IL-18 intracellular levels, an interleukin 
which has been shown to have potential anti-neoplastic activity (Kalina et al., 2002). 
1.5.5.2 Propionate. 
Propionate is partly metabolised by colonocytes but is primarily metabolised by the 
liver, thus propionate could elicit a biological effect on colonic epithelial cells 
(Reviewed by Rombeau and Roth, 1995; Reviewed by Macfarlane and Gibson, 
1994). The fact that the majority of fibres that produce high levels of propionate 
lowers cholesterol lead to the suggestion that propionate may be a mediator of NSP 
in reducing cholesterol levels (Reviewed by Ink and Hurt, 1987; Reviewed by 




inhibit hepatic cholesterol synthesis (Reviewed by Behall, 1997), propionate has 
specifically been shown to inhibit cholesterol synthesis in vitro in isolated 
hepatocytes, an effect produced by certain drugs used to lower plasma cholesterol in 
humans with hypercholesterolemia (Reviewed by Topping, 1995; Reviewed by 
Rombeau and Roth, 1995) possibly by the redistribution of cholesterol from the 
plasma to liver (Reviewed by Rombeau and Roth, 1995). Propionate may also 
inhibit 3-hydroxy-3-methyl-glutary CoA reductase (HMG-CoA), the rate limiting 
enzyme in hepatic cholesterol synthesis (Reviewed by Ink and Hurt, 1987). Other 
fibres (gum arabic for example) which also produce high propionate levels have 
failed to reduce cholesterol in vivo (Reviewed by Topping, 1995) suggesting other 
factors are involved, possible factors include viscosity and butyrate production 
(Reviewed by Topping, 1995). Propionate has been shown to be a weak deactylase 
inhibitor thus possibly affecting gene expression although it is less effective than 
butyrate in altering NF-xB activity in vitro (Yin et al., 2001). * Propionate has also 
been shown to be a potent colonocyte mitogen in vitro (Friedman et al., 1988), others 
have shown it to reduce invasion in vitro (Emenaker and Basson, 1998) and to induce 
apoptosis in vitro (Marchetti et al., 1997) 
1.5.5.3 Butyrate. 
Colonocytes undergo apoptosis in the absence of SCFAs, interestingly, SCFAs, 
particularly butyrate, have the opposite effect on transformed cells in culture, 
inducing rather than suppressing apoptosis (Yin et al., 2001). Singh et al. (1997) 
showed that butyrate is both growth stimulatory and growth inhibitory depending on 
the availability of other energy sources such as glucose. Tumour and normal cells 
may have different responses to butyrate and may rely on other energy sources such 
as glucose, this is also suggested by increased GLUT-2 expression in tumour cells 
(Reviewed Hague et al., 1997). Others have suggested that the paradoxical effects of 
butyrate (in vivo versus in vitro) do not appear to represent inherent differences 
between normal and transformed cells (Gibson et al., 1999). Rather, the response 




Butyrate is the most important fuel for colonocytes contributing to 70% of oxygen 
consumption during cell oxidation, even though it is produced at the lowest amount 
(Reviewed by Rombeau and Roth, 1995). Butyrate has a short half-life and is 
metabolised quickly (Reviewed by Rephaeli et al., 2000), butyrate prodrugs are 
being developed for use in anti-cancer, haemoglobinopathies and protection against 
chemotherapy induced alopecia (Reviewed by Rephaeli et al., 2000) revealing the 
diversity of butyrate activity. Butyrate has been shown to have a number of 
biological effects, in vivo, including the proliferation of epithelial cells (Reviewed by 
Rombeau and Roth, 1995). The mechanism of this increase in proliferation is 
unknown but could be due to energy source, increase blood flow, increase in 
enterohepatic gastrointestinal hormones and increases in pancreatic and biliary 
secretion (Reviewed by Rombeau and Roth, 1995). Butyrate causes differentiation, 
growth inhibition and apoptosis in vitro, and these may attribute to butyrates 
underlying mechanisms of protecting against colorectal cancer development (Hague 
et al., 1995; Reviewed by Rombeau and Roth, 1995; Ltlhrs et al., 2002). 
Transformed Caco-2 cells treated with sodium butyrate where shown to lose their 
malignant phenotype undergoing reduced proliferation, enhanced differentiation, 
stimulation of apoptosis leading to decreased viability of cells, and stimulation of 
interleukin-8 secretion (Dzierzewicz et al., 2002). SCFAs induce cell cycle 
inhibitors in colonocytes, with butyrate blocking cells mainly in the G1 phase of the 
cell cycle (Siavoshian et al., 2000). Butyrate mediates growth inhibition of colonic 
cancer cells by inducing p2l mRNA and protein expression (Archer et al, 1998a; 
Archer et al., 1998b; Siavoshian et al., 2000) and also results in the induction of 
p27kipl (Wang and Friedman, 1998) and Cyclin D3, with p2l being responsible for 
the GI blockage (Buecher et al., 2001) thus effecting proliferation and differentiation 
(Siavoshian et al., 2000). Butyrate also induces histone H4 hyperacetylation 
(Siavoshian et al., 2000) and reduces cyclin DI and p53 levels (Coradini et al., 
2000). 
Avivi-Green et al. (2000b) has shown that apoptosis cascade proteins are 
differentially localised along the lumen-crypt axis, and their expression and activity 
may be controlled by dietary components and may partially account for the 
documented protective effect of butyrogenic fibres on colorectal cancer (Avivi-Green 




al., 1997; Chen et al., 2002; Menzel et al., 2002) via Fas receptor dependent signal 
transduction (Fan et al., 1999, Reviewed by Chapkin et al., 2000). Avivi-Green et 
al. (2000b) found that high levels of butyrate inhibit early and late events in colon 
tumourigenesis by controlling the transcription expression and activity of key 
proteins involved in the apoptotic cascade including caspase I and Bcl-2. Butyrate- 
induced apoptosis correlated with an increase in Bak expression and a decrease in the 
expression of Bcl-xl (Menzel et al., 2002). The induction of p2l and p27 and the 
down-regulation of Bcl-2 and Bcl-xl by butyrate suggests a link between the cell- 
cycle mechanisms regulating enterocyte differentiation and apoptosis (Litvak et al., 
1998). Litvak et al. (1998) showed that differentiation and apoptosis occurred 
simultaneously in Caco-2 cells, which suggested that apoptosis maybe linked to 
enterocyte differentiation (Litvak et al., 1998). Butyrate has been shown to result in 
the inhibition of DNA synthesis in the GI phase of the cell cycle and leading to 
differentiation (Reviewed by' Rombeau and Roth, 1995). SCFAs affects mucosdl 
colonocyte brush-border enzymes indicating enterocyte differentiation (Basson and 
Sgambati, 1998; Siavoshian et al., 2000). Differentiation induced by butyrate in 
HT'29 cells found parallel increases in the enzyme glutathione S-transferases and 
other detoxification systems activities (Kirlin et al., 1999). TGF-PI is required for 
butyrate induced Caco-2 cell differentiation (Schroder et al., 1999) and has been 
shown to reduce protein kinase C (PKC) activity (Rickard et al., 2000). Butyrate 
differentiation is thought to model the migration to the surface epithelium 
(Mariadason et al., 2000). Dietary fibre may protect against invasive colon cancer 
through stimulation of tissue inhibitor matrix metalloproteinases (TIMPs) and the 
inhibition of urokinase plasminogen activator (uPA) activities, with butyrate 
inhibiting SWI 116 invasion (Emenaker and Basson, 1998). 
Other biological effects include the modifying cell morphology and ultrastructure (by 
organising actin and vimentin) (Reviewed by Rombeau and Roth, 1995). Butyrate is 
able to induce a variety of changes in the nucleus, including histone 
hyperacteylation, inhibition of histone phosphorylation and DNA methylation (Liffirs 
et al., 2002). Butyrate causes histone hyperacetylation through non-competitive and 
reversible inhibition of histone deacetylases (HDACs) (Reviewed by Cress and Seto, 
2000; Mrs et al., 2002). Histone hyperacetylation has been associated with both a 




decrease in cell growth and activation of specific genes (Ullirs et al., 2002). Several 
studies have pointed to the possible involvement of histone deacetylases in human 
cancer, thus butyrate may have potent anti-tumour effects (Reviewed by Cress and 
Seto, 2000). Butyrate has also been shown to result in hyperacetylation of the 
nonhistone nuclear protein HMG-N2 (high mobility group) protein in vitro, which 
changes its binding properties to chromatin potentially changing gene expression 
(Lillirs et al., 2002). Modulation of this non-histone chromatin protein may be partly 
responsible for the wide range of butyrate effects (Liffirs, et al., 2002). 
The influence of butyrate on cellular gene expression has received attention due to its 
ability to inhibit histone deactylases (Yin et al., 2001). A number of transcription 
factors are directly regulated by acetylation, and butyrate can enhance their activity 
(including GATA-1 and p53) (Yin et al, 2001). There are conflicting reports as to 
whether butyrate affects proteosome activity (Buecher et al., 2001; Yin et al., 2001) 
thus it maybe dependent on the protein being investigated and the cell system. If 
Butyrate suppresses proteosome activity in the cell this could have an impact on a 
number of colonocyte and colon cancer cell activities as many proteins that regulate 
the cell cycle (eg cyclins and P-catenin) and cell death (p53) are regulated by the 
ubiquitin-proteosome pathway (Yin et al., 200 1). 
Retinoblastoma protein (RB) is involved in the regulation of the cell cycle, 
preventing entry into S phase, by binding to E2F, and has also been shown to bind to 
HDACs. There is a connection between butyrate exposure (a HDAC inhibitor) and 
retinoblastoma (RB) turnour suppressor gene function. p2l mRNA increases 
following treatment with butyrate, with p2l being essential for butyrate to induce 
growth arrest (Reviewed by Cress and Seto, 2000). Other studies have revealed that 
RB functions downstream from p2l resulting in growth arrest (Mal et al., 2000). 
APC also works upstream from RB to prevent entry into S phase resulting in cell 
cycle arrest (Reviewed by Sellin, 2001). Basson et al. (1998) showed that the SCFA 
butyrate downregulated c-myc expression and altered the tyrosine phosphorylation 
status of some intracellular proteins in CaCo2 cells. Sodium butyrate has also been 
shown to result in a redic-tion of nuclear c-myc levels (Taylor et al., 1992). Butyrate 




cell lines (Rickard et al., 2000). A number of luminal factors activate PKC such as 
diacylglycerol (DAG), secondary bile acids and faecapentenes (Rickard et al., 2000). 
Secondary bile acids and faecapentenes are potentially positively associated with 
colorectal cancer thus if butyrate reduces PKC activity this could be another potential 
protective mechanism of butyrate against colorectal. cancer (Rickard et al., 2000). 
The Cdx genes CDX1 and CDX2 are expressed in the colorectal epithelium and are 
frequently downregulated during turnourigenesis, butyrate showed no regulation of 
these proteins when induced to differentiate (Qualtrough et al., 2002). 
Butyrate also appears to have anti-inflammatory activities (Yin et al., 2001). IL-18 
has been associated with anti-tumour activity and butyrate has been shown to 
activate the IL-18 promoter upregulating IL-18 protein expression in intestinal 
epithelial cells (Kalina et al., 2002). The anti-inflammatory effects of butyrate has 
also been shown by its ability to modulate IL-12 and IL-10 receptor expression, 
down regulating IL-12R expression and upregulating IL-IOR expression (Raingeard 
de la Bldtiere et al., 2001a). Butyrate pre-treatment of a human colon cell line 
(HT'29 cells) inhibited the turnour necrosis factor-a induced nuclear translocation of 
the proinflammatory transcription factor NF-O (Yin et al., 200 1). 
Butyrate has also been proposed to have an effect on cholesterol metabolism, again 
the mechanism is unknown, but as for propionate could be by shifting cholesterol 
from the plasma to the liver (Reviewed by Rombeau and Roth, 1995; Reviewed by 
Topping, 1995). Butyrate may regulate apolipoprotein A-IV (apoA-lV) secretion, a 
ligand for high density lipoproteins, thus modulating reverse cholesterol transport 
resulting in a 20-30% increase in cholesterol efflux, the moving of cholesterol out of 
the body (Nazih et al., 2001). Butyrate has also been shown to have a small effect on 
glucose and glutamine metabolism (Reviewed by Rombeau and Roth, 1995). In 
Caco-2 cells butyrate was shown to modulate lipid synthesis, apolipoprotein 
biogenesis, and lipoprotein assembly thus suggesting a potential regulation of 





1.5.6 Health Benefits ofDietary Fibres and their use in disease states. 
Dietary Fibre is thought to have a number of properties that influence a number of 
prevailing western diseases. Diet gives clues to the actiology of many of the life 
style diseases, such as colon cancer and heart disease (Reviewed by Kritchevsky, 
2001). Metabolic effects of fibres include reducing obesity (by reducing calorie 
intake), gallstones (through reducing cholesterol saturation and possibly affecting the 
bile acid pool), diabetes (normalising glucose tolerance and plasma insulin levels), 
coronary heart disease and colon cancer (Reviewed by Kritchevsky, 2001). 
1.5.6 1 Large Bowel Disorders. 
The majority of diseases that occur in the human large intestine are of unknown 
aetiOlogy, but diet and bacteria have been implicated in having a role (Reviewed by 
Gibson and Macfarlane, 1994). The mechanical action of dietary fibre includes 
influencing stool weight resulting in the relief of constipation, diahorrea, irritable 
bowel syndrome and diverticular disease (Reviewed by Lembo, 1998; Reviewed by 
Kritchevsky, 2001) with fibre therapy improving symptoms (Reviewed by Lembo, 
1998). SCFA (Butyrate) intracolonic infusions have been shown to have beneficial 
effects on diversion colitis and distal ulcerative colitis (Reviewed by Gibson and 
Macfarlane, 1994; Reviewed by Rombeau and Roth, 1995). Antibiotic associated 
colitis, inflammatory bowel disease (IBD) and colon cancer are all thought to have 
an aetiology connected with the activities of the gut flora (Reviewed by Gibson and 
Macfarlane, 1994), which are in turn affected by fibre. In Crohn's disease fish oils 
including (n-3) PUFAs inhibit the inflammatory reaction (Reviewed by Rogers, 
1997), showing a possible role of dietary modification of immune function. 
1.5.62 Colorectal cancer. 
Burkitt was the first to propose the link between fibre intake and susceptibility to 
cancer of the colon and rectum (Reviewed by Kritchevsky, 2001). A diet rich in 
plant foods contains a number of possible anti-carcinogenic phytochemicals which 
may augment fibre action, exert a specific action of their own, or even antagonize the 




a disease of excess, over nutrition, which is a symptom of westernisation, resulting in 
an increase intake of refined carbohydrates and fast foods (Reviewed by Hill, 1999a). 
This accompanied by a decline in the level of physical exercise has attributed to an 
increase in obesity (loss of energy balance) (Reviewed by Hill, 1999a). Physical 
activity is protective (Reviewed by Oliveria and Christos, 1997), consistently being 
associated with a low risk of colorectal cancer, breast and prostate cancers 
(Reviewed by Hill, 1999a; Reviewed by Gerber and Corpet, 1999). Obesity (energy 
imbalance) is positively associated with colorectal adenomas and cancer risk, with 
several determinants of obesity being related to colorectal. cancer risk (Reviewed by 
Stephen, 1995; Reviewed by Gerber and Corpet, 1999; Reviewed by Hill, 1999a). 
Whether fibre has a protective role is unclear (Reviewed by Kritchevsky, 2001). 
Overwhelming epidemiological evidence suggests that diet is related to colorectal 
cancer development, including dietary fibre (Reviewed by Cummings and Bingham, 
1987; Reviewed by Bingham, 1990; Reviewed by Cummings and Bingham, 1998). 
Epidemiological studies on black Africans revealed a low incidence of colorectal 
cancer and this was associated with a high fibre, low calcium and low fat diets 
(Reviewed by Walker, 1995). The protective effects of fibre in laboratory animals 
against colorectal cancer have also been studied; these results have given confusing 
information suggesting a protective, neutral or even promotional effect on colon 
cancer development. These mixed results could be the result of the use of different 
fibres and differences in experimental models (Reviewed by Jacobs, 1990; Reviewed 
by Kurfeld, 1990; Reviewed by Harris and Ferguson, 1993; Reviewed Kritchevsky, 
2001). There is a suggested association between insulin resistance and colon cancer 
with a plausible suggestion that low glycaemia index foods are protective for colon 
cancer through the systemic effects in reducing risk factors associated with the 
development of type 2 diabetes (Reviewed by Jenkins and Kendall, 2000). High 
calorie intake, particularly refined carbohydrate, may result in the synthesis of IGF- I 
through the insulin-resistance syndrome (Reviewed by Gerber and Corpet, 1999). If 
carbohydrate has a protective role in colon cancer prevention, it may lie in the 
systemic effects of low glycaemic index foods (Reviewed by Jenkins and Kendall, 
2000). Interestingly, calorie restriction is also shown to reduce the number of 
spontaneous and carcinogen induced colorectal cancers in animal models, even in the 




(Reviewed by Hill, 1997a; Reviewed by Gerber and Corpet, 1999; Reviewed by Hill, 
1999). The role of energy restriction is thought to be due to reducing colonic 
epithelial cell proliferation and enhancing apoptosis (Reviewed by Gerber and 
Corpet, 1999). 
Fat and red meat was found as a risk factor in colorectal cancer, dietary fat modifies 
many colonic parameters, including bile acid and fatty acid concentrations, gut flora 
metabolism of bile acids (Reviewed by Gerber and Corpet, 1999). Although not all 
fat is bad for you, there is a positive association with animal fat but there is a 
negative association with vegetable fat and with fish oils and colon cancer (Rodgers, 
1997). 
1.5.63 Possible protective mechanisms ofdietaryfibres. 
A number of other mechanisms have been proposed for the protective effect of 
dietary fibre (Reviewed by Harris and Ferguson, 1993) including the effect on 
immune function, transit time (decreasing transit time thus reducing the length of 
time carcinogens are in contact with the colonic mucosa and changes in nutrient 
absorption), hormones (gastrin, motilin or glucagon, insulin, oestrogen, IGF-I), body 
fat and blood concentration of energy nutrients (glucose, triglycerides, fatty acids) 
(Reviewed by Stephen, 1995; Reviewed by Oliveria and Christos, 1997; Reviewed 
by Gerber and Corpet, 1999). These blood factors could in turn lead to insulin 
resistance, and enhance the proliferation of normal and neoplastic cells (Reviewed by 
Gerber and Corpet, 1999). 
Possible protective effects of dietary fibre may be due to their bulking ability 
resulting in a reduced calorie density and digestibility as well as their own low 
calorie content (Reviewed by Gerber and Corpet, 1999). Fibre increases the stool 
bulk and speeds up intestinal transit thus results in the dilution of any possible 
carcinogen along with their contact with the colonic mucosa. Fibre is thought to 
increase bulk (McNeil, 1978) by increasing bacterial biomass, water and bulk content 
thus diluting down the carcinogen and decreasing transit time (Reviewed by Mason, 
1998; Reviewed by Lembo, 1998). This decrease in transit time subsequently 




(Reviewed by Greenwald and Clifford, 1995). The increasing fibre intake would 
reduce the amount of protein digested and the level of toxic by products produced 
(Reviewed by Eggum, 1995). The colonic microflora have been shown to play an 
important role in human health and disease (Reviewed by Rao, 1995). Interestingly 
in Africa there is a correlation between bacterial species and colorectal cancer 
incidence, those that possess methogenic bacteria appear to have the lowest 
colorectal cancer incidence (Reviewed by Walker, 1995). Tumours are also more 
common in the large bowel compared to the small bowel suggesting that the 
microflora may contribute towards the carcinogenesis (Reviewed by Gibson and 
Macfarlane, 1994). Diets high in fat and protein and low in fibre can result in an 
unfavourable microbial environment in the human colon. Different fibres and 
bacteria also differ in SCFA profiles when fermented in the colon, which could 
significantly effect the development of colon cancer. Different changes in microflora 
associated with different fibres in"turn affect the ability of the microflora to ferment 
different fibres subsequently affecting SCFA profiles (section 1.5.4). The 
fermentation of fibre also results in butyrate production within the large intestine, 
which might protect against colorectal cancer as butyrate has been shown to induce 
differentiation, apoptosis, along with SCFAs lowering the pH of the lumen 
decreasing the levels of secondary bile acids being produced (Reviewed by Key et 
al., 2002). Faecal butyrate levels have been shown to negatively correlate with 
turnour mass (Reviewed by Kritchevsky, 2001) and has been shown to protect 
against DMH induced turnourigenesis in vivo (McIntyre et al., 1993). 
The major mechanism by which the gut flora may be involved is by the production of 
carcinogens from non-toxic precursor molecules (Reviewed by Gibson and 
Macfarlane, 1994). Low risk populations contained lower populations of 
Bacteroides and Bili'dobacteria, with increased counts of faecal streptococci and a 
low anaerobic: aerobic ratio (Reviewed by Gibson and Macfarlane, 1994). Faeces 
from individuals from the west frequently contain mutagenic substances (Reviewed 
by Gibson and Macfarlane, 1994). Faecapentaenes are the most prevalent genotoxin 
in the western diet being conjugated to lipids, which exert potent mutagenic activity 
(Reviewed by Gibson and Macfarlane, 1994). Microflora enzymes are readily 
induced by changes in the metabolic environment, which can be attributable to 




reduced, degraded or synthesised by these flora (Reviewed by Bingham, 1990). This 
could be especially important in the activation or degradation of carcinogens 
(Reviewed by Bingham, 1990). Other enzymes that bacteria produce that may be 
carcinogenic are nitroreductases and azoreductases as they convert procarinogens 
into carcinogens (Reviewed by Gibson and Macfarlane, 1994). These compounds 
have adverse effects towards colonic epithelial cells and are potentially harmful 
(Reviewed by Gibson and Macfarlane, 1994). 
Interestingly human populations with lower faecal pH show lower rates of colorectal 
cancers (Reviewed by Bruce, 1987). The fermentation of fibre lowers faecal pH 
(Ranhotra 2001), which in turn affects enzyme activity such as 7-a-hydroxylation 
and p-glucuronidase. P-glucuronidase is an inducible enzyme involved in the 
activation of procarcinogens and carcinogens, and may thus be a risk factor for the 
development of colon cancer (Rodgers, 1997). When pH decreases, due to the SCFA 
production, the bile acid solubility also changes. A decrease in pH results in a 
reduction in free primary bile acids in the faecal water, which subsequently decreases 
the number of primary bile acids free to be converted into secondary bile acids 
(Reviewed by Harris and Ferguson, 1993). Bile acids are also though to be a causal 
factor in colorectal cancer (Reviewed by Chaplin, 1998). Faecal bile acid 
concentrations correlates with the risk of large bowel cancer, it is thought that 
colonic bacteria convert bile acids into steroids, which have carcinogenic properties 
(Reviewed by Gibson and Macfarlane, 1994; Reviewed by Chaplin, 1998). 
Secondary bile acids having been shown to promote colorectal cancer development 
in animal models (Reviewed by Jacobs 1988; Reviewed by Chaplin, 1998; Reviewed 
by Blackwood et al., 2000; Reviewed by Kritchevsky, 2001). Thus a decrease in pH 
should theoretically decrease the potential turnour promoter activity of secondary 
bile acids (Reviewed by Harris and Ferguson, 1993). The concentration of bile acids 
in faeces in populations at high risk have been shown to be elevated, probably 
because of less dilution of colonic content (Reviewed by Kritchevsky, 2001). With 
colorectal cancer the ratio of lithocholic acid and deoxycholic acids has been shown 
to be an important aetiological factor (Reviewed by Story, 1995; Reviewed by 
Kritchevsky, 1995). All together dietary fibre (NSP) itself could be protective by 




produces toxic by products such as amines. Although a decrease in pH may also be 
seen as a risk factor due to the increase in cell proliferation this causes, potentially 
enhancing chemically induced/initiated carcinogenesis (Newmark and lupton, 1990). 
Thus changes in colonic homeostasis is also important (Reviewed by Roncucci, 
2000) with a number of groups showing dietary fibre to effect proliferation (Robblee, 
1989; Pell, 1995), changes in crypt number (McCullough et al., 1998) and apoptosis 
(Avivi-Green et al., 2000a; Aviv-Green et al., 2000b). 
1.6 Models of Colorectal Cancer 
1.61 Animal Studies -In vivo models ofcolorectal cancer. 
Animal studies are selectively designed to demonstrate how specific dietary 
components influence a given outcome (Rodgers, 1997). Rodent studies are a useful 
tool in studying the role of nutritional factors in cancer development determining 
how non-absorbable dietary components influence the development of colonic 
neoplasia (Rodgers, 1997). Animal models provide a relatively quick analysis, 
colon cancer can take up to 50 years to develop in humans, whereas a rodent life 
cycle can be completed within 3 years. Advantages of animal models include the 
fact that each mouse is genetically identical suggesting that they share the same 
microflora thus it would only be the luminal influences (Fibre) that would affect 
microflora and cancer development. Mice and rats are usually the model of choice 
because they are easy to house, easy to maintain and well characterised 
physiologically (Reviewed by Salyers, 1995). Using animal models individual 
stages of carcinogenesis can be studied helping eliminate some of the disadvantages 
of epidemiological studies (Reviewed by Hill, 1997a). They also have a number of 
disadvantages, rodents have a very low rate of spontaneous cancers, probably 
because of their short life span, therefore cancer needs to be induced with specific 
carcinogens which may not itself be an environmental carcinogen. There is also 
strain selectivity/sensitivity to the carcinogen thus giving a variety of results, but this 
is the same for the human population, and are probably due to differences in 
metabolism, genetics, being dependent on the initiator used, route of administration 




models in dietary studies come from differences in microflora to humans and also 
most rodents indulge in coprophagy (Reviewed by Salyers, 1995). Structural 
difference between mouse and man include the structure of the caecum, it is 
proportionally much larger in the mouse being the main fermentation site, whereas 
the caecuin in man plays a less significant function. There are also differences in 
bacteria between man and mouse (Reviewed by Salyers, 1995), murine microflora 
have similar bacterial genres but has differences in species. In man there are also 
large differences between individuals. In human cancer the initiator is rarely known 
thus difficult to apply to animal studies (Reviewed by Hill, 1999). Diet manipulation 
is then studied to see whether the proportion with cancer can be decreased 
(protection) or increased (promotion) (Reviewed by Hill, 1999). In the case of 
colorectal. cancer the main etiological agents, fat and fibre, act during the promotion 
stages, therefore if a carcinogen is used to initiate then can see if fat/fibre changes the 
rate of pfomotion/progression (Reviewed by Hill, 1997a). 
There are a number of rodent models available including knockout mouse models 
where cancer related genes are over expressed (oncogenes) or inactivated (tumour 
suppressor genes) (Reviewed by Hursting et al, 1997). Those of particular interest 
are those involving the APC gene including APC (delta716) a model constructed by 
Oshima et al (1997) where APC gene contains a truncated mutation at codon 716 and 
were shown to develop numourous intestinal polyps, this model has been modified 
with other genes being knocked out including Smad4 and Smad2 (Takaku et al, 
2002), APC(delta474) which also result in small intestinal adenomas (Sunayama et 
al., 2002) and APC(1638N) (Smits et al, 2000). The two most commonly used 
murine models are the multiple intestinal neoplasia (MIN) (Moser et al., 1990; Su et 
al., 1992; Dietrich et al., 1993; Moser et al., 1995; Bames and Lee, 1998; Philipp- 
Staheli 2002; Anderassen, 2001; Roberts et al, 2002) and the 1,2-dimethylhydrazine 
mouse (Reviewed by Rogers and Nauss, 1985; Reviewed by Klurfeld, 1995; 




1.6 3.2 Multiple Intestinal Neoplastic mouse. 
FAP has provided a useful model for studying colorectal cancer and is characterised 
by the development of 1000's of polyps at a young age. An animal model of familial 
colon cancer has been developed known as the multiple intestinal neoplasia (MIN) 
mouse (Moser et al., 1990; Dietrich, 1993; Moser et al., 1995; Barnes and Lee, 1998). 
The MIN mouse model is reflective of inherited (FAP) colorectal cancer (5% of all 
colorectal cancers), having an APC mutation (found in 80-85% of all colorectal 
cancers), which results in the production of a large number of small bowel tumours. 
The MIN mouse provides an excellent model to study genetic interactions and 
environmental influences such as diet on the colon (Dietrich, 1993; Moser, 1995). 
1.63.3 1,2-dimethylhydrazine mouse (DMH) model. 
DMH is widely used to study chemically induced colon cancer (Reviewed by Rogers 
and Nauss, 1985; Reviewed by Klurfeld, 1995; Jackson et al. 1999) and provides a 
useful model for studying early carcinogenesis. In 1967 Druckrey discovered that 
1,2-dimethylhydrazine (DMH) was a specific colon carcinogen (Reviewed by 
Pozharisski et al., 1979; Reviewed by Rogers and Nauss, 1985; Reviewed by 
Klurfeld, 1995; Zhurkov et al., 1996) being highly carcinogenic in rodents 
(Reviewed by Klurfeld, 1995). DMH mouse model is initiated using a chemical 
carcinogen, reflective of sporadic cancers (95% of all colorectal cancers). The 
chemical carcinogen is site specific to the large bowel. DMH is activated 
(metabolised) in the liver, and these active metabolites reach the dividing cells at the 
bottom of the crypt via the bloodstream (Weisburger et al., 1977; Reviewed by 
Pozharisski et al., 1979; Reviewed by Klurfeld, 1995). Pozharisski et al. (1979) also 
suggests DMH metabolites to also be excreted from the liver via biliary secretion but 
other groups have found no evidence for this biliary secretion (Reviewed by Sunter, 
1980). The metabolism of DMH, suggested by Druckrey (Fig 1.8), results in the 
production of an intermediate compound methylazoxymethanol (MAM), an unstable 
compound in aqueous solution with alkylating properties being observed both in 
vitro and in vivo (Reviewed by Sunter, 1980). The evidence points to 
methyldiazonium producing the alkylating properties providing the carcinogenic 




The metabolite of DMH, methylazoxymethanol (MAM), is known to be a DNA 
akylating agent (Reviewed by Sunter 1980; Reviewed by Klurfeld 1995) and the pro- 
mutagenic lesion 06 -Methylguanine has been detected in DNA from various rat and 
mouse tissues following exposure to DMH (Jackson et al, 2000). Many groups have 
looked at the various genes found mutated in human colorectal cancer to see if they 
are affected. For example Rudzki et al. (1997) found that there was marked global 
overexpression of standard and variant CD44. Jackson et al. (1999) found that there 
was no mutations found in either codon of K-ras (a gene commonly mutated in 
human tumours). Another study revealed that K-ras mutations were an early event in 
colorectal tumourigenesis when examining tumours induced by DMH in rats (Jacoby 
et al., 1991). It has been shown that AOM, a derivative of DMH, causes a mutation 
in the GSK-30 consensus motif of fl-catenin in rats (Takahashi et al., 1998), and 
mice (Takahashi et al., 2000a; Takahashi et al., 2000b). The role of p53 in DMH 
turnour development has been studied and revealed that IgG antibodies against 
turnour associated antigens including p53 resulted in the decrease in incidence and 
progression of the tumours, suggesting a role for p53 in DMH turnour development 
(Zusman et al., 1996). Further studies found that germline mutations in p53 enhance 
the incidence of DMH induced colon turnours (Lubet et al., 2000). Subsequent 
studies have revealedp53 mutations, with majority of mutations occurring in intron 6 
(non-coding) and exon 4 region (Jenkins et al., 1997). Refer to chapter 4 for more 
information on genetic changes within the DMH model. 
Observations in the DMH mouse have revealed that the changes seen in the mouse 
bear many similarities with the morphological changes observed in human 
adenomatous polyposis (Reviewed by Rogers and Nauss, 1985; Carter et al., 1994; 
Moorghen et al., 1998). Subcutaneous administration of DMH initially results in 
necrosis of the colonic crypt epithelial cells with crypts appearing markedly reduced 
in size with the appearance of morphologically abnormal crypt cells (Reviewed by 
Sunter, 1980). Chronic administration of DMH results in hyperplasia (characterised 
by increased crypt length and proliferative compartment, dilatation, tortuosity and 
crypt branching) (Chang, 1978; Chang, 1980; Moorghen et al., 1998) followed by 




mucosal surface(Reviewed by Sunter, 1980; Chang, 1980). These microadenomas 
grow into macroscopic sessile polyps (adenomas), which can become invasive 
(invasive adenocarcinoma) (Carter et al., 1994; Moorghen et al., 1998). 
Figure 1.8 Metabolism of DMH ( cycasin-related Compounds) ( Sunter, 1980) 














The main aim of this study was to evaluate whether dietary fibre supplements elicit a 
protective effect against colorectal cancer development and if this is mediated via the 
cadherin/catenin complex since the regulation of P-catenin expression levels appears 
to be a fundamental component of colorectal cancer development. 
Initially a study was conducted to determine the physical and chemical 
characteristics of the dietary fibres; ispaghula husk, pectin and cellulose, as 
individual fibres and constituents of a fibre supplemented diet used within this study. 
The rate, site and extent of fermentation of dietary fibres, which are based on their 
structural characteristics, are important factors in determining dietary fibre 
physiological properties. Different fibres have also been shown to produce different 
levels of fermentation products, particularly butyrate, propionate and acetate, which 
have been previously shown to have differential biological effects on the colonic 
epithelium. 
The 1,2-dimethylhydrazine mouse model was chosen to examine the effects of 
dietary fibre on tumour development in vivo. Preliminary studies on archival tissues 
revealed an increase in cytoplasmic and nuclear localisation of P-catenin within the 
dysplastic epithelium. Therefore the determination of cadherin/catenin component 
expression within the dysplastic and non-dysplastic epithelium of the 1,2- 
dimethy1hydrazine mouse model was examined. 
The effects of dietary fibre supplements (ispaghula husk, pectin and cellulose) on 
1,2-dimethylhydrazine induced colonic adenomas and cadherin/catenin expression 
was then investigated. This involved a 17 week feeding study, where mice were fed 
on a basal diet supplemented with the various dietary fibres accompanied by weekly 
injections of the carcinogen. A number of parameters were to be examined including 
tumour incidence, number, burden and cell proliferation. The parameters chosen 




The effects of dietary fibre were examined further to try and elucidate any biological 
mechanism of action from the effects observed in vivo. This involved the 
examination of the effects of luminal factors (dietary fibres and short chain fatty 
acids butyrate, acetate and propionate) on a parameters of colonic homeostasis and 
cadherin/catenin protein expression in human and murine colonic epithelial cell lines. 
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2.1 Fibre Characterisation. 
2.1.1 Fermentation Study usingfaecal slurries under anaerobic conditions. 
Fresh human faecal stool samples from a male Caucasian, 51 years of age, and of 
good health with no recent intake of antibiotics, were collected into a polythene bag, 
immediately sealed to occlude oxygen, and stored at 37 'C for I hour. 0.1 g of fibre 
(ispaghula husk, pectin, cellulose, resistant starch, Table 2.1) or 0.2g of diet (basal, 
basal supplemented with ispaghula husk, pectin or cellulose) were hydrated in 5 ml 
(2% w/v and 4% w/v respectively) of anaerobic mineral salts medium (MSM, Table), 
within the anaerobic cabinet (MACS-VA500 - Microaerophilic workstation, Don 
Whitley Scientific, Shipley, West Yorks) under anaerobic conditions (10% Carbon 
dioxide, 10% hydrogen, 80% nitrogen) for 2 hours. 
Table 2.1 
Dietary Fibre Brand Name Supplier 
Ispaghula Husk _ Fybogel ReckittBenckiser 
Healthcare limited 
Pectin Genu Pectin Type FIT-1 Copenhagen Pectin A/S, 
Division of Hercules Incorporated, Denmark 
ellulose Solkafloc James River 
Corporation, NJ 
Rice Starch Special Dietary Services, 
Witham, Essex 
Resistant Starch Novelose National Starch and Chemical, ýZea 
Mais, Corn Maize) Manchester, UK 
The mineral salts medium (MSM, Table 2.2a and b) was previously placed in an 
anerobic enviromnent for 24 hours. A faecal homogenate was achieved by adding 
40g fresh stool sample to 200 ml of anaerobic MSM (16.67% w/v) in a class 2 cabinet 
(Endair). The faecal homogenate was stomached (Seward stomacher 400) in a 
stomacher bag for 30 seconds. The resulting slurry was centrifuged (3 000 rpm for 10 
minutes; MSE, Mistral 2000) separating out the solids from the supernatant (which 
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contained the relevant bacteria), and returned to the anaerobic cabinet to minimise the 
oxygen content. 
Three different reaction mixtures were set up within the anaerobic cabinet; firstly the 
test sample (in triplicate) containing 5 ml of hydrated fibre in MSM diluent and 5 ml 
faecal homogenate supernatant (1% w/v fibre), a fibre control containing 5 ml of 
hydrated fibre in MSM diluent and 5 ml MSM (1% w/v fibre) and three faecal 
controls containing 5 ml of faecal homogenate supernatant and 5 ml MSM diluent. 
All were then agitated. Anaerobic conditions were monitored using internal and 
external oxygen meters and remained around 0.1% throughout. 
At designated times (0,3,6 and 24 hours) 0.1 ml of reaction mixture was removed in 
duplicate and diluted (xlO) with 0.9 ml acidified propan-2-ol containing 5.55MM 
internal standard (ethyl butyric acid) followed by Centrifugation (130OOrpm, 5 
minutes). Aliquots of the clear supernatant were pipetted into crimp sealed gas 
chromatography injection vials and stored at 4"C until analysis by gas 
chromatography. 
An external standard solution was prepared for gas chromatography analysis 
containing 5mM concentration of acetic acid, propionoic acid and butyric acid (the 
three principle short chain fatty acids produced by bacterial fermentation, Sigma). 
GC analysis (Supelco Nukol 24107 capillary column (30m x 0.25mm. x 0.25ýLm) oven 
maintained at 160"C, injector and detector maintained at 250*C, with injection 
volume of lgl- Carrier gas (helium at 16.6psi) flow rate of 8.2ml/min. Hewlett 
Packard instrumentation) coupled with external standard solutions (5mM 
concentration of acetate, propionate and butyrate) was performed in duplicate. 
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The concentration (Conc) of short chain fatty acids (SCFAs) in the sample was 
calculated using the following formula for each dietary fibre at each time point: 
For each SCFA 
Conc. SCFA in sample = (Conc of std/response of std) x response of sample 
Therefore the standard (std) for butyrate would be used to calculate the level of 
butyric acid present within the sample. 
The mean mM concentration minus the mean concentration for the faecal 
homogenate control was then determined for each dietary fibre or diet at each time 
point. 
mM concentration of SCFA - mM concentration of SCFA 
Within the sample with faecal control 
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Table 2.2a Mineral Salts Media (MSM) pH 7 
Compound Weight (g) 
Disodiuni hydrogen phosphate 2.00 
Potassium dihydrogen orthophosphate 4.00 
sodium chloride 6.00 
Cysteine 0.8 
sodium hydrogen carbonate 1.5 
calcium chloride 0.1 
Magnesium chloride 0.15 
Cobalt chloride 0.1 
manganese chloride 0.15 
ferrous sulphate 0.005 
haernin (I mg/ml in 00 1M KOH) 5 ml 
purified water made up to 1000 ml 
Vitamin mixture (See Table I b) lml 
Table2.2b Vitamin mix 
Compound weight (mg) 
Vitamin B12 0.5 





Materials and Methods 
Z1.2 Non-Starch Polysaccharide analysis using the Englyst technique. 
Englyst (Modified from Englyst et al., 1992) was used to determine total and 
insoluble non-starch polysaccharides (NSP) levels of ispaghula husk, pectin, resistant 
starch and cellulose (Table 2.1). It was further used to measure NSP levels of fibre 
based diets: basal, basal supplemented with ispaghula, basal supplemented with 
pectin and basal supplemented with cellulose. Isphagula husk also acted as a control 
sample as it has been characterised on numerous occasions by ReckittBenckiser 
Healthcare limited using the same technique. 
100mg (fibre) and 200mg (diet) aliquots were weighed out into 50ml plastic screw 
top centrifuge tubes (TCR, Fischer), where 0.5ml acid rinsed sand (to prevent 
aggregation of sample) and a PTFE magnetic flea were then added to each tube. 
Dispersion of starch, to allow more effective starch hydrolysis, was achieved by 
boiling the samples in 2 ml of dirnethylsulphoxide (DMSO, Sigma) for 30 minutes 
with continuous mixing. Enzymatic hydrolysis of starch was achieved by 
immediately adding 8 ml of OAM sodium acetate buffer (pH 5.2) and mixed (Table 
2.3). Once samples had cooled to below 351C 0.5 ml (x-amylase (2150 units/ml, 
Sigma) and 0.1 pullulanase (I unit/ml, Sigma) (Table 2.3) were added to each sample 
and incubated at 42*C (± 2) for 16 to 18 hours mixing after the first hour. 
Depending on whether total or insoluble NSP was being determined the tubes were 
treated differently at this point. With total fibre analysis, the tubes were cooled to 
room temperature, 40 ml of absolute ethanol (BDH) added to each tube, mixed by 
inversion and placed on ice water for 30 minutes. The tubes were then centrifuged 
(2610rpm, 10 minutes), the supernatant aspirated and 10 ml 85% ethanol added. The 
samples were vortexed, filled to 50 ml with 85% ethanol, stiffed for at least 5 minutes 
(at room temperature) and centrifuged (2610rpm, 10 minutes), supernatant aspirated. 
With insoluble fibre analysis, samples were boiled for 30 minutes in 40ml of 0.2 M 
sodium phosphate buffer (pH7) (Table 2.3) with continuous stirring. The samples 
were then cooled in water for ten minutes, centrifuged (2610rpm, 10 minutes) and 
supernatant removed. 10ml of water added, vortex mixed and topped up to 50ml with 
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water. Samples were then stiffed for 5 minutes, centrifuged (2610rpm, 10 minutes) 
and supernatant removed by aspiration. 
All samples were treated the same from this point on: 10ml absolute ethanol (BDH) 
was added to all samples, mixed by inversion and filled to 50ml with absolute 
ethanol. After 5 minutes of mixing the tubes were centriftiged (26 1 Orpm, 10 minutes) 
and the supernatant removed. 10ml acetone (BDH) was then added, vortex mixed 
and filled to 50ml with acetone. The tubes were stirred for 5 minutes, centrifuged 
(2610rpm, 10 minutes) and supernatant aspirated. The remaining residue was dried in 
a 80 OC water bath, with continual mixing. 
Acid hydrolysis of the polysaccharides was achieved by adding 5 ml 12 M sulphuric 
acid (BDH) to the dry residue, vortex mixed and incubated at 35'C (±I) for 1 hour. 
The samples were periodically mixed to help disperse any cellulose. Twenty five ml 
of water was then rapidly added to each sample, vortex mixed, and boiled for I hour 
with continuous stirring. The samples were cooled, filtered (GF/C filter paper 
11 Omm, Whatmann) into 8 dram glass vials and stored overnight at PC 
Alditol acid derivatisation of the sugars was achieved by aliquoting out 3ml of the 
hydrolysate or external sugars (0.5mg/ml rhamanose, xylose, arabinose, mannose, 
galactose and glucose in 2M sulphuric acid) into 4 dram glass vials and I ml of 
allose internal standard (1.002mg/ml) added (Table 2.3). On ice, 2.4ml of 12M 
ammonium hydroxide (BDH) was added, followed by 0.4ml of sodium 
borohydride/ammoniurn hydroxide solution (200mg sodium borohydride (BDH) in 
Iml 12M ammonium hydroxide (BDH) and 3ml of water) and 5ýd of octan-2-ol (anti- 
foaming agent; BDH). After shaking, the vials were incubated at 4011C for I hour 
after which 0.8ml glacial acetic acid (BDH) was added. 
Acetylation of the sugars was achieved by transferring 0.5ml of the acidified solution 
to an 8 dram vial where 0.5ml 1-methylimidazole (Sigma) and 5ml acetic anhydride 
(BDH) was added. The samples were shaken and left capped for 10 minutes. 1.25ml 
absolute ethanol was added, vials shaken, and left capped for 5 minutes. 10ml of 
water was added, shaken and left capped for a fiu-ther 5 minutes. 0.5ml of 0.004% 
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bromophenol blue solution was then added to the vials, mixed and placed on ice 
water. 5ml 7.5M potassium hydroxide (BDH) was added to each vial followed by a 
further 5ml and then inverted to mix. The vials were left for 15 minutes while phase 
separation occurred. The clear phase was transferred to an autosampler vial 
containing a 250ýd micro-insert for analysis by gas liquid chromatography (Hewlett 
Packard HP 5890 GC with HP7673 autosampler). Using the chemical/enzymatic 
Englyst method coupled with gas-liquid chromatography (GC, Supelco SP2380 
capillary column (30m x 0.25mm) with flame ionisation detector, column maintained 
at 250'C, with the injector kept at 2600C and the detector at 2801C, carrier gas 
(helium) flow rate of 3ml min-) and colourimetery (UV spectroscopy), the total, 
soluble and insoluble NSP levels of the dietary fibres ispaghula husk, pectin, 
cellulose and resistant starch and their associated diets were determined. 
For each run the response factors (RF) were calculated using the following formula: 
RF = Conc. of sugar in external standard (mg/ml)*3*allose peak area 
Conc. of allose in internal standard (mg/ml) * sugar peak area 
This was then used to determine the concentration (%w/w) of the neutral sugars using 
the following formula: 
RFx 890 x conc. of allose soln. (mjz/ml) x suizar veak area in sample 
Allose peak area x sample weight 
Uronic acid derivatisation was achieved by transferring 0.3ml of the original 
hydrolysate to a plastic centrifuge tube. Samples were diluted with 1.2ml 2M 
sulphuric acid to ensure uronic acid concentration was less than 100 ppm. 0.3ml 
sodium acetate/boric acid solution and 5ml concentrated sulphuric acid was added to 
each tube and vortex mixed immediately. The samples were then heated in a 700C 
oven for 40 minutes. The tubes were cooled in water at room temperature. 0.2ml 
3,5-dimethylphenol solution (Table 2.3) was added followed by vortexing. After 15 
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minutes absorbance at 400nm and 450nin was measured against a de-ionised water 
reference. 
The concentration (%w/w) of uronic acid in each sample was determined using the 
following calculation: - 
tN5o-A, Loo-C)x2.9xO. 89 
Mx sample weight (mg) 
where A450 is the absorbance at 450nin, A400 is the absorbance at 400mn, c is the Y 
intercept of the calibration graph and M is the gradient of calibration graph. A 
dilution factor was also included where necessary. 
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Table 2.3 
Solution Chemical Weight Supplier 
Sodium Acetate Sodium acetate 8.2g BDI i 
Buffer anhydrous 
Benzoic acid 50% Saturated BDH 
Glacial acetic acid To adjust to pH 5.2 BDH 
IM calcium chloride 4ml/L BDH 
ddH20 IL 
cc-Amylase solution cc-amylase 90[tl Sigma A-4268 
suspension 
Sodium acetate Iml 
buffer 
Pullulanase solution Pullulanase I 0[d Sigma P-5420 
suspension 
Sodium acetate Iml 
buffer 
Sodium Phosphate Anhydrous 28.4g BDH 
buffer disodiurn hydrogen 
orthophosphate 
ddH20 IL 




0.2M sodium Anhydrous 24g 
dihydrogen Or BDH 
orthophosphate Monohydrated salt 27.6g 
solution 
ddH20 IL 
Allose internal allose I mg/ml Sigma 
standard 
Benzoic acid 50% saturated BDH 
3,5-dimethylphenol 3,5-dimethylphenol O. Ig BDH 
solution 
Glacial acetic acid I 00ml BDH 
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Z1.3 Solubility of thefibres as determined by Image analysis 
Individual fibres were placed onto microscope slides (BDH) and hydrated in ddH20 
for 1 hour, images of hydration were then observed (Zeiss microscope) and recorded 
using image analysis (Zeiss KS300 3.0). 
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2.2 1,2-dimethylhydrazine mouse model. 
ZZ1 Housekeeping 
Two week old Female Balb/C Mice (BNK) were caged in groups of 10 and housed 
under standard conditions (12 hour light and dark cycle at 250C). The mice were 
randomly divided into 5 groups, group I consisting of 10 mice, the other 4 groups 
containing 30 mice. Group I were wild type female Balb/c mice fed on a powdered 
basal diet (fibre deficient diet, Special Diets Services, Table 2.4). The second group 
of mice were fed on the same basal diet but were injected with the carcinogen 1,2- 
dimethy1hydrazine (DMH) (section 2.2.2). The third, fourth and fifth groups were fed 
on a basal diet supplemented with 14.5 % of Ispaghula husk (Reckitt Benckiser 
Healthcare p1c), pectin (Hercules, Genu pectin type FIT-1, Denmark) and cellulose 
(Solkafloc, Special Diet Services, Witham, Essex) (Table 2.1) respectively and were 
also subjected to DMH administration. The mice were allowed free access (ad 
libitum) to the specified diet and water with their weight and water intake continually 
monitored throughout the duration of the experiment. 
The diets were formulated and manufactured by Special Diets Services (SDS, 
Witharn Essex), eradicating the irradiation of the feed to minimise structural damage 
of the fibres. Thus due to the nature of the diets they were received in three batches 
to maintain food quality at the highest nature. 
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Table 2.4 Composition of the Diets used in the Maintenance of Balb/C mice. 
Diet 
/Composition. 






Rice Starch 37.5 30 30 30 
Ispaghula Husk 0 14.5 0 0 
Pectin 0 0 14.5 0 
Cellulose 0 0 0 14.5 
Ca Caseinate, 20 20 20 20 
Sucrose 32.5 25.5 25.5 25.5 
SoyaOil (0.5%) 5 5 5 5 
VitaminMineral 
2.5% 
5 5 5 5 
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2.22 Treatment with 1,2-dimethylhydrazine 
Female Balb/C mice were injected subcutaneously with 1,2-dimethylhydrazine 
hydrochloride (Aldrich Chemical Co. Ltd. ) dissolved in EDTA (0.4%, sigma) and 
normal saline (0.9%) pH6.5 (25mg DMH base/Kg body weight) once weekly for 17 
weeks. After 17 weeks, the mice were sacrificed by cervical dislocation and colons 
removed. The colon was opened longitudinally, pinned onto corkboard serosal side 
down thus exposing the colonic mucosa. The tissue was fixed in carnoys reagent for 
3 hours followed by fixation in 10% formalin. Nodules were then counted, measured 
and position noted (fig. 2.1 and fig. 2.2) using a dissecting microscope. 
Representative histological samples were taken from the macroscopic nodules, 
adjacent normal mucosa and midpoint regions (fig 2.1) in the distal portion of the 
colon for fiu-ther analysis. 
ZZ3 Bromodeoxyuridine (BrA9 as a measurement ofproliferation 
Female Balb/c mice were injected IP with BrdU (Sigma) and left for 1 hour (Flash 
labelling). The mice were sacrificed by cervical dislocation and colons removed. 
The colon was opened longitudinally, pinned onto corkboard serosal side down thus 
exposing the colonic mucosa. The tissue was then fixed as in section 2.2.2. Tissues 
were sectioned (4pm) using a microtome and mounted onto poly-L-lysene slides 
(BDH) so that every fifth section was assessed (to avoid crypt replication). The 
tissues were dewaxed and dehydrated using histoclear and graded alcohol washes. 
Endogenous peroxidase activity was blocked by incubating the slides in 0.6% H202 
(Sigma). The paraffin sections were hydrolysed using 1M hydrochloric acid (HCI) 
(BDH) at 60 OC for 8 minutes. The tissues were cooled using water and non-specific 
binding was blocked using Goat serum (1: 20, DAKO). The tissues were incubated 
with the primary antibody, rat anti-BrdU (Harlan-seralab, 1: 2000) for 2 hours at room 
temperature. Primary antibody was localised by incubating the tissues in secondary 
antibody, biotin conjugated goat anti-rat (MAS 250c Harlan-seralab, 1: 2000) for 30 
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Fig 2.1 Representation of the colon revealing the colonic divisions made when 




Figure 2.2 Representative nodules. Example of nodules excised from the colon, 
here turnours are found in the distal and distal middle parts of the colon (Mouse 5J, 
from the Pectin fed group). 
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incubated in streptavidine (1: 250, DAKO) for 30 minutes, followed by DAB (Dako 
kit) and counterstained with Haernatoxylin (Gills) and lithium carbonate (Scotts), and 
mounted using pertex mountant. The tissues were examined under a light 
microscope, counting the number of truly positive cells in each intact crypt, where 
possible 50 crypts were scored. 
22.4 Bromodeoxyuridine (BrdU)-Labelling Index 
BrdU labelling was used to examine the number of crypts undergoing DNA 
replication (in S phase of the cell cycle) as a measure of cell proliferation within the 
crypt. The BrdU - labelling index for each mouse was calculated as follows; 
Labelling index = Total number of positive cells for a single cryp 
Number of cells within that crypt 
All 50 crypts from that mouse were added together and 
divided by 50 to give the percentage of positive cells 
representing the labelling index. 
Z2.5 Tumour Burden 
Tumour burden was calculated using the following formula based on the assumption 
that each tumour can be represented as a hemisphere with a mean diameter of 
V2(dl+d2) its volume was determined as IE/96(dl+d2). For each turnour-bearing mouse 
the tumour volumes were added and the diameter V of the hemisphere corresponding 
to the total volume was calculated: 
d=! /21, vý-'(dj+d2)3 
where d is the diameter of the sum total, thus this value was used as a measure of 
total tumour burden for each individual mouse. d, and d2 are the length and width of 
each individual tumour for that mouse (Moorghen, 1992). 
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2.3 1,2-dimethylhydrazine mouse model characterisation. 
Z3.1 Histopathology 
Identification of microadenomas and turnours were determined using haematoxylin 
and eosin (H&E) staining. 4pm sections of paraffin embedded tissues were mounted 
onto superfrost slides (BDH), dewaxed and rehydrated using histoclear and graded 
alcohol washes to water. The slides were stained with haernatoxylin (Gills) for 3 
minutes, Lithium carbonate (Scotts), eosin for 4 minutes, with ddH20 washes 
between each step, then dehydrated in graded alcohol washes, histoclear and 
mounted. Tissues were examined by two independent observers (E. Tucker and Prof. 
M. Pignatelli, except microadenomas E. Tucker and Dr. J. Gupta), using a light 
microscope. 
Z3.2 Immunohistochemistry 
Expression and cellular localisation of catenins was determined using standard 
avidin-biotin complex (ABC) immunohistochemical technique on camoys-fixed 
paraffin embedded tissue sections. 41im sections of paraffin embedded tissues were 
mounted onto poly-L-lysene (BDH) slides. The tissue was dewaxed and rehydrated 
using histoclear and graded alcohol washes. Endogenous peroxidase activity was 
blocked by incubating the slides in 0.6% H202. Antigen retrieval was achieved by 
heating (microwave) the slides in O. IM citrate buffer (pH 6) for 20 minutes. Non- 
specific binding was blocked using goat serum (Dako, 1: 20) for 10 minutes. The 
tissues were incubated with the primary antibody (Table 2.5) overnight at 4"C. 
Localisation of the primary antibody was achieved using biotin labelled goat anti- 
mouse (DAKO, 1: 250) for 30 minutes followed by peroxidase labelled streptavidin 
(DAKO, 1: 100) for 30 minutes. Visualisation was achieved using diaminobenzadine 
(DAB kit, DAKO), counter stained using haernatoxylin (Mayers) and lithium 
carbonate (Scotts). Slides were then dehydrated and mounted using pertex mountant. 
Tissues were examined under a light microscope by two independent observers (E. 
Tucker and Prof M. Pignatelli) without knowledge of origin. The cellular 
localisation and immunoreactivity was always assessed relative to adjacent non- 
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malignant epithelium within the same tissue. Staining was assessed in terms of the 
percentage epithelial cells with membranous, cytoplasmic or nuclear staining. 
Tumours were scored as follows: - a score of 3 for >90% positive epithelial cells, 2 for 
90-50% positive cells and I for <50%. A negative control was carried out for each 
round of staining (Figure 2.4) 
Table 2.5 Antibodies. 
Antibody Supplier Concentration 
p-catenin BD Transduction Labs 1: 500 
cc-catenin BD Transduction Labs 1: 100 
y-catenin BD Transduction Labs 1: 100/1: 250 
p120 BD Transduction Labs 1: 250 
E-cadherin BD Transduction Labs 1: 500 
BRDU Harlan-seralab 1: 1000 
Z3.3 Tissue Lysatesjor varifying specificity of antibodies in mouse tissues 
Frozen tissues were sectioned (30x25ýtrn) on a cryostat at -30'C and stored at -80'C. 
ME sections were taken at three stages of the cutting process to determine histology 
of the tissues. 300ýd of soluble fraction lysis buffer (0.5% Triton-X, 50mM NaC12. 
I OmM Pipes (pH6.8), 3mM M9CI2,300mm Sucrose) were added to each tube, kept 
on ice for 20 minutes with periodic vortexing. The lysates were then centrifuged at 
130OOrpm for 10 mins at 4"C, supematent removed and stored at -2011C (soluble 
fraction). The pellet was then lysed in 200ýd of insoluble fraction (SDS) lysis buffer 
(I 5mM Tris-HCI (pH7.5), 5mM EDTA, 2.5mM EGTA, I% SDS) at I OO'C for 15 
minutes, centrifuged (130OOrpm) for 10 minutes at 4'C. The supernatant was 
collected, insoluble fraction, and stored at -200C. Protein concentration was 
determined for each lysate using a BioRad protein assay (BioRad) and cricket graph. 
Western blot samples were then made using equal concentrations of protein extract , 
boiled in sample buffer for 5 minutes, cooled on ice, pulse spun and loaded. See 
section 2.6.1.2 for SDS-PAGE protocol. 
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Z3.4 Protein extract anaylsis to determine equal loading 
Two different methods were implemented depending on whether a high level of 
detergent was found in the lysates. The BioRad colourimetric protein assay kit (Bio- 
Rad) was used per manufacturers instructions, bovine serium albumin (BSA) was 
used as a control and spectrophotometry was used to determine protein 
concentrations, with protein concentrations being calculated using the Gricket Graph 
or Microsoft Excel. 
79 
Chapter 2 
Materials and Methods 
2.4 Mutational analysis 
Z4.1 Primer design 
P-catenin was amplified using primers designed by Takahashi et al. (2000a) obtained 
from MWG-Biotech. 
Z4.2 Polymerase Chain Reaction (PCR)for fi-catenin gene amplification 
DNA was extracted from paraffin and frozen tissues using a Qiagen@ kit (Qiagen 
Ltd, West Sussex, UK). PCR primers were used to amplify exon 3 of 0-catenin 
containing the consensus sequence for GSK-3p phosphorylation. 5'-primer, 
GCTGACCTGATGGAGTTGGA; 39-primer, . GCTACTTGCTCTTGCGTGAA 
(Takahashi et al., 2000a), with a PCR product length of 227bp obtained from MWG- 
Biotech. For frozen tissues 50 pI PCR reaction mixture consisted of 0.5AI (50pMol) 
of each primer, 51il dNTP (2mM, Gibco), 5ýd PCR buffer (xlO, Gibco), 31d MgC12 
(50mM, Gibco), 0.3til platinum Taq (5U/[tl, Gibco), 6ýd DNA (tissue lysate) and 
made up to 50ptl with sterile distilled water. Forty cycles were then performed, each 
cycle consisting of a denaturing step (940C for I minute) annealing step (58"C for I 
minute) and elongation step (7211C for 1 minute, except the last cycle which lasts 7 
minutes) using a DNA engine, MJ block, Peltier Thermal cycler, DyadTm. A negative, 
and where possible, a positive control were run in parallel. Fifteen microlitre aliquots 
of DNA (PCR product) in 5pl ficol buffer (0.25% bromophenol blue, 0.25% xylene 
cyanol FF, 15% ficoll (type 400; pharmacia) in water; Molecular Cloning, Maniatis) 
were then fractionated by gel electrophoresis on a 1% (w/v TBE) agarose gel 
containing 0.14 pg m1: 1 ethidium bromide running in Ix Tris-Borate EDTA (TBE) 
buffer (0.045 M Tris-Borate, 0.001 M EDTA, pH 7.5) at IOOV for 1 hour. The 
separated DNA was visualised on an ultra violet transilluminator, bands of relevent 
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2.4.3 Single Strand Conformational Polymorphism (SSCP) 
2-8gl DNA (PCR product) together with 2gl SSCP loading buffer (5M NaOH, 0.05M 
EDTA, 50% Glycerol, 5% BPB/Xylene cyanol and water, Orita) were heated to 370C 
for 2 minutes, placed on ice for 5 minutes and then loaded. SSCP gel (6.3ml MDE, 
3ml 5XTBE, 16.1ml ddH20,60gl (TEMED), 400gl 10% APS) was run in 0.6xTBE 
at 4"C. For P-catenin the samples were run for 7 hours at 20OV. Band visualisation 
was achieved by washing the gel in 10% ethanol and acetic acid (BDH), incubated in 
0.1% silver nitrate (AgN03) for 15 minutes, washed with ddH20, developed using 
1.5% NaOH and 0.1% formaldehyde (37%). Once developed the gel was fixed in 
0.75% sodium carbonate (Na2COA visualised using a light box and photographed 
using a digital camem (Figure 2.3). 
Z4.4 Sequencing 
PCR products for sequencing were first cleaned up using Microns kit, per 
manufacturers' instructions to remove excess primer and primer dimer. PCR primers 
were then added to the cleaned PCR product, made up to 14pl and sequenced by 
Department of Biochemistry, University of Bristol, BS8 ITD. The sequencing data 
was analysed using websites (Blast search Genebank database at ncbi, 




Figure 2.3 A diagrammatic representation for single strand 
conformational polymorphisms. 
Normal Mutant 
5' 5' x 
3' 3' 0 
Heat, 95'C 
C0019 
N N/M M 
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2.5 In vitro Cell Culture. 
Z 5.1 Cell Lines (See Table Z 6) 
The human colorectal. adenocarcinoma, cell lines used in this model were HT29, 
SW1222, HCT116 and LS174T along with a human colorectal adenoma cell line 
RG/C2 and CMT-93 a murine rectal carcinoma. 
2.5.1.1 Maintenance ofcell cultures 
Routine tissue culture was carried out using aseptic techniques in a class II 
microbiology safety cabinet (Envair). Cells were routinely cultured in plastic T25 or 
T75 flasks (Falcon) in standard culture medium, Dulbecco's Modified Eagles Medium 
(DMEM) (GibcoLife technologies inc., UK) supplemented with Foetal Calf Serum 
(FCS) (Gibco, batch selected), 2mM L-Glutamine, 100 units/ml Penicillin (Gibco), 
100 pghnl Streptomycin (Gibco). Carcinoma and murine cell lines were maintained 
in 10% FCS and the adenoma derived cell line was maintained in 20% FCS 
supplemented with 1 gg/ml Hydrocortisone (Sigma) and 0.2 units/ml insulin. The 
flasks were medium changed twice a week, and grown in humid incubators (LEEC) at 
36 OC and 5% C02 (Carbon dioxide). 
2 5.1.2 Subculturing cells 
Cells were examined using phase contrast microscopy (PK40, Olympus, Essex, Uk) 
and routinely passaged (sub-cultured) when they reached confluency, this occurred 
once per week for the carcinoma cell lines and approximately every 2-4 weeks for the 
adenoma cell line, depending on growth characteristics. Media was aspirated, the 
adherent monolayer of cells were washed with versene or phosphate buffered solution 
(PBS), removing any residual serum which would inactivate trypsin. Cell detachment 
was achieved by adding Difco Trypsin 0.25% (w/v ImM EDTA in hanks buffered 
salts solution without CaC12, M902, MgS04) (Gibco) to the cells and incubating 
them for approximately 5 minutes at 37*C. Media containing FCS was then added, to 
stop the reaction, centrifuged for 5 minutes at 1000 rpm, the supernatant removed and 
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the cells were resuspended in the appropriate medium, at the required split ratio (see 
Table 2.5). 
2.5.1.3 Storage and RetrievaL 
Cells were resuspended in a mixture of 90% Foetal calf serum and 10% 
dimethylsulphoxide (DMSO; Sigma), alliquots were placed into cryotube vials and 
frozen at -700C for 24 hours before being placed in liquid nitrogen for long term 
storage. Retrieval of cells was achieved by the cells being rapidly defrosted at 37"C 
and transferred to a T25 vented tissue culture flask containg fresh media. The cells 
were then incubated overnight as in 2.5.1.1 and media changed after 24 hours. 
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2.6 Cell line characterization and protein expression 
Z6.1 PrimersIPCRISSCPISequencing 
RG/C2 and LS174T cell line was characterised in terms of 0-catenin gene exon 3 
using carcinoma cell lines as positive controls. Primers received from 
B. J. Wijnhoven, Rotterdam, Holland (WiJnhoven et al., 2000). The primer pairs IF 
(5'-primer CATTTCCAATCTACTAATGCT) and IR (39-primer 
CTGCATTCTGACTTTCAGTA 
A) were used to amplify the P-catenin gene (Fukuchi et al., 1998). The 50 jil PCR 
reaction mixture contained buffer (xIO; Gibco) 5[LI, dNTP (2mM, Gibco) 5pl, 
Magnesium chloride (50mM, Gibco) 3[il, lgI of each primer at a concentration of 
0.1 pg per reaction, with 3pl DNA per reaction and 0.25ýd Platinum Taq and made up 
to 50pl using injection water. PCR was performed for 40 cycles at an annealing 
temperature of 55*C. Mutational analysis was carried out using SSCP analysis 
(Section 2.4.3) for P-catenin it was run at 200V for 18-20 hours. 
Z 6.2 SDS-PA GE Western Blotting 
2.6 2.1 Cell lysates. 
A. 
Cells were detached from the plates using trypsinisation or cell scraping (rubber 
policeman) and washed 3 times in PBS. Cells were resuspended in Iml lysis buffer 
(50mM Tris HCL pH6.8,2% SDS, 5% P-mercaptoethanol, 10% glycerol, ImM 
EDTA, complete protease inhibitor cocktail tablets (Boehringer Mannheim) (pH 8), 
boiled for 10 minutes, put on ice for 10 minutes and spun (10000g) at 411C for 10 
minutes. Protein concentration was determined using a BioRad colourimetric protein 
assay (Biorad protein assay kit) according to the manufacturers' instructions (BSA 
was used as the standard) and read at 595nm on a spectrophotometer. Protein 
concentrations were then determined using cricket graph and samples were stored at - 
20"C. Relevant protein lysate volumes were then diluted in sample buffer (to give 
equal protein concentrations) boiled for 5 minutes, cooled, spun for 2 minutes and 
were then ready to load. 
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B. 
Cells were detached from the plates using trypsinisation or cell scraped using a rubber 
policeman, washed 3 times in phosphate buffered solution (PBS). Cells were then 
resuspended in a known volume of PBS (University stores), passed through an 18G 
syringe needle to obtain a single cell suspension. Cell number was determined using 
a haemocytometer (counting chamber), four fields of view were used and a mean 
number of cells obtained. IX 106 were resuspended in 300gl lysis buffer (50mM Tris 
HCL pH6.8,2% SDS, 5% P-mercaptoethanol, 10% glycerol, ImM EDTA, complete 
protease inhibitor cocktail tablets (Boehringer Mannheim) (PH 8), boiled for 10 
minutes, ice for 10 minutes and centrifuged (10000g) at 4*C for 10 minutes. The 
supernatant was collected and placed into clean microfuge tubes and added to fresh 
lysis buffer containing bromophenol blue (Sigma) boiled for 5 minutes, cooled on ice, 
pulse spun and were then ready to load. 
2622 SDS-PA GE 
Sodium dodecyl sulphate - polyacrylamide gel electrophoresis was used to separate 
proteins in respect of their molecular weight. BioRad mini-PROTEAN 3 and mini- 
PROTEAN 2 electrophoresis kits were used. Resolving gel was prepared and allowed 
to set before being overlaid with the stacking gel which was also allowed to solidify 
(Table 2.7), for P-catenin 10% polyacrylamide gels were used. The gels were loaded 
with 15 gl of the relevant samples into each well under SDS-PAGE running buffer 
(Table 2.8) along with standard molecular weight markers. The gels were run 
vertically at 90V for 5 minutes and then 180V for approximately 45-60 minutes, 
transferred for 2 hours at 25OmA onto PDVF membrane (Immobilon-P, Millipore) 
(Table 2.8). The PDVF membrane was blotted in milk (5% Marvel in lxTBS, table) 
and incubated with primary antibody (Table 2.9) together with an a-tubulin loading 
control (Sigma), heatsealed into a plastic bag, overnight at 4"C on a rotating platform. 
The blots were washed with TBST (Tris-buffered saline and tween, Table 2.7) and 
incubated with the secondary antibody (rabbit anti mouse-HRP labelled, DAKO used 
1: 2000-1: 3000) for I hour at room temperature, heat sealed in a plastic bag and 
placed on a rotating platform. The blots were then washed for I hour with frequent 
changes of TBST. Visualisation was achieved by using enhanced chemiluminescence 
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(ECL, amersham phannacia Biotech UK Ltd) followed by exposure of the 
membranes to light sensitive film (Kodak). Blots were stripped by incubating them 
in stripping buffer (I OOmM 2-Mercaptoethanol, 2% SDS, 62.5mM Tris-HCL pH 6.7) 
for 30minutes at 50'C. The blots were washed twice with TBST, blocked in milk for 
I hour and re-probed by incubating in primary antibody as before. 
Table 2.7 Acrylamide gels. 
29: 1 Acrylamide 3.3ml 5.3ml 6.7ml 800gl 
1.5M Tris pH 8.8 5. Oml 5. Oml 5. Oml 410gi (pH6.8) 
50% 3lycerol Iml Iml Iml ---- 
DH20 10.5ml 8.5ml 7.1ml 3.74ml 
10% SDS 200pl 200gl 200gl 50gl 
Temed 32gl 32gl 32g] 5gl 
10% kps 72gl 72pi 72g] 50[t] 
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Table 2.8 Western blotting solutions. 
tions ! t ( Chemical Per 1000ml (g) 
ngBu ffe r -i unn R Tris base 30g 
5x SDS Page Glycine 144g 
SDS log 
ddH20 1000 
Transfer Buffer Tris base 3g 
Glycine 14.4g 
MeOH 200 
10% SDS Iml 
ddH20 799ml 
10 x TBS Tris base 30.25g 
NaCI 84g 
HCI (conc) 20ml 
ddH20 980ml 






Table 2.9 Western blotting (WB) and immunocytochemistrýv (ICC) antibodies. 
Antigen Antibody Clone Class Supplier Working Conc. 
specificity Type WB ICC 
P-catenin Monoclonal 1, -, 
G I Transduction labs 1: 2000 1: 1000 
y-catenin Monoclonal IgG I Transduction labs 1: 2000 1: 500 
ot-catenin Monoclonal IgG I Transcluction labs 1: 250 1: 250 
P120 Monoclonal IgG I Transduction labs 1: 2000 1: 1000 
E-Cadherin Monoclonal HECDI IgG ICRF 1: 500 1: 500 
E-Cadherin Monoclonal Transduction labs 1: 500 1: 500 
a-Tubulin Sigma 1: 2000 - 
Ki-67 Monoclonal MIB-I Coulter 
Electronics 
- 1: 50 
2.6 2.3 SCFA and Fibres. 
Each cell line was subcultured into T25 Flasks, grown to 50-60% confluency and 
then treated (in duplicate or triplicate) with the relevant SCFA or fibres at the relevant 
molar concentrations; The molar concentrations of Sodium Butyrate (Sigma) used 
were OmM (control), ImM, 2mM and 4mM, for Sodium Acetate (Sigma) OmM, 
6mM, 12mM and 15mM, and for Propionic acid (Sigma) OmM, 3mM, 5mM and 
lOmM)). The fibres were used at a concentration of 0.1% diluted in ddH20. The 
SCFAs and fibres were made up in sterile ddH20, and syringe filtered. The cells 
were incubated for 48hrs and then cell lysates made (Refer to section 2.6.1 A and B) 
or used in the following experiments. 
2.6.3 Immunocytochemistry (ICC) 
Cells were grown to 50-60% confluency and treated with SCFAs as for section 
2.6.2.3 for 48 hours. There were two different techniques employed cells were either 
embedded in agar or cytospun onto slides. If the cells were to be embedded in agar, 
the cells were then trypsinised or cell scraped using a rubber policeman fixed in 
buffered neutral formaldehyde, pelleted and embedded in 1% agar or cytospun 
directly onto slides and fixed in ethanol. If agar embedded 4Am sections were cut 
and mounted onto poly-l-lysine slides. These sections were then treated as in section 
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2.2.8, for primary antibody concentrations refer to Table 2.9. If the cells were 
cytospun, the cells were trypsinised or cell scraped (depending on whether E-cadherin 
was being examined), washed three times in PBS and then spun onto superfrost slides 
(BDH) using a cytospin (Shandon) at 100g for 5 minutes, cells were then fixed onto 
the slides in 100% ethanol, left to dry and frozen in a heat sealed bag containing silica 
gel (BDH) until used, the slides were then treated as in section 2-2.8 except no 
antigen retrieval (heating in citric acid buffer) was required. A negative control was 
used for each round of staining (Figure 2.4). 
2 6.4 Cell Proliferation 
Cells were cultured to 80-90% confluent in 10% FCS medium. The cells are then 
trypsinised and a single cell suspension was obtained via syringing (18G) and cell 
number obtained using a haemocytometer. IX 106 (for carcinomas) or 2xI 06 (for 
adenoma) cells were plated out into T25 flasks. After 24 hours the flasks were treated 
(section 2.6.2.3), either in duplicate or triplicate (some single studies were also 
performed) and two T25 flasks were trypsinised and cell number determined using a 
heamocytometer to give the first time point (zero). At each time point the total 
number of cells in each flask for each treatment was determined. 
Z 6.5 3D-Collagen Gel ProtocoL 
Cells were subcultured, cell number determined using a haemocytometer. The cells 
were resuspended to give a concentration of I- 2x 106 per ml (depending on growth 
rate), aliquoted out and pelleted. Vitrogen (Invitrogen) was neutralised (pH 7.4±0.2) 
using a number of drops of a solution consisting of I ml IM NaOH and 2ml (10 x) 
BME (Gibco) on ice. Cells were resuspended in neutralised vitrogen, plated out on 
35mm. petri dishes (Falcon), and set in the incubator (10-15 minutes). After the gels 
had set they were overlaid with I. Sml of Media, incubated for I hour, fresh media 
containing the relevant SCFA or fibre (section 2.6.2.3) for up to 4-14 days, 
monitoring differentiation and media changing every 48 hours. To terminate the 
experiment the media was removed and 2ml BNF (fixative) was added to each well 
and left for around 24 hours. The gel was removed placed into a cassette and put into 
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70% alcohol. The blocks were processed using serial (increased) concentrations of 
alcohol, followed by histoclear. The gels were then embedded in paraffin wax, cut 
into 41im sections and mount on poly-L-lysene slides (BDH). These sections were 
then treated as in section 2.2.8. Primary antibody concentrations Table 2.9, as for 
ICC 
Z 6.6 Immunofluorescence using Confocal Microscopy 
Cells were seeded, 1-2xl 04 or 105, onto a glass cover slip and then treated with 
varying concentration, 0,2mM and 4 mM, of sodium butyrate (Sigma) for 48 hours. 
Cover slips were washed using PBS prior, cells were fixed for 5 minutes in 4% (w/v) 
paraformaldehyde and permeabilised using Triton-X 100 (0.05%) (Sigma, MO). P- 
catenin within the cells were immunofluorescently labelled (Figure 2.5) by incubating 
in mouse monoclonal antibodies for P-catenin (Pharminogen) for 45 minutes 
followed by incubation in FITC-conjugated goat anti-mouse F(ab')2 fragments (Dako, 
UK) for 30 minutes. Cover slips were then mounted onto glass slides using 
Vectashield containing 4', 6-diamino-2-phenylindole dihydrochloride (DAPI) (Vector, 
Burlington, CA) with slides being stored at 411C in darkness until visualisation. Slides 
were then viewed on a Leica TCS-NT confocal laser scanning microscope attached to 
Leica DM IRBE inverted epifluorescence microscope (Leica Microsystems, 
Mannheim, Germany). An oil-immersion objective lens x 63, NA 1.32 was used and 
imaging parameters were selected to optimize resolution. 
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Figure 2.4 Representative negative controls fo r 










(A) Representative negative control for non-specific binding (no primary 
antibody) for immunocytochernistry (Magnification x40 plus telescopic 
zoom). (B) Representative negative control for non-specific binding (no 
primary antibody) for immunohistochemistry (Magnification x20). (C) 
Representative negative control for non specific binding (no primary 
antibody) for immunoflouresence; (1) field of view for non-specific 
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2.7 Statistical analysis. 
Z 7.1 Anova 
Anova was performed by John Sykes (ReckittBenckiser Healthcare Ltd, Hull, UK) 
using an SAS package. The data for tumour incidence, BrdU-LI and crypt length was 
analysed using untransformed data, whereas the turnour number, burden and 
microadenoma number was determined using transformed data as the untransformed 
data did not satisfy the requirements of ANOVA. 
Z 7.2 Student T-test 
The student T-test was performed to determine any significant difference between 
two-tailed unpaired data. A p-value of less than 0.05 (P<0.05) then there was deemed 
to be a significant difference. The software used to perform this statistical analysis 





The characterisation of the fibres Ispaghula husk, Pectin, Cellulose, 
Rice starch and Resistant starch and their associated diets. 
3.1 Introduction. 
Dietary fibre (NSP) has a number of physiological roles within the colon and these 
vary depending on the physical and chemical properties of the dietary fibre 
(Reviewed by Spiller, 1994; Reviewed by Cummings, 1997). The various 
physiochernical properties include viscosity, water-holding capacity, bile acid 
binding, faecal bulking capacity and fermentability (Reviewed by Davidson and 
McDonald, 1998). Thus it is important to explore a number of these parameters to 
determine their physiological roles. 
A number of methods exist to analyse the dietary fibre content of food including the 
Prosky method (Reviewed by Cummings, 1997), modified AOAC method (Ohkuma 
et al., 2000) and the Englyst methods (Englyst et al., 1992). A number of other 
techniques such as NMR (Black et al., 1999), methylation analysis (Edwards et al., 
2001), high performance anion-exchange chromatography (HPAEC) and glycosidic 
hydrolysis by carbohydrases coupled with molecular remodelling (Blackwood and 
Chaplin, 2001) can be used to determine precise structural information. The Englyst 
procedure defines fibre as non-starch polysaccharides (NSP, non-cc-glucans) and is a 
measurement of total, soluble and insoluble NSP, providing an index of plant 
material (Englyst et al., 1992). Englyst also elucidates the constituent sugars within 
the varying fractions of NSP, thus helping to give an indication of its structure. The 
Englyst procedure is used to determine the NSP values of over 400 foods that are 
included in the UK food tables (Englyst et al., 1992) (section 1.5). 
Fermentation is a very important parameter of dietary fibre characterisation, not only 
the rate, site and extent to which they are absorbed or fermented but also the type of 
products produced during this fermentation, being critical to their physiological 
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properties within the colon (Reviewed by Edwards, 1995; Reviewed by Chaplin, 
1999; Reviewed by Blackwood et al., 2000). Fermentation of dietary fibre (NSP) by 
colonic bacteria results in the production of a number of products, the short chain 
fatty acids (SCFAs, primarily butyrate, propionate and acetate), lactate, methane and 
hydrogen. Fermentation primarily occurs in the proximal colon of humans (caecurn 
in mice) making it difficult to measure fermentation in vivo (Reviewed by Edwards, 
1995). There are a number of techniques to determine the level of fermentation in 
vivo, such as breath hydrogen, methane production and faecal levels of SCFAs 
(Reviewed by Cummings, 1997), to animal models such as human flora associated 
(HFA) rats and human trials (Rycroft et al., 2001), but all have their limitations. A 
number of methods have been devised to determine the fermentative properties of 
dietary fibres (polysaccharide) and oligosaccharides (some used as prebiotics) in 
vitro; these include pure culture studies using a range of intestinal bacteria and mixed 
faecal cultures (Rycroft et al., 2001). The faecal slurries provide rapid (completed 
within 24hours), and comparative (several can be set up simultaneously) evaluation 
of individual polysaccharides representing a relatively diverse gut microflora 
(Rycroft et al., 2001) with analytical measurements of SCFA production using gas- 
liquid chromatography (Reviewed by Rombeau and Roth, 1995). SCFA production 
from ileal effluent correlated well with that from fibre isolates but not with the 
production from whole foods, and they concluded that fibre isolates, rather than 
whole foods provide the nearest estimate of colonic SCFA production (Reviewed by 
Brydon, 1995). A number of in vitro fermentation studies have already been carried 
out showing that the more soluble the NSP the more rapidly it is fermented 
(Reviewed by Blackwood et al., 2000). Different sugars have also been shown to 
give rise to different SCFAs (Reviewed by Toole and Toole, 199 1), giving individual 
fibres unique SCFA profiles. A number of structural properties of the fibre; degree 
of stiffness and regularity of the polysaccharide chains, esterification, side chains and 
monosaccharide composition all affect the rate and extent of their fermentation 
(Reviewed by Blackwood et al., 2000), along with a number of intrinsic factors of 
the host including microflora composition. The ratios of different SCFA production 
is thus very important (Reviewed by Eastwood, 1995), with different fibres 
producing different levels of these SCFAs due to the differences in carbohydrate 






To evaluate the physical and chemical characteristics of the dietary fibres; ispaghula 
husk, pectin and cellulose, as individual fibres and constituents of a fibre 
supplemented diet. 
3.3 Objectives 
1. To determine the solubility and NSP content of the dietary fibres of interest; 
ispaghula husk, pectin, cellulose, rice starch and resistant starch. 
2. To determine the NSP content and solubility of the feeding study diets 
(Chapter 5); Basal, ispaghula husk supplemented, pectin supplemented and 
cellulose supplemented. 
3. To determine the rate of fermentation of the fibres; ispaghula husk, pectin, 
cellulose, rice starch and resistant starch; and their individual SCFA profiles. 
4. To determine the rate of fermentation of the diets; Basal, ispaghula husk 
supplemented, pectin supplemented and cellulose supplemented; and their 
individual SCFA profiles. 
5. To relate the structural characteristics of the individual fibres and diets to 





These studies, dietary fibre measurements and fermentation properties, utilized 
methods proposed by A Havler (ReckittBenckiser, Hull), the Englyst experiment 
was adapted from the Englyst et al. (1992). The Englyst procedure was undertaken 
with support and guidance from L. Lewis (ReckittBenckiser, Hull) and the 






3.5.1 Solubility and NSP content of the fibres Ispaghula husk, Pectin, Cellulose, 
Rice and Resistant starch and their associated diets. 
Using the chemical/enzymatic Englyst method coupled with gas-liquid 
chromatography (GC, Supelco SP2380 capillary column (30m x 0.25mm) with flame 
ionisation detector, column maintained at 250"C, with the injector kept at 2600C and 
the detector at 280'C, carrier gas (helium) flow rate of 3ml min") and colourimetery 
(UV spectroscopy), the total, soluble and insoluble NSP levels of the dietary fibres 
isPaghula husk, pectin, cellulose and resistant starch (Table 3.1a) and their 
associated diets (Table 3.1b) were determined. Englyst, defining dietary fibre as 
NSP, determines the concentration of NSP in samples as a percentage of their weight 
(Englyst et al., 1992). 
3.5.1.1 Ispaghula husk 
Ispaghula husk has been fairly well studied (Reviewed by Youngken, 1932; Kennedy 
et al., 1979; Sandhu et al., 1981; Reviewed by Dettmar, 1996). Reviewed by 
Dettmar (1996) published a mean NSP value for ispaghula of 80-85% (using the 
same technique as in this study) although others have found values as high as 99% 
using the Englyst procedure (Edwards and Eastwood, 1992). Table 3.1a gives a 
representative value (n--2) for ispaghula husk (batch 196/56. Reckitt Benckiser) of 
81.43% total NSP, which lies within this range quoted by Dettmar (1996). The 
majority of this NSP was found to be soluble, 72.18% (88.6% of total), with the 
remaining fraction, 9.26% (11.4% of total), being insoluble, thus ispaghula husk has 
a solubility ratio of 7.78: 1. The solubility of ispaghula husk is well known, forming 
a viscous mucilage in water (Reviewed by Youngken, 1932; Kennedy et al., 1979; 
Sandhu et al., 1981; Reviewed by Spiller, 1994). This was observed, figure 3.1, 
using Image analysis (Zeiss microscope, Zeiss KS300 3.0) of ispaghula after 
hydration in water for one hour. Observations during hydration have shown that the 
mucilaginous (soluble) fraction is released from, but remains attached to, the 
insoluble fraction. These observations have previously been described by Youngken 
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Fig 3.1 Solubility of the fibres; ispaghula husk, pectin, cellulose, rice 
starch and resistant starch, after hydration in water for approximately 






A. Ispaghula Husk (M) is partially soluble forming a gel like structure (mucilage) which is eluted 
from the insoluble husk, B. Pectin (XIO) shows almost complete solubilisation after I hour; C. 




Table 3.1 Total, soluble and insoluble NSP content of (a) ispaghula 
husk, pectin, cellulose, rice and resistant starch (b) basal diet and 
basal diets supplemented with the following fibres ispaghula husk, 
pectin and cellulose, determined using the Englyst procedure. 
(a) NSP of various fibres 
Concentration (%W/W) Total 
Fibres Total Insoluble Soluble Sol/Insol ratio 
Ispaghula husk 81.43 9.26 72.18 7.78 
Pectin 60.48 0.18 60.31 344.6 
Cellulose 108.35 99.85 8.51 0.09 
Resistant Starch 0.72 0.26 0.46 1.9 
Rice starch* 1.86 0.17 1.69 10.10 
* Results provided by M. Havler and K. Doyme (ReckittBenckiser healthcare Ltd, Hull) during a 
separate experiment. 
(b) NSP of various diets 
Concentration (%W/W) Total 
Diets Total Insoluble Soluble Sol/Insol ratio 
IsPaghula husk 10.97 (11.81) 4.93 6.04 1.22 
ectin 15.15 (8.77) 0.28 14.88 54.09 
Cellulose 13.76 (14.5) 13.57 0.19 0.01 
Basal 0.72(0) 0.26 0.46 1.75 
Key: Predicted NSP values in brackets, calculated as a% of NSP retrieved from the individual fibres, 
based on the diet consisting of 14.5% fibre. 
(a) The results demonstrated that ispaghula husk consisted of 81.43% NSP and the 
majority was soluble. Pectin consisted of 60.48% NSP and was primarily soluble in 
nature. Cellulose was composed of insoluble NSP (108.35% Total). Resistant starch 
had trace levels of NSP, 0.72% in total. Rice starch consisted of a low level of NSP 
(1.86%). (b) The ispaghula husk diet consisted mainly of soluble NSP. The NSP 
within the pectin supplemented diet was primarily soluble. The NSP within the 
cellulose supplemented diet was primarily insoluble and the basal diet had only trace 
levels of NSP. Thus the diets NSP profiles appeared to reflect those obtained for the 
individual fibres (N=2, except for rice starch N=1). 
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(1932) and Havler and Spicer (1999), where Havler suggested the insoluble fraction 
acts as a support network, possible forming a cytoskeleton. Table 3.1b reveals that 
the ispaghula husk supplemented diet reflects the pattern obtained for the fibre. The 
diet consists of 10.97% NSP, this is slightly lower than the predicted value of 
11.81%. The predicted value was calculated by dividing the fibre content of the diet 
(14.5%) by 100 and multiplying the % NSP obtained for the fibre used to supplement 
the diet (as in Table 3.1a). The majority of the NSP is soluble 6.04% (55% of total) 
with a slightly smaller insoluble fraction 4.93% (45% of total) thus giving a 
solubility ratio of 1.22: 1. Thus there are some differences between the two with the 
diet consisting of a slightly lower NSP value than predicted and a larger insoluble 
fraction. This could be due to a non-homogenous mix of all constituents within the 
diet. 
3.5.1.2 Pectin 
Pectin is a known soluble dietary fibre, forming gels in water having considerable 
water-holding capacity (Reviewed by Spiller, 1994). The Pectin used in this study 
was fruit derived (orange) for human consumption (Hercules, GENU pectin type 
FIT-1). This pectin was shown to consists of 60.48% NSP (n--2), with the NSP 
being soluble in nature, 60.31% (99.7% of total), having a soluble to insoluble ratio 
of2200.045: 1. This is consistent with the image analysis, Fig 3.1b, where pectin was 
shown to be almost completely soluble forming a gel in water after hydration for one 
hour in water. The pectin supplemented diet (Table 3.1b) basically reflects the 
results found for the individual fibre (Table 3.1a) consisting of 15.15% NSP, which 
is higher than the predicted value of 8.77%, but is soluble, 14.88% (98% of total), 
having a soluble to insoluble ratio of 54.09: 1. 
3.5.1.3 Cellulose 
Cellulose is a well defined dietary fibre, being insoluble in water although capable of 
binding some water (Reviewed Spiller, 1994). Cellulose (Solkafloc) was shown 
(Table 3.1a) to be solely NSP, 108.35%, with the majority of it being insoluble, 
99.85% (92.2% of total), a small fraction being soluble, 8.51% (7.8% of total), 




the cellulose is still intact after hydration in water for one hour suggesting that it is 
insoluble. The cellulose supplemented diet, Table 3.1b, reflects the results found for 
the individual fibre. Although the NSP content, 13.76% was slightly lower than 
predicted 14.5%, it did show that the majority of this NSP was insoluble, 13.57% 
(9 8.6% of total NSP), with a soluble to insoluble ratio of 0.0 14: 1. 
3.5.1.4 Rice and Resistant starch 
Resistant starch, from com (Zea mais, National starch and chemical/starch division), 
also enters the colon but is not included in the definition of dietary fibres as non- 
starch polysaccharides (Englyst et al., 1992). Rice starch (provided by SDS) would 
not be expected to reach the colon but may provide it with some resistant starch. 
During the Englyst procedure all starch is removed by cc-amylase and pullanase 
digestion, thus resistant starch and rice starch would be expected to contain no NSP. 
The results in Table 3.1 a show that the resistant starch and rice starch have only trace 
levels of NSP, 0.72% and 0.19% respectfully. This small level of NSP could be the 
result of incomplete enzymatic removal of starch, possibly leaving traces of glucose 
(Table 3.5a) and in the case of rice starch possible contamination as also has trace 
sugars not seen in the basal diet that contains rice starch. Using image analysis 
(Zeiss microscope, Zeiss KS300 3.0), Fig 3.1, it was also shown that both the rice 
starch (used to supplement the basal diet) and the resistant starch are insoluble in 
water, as demonstrated after one hour hydration in water. The basal diet is 
supplemented with sucrose and rice starch (which may contain traces of resistant 
starch). The basal diet is also referred to as a fibre deficient diet (SDS, Witham, 
Essex) as it is said to contain only very low levels of crude fibre and no other specific 
dietary fibres (Table 3.6a and 3.7), thus it is expected to be NSP free. As Table 3.1b 
shows the basal diet is primarily NSP free (0.72%), only having trace levels, as for 
the resistant starch and rice starch. The diet mirrors the findings for resistant starch 
to a greater extent than the rice starch, which is intriguing as the basal diet consists of 
a large percentage of rice starch (37.5%). This could be accounted for as the rice 
starch results were obtained during a separate experiment or the rice starch could 





3.5.2 Constituent NSP sugars within the total, insoluble and soluble fractions of 
the fibres Ispaghula husk, Pectin, Cellulose and Rice and Resistant starch and 
their associated diets. 
The Englyst procedure was used to determine the monosaccharide profiles of the 
NSP within the different fibres; ispaghula husk, pectin, cellulose, rice starch and 
resistant starch. Englyst results in the hydrolysis of the NSP into individual sugars 
which are then reduced and acetylated before analysis by Gas-liquid chromatography 
(Supelco SP2380 capillary column (30m x 0.25mm) with flame ionisation detector, 
column maintained at 250"C, with the injector kept at 2600C and the detector at 
2800C, carrier gas (helium) flow rate of 3ml min7l). The uronic acid content of the 
fibres was measured separately using colourimetric reagents and UV spectroscopy 
(ATLUNICAM UV4 spectrometer, at 400nm and 450nm). 
3.5.2.1 Ispaghula Husk 
Ispaghula husk has been fairly well analysed (Kennedy et al., 1979; Sandhu et al., 
19 8 1). Ispaghula is known to have an arabinoxylan backbone (Kennedy et al., 1979; 
Sandhu et al., 1981; Reviewed by Spiller, 1994), thus we would expect to see 
arabinose and xylose within the sugar profile. A number of other sugars are also 
found associated with this backbone, such as uronic acids, rhaninose and glucose 
(Kennedy, et al., 1979; Sandhu et al., 19 8 1; Edwards and Eastwood, 1992; Reviewed 
by Spiller 1994). Garcia (1976) showed that the mucilage (soluble fraction) 
consisted mainly of xylose, arabinose and galacturonic acids, with lower levels of 
rhamanose and galactose. Table 3.2a represented the constituent NSP sugars within 
total, insoluble and soluble fractions of ispaghula husk (n--2). The results 
demonstrate that the NSP within ispaghula husk is mainly composed of arabinose 




Table 3.2 Constituent NSP sugars within total, insoluble and soluble 
fractions of (a) ispaghula husk and (b) ispaghula husk supplemented 
basal diet, as determined using the Englyst procedure. 
(a) Ispaghula husk 
(%W/W) 
Monosaccharide Total Insoluble Soluble 
Rhamanose 1.17 0 1.17 
Arabinose 17.31 4.03 13.28 
Xylose 47.77 0.37 47.4 
Mannose 0.74 0.6 0.14 
Galactose 2.76 1.48 1.28 
Glucose 2.84 2.65 0.19 
Uronic Acid 8.87 0.15 8.73 
(b) Ispaghula husk supplemented basal diet 
(%W/W) 
Monosaccharide Total Insoluble Soluble 
Rhamaiiose 0.0-1) 0 0.03 
Arabinose 1.35 0.4 0.95 
Xylose 4.51 0 4.51 
Mannose 0.12 0.09 0.03 
Galactose 0.28 0.15 0.13 
Glucose 4.1 1.73 2.37 
Uronic Acid 0.59 0 0.59 
The above tables represent the constituent NSP sugars within total, insoluble and 
soluble fractions of (a) Ispaghula husk (100mg) (b) Basal diet supplemented with 
ispaghula husk (200mg), using an adapted Englyst method and gas-liquid 
chromatography (n=2). (a) The NSP within ispaghula husk was mainly composed of 
arabinose and xylose with lower levels of uronic acids with trace levels of glucose, 
galactose, rhamanose and mannose. The soluble fraction primarily comprised of 
xylose, arabinose and uronic acids, whereas the insoluble fraction consisted of 
arabinose and glucose. (b) The majority of the ispaghula supplemented diet 
consisted of xylose, arabinose and glucose, with lower levels of uronic acids, 
galactose, mannose and rhamanose. The xylose and uronic acids were within the 
soluble fraction, whereas the glucose and arabinose were found within both the 




also low levels of rhamanose, mannose, galactose and glucose. The soluble fraction 
is mainly composed of the sugars; xylose, arabinose and uronic acids, while the 
insoluble fraction consists of arabinose and glucose. The insoluble fraction 
consisting of glucose is consistent with the theory that the insoluble fraction of 
ispaghula husk may be like cellulose, acting as a cell wall (personal communication 
with M. Havler, ReckittBenckiser). Table 3.2b represented the constituent NSP 
sugars within total, insoluble and soluble fractions of the ispaghula husk 
supplemented basal diet (n--2). The table reveals that the resulting profiles are 
consistent with those obtained for the individual fibre, ispaghula husk, used to 
supplement the diet. The majority of the ispaghula supplemented diet is made up of 
xylose, arabinose and glucose with lower levels of uronic acids. The xylose, 
arabinose and uronic acids are found within the soluble fraction, which is consistent 
with the findings for the dietary fibre. The insoluble fraction also consists of 
arabinose and glucose, as for the fibre, but the major difference is that the glucose is 
not only found within both the soluble and insoluble fractions, it is proportionally at 
a much higher level than expected. Reasons for this are unclear but could be related 
to the non-homogenous mixing of the diet resulting in a non-proportionate amount of 
sucrose being analysed. 
3.5.2.2 Pectin 
Pectin is a known galactouronic acid (Reviewed by Reiser, 1987; Reviewed by 
Spiller, 1994), found with areas of rhamanose and side chains composed of galactose 
(galacturonic acids), glucose (glucuronic acid), xylose and arabinose (Reviewed by 
Reiser, 1987; Reviewed by Spiller, 1994) thus high level of uronic acids would be 
expected from an Englyst profile. Table Ma represented the constituent NSP sugars 
within total, insoluble and soluble fractions of pectin (n--2). The results demonstrate 
that the NSP within pectin is primarily made up of uronic acids (54.26%, 89.7% of 
total NSP) and these are found within the soluble fraction. Within the soluble NSP 
fraction there is also a low level of galactose (4.52%, 7.47% of total NSP) which 
could also be derived from the galactouronic acids although other sugars have been 
found associated with pectin, for example galactose and arabinose (Reviewed by 
Spiller, 1994). There are also low levels of arabinose, rhamanose, glucose and 




Table 3.3 Constituent NSP sugars within total, insoluble and soluble 
fractions of (a) pectin and (b) pectin supplemented basal diet as 
determined by the Englyst procedure. 
(a) Pectin 
(%W/W) 
Monosaccharide Total Insoluble Soluble 
Rhamanose 0.533 0 0.53 
Arabinose 0.97 0.1 0.87 
Xylose 0 0 0 
Mannose 0.08 0.08 0.01 
Galactose 4.52 0 4.52 
Glucose 0.13 0 0 13 
Uronic Acid 54.26 0.01 54.25 
(b) Pectin supplemented basal diet 
(%W/W) 
Monosaccharide, Total Insoluble Soluble 
Rhainanose 0 0 0 
Arabinose 0.19 0.07 0.12 
Xylose 0 0 0 
Mannose 0.04 0 0.04 
Galactose 0.6 0 0.61 
Glucose 1.05 0.21 0.84 
Uronic Acid 13.27 0 13.27 
The above tables represent the constituent NSP sugars within total, insoluble and 
soluble fractions of (a) Pectin (100mg) and the (b) Pectin supplemented basal diet 
(200mg), using an adapted Englyst method and gas-liquid chromatography (n=2). 
(a) The NSP within pectin primarily consisted of uronic acids and are within the 
soluble fraction. Within the soluble NSP fraction there was also a low level of 
galactose along with traces of arabinose, rhamanose, glucose and mannose. (b) The 
pectin supplemented basal diet primarily consisted of uronic acids found within the 
soluble fraction, along with glucose and traces of galactose, arabinose and mannose. 
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and soluble fractions of the pectin supplemented basal diet (n--2). The results show 
that the pectin supplemented basal diet is also primarily made up of uronic acids 
(13.27%, 87.6% of total NSP) found within the soluble fraction. Glucose is also 
present, mainly found within the soluble fraction, but probably from the diets' 
sucrose content as for the ispaghula husk supplemented diet. As for the fibre there 
are also low levels of galactose, arabinose and mannose. 
3.5.2.3 Cellulose 
Cellulose is a long unbranched glucose polymer made up of P(I-4) linked glucose 
residues (Reviewed by Spiller, 1994; Reviewed by Toole and Toole, 1991). Using 
the Englyst procedure we would expect to find high levels of glucose within the 
insoluble fraction of the NSP. Table 3.4a represents the constituent NSP sugars 
within total, insoluble and soluble fractions of cellulose (n--2). The results show that 
the NSP within cellulose is primarily made up of glucose, 97.87% (90.3% of total 
NSP), with a small fraction of uronic acids, 6.95% (6.4% of total NSP). These 
sugars are found within the insoluble fraction of cellulose, with a small fraction of 
glucose being soluble (7.78% of total glucose). Xylose and mannose are also found 
at low levels within the insoluble fraction. Table 3.4b represents the constituent NSP 
sugars within total, insoluble and soluble fractions of the cellulose supplemented 
basal diet (n7--2). The cellulose supplemented basal diet reflects the profile found for 
the fibre, comprising mainly of insoluble NSP made up of glucose (91.13% of total 
NSP). It also contains low levels of uronic acids, mannose and xylose, this could be 
due to contamination. 
3.5.2.4 Rice and Resistant starch 
Resistant starch has a well elucidated structure consisting of a(I -4) and a(I -6) linked 
glucose residues forming amylose and amylopectin (branched) respectively 
(Reviewed by Spiller, 1994). The resistant starch in this study is of high amylose 
maize consisting primarily of straight chains of a(I-4) linked glucose residues. 




Table 3.4 Constituent NSP sugars within total, insoluble and soluble 
fractions of (a) cellulose and (b) cellulose supplemented basal diet as 
determined using the Englyst procedure. 
(a) Cellulose 
(%W/W) 
Monosaccharide Total ýInsoluble I Soluble 
116amanose 100 0 
Arabinose 0 0 0 
Xylose 1.94 1.63 0.31 
Mannose 1.62 1.46 0.16 
Galactose 0 0 0 
Glucose 97.87 90.26 7.61 
Uronic Acid 6.95 6.51 0.44 
(b) Cellulose supplemented basal diet 
I (%W/W) 
Monosaccharide ýotal ýnsoluble Soluble 
ýhamanose U 0 0 
Arabinose 0 0.06 0 
Xylose 0.23 0.17 0.06 
Mannose 0.18 0.18 0 
Galactose 0 0 0 
Glucose 12.54 11.99 0.56 
Uronic Acid 0.81 1.18 0 
The above tables represent the constituent NSP sugars within total, insoluble and 
soluble fractions of (a) cellulose (100mg) and the (b) cellulose supplemented basal 
diet (200mg), using an adapted Englyst method and gas-liquid chromatography 
(n=2). (a) The NSP within cellulose primarily comprised of glucose with a small 
fraction of uronic acids. These sugars were found within the insoluble fraction of 
cellulose, with a small fraction of glucose being soluble. Xylose and mannose were 
also found at low levels within the insoluble fraction. (b) The cellulose 
supplemented basal diet consisted mainly of glucose within the insoluble fraction of 




Table 3.5 Constituent NSP sugars within total, insoluble and soluble 
fractions of (a) resistant starch, (b) rice starch and (c) basal diet as 
determined using the Englyst procedure. 
(a) Resistant Starch 
(%W/W) 
Monosaccharide Total Insoluble Soluble 
Rhainanose 0 0 0 
Arabinose 0 0.06 - 0 
Xylose 0 0 0 
Mannose 0 0 0 
Galactose 0 0 0 
Glucose 0.72 0.21 0.51 
ýJronic Acid 0 0 0 
(b) Rice Starch 
(%W/W) 
Monosaccharide Total Insoluble Soluble 
Rhamanose 0 0 0 
Arabinose 0.22 0 0.22 
Xylose 0.47 0 0.47 
Mannose 0 0 0 
Galactose 0.02 0 0.02 
Glucose 0.59 0 0.59 
ýJronic Acid 0.56 0.17 0.39 
(c) Basal diet 
(%W/W) 
Monosaccharide Total Insoluble Soluble 
Rhamanose 10 0 0 
Arabinose 0.06 0.07 0 
Xylose 0 0 - 0 
marmose 0 0 0 
Galactose 0 0 0 
Glucose 0.36 0 0.36 
Pronic Acid 0 0 0 
The above tables represent the constituent NSP sugars within total, insoluble and 
soluble fractions of (a) Resistant starch (100mg), (b) Rice starch (100mg) and the (b) 
Basal diet, using an adapted Englyst method and gas-liquid chromatography (n==2, 
except for rice starch n=l). (a) The low level of NSP found within the resistant 
starch consisted of soluble glucose. (b) The rice starch was found to primarily 
consist of soluble glucose along with soluble xylose and soluble uronic acids and 
trace levels of arabinose and galactose. (c) The low level of NSP found within basal 




fractions of resistant starch. The results show that the low level of NSP found within 
the resistant starch is made up of glucose (100%). This sugar is found within both 
the soluble and insoluble fraction of the resistant starch but is primarily soluble 
(71.33% of total glucose). The origin of this glucose is unclear but could be derived 
from the incomplete enzymatic digestion of the starch. There are traces of the sugar 
arabinose in the insoluble fraction, which could be due to contamination. The rice 
starch was found to primarily consist of soluble glucose, which could be residual 
from the incomplete hydrolysis of starch, soluble xylose, and soluble uronic acids 
with trace levels of arabinose and galactose. The elucidation of the basal diet sugar 
profile would be predicted to follow the pattern for rice starch as it is one of its main 
constituents and expected to only contain low levels of resistant starch. The basal 
diet was shown to have very little constituent NSP reflecting the pattern observed for 
resistant starch. Table 3.5b represents the constituent NSP sugars within total, 
insoluble and soluble fractions of the basal diet (n--2). The results show that the low 
level of NSP observed within the basal diet consists of glucose and arabinose. The 
glucose is found within the soluble fraction whereas the arabinose is found within the 
insoluble fraction, thus principally reflecting the profile found for resistant starch. 
Variation between the basal diets' results and that of rice starch could be due to 
contamination of the sample or due to differences in experimental conditions as they 
were carried out separately. 
3.5.3 Fermentation characteristics of the fibres; Ispaghula husk, Pectin, 
Cellulose, Rice and Resistant starch. 
3.5.3.1 pH changes 
When dietary fibre is fermented (anaerobically) by colonic bacteria it produces a 
number of products, most importantly the short chain fatty acids (SCFAs) butyrate, 
propionate and acetate. The SCFAs are thought to carry out many of the biological 
functions attributed to different dietary fibres, thus it is important to determine the 
SCFA profiles for the individual fibres along with their rate of production. 




Fig 3.2 pH changes within human faecal homogenates supplemented 
with the dietary fibres; ispaghula husk, pectin, cellulose, rice and 
resistant starch. 
pH changes in faecal homogenates supplemented with different 






FH/MSM IH Pectin Cellulose Rice RS 
Fibre group 
Key: MSM = Mineral salts media supplemented with fibre, FH = Faecal homogenate supplemented 
with fibre. 
pH changes in human faecal homogenates supplemented with I% (w/v) fibres; 
ispaghula husk, pectin, cellulose, rice starch and resistant starch, after 24 hours 
incubation under anaerobic conditions (80% N2,10% C02 and 10% F12) at 37"C 
using a MACS VA500 microaerophilic cabinet (Don Whitley Scientific Ltd, Shipley, 
West Yorks). This graphic representation showed that within all the fibre controls 
(MSM plus fibre, n=l) the pH was consistent the slight decrease in the pectin control 
was probably due to its own acidity. The fennentation of the fibres with faecal 
homogenate (n=3), revealed that pectin, rice starch (rice) and resistant starch (RS) 
resulted in the largest decrease in pH. Ispaghula husk resulted in a smaller reduction 





fermentation. Each of these parameters determines the action of dietary fibre on 
stool output, colonic motility and cellular proliferation of the colonic mucosa 
(Reviewed by Edwards, 1995). An in vitro system, which utilises bacteria excreted 
in human faeces as a representative of colonic microflora, was used to determine the 
production of SCFAs. The production of SCFAs results in an increase in acidity due 
to their acidic nature reflected by a lowering of pH with pH being good indicators of 
successful fermentation, and a predictor for the extent of fibre fermentation. pH was 
also used to detect contamination of the control batches (fibre in MSM) with faecal 
bacteria. Fig 3.2 represents the pH changes in human faecal homogenates (16.67% 
w/v) supplemented with 1% (w/v) fibres; ispaghula husk, pectin, cellulose, rice 
starch and resistant starch, after 24 hours incubation under anaerobic conditions 
(80% N2,10% C02 and 10% H2) at 37"C using a MACS VA500 microaerophilic 
cabinet (Don Whitley Scientific Ltd, Shipley, West Yorks). The graph clearly shows 
that for all fibres the controls (MSM plus fibre, n--l) were free from contamination, 
the slight decrease in the pectin control was probably due to its own acidity or 
immediate utilization. The fermentation of the fibres with faecal homogenate (n--3), 
revealed that rice starch, resistant starch and pectin resulted in the lowest pHs, 4.46 
(decrease of 2.31), 4.77 (decrease of 2), 4.72 (decrease of 1.65) respectively, 
suggesting that they have been readily fermented. Ispaghula husk resulted in a 
smaller reduction in pH, 5.18 (decrease of 1.6), although a similar decrease to pectin, 
suggesting it was partially fermented. With cellulose there was no significant change 
in pH, 6.64 (decrease of 0.11) suggesting little, or no, fermentation has occurred 
indicated by comparison with the mineral salts medium (MSM)/faecal homogenate 
control (pH 6.68, n--3). The MSWfaecal homogenate control was included to 
determine the intrinsic fermentation of the faeces. 
3.5.3.2 Total Short chainfatty acidproduction 
With the majority of the fibres resulting in a decrease in pH it suggested that 
fermentation had been successful, thus the level of SCFA production was 
determined. Figure 3.3 represents the total short chain fatty acid production, above 




Figure 3.3 Total short chain fatty acid production from the 
fermentation of the dietary fibres ispaghula husk, pectin, cellulose, 
rice and resistant starch. 
Total SCFA levels produced by the fermentation of fibre supplemented 
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Total short chain fatty acid production, above control, from the fermentation of I% 
(w/v) of the fibres; ispaghula husk, pectin, cellulose, rice starch and resistant starch 
by faecal homogenates (n=3). Fibre supplemented faecal homogenates were sampled 
at 0,3,6 and 24 hour time intervals, the levels of SCFAs were determined using GC 
analysis (Hewlett Packard). The graph revealed that pectin, rice starch and resistant 
starch were readily fermented ispaghula husk was fermented but at a slower rate 





rice starch or resistant starch; by faecal homogenates (n=3). Fibre supplemented 
faecal homogenates were sampled at 0,3,6 and 24 hour time intervals, the levels of 
SCFAs were determined using GC analysis (Supelco Nukol 24107 capillary column 
(30m x 0.25mm x 0.25gm) oven maintained at 160*C, injector and detector 
maintained at 250*C, with injection volume of I gl. Carrier gas (helium at 16.6psi) 
flow rate of 8.2ml/min. Hewlett Packard instrumentation) coupled with external 
standard solutions (5mM concentration of acetate, propionate and butyrate). The 
graphic representation of total SCFAs suggests that pectin, rice starch and resistant 
starch were fermented at a greater rate and extent than the fibres ispaghula husk and 
cellulose, with cellulose undergoing minimal fermentation. This pattern was 
observed at 3,6 and 24 hours fermentation. After 24 hours fermentation pectin was 
found to be fermented to the greatest extent producing the highest levels of SCFAs 
(48.68mM total), followed by rice starch (45.71mM total), resistant starch (49.07MM 
total), ispaghula husk (30.8lmM) and lastly cellulose (1.37mM total) which 
produced very low levels of SCFAs. This pattern of SCFA production reflects the 
changes seen in pH (Fig 3.2). The rate of fermentation is thought to be intrinsic to 
the physiological roles of dietary fibres (Reviewed by Edwards, 1995). Figure 3.4 
provides a graphic representation of the rate of fermentation as determined by total 
SCFA production for the dietary fibres ispaghula husk, pectin, cellulose, rice starch 
and resistant starch. Pectin, rice starch and resistant starch fermentation started 
rapidly with a SCFA production rate of 4.23mM/hour, 4.13mM/hour and 
4.66niNl/hour respectively at 3 hours and 3.6lmM/hour, 3.12mM/hour and 
2.12mM/hour respectively at 6 hours. The rate of fermentation then tails off with 
rates for pectin, rice starch and. resistant starch decreasing to 1.25mM/hour, 
1.21mM/hour and 0.94mM/hour respectively. This decrease could be due to a lack 
of substrate due to its rapid fermentation within the in vitro fermentation system. In 
previous studies, pectin was metabolised rapidly within the colon of humans and the 
caecurn of mice (Edwards and Eastwood, 1992; Reviewed by Spiller, 1994). 
Resistant starch was previously shown to be metabolised by colonic bacteria but at a 
slower rate and to a lesser extent than normal starch (Reviewed by Spiller, 1994). 
Observation for rice starch and resistant starch supplemented faecal homogenates 
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Figure 3.4 Rate of total SCFA production by the fibres ispaghula 
husk, pectin, cellulose, rice starch and resistant starch during 
fermentation by faecal homogenates. 










)K Resistant Starch 
The rate of total short chain fatty acid production, above control, from the 
fermentation of 1% (w/v) of the fibres; ispaghula husk, pectin, cellulose, rice starch 
and resistant starch by faecal homogenates (n=3). Fibre supplemented faecal 
homogenates were sampled at 0,3,6 and 24 hour time intervals, the levels of SCFAs 
were determined using GC analysis (Hewlett Packard). The rate of SCFA 
production for the individual fibres revealed that initially resistant starch, pectin and 
rice starch were rapidly fermented, with their rate of SCFA production decreasing 
over time. The rate of ispaghula husks fermentation started slowly, in comparison to 
the other fibres, but gradually increased over time, whereas cellulose rate of 
fermentation was very slow throughout the duration of the experiment. 
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suggested that these fibres were not completely fermented, as residual fibre was still 
visible at the experiments termination. Ispaghula husk was shown to be fermented at 
a much slower and consistent rate when compared to the other fibres. Ispaghula husk 
was associated with a gradual increase in fermentation rate over time, 0.85mM/hour, 
0.53mM/hour and 1.37mM/hour at 3,6 and 24 hours respectively this could be due 
to bacterial adaptation to the carbohydrate source. Ispaghula husk has been shown to 
be fermented rapidly in the colon with 20-30% escaping digestion in the colon 
(Reviewed by Spiller, 1994). Observations throughout revealed that the structure of 
ispaghula husk was partially maintained along with its mucilaginous properties. This 
is consistent with the finding that ispaghula husk is fermented throughout the colon 
but maintains a high water content (Edwards and Eastwood, 1992). Cellulose was 
virtually unfermented producing SCFA levels over the control only at 24 hours. 
Total SCFA production rate for the 24 hour period being at a level of 0.08mM/hour, 
thus it was very slowly fermented. Previous studies have also shown that cellulose is 
largely unaltered through the gut, being variably fermented by colonic cellulases but 
up to 80% can be excreted in the faeces (Reviewed by Spiller, 1994). This lack of 
fermentation may be due to a lack of cellulases within the faeces or due to the fact 
that this experiment used purified cellulose, which has been shown to be less 
fermentable than cellulose found in plant cell walls (Reviewed by Wolever, 1995). 
3.5.3.3 Acetate production 
Acetate was consistently shown to be the main SCFA produced during the 
fermentation of these dietary fibres. Fig 3.5 shows the total acetate production, 
above control, from the fermentation of 1% (w/v) of the fibres; ispaghula husk, 
pectin, cellulose, rice starch and resistant starch by faecal homogenates (n--3). These 
fibre supplemented faecal homogenates were sampled at 0,3,6 and 24 hour time 
intervals with the level of acetate being determined using GC analysis. Fig 3.5a 
shows that all fibres, except cellulose, produce measurable levels of acetate with 
pectin appearing to be the largest producer, followed by rice starch, resistant starch 




Figure 3.5 Total acetate production from the fermentation of the 











Acetate levels produced by the fermentation of fibre 
supplemented faecal samples over a 24 hour time course. 





W Resistant Starch 
Total acetate production, above control, from the fermentation of I% (w/v) of the 
fibres; ispaghula husk, pectin, cellulose, rice starch and resistant starch by faecal 
homogenates (n=3). Fibre supplemented faecal homogenates were sampled at 0,3,6 
and 24 hour time intervals, the level of acetate determined using GC analysis. The 
graph revealed that all fibres except cellulose produced acetate. Pectin appeared to 
be the largest producer of acetate, followed by rice starch, resistant starch and then 
isPaghula husk. At 3 hours there was no obvious difference between pectin, rice 
starch and resistant starch, ispaghula husk produced less acetate. At 6 hours there 
was a larger distinction between the fibres, pectin produced the largest amount of 
acetate, followed by rice and resistant starch, with lower levels produced by 
ispaghula husk. At 24 hours there was no major distinction between the fibres 
although pectin appeared to be the greatest producer followed by rice starch, resistant 




pectin, rice starch and resistant starch (10.79mM, 7.89mM and 8.66mM 
respectively), although pectin is the largest producer. Ispaghula husk produced less 
acetate (3.22niM) probably due to its slower fermentation rate. At 6 hours there was 
a greater distinction in acetate production between the fibres with pectin producing 
the highest levels (18.4mM), followed by rice (13. lOmM) and then resistant starch 
(10.43mM) with lower levels being produced by ispaghula husk (3.74mM). At 24 
hours there was no major distinction, as seen by the large standard deviations, 
although the pattern appears the same, pectin (30mM) the biggest producer followed 
by rice starch (25mM), resistant starch (I 9.6mM) and then ispaghula husk (1 6.8mM). 
The rate of acetate production varied between the fibres as shown in Fig 3.6. 
Cellulose was shown to be very slowly fermented, if at all, for ispaghula husk the 
rate of acetate production was fairly constant, initially at a slower rate than the other 
fibres pectin, rice starch and resistant starch, but at a similar rate at 24 hours 
(1.37mM/hour at 24 hours). Pectin produced acetate at a very fast rate initially 
(2.94mM/hour at 3 hours) with this rate of production gradually decreasing over time 
to a level similar to the other fibres, except cellulose. This is a similar pattern for 
rice starch, although not at such a rapid rate, reaching its height at 3 hours 
(2.23mM/hour). Resistant starch was rapidly fermented initially (2.54mM/hour at 3 
hours), but this rate then dramatically reduced at 6 hours but then remained constant. 
Tbus all fibres produced high levels of acetate, but at different rates and quantities, 
with pectin being the biggest producer. This pattern appears to reflect the pattern for 
total SCFA production, thus acetate is possibly a good indicator of rate and extent of 
fermentation. 
3.5.3.4 Butyrate production 
As all fibres appeared to produce high levels of acetate, it is thought that the 
determining factors for fibre profiles are their butyrate and propionate production. 
Fig 3.7(a) showed the total butyrate production with Fig 3.7(b) the ratio of butyrate 
to acetate production, above control, from the fermentation of 1% (w/v) of the fibres; 
ispaghula husk, pectin, cellulose, rice starch and resistant starch; by faccal 
homogenates (n--3). Fibre supplemented faecal homogenates were sampled at 0,3,6 




Figure 3.6 Rate of acetate production by the fibres ispaghula husk, 
pectin, cellulose, rice starch and resistant starch during 
fermentation in faecal homogenates. 
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ME Resistant Starch 
The rate of acetate production, above control, from the fermentation of 1% (w/v) of 
the fibres; ispaghula husk, pectin, cellulose, rice starch and resistant starch by faecal 
homogenates (n=3). Fibre supplemented faecal homogenates were sampled at 0,3,6 
and 24 hour time intervals, the levels of SCFAs were determined using GC analysis 
(Hewlett Packard). The rate of acetate production appeared to fundamentally mirror 
that of total SCFAs revealing that pectin, resistant starch and rice starch initially 
produced acetate at the greatest rate, this was shown to steadily reduce over time, 
interestingly resistant starch rate of acetate production dramatically decreased 
between the 3rd and 6th hour suggesting a possible switch in SCFA production to 
propionate or butyrate. Ispaghula husk and cellulose rate of acetate production 
mirrored that of total SCFA production. At 24 hours the rate of acetate production 
was similar in all the fibres except cellulose. 
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Figure 3.7a) Total butyrate production (b) Ratio of bu ty rate: acetate 
production from the fermentation of the dietary fibres; ispaghula 
husk, pectin, cellulose, rice and resistant starch. 
a) Butyrate levels produced by the fermentation of fibre 
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Ratio of butyrate: acetate production 
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Time in hours 
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--ff- Pectin 
Cellulose 
X Rice Starch 
A Resistant Starch 
a) Total butyrate production (b) Ratio of butyrate to acetate production, above 
control, from the fermentation of 1% (w/v) of the fibres; ispaghula husk, pectin, 
cellulose, rice starch and resistant starch by faecal homogenates (n=3). Fibre 
supplemented faecal homogenates were sampled at 0,3,6 and 24 hour time intervals, 
the level of butyrate determined using GC analysis. (a) Both cellulose and ispaghula 
husk produced very low levels of butyrate. Resistant starch produced the largest 
amount of butyrate and at the fastest rate followed by rice starch then pectin, 
although at 24 hours pectins butyrate production exceeds rice starch. (b) 
Proportionally the largest producer of butyrate was resistant starch along with rice 
starch (up until 6 hours) the level decreased below that of pectin and cellulose, which 
both increased their butyrate production with time. Ispaghula husk proportionally 
produced very low levels. 
122 
Time in hours 
Chapter 3 
Fibre Characterisation 
Fig. 3.7(a) shows that both cellulose and ispaghula husk produced very low levels of 
butyrate throughout (0.25mM and l. 4lmM at 24 hours, respectively). Resistant 
starch produced the largest amount of butyrate, 10.25mM at 24 hours. Rice starch 
initially produced high levels of butyrate up until 6 hours but at 24 hours levels 
decreased. Pectin produced low levels of butyrate initially but over time this appears 
to increase to levels higher than that found for rice starch. This was also reflected by 
the rate of production represented in figure 3.8. Ispaghula husk had a very slow rate 
of butyrate production, which was fairly constant accompanied by a very slight 
gradual increase to 0.06mM/hour. Cellulose also produces very low levels of 
butyrate at a very slow rate of O. OlmM/hour. Pectin produced butyrate at a fairly 
constant rate of 0.48mM/h, 0.53mM/h and 0.32mM/hour, although there was a 
gradual decrease over time, even so pectin was the greatest producer of butyrate at 24 
hours when compared to the other fibres. Pectin, as discussed previously, is mainly 
made up of galacturonic acids, which have been shown to produce butyrate when 
fermented (Reviewed by Toole and Toole, 1991), which may provide an explanation 
as to why pectin produced fairly high levels of butyrate. Both rice and resistant 
starch initially produced butyrate very rapidly, at a rate of 1.09mM/h and 1.11 mM/h 
respectively after 3 hours incubation. The production of butyrate gradually decreases 
over time particularly for rice starch with levels as low as 0.07mM/hr at 24 hours. 
Figure 3.7(b) shows that proportionally the highest producer of butyrate is resistant 
starch. Up until 24 hours rice starch proportionally produced higher levels of 
butyrate, but at 24 hours the level decreased to below that of pectin, which increased 
the proportion of their butyrate production with time. Ispaghula husk is shown to 
produce very low levels. 
3.5.3.5 Propionate production 
Propionate production is also very important for many physiological reasons. Fig 3.9 
represents the (a) total propionate production (b) ratio of propionate to acetate 
production, above control, from the fermentation of 1% (w/v) of the fibres; ispaghula 
husk, pectin, cellulose, rice starch and resistant starch; by faecal homogenates (n=3). 
123 
Ch apter 3 
Fibre Characterisation 
Figure 3.8 Rate of butyrate production by the fibres ispaghula husk, 
pectin, cellulose, rice starch and resistant starch. 
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The rate of butyrate production, above control, from the fermentation of 1% (w/v) of 
the fibres; ispaghula husk, pectin, cellulose, rice starch and resistant starch by faecal 
homogenates (n=3). Fibre supplemented faccal. homogenates were sampled at 0,3,6 
and 24 hour time intervals, the levels of SCFAs were determined using GC analysis 
(Hewlett Packard). The graph revealed that initially the greatest rate of butyrate 
production was for resistant and rice starch. The rate of butyrate production by these 
two fibres then decreased steadily over time. Pectins rate of butyrate production 
steadily increased up until 6 hours and then decreased after 24 hours incubation. 
Ispaghula husks rate of butyrate production increased over time but butyrate was 
produced at a much slower rate than the other fibres. Cellulose rate of butyrate 




Figure 3.9a) Total propionate production (b) Ratio of 
propionate: acetate production from the fermentation of dietary 
fibres; ispaghula Husk, pectin, cellulose, rice and resistant starch. 
Propionate levels produced by the fermentation of fibre 
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(a) Total propionate production (b) Ratio of propionate to acetate production, above 
control, from the fermentation of 1% (w/v) of the fibres; ispaghula husk, pectin, 
cellulose, rice starch and resistant starch by faecal homogenates (n=3). Fibre 
supplemented faecal homogenates were sampled at 0,3,6 and 24 hour time intervals, 
the level of butyrate determined using GC analysis. (a) Cellulose was shown to 
produce very low levels of propionate as for all SCFAs. Ispaghula husk initially 
produced lower levels of propionate than the other fibres, but at 24 hours it produced 
levels similar to that for rice starch. Pectin, rice starch and resistant starch all 
produced similar levels of propionate. (b) The graph revealed that pectin, as a 
proportion of its total SCFA production, was the smallest producer of propionate. At 
3 hours ispaghula husk and resistant starch the ratio of propionate was very similar 
up until 6 hours. At 24 hours it is clear that ispaghula husk proportionally produced 
the greatest amount of propionate, rice and resistant starch produce similar levels 




Fibre supplemented faecal homogenates were sampled at 0,3,6 and 24 hour time 
intervals, the level of propionate determined using GC analysis. Figure 3.9(a) 
revealed that cellulose produced very low levels of propionate (0.5 1 mM at 24 hours) 
as for all SCFAs. Ispaghula husk initially produced lower levels of propionate than 
the other fibres, 1.14mM and 2.07mM at 3 and 6 hours respectively, but at 24 hours 
it produces levels similar to that of rice starch (12.58mM and 13.64mM 
respectively). Pectin, rice starch and resistant starch all produced similar levels of 
propionate (4.44mM, 4.89mM and 5.77mM respectively at 6 hours) up until 24 hours 
where rice starch was found to produce higher levels. This can also be seen when 
examining the rate of production, shown in figure 3.10, as when the slower rate of 
isPaghula fermentation is taken into consideration it shows that ispaghula husk is a 
high producer of propionate. Ispaghula husk's production of propionate gradually 
increases over time, reaching its highest production rate at 24 hours, 0.58mM/hour, 
and a rate greater than any other fibre at 24 hours. Cellulose, as for all SCFAs 
produced very low levels at a very low rate of production. Resistant starch initially, 
as for all the SCFAs, produced propionate at a very rapid rate, 1.02mM/hour at 3 
hours, this then gradually decreased and by 24 hours propionate production rate was 
very low and this is a pattern consistent with resistant starch total SCFA production. 
Pectin and rice starch initially produced propionate at a similar rate; this rate of 
production then reduces for both fibres over time, but at a greater rate for pectin. 
Figure 3.9(b) revealed that proportionally, pectin was the lowest producer of 
propionate. At 3 hours ispaghula husk, rice starch and resistant starch proportionally 
produce similar levels, at 6 hours a similar pattern was observed but with rice starch 
propionate production decreasing. At 24 hours it was clear that ispaghula husk, 
proportionally, produced the greatest amount of propionate. As discussed previously 
the main backbone of isPaghula husk is arabinoxylan, thus being made up of 
arabinose and xylose. Both arabinose and xylose have been shown to produce 
propionate when fermented (Reviewed by Toole and Toole, 1991), giving a possible 
explanation for ispaghula husks production of high levels of propionate. Rice and 
resistant starch produced similar levels of propionate, the ratio of propionate 




Figure 3.10 Rate of propionate production by the fibres ispaghula 
husk, pectin, cellulose, rice starch and resistant starch during 
fermentation in faecal homogenates. 







Time in hours 




)K Resistant Starch 
The rate of propionate production, above control, from the fermentation of I% (w/v) 
of the fibres; ispaghula husk, pectin, cellulose, rice starch and resistant starch by 
faccal homogenates (n=3). Fibre supplemented faecal homogenates were sampled at 
0,3,6 and 24 hour time intervals, the levels of SCFAs were determined using GC 
analysis (Hewlett Packard). The rate of propionate production was initially greatest 
for resistant starch, rice starch and pectin, production decreased over time. Ispaghula 
husk rate of propionate production increased over time, and at 24 hours the rate of 
propionate production by ispaghula husk exceeded that of all other fibres. 
127 
0 0-3 3-6 6-24 
Chapter 3 
Fibre Characterlsallon 
3.5.4 SCFA profiles for the fibres; Ispaghula husk, Pectin, Cellulose, Rice starch 
and Resistant Starch. 
As all fibres produced high levels of acetate, ratios of butyrate (fig 3.6b) and 
propionate (Fig 3.8b) were determined, along with their rates of production (Fig 3.7 
and 3.9). Ispaghula husk resulted in an increase in SCFA levels over time and was 
shown to produce a consistent pattern of SCFA production with acetate production 
exceeding propionate production, which exceeds butyrate production. At 24 hours 
the acetate: propionate: butyrate ratio (A: P: B) was 1>0.75>0.08 respectively, which 
clearly shows that ispaghula husk proportionally produced high levels of propionate 
(40.8% of total) but very low levels of butyrate (4.6% of total) when fermented by 
the faecal homogenates. The rate of fermentation was fairly slow and consistent, 
although the rate of propionate production appeared to increase over time. Thus 
ispaghula husk was characterized as being fermented slowly and by 'Producing high 
levels of propionate at 24 hours. Pectin also showed a consistent pattern in the ratio 
of SCFA production, producing acetate in the greatest quantity followed by 
propionate then butyrate (A>P>B), at 24 hours the A: P: B ratio was 1>0.32>0.299, 
suggesting that pectin's production of propionate (19.9% of total) and butyrate 
(18.5% of total) were very similar. The rate of fermentation for pectin was initially 
very rapid but decreased over time this pattern was reflected not only when looking 
at total SCFA production but also for the individual SCFAs. Thus pectin was 
characterized as being rapidly fermented producing similar levels of propionate and 
butyrate. Cellulose produced very low levels of SCFAs and at a very slow rate 
throughout, at 24 hours a pattern could be established and revealed a ratio of 
1>0.84>0.41 for A: P: B, suggesting that cellulose proportionally produces high 
levels of propionate (38.3% of total) with lower levels of butyrate (18.3% of total). 
Thus cellulose was characterized as being a very slowly fermented fibre, producing 
high levels of propionate. Rice starch was shown to initially produce a ratio pattern 
of A>B>P, but at 24 hours propionate production exceeded butyrate production. 
Thus at 6 hours the A: P: B ratio was 1: 0.37: 0.45 respectively, but at 24 hours the 
ratio changed to 1>0.55>0.28, suggesting that rice starch produced high levels of 
propionate (29.8% of total) and lower levels of butyrate (15.5% of total). The rate 
of rice starch fermentation appeared to also have a consistent pattern, initially very 




being for butyrate, as reflected in the changes in ratios. Thus rice starch was 
characterized as being rapidly fermented, initially producing high levels of butyrate 
but with propionate production exceeding butyrate production at later stages. 
Resistant starch was shown to produce an A: P: B ratio of 1: 0.47: 0.52 at 24 hours, 
suggesting that although propionate and butyrate levels were very similar, it 
produced more butyrate (26.25% of total) than propionate (23.5% of total). The rate 
of fermentation for resistant starch also appeared to have a fairly consistent pattern, 
again being fermented very quickly initially but then gradually decreasing over time. 
Thus resistant starch was characterized as being rapidly fermented, producing high 
levels of butyrate. 
3.5.5 Fermentation characteristics of the basal and fibre supplemented diets 
Ispaghula husk, Pectin, Cellulose. 
3.5.5.1 pH changes 
Fig 3.11 Represents the pH changes found within human faecal homogenates 
(16.67% w/v) supplemented with 2% (w/v) of basal diets consisting of one of the 
following fibres; ispaghula husk, pectin, and cellulose, after 24 hours incubation 
under anaerobic conditions (80% N2,10% C02 and 10% H2) at 370C using a 
MACS VASOO microaerophilic cabinet (Don Whitley Scientific Ltd, Shipley, West 
Yorks). pH was used to determine whether fermentation had been successful, as 
seen by a decrease in pH, and to detect any unwanted contamination. The graph 
clearly showed that for all diets the controls (MSM plus fibre, n--l) were free from 
contamination with faccal bacteria, the slight decrease in the pectin control was 
probably due to its own acidity. pH also revealed the extent of fermentation of the 
fibre supplemented diets within the faecal homogenate (n--3) after 24 hours. All 
diets resulted in a similar decrease in pH, an increase in acidity, suggesting they were 
all readily fermented, this fermentation pattern was probably the result of the sucrose 
and rice starch content. The graph showed a very subtle difference between the 




Fig 3.11 pH changes within human faecal homogenates 
supplemented with the basal diet and the basal diet supplemented 
with the dietary fibres ispaghula husk, pectin and cellulose. 
FH/MSM IH Diet Pectin Diet Cellulose Basal Diet 
Diet (Rice) 
pH changes in faecal homogenates supplemented with different diets 
after a 24 hour incubation. 
x CL m msm MFH 








Key: MSM = Mineral salts media supplemented with fibre, FH = Faecal homogenate supplemented 
with fibre. 
pH changes in human faecal homogenates containing 2% (w/v) of diets 
supplemented with the following fibres; Basal, Ispaghula husk, Pectin, and Cellulose, 
after 24 hours incubation under anaerobic conditions (80% N2,10% C02 and 10% 
H2) at 37'C using a MACS VA500 microaerophilic cabinet (Don Whitley Scientific 
Ltd, Shipley, West Yorks). This graphic representation showed that for all diets the 
controls (MSM plus fibre, riýl) were free from contamination. All fibre 
supplemented diets and the basal diet (n=3) resulted in a decrease in pH after 24 
hours. This fermentation pattern was probably due to the sucrose and rice starch 
(See Table 3.6a, Table 3.7 and Fig 3.2) content. The graph showed a very subtle 
difference between the groups, with the basal and pectin supplemented diets resulting 
in the largest decrease in pH, followed by ispaghula husk and cellulose, a pattern 




pH, 4.05 and 4.02 respectively, followed by ispaghula husk, pH 4.16, and cellulose, 
pH4.2. The largest decrease in pH was found to be basal diet (pH decreased by 
2.58), followed by ispaghula husk (2.52), pectin (2.51) and cellulose (2.46). This 
could have been due to a number of factors including non-homogenous mixing of the 
diets, rate of fermentation of fibres may differ in the presence of other constituents, 
or differences in acidity of the individual SCFAs. 
3.5.5.2 Total short chainfatty acidproduction 
Figure 3.12 represents the total short chain fatty acid production, above control, from 
the fermentation of 2% (w/v) of the basal diet and those supplemented with the 
fibres; Ispaghula husk, pectin, and cellulose; by faecal homogenates (n=3). Diet 
supplemented faecal homogenates were sampled at 0,3,6 and 24 hour time intervals, 
the levels of SCFAs were determined using GC analysis (SupelcO Nukol 24107 
capillary column (30m x 0.25mm. x 0.25pm) oven maintained at 16011C, injector and 
detector maintained at 2500C, with injection volume of lpl. Carrier gas (helium at 
16.6psi) flow rate of 8.2ml/min. (Hewlett Packard instrumentation) coupled with 
external standard solutions (5mM concentration). The graph revealed that the diets, 
up to 6 hours of incubation in the faecal homogenates, were fermented to a similar 
extent. At 24 hours there were differences in the final SCFA levels in both 
experiments not giving consistent findings. In experiment one the largest SCFA 
producer was ispaghula husk whereas in the second experiment it fell to cellulose. 
This could be the result of problems occurring within the internal standards for 
acetate levels within experiment 2 suggesting that the production of butyrate and 
propionate may provide clearer indicators of fermentation. 
3.5.5.3 Acetate production 
Figure 3.13 represent the total acetate production, above control, for the fermentation 
of 2% (w/v) of the basal and fibre supplemented diets; ispaghula husk, pectin, 




Figure 3.12 Total short chain fatty acid production from the 









Total SCFA levels produced by the fermentation of diet 
supplemented faecal homogenates over a 24 hour time course. 
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Total short chain fatty acid production, above control, from the fermentation of 2% 
(w/v) of the fibre supplemented diets; ispaghula husk, pectin, cellulose and basal diet 
(no fibre added) by faecal homogenates (n=3). Diet supplemented faecal 
homogenates were sampled at 0,3,6 and 24 hour time intervals, the levels of SCFAs 
were determined using GC analysis (Hewlett Packard). The graph showed that the 
diets, up until 6 hours were fen-nented to a similar extent. At 24 hours there were 
differences in the final SCFA levels with both experiments giving inconsistent 
findings, in experiment one the largest SCFA producer was ispaghula husk whereas 
in the second experiment it falls to cellulose. Thus could have been due to problems 




Figure 3.13 Total acetate production from the fermentation of fibre 
supplemented diets. 
(a) Experiment I 
Acetate production levels from the fermentation of diet 
supplemented faecal homogenates over a 24 hour time course 
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Acetate levels produced by the fermentation of diet supplemented 
faecal homogenates over a 24 hour time course 
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Total acetate production, above control, from the fermentation of 2% (w/v) of the 
fibre supplemented diets; Ispaghula husk, pectin, cellulose and basal diets by faecal 
homogenates (n=3). Fibre supplemented faecal homogenates were sampled at 0,3,6 
and 24 hour time intervals, the level of acetate determined using GC analysis. The 
graph revealed that all fibres produced acetate at similar levels up until 6 hours. At 
24 hours there were variations between the two experiments, as for total SCFA 
production, with cellulose producing the greatest level of acetate in experiment 2 and 




were sampled at 0,3,6 and 24 hour time intervals, the level of acetate determined 
using GC analysis. The graph showed that all fibres produced acetate at similar 
levels after 6 hours incubation, this may suggest that the common constituents, 
sucrose and rice starch were fermented initially due to the preference of the bacteria. 
At 24 hours there are variations between the two experiments with cellulose 
producing the most in experiment 2 and ispaghula husk in experiment 1. Again this 
is probably due to problems with the acetate internal standards during experiment 2. 
3.5.5.4 Propionate production 
Figure 3.14(a) showed the total propionate production and (b) the ratio of propionate 
to acetate production, above control, from the fermentation of 2% (w/v) of the fibre 
supplemented diets; ispaghula husk, pectin, cellulose and basal diet; by faecal 
homogenates (n7-3). Fibre supplemented fadcal homogenates were sampled at 0,3,6 
and 24 hour time intervals, the level of butyrate determined using GC analysis. 
Figure 3.14 (a) reveals that the level of propionate production in all the diets was 
consistent up to 6 hours incubation in both experiments, with both experiments 
producing similar levels at this time. After 24 hours there were minor differences in 
propionate levels found between the fibre supplemented diets but in both 
experiments ispaghula and cellulose produced the highest levels of propionate. The 
ratio of propionate production, shown in figure 3.14b, as a proportion of acetate 
production revealed that in both experiments the pectin diet proportionally produced 
the highest level of propionate. This was observed up until 6 hours in experiment I 
and 24 hours within experiment 2 with cellulose being the greatest producer in 
experiment 1. Within all the fibre supplemented diets propionate production was 
proportionally higher than butyrate, with each diet having a profile of 
acetate>propionate>butyrate, for example the A: P: B ratio for pectin was 1: 0.75: 0.1 




Figure 3.14a) Total propionate production (b) Ratio of 
propionate: acetate production from the fermentation of fibre 
supplemented diets. 
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Ratio of propionate production to actetate for the fibre 
supplemented diets. 
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a) Total propionate production (b) Ratio of propionate to acetate production, above 
control, from the fermentation of 2% (w/v) of the fibre supplemented diets; ispaghula 
husk (111), pectin, cellulose (cell) and basal diet; by faecal homogenates (n=3). Fibre 
supplemented faecal homogenates were sampled at 0,3,6 and 24 hour time intervals, 
the level of butyrate determined using GC analysis. (a) The level of propionate 
production in all the diets was consistent up to 6 hours in both experiments, with 
both experiments revealing similar patterns. After 24 hours there were minor 
differences found between the fibre supplemented diets, in both experiments 
ispaghula husk and cellulose being the greatest producers. (b) The ratio of 
propionate production as a proportion of acetate production revealed, in both 
experiments, to be greatest in the pectin diet up until 6 hours it continued to be the 




. ýrate production 
3.5.5.5 But 
Figure 3.15 revealed (a) total butyrate production and (b) the ratio of butyrate to 
acetate production, above control, from the fermentation of 2% (w/v) of the fibre 
supplemented diets; ispaghula husk, pectin, cellulose and basal diet; by faecal 
homogenates (n--3). Fibre supplemented faccal homogenates were sampled at 0,3,6 
and 24 hour time intervals, the level of butyrate determined using GC analysis. Both 
experiments I and 2 (figure 3.15a) revealed a similar pattern for butyrate production, 
the ispaghula husk supplemented diet producing the highest level of butyrate, 
followed by the basal diet, cellulose and the pectin producing the lowest amount. 
The ratio of butyrate production (figure 3.15b) by the fibre supplemented diets 
showed a slight variation between experiments although both revealed that the ratio 
of butyrate production decreased over time for all diets. Butyrate production was 
proportionally the lowest for all fibre supplemented diets after 3 *6 and 24 hours, with 
each diet having a ratio of acetate>propionate>butyrate for these time periods. 
3.5.5.6 Rate offermentation 
The rate of fermentation, as suggested by the rate calculated for the total SCFA 
production (figure 3.16) for experiments 1 and 2 revealed different time trends, 
although both suggested that the rate of SCFA production slows rapidly over the 6 to 
24 hour period. 
3.5.6 Comparison of fermentation characteristics of the fibres; Ispaghula husk, 
Pectin, Cellulose, Rice and Resistant Starch and their associated diets. 
The fibre supplemented diets were fermented to a similar extent as indicated by their 
total SCFA levels (Figure 3.12) after 6 hours of incubation within the faecal 
homogenate. This may be due to all the fibre supplemented diets containing the 
same level of rice starch and sucrose, although the basal diet had higher levels of 




Figure 3.15a) Total butyrate production (b) Ratio of 
butyrate: acetate production from the fermentation of fibre 
supplemented diets. 
(a) Experiment I Experiment 2 
Butyrate levels produced from the fermenation of Butyrate levels produced from the fermenation of diet 
diet supplemented faecal homogenates over a 24 supplemented faecal homogenates over a 24 hour time 







Time in hours 
(b) Experiment I 
0 Ispaghula 6 
Husk 




x Basal 036 24 
Time in hours 
Ratio of butyrate production to acetate for the fibre 
supplemented diets. 
0.4 
0.3 4 IH diet 
0 -M- Pectin d ýo 0.2 Cell d 12 
0.1 X basal 
0 
0 hrs 3 hrs 6 hrs 24 hrs 
Time in hours 





Ratio of butyrate production to acetate for the fibre 
supplemented diets. 
0.4 
0.3 0 IH diet 
0 -*--Pectin Diet = 0.2 
12 x Cell Diet 
0.1 - Basal 
0 
0 hrs 3 hrs 6 hrs 24 hrs 
Time in hours 
(a) Total butyrate production (b) Ratio of butyrate to acetate production, above 
control, from the fen-nentation of 2% (w/v) of the fibre supplemented diets; ispaghula 
husk (IH), pectin, cellulose (cell) and basal diet by faecal homogenates (n=3). Fibre 
supplemented faecal homogenates were sampled at 0,3,6 and 24 hour time intervals, 
the level of butyrate determined using GC analysis. (a) Both experiments I and 2 
show a similar pattern for butyrate production with the ispaghula husk diet producing 
the highest level of butyrate, followed by the basal diet, cellulose and the pectin 
producing the lowest amount. (b) The ratio of butyrate production by the diets varied 
slightly between experiments although both show that the ratio of butyrate 




Figure 3.16 Rate of SCFA production from the fermentation of fibre 
supplemented diets within faecal homogenates. 
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Experiments I and 2 show different time trends for fermentation initially, although 
both suggest that the rate of SCFA production slows rapidly over the 6 to 24 hour 
period. 
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production. At 24 hours there were differences in the final SCFA levels with both 
experiments not giving consistent findings. In experiment one the largest SCFA 
producer was ispaghula husk whereas in the second experiment it fell to cellulose. 
This is again in contrast to the findings for the fibres where pectin, rice starch and 
resistant starch had the highest production of SCFAs and ispaghula husk and 
cellulose had the lowest. This could be due to a non-homogenous mix of the diet, 
but it could also suggest that diet could influence the rate of fibre fermentation. 
Figure 3.14a revealed that the level of propionate production in all the diets was 
consistent up to 6 hours incubation within both experiments. After 24 hours there are 
minor differences found between the fibre supplemented diets but in both 
experiments ispaghula and cellulose produced the highest levels of propionate. The 
ratio of propionate production as a proportion of acetate production (figure 3.14) 
revealed that in both experiments * the pectin diet to be greatest producer 
proportionally up until 6 hours, continuing to be the highest in experiment 2 but 
cellulose was the highest producer proportionally within experiment 1. Interestingly 
all the fibre supplemented diets' propionate production was at a higher ratio than 
butyrate, with each diet having a profile of acetate>propionate>butyrate, for example 
the A: P: B ratio for pectin was 1: 0.75: 0.1 after a 24-hour incubation. This does not 
reflect the profile found for rice starch, which appeared to have a greater butyrate 
production initially up until 6 hours, although it is similar to the pattern found at 24 
hours. This is probably due to the availability of other substrates in the diets for the 
bacteria within the faecal homogenate. 
Both experiments I and 2 in figure 3.15a show a similar pattern for butyrate 
production, the ispaghula husk supplemented diet produced the highest level of 
butyrate, followed by the basal diet, cellulose and the pectin producing the lowest 
amount. This is in complete contrast to the individual fibres as ispaghula husk was 
found to be one of the lowest producers with pectin being one of the highest. This 
could be for a number of reasons, including a non-homogenous mix of the diets 
being examined, possibly the pectin diet had little pectin, rice starch or sucrose 
available. It could also suggest that other dietary constituents affect the fermentation 
of fibres and their SCFA production possibly by selecting for different bacteria. The 




diets showed a slight variation between experiments although both showed that the 
ratio of butyrate production decreases over time for all diets. Butyrate production 
was proportionally the lowest for all fibre supplemented diets after 3,6 and 24 hours, 
with each diet having a ratio of acetate>propionate>butyrate for these time periods. 
This was true for all fibres, except resistant starch, which would only be found at 
trace levels, with rice starch butyrate production falling rapidly at 24 hours, which 
may reflect why this occurred in all the fibre supplemented diets, with rice starch 
being one of the main constituents. 
The rate of fermentation, as suggested by the rate calculated for the total SCFA 
production shown in figure 3.16, in experiments I and 2 show different time trends, 
although both suggest that the rate of SCFA production reduced rapidly over the 6 to 
24 hour period. Interestingly the rate of SCFA production decreased after 24 hours 
incubation, this mimics the findings of rice starch, one of the main constituents. 
The differences and similarities found between the individual fibres ispaghula husk, 
pectin, cellulose, rice starch and resistant starch to the fibre supplemented basal diets 
and the basal diets itself could simply be attributed to a non-homogenous mixture of 
dietary constituents giving unequal measures of fibre, rice starch and sucrose. Other 
constituents within the diet may also interfere with the fibres digestion, for example 
other constituents may be more readily fermented or may actually aid the 





Dietary fibre (Section 1.5) is generally considered to be a complex mix of cellulose, 
hernicellulose, pectic substances, gums and mucilages, lignins, algal polysaccharides 
and starch (Reviewed by Dreher, 1995; Reviewed by Lembo, 1998). Dietary fibre is 
heterogeneous in both structure and function with a wide variety of chemical and 
physiological properties. The physiological effects of fibres are partly predictable on 
the basis of their physiochernical properties (Reviewed by Blackwood et al., 2000). 
These properties are dependent on a number of factors intrinsic to the fibre, the host 
and other extrinsic factors (refer to section 1.5). 
The dietary fibres intrinsic properties were examined, this included their NSP and 
monosaccharide content, waterholding capacity via solubility (Weisburger et al, 
1977; Reviewed by Blackwood et al., 2000; Reviewed by Morris, 2001; Reviewed 
by Kritchevsky, 2001) and those factors intrinsic to the fibre and host via 
fermentation. The interactions of the fibres with other components of the digesta 
were examined by profiling the diets using the Englyst technique and a fermentation 
study being representative of intrinsic factors of the fibre and host. 
Fermentation is a very important parameter of dietary fibre characterisation, not only 
in terms of products produced during fermentation but also the rate and site of 
fermentation, giving some indication of its degradation during transit through the 
large intestine. The site, rate and extent to which they are absorbed or fermented in 
the colon and the type of products produced during fermentation all affect the 
physiological properties of the fibre (Reviewed by Chaplin, 1999; Reviewed by_ 
Blackwood et al., 2000). 
Acquisition of the microflora itself influences host biochemistry, such as enzymatic 
activity of the intestinal contents (e. g. P-D-Glucuronidase, azoreductase, bile salt 
hydrolyase), SCFA concentrations, oxidation-reduction potential, host physiology 
(e. g. rate of replacement of enterocytes), immunology (stimulation of 
reticuloendothelial tissues) and the modiflcation of host-synthesized molecules (e. g. 




form secondary bile acids, mucin degradation) (Reviewed by Tannock, 1994). The 
colonic microflora also influences colonic mucosal architecture, mucosal cell 
turnover and intestinal motility, the precise mechanisms involved are unknown but 
could be due to SCFA production (Reviewed Salyers, 1995). 
The ratio of SCFA production is thus very important (Reviewed Eastwood, 1995), 
with different fibres producing different levels of these SCFAs (Wang and Friedman, 
1998; Reckitt and Colman personal communication). A number of structural 
properties of the fibre; degree of stiffness and regularity of the polysaccharide chains, 
esterification, side chains and monosaccharide composition all affect the rate and 
extent of their fermentation (Reviewed by Blackwood et al., 2000), along with a 
number of intrinsic factors of the host including their type of microflora. Overall 
soluble fibres are more readily fermented and earlier in the colon, than insoluble 
fibres (Reviewed by Blackwood et al., 2000). The metabolism of the three main 
SCFAs: acetate, propionate and butyrate, are very different (Reviewed by Rombeau 
and Roth, 1995) and have a number of biological effects profoundly altering the 
milieu of the colon (Refer to section 1.5.4). The physiological effects of SCFA 
production include the enhancement of sodium absorption, stimulation of blood flow 
improving peripheral artery dilation (mainly by acetate), and regulation of 
carbohydrate and lipid metabolism (Reviewed by Rombeau and Roth, 1995) and 
water retention in faecal matter (Reviewed by Brydon, 1995; Reviewed by Lembo, 
1998). 
3.6.1 The physiochemical properties of the dietary fibres 
3.6.1.1 Ispaghula husk 
Ispaghula husk is a rich source of non-starch polysaccharides; (dietary fibre) 
comprising 80-85% NSP, as determined by the Englyst method (Reviewed by 
Dettmar, 1996). Using the Englyst technique our ispaghula husk was shown to have 
81.43% NSP content which lies within this range. Ispaghula husk is an 
arabinoxylan, having a xylose backbone with arabinose side chains (Kennedy et al., 
1979; Sandhu et al., 1981) with other sugar side chains associated. Arabinoxylans, 
such as ispaghula, husk, consist of P-xylosyl chains forming a backbone with 
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arabinose side-chains. This structure results in a relatively stiff molecule with short 
branch points (Kennedy et al., 1979; Sandhu et al., 1981). Arabinoxylans form 
extended conformations; exhibit a high viscosity and can vary in flexibility and 
stiffness, which can also be affected by the level of arabinosylation (Reviewed by 
Blackwood et al., 2000). Of the 81.43% NSP content for our ispaghula husk, 88.6% 
was soluble and comprised of xylose, arabinose and uronic acids, 11.4% of which is 
insoluble made up primarily of glucose and arabinose, which reflect its structure. 
Our ispaghula husk was shown to be primarily soluble with a solubility ratio of 
7.78: 1. Observations using the image analyser confirmed the solubility of ispaghula 
husk, with the soluble fraction being gel-like in nature and attached to an insoluble 
cytoskeleton. This is consistent with previous findings where isphagula husk was 
shown to be partially soluble (forming a mucilage/gel) (Kennedy et al., 1979; 
Sandhu et al., 1981) having a high water holding capacity giving it a viscous nature 
(Kennedy et al., 1979; Sandhu et al., 198 1; Reviewed by Blackwood et al., 2000). 
The ispaghula husk used in this study was found to be partially fermented at a fairly 
consistent rate which steadily increased over a 24 hour period, producing a SCFA 
profile of acetate>propionate>butyrate (A>P>B), where acetate was the main SCFA 
produced but it also produced high levels of propionate when compared to the other 
fibres. McBumey (1991) showed that different fibres produced different levels of 
SCFAs with psyllium producing all three of the main SCFAs (McBumey, 1991; 
Reviewed by Brydon, 1995), but was noted for particularly producing propionate 
(Reviewed by Blackwood et al., 2000). Ispaghula husk has previously been shown 
to ferment relatively slowly retaining its structure (Marteau et al., 1994) throughout 
the colon (Reviewed by BeMiller, 1993). A study of the ability of Bacteriodes from 
the human colon in degrading ispaghula husk found that the ability of bacteria to 
degrade psyllium (Ispaghula husk) was uncommon (Salyers et al., 1978). 
Observations of ispaghula husk after 24 hours of fermentation in a faecal slurry 
suggested that ispaghula husk was not only partially fermented but also maintained 
its viscosity throughout. This compares the findings by others where with psyllium, 
once formed, the gels are relatively unaffected by temperature and pH maintaining its 
viscosity even when subjected to artificial gastric and intestinal juices suggesting that 
it maintains its viscosity within the colon (Reviewed by BeMiller, 1993). Hydrolysis 




human volunteers (Andersen et al., 1988). This suggests that ispaghula husk is 
fermented throughout the colon releasing a steady stream of SCFAs throughout the 
colon. The viscous nature could also result in microflom adhering to the fibre 
allowing for its fermentation to continue, the viscosity and maintenance of its 
structure also allows for extra bulking of the faeces (Marteau et al., 1994). 
3.6.1.2 Pectin 
Over half of the pectin used in this study was made up of NSP (60.48%) 99.7% of 
which was soluble and primarily consisted of uronic acids with low levels of 
galactose, 0.3%. The insoluble fraction of the pectin comprised of arabinose, 
rhamanose and mannose. Thus pectin is primarily soluble with a solubility ratio of 
344.6: 1. This reflects previous findings for pectin, citrus peel, being virtually 
completely soluble (forms a weak gel), fermented very quickly (completely in the 
caecum) (Reviewed by May, 1999). Pectin is heterogeneous in nature (Reviewed by 
Reiser, 1987; Reviewed by May, 1999) but is primarily made up of poly-ot-D 
galactouronic acid (Reviewed by May, 1999; Reviewed by Morris, 2001). The 
polygalacturonic acid regions are partially esterified with methanol, linked to 
complex regions based on a galactouronic acid-rhamanose copolymer bearing 
extensive side chains (Reviewed by Reiser, 1987). The level of esterification of 
pectin affects the rate of its degradation (Dongowski et al., 2000). These 'hairy 
regions' have arabinogalactans attached tending to expand the structure and 
flexibility of pectin (Reviewed by May, 1999; Reviewed by Blackwood et al., 2000). 
Pectin can also have regions of rhamnogalaturonosyl within its backbone (Reviewed 
by Morris, 2001), which may explain rhamanous being found within the insoluble 
fraction. 
Pectins are very soluble in water giving a viscous solution and are easily degraded, 
although not by human gut enzymes (Reviewed by May, 1999), being fermented 
rapidly in the caecum/colon. Polysaccharide chains are fermented at the terminal 
region first and carbohydrates containing a-arabinose (pectin/ispaghula husk) and a. 
galacturonic acid (pectin) residues are generally more susceptible to fermentation. 




intestine. Pectin initially has a high water holding capacity (WHC) but because it is 
completely fermented in the colon it has little effect on transit time (Reviewed by 
Blackwood et al., 2000). The pectin used in this study was rapidly and fully 
fermented throughout the 24 hours experimental period slowing at the 24 hour period 
which could be due to lack of substrate, thus reflecting that seen for a typical pectin. 
The pectin also produced a SCFA profile of A>P>B, as for all fibres acetate was 
produced in the largest quantity and this was accompanied by the production of 
propionate and butyrate at similar levels. This suggests that with pectin being readily 
fermented by the faecal slurries, that our pectin, as for all other pectins, would be 
fermented very quickly and within the caecum. This would result in the SCFAs 
having little effect on the distal colon and possibly minimal effect on the proximal 
colon and possibly enlarged caecum. Armstrong et al. (1990) found that in the rat, 
pectin increased free water in both the caecal content and faeces (Reviewed by 
Brydon, 1995). This was also accompanied with the finding that pectin had the 
highest SCFA production when compared to a number of other fibres including 
carboxymethy1cellulose (CMC) and Bran, when using faecal cultures (Reviewed by 
Brydon, 1995). Pectin has previously been shown to result in an increase in cell 
turnover (Reviewed by Cassidy and Fitzpatrick, 1995) this could be due to the high 
levels of SCFAs being produced due to its fermentation. Pectin is affected by 
temperature and pH, it is stable under acid conditions but is less stable as pH 
increases, especially at higher temperatures (Reviewed by May, 1999). 
3.6.1.3 Cellulose 
The purified cellulose used in this study was found to comprise of NSP (108.35%), 
which compares to findings where cellulose was shown to have a total dietary fibre 
content of 99% (Reviewed by Dreher, 1995). Cellulose varies with purity depending 
on its origin, acid hydrolysis found almost 96% glucose (Reviewed by Aspinall et 
al., 1967). From the purified cellulose 7.8% was found to be soluble and made up of 
glucose, 92.2% of which is insoluble and made up of glucose, thus cellulose is 
primarily insoluble with a solubility ratio of 0.09: 1. Cellulose is made up of poly. 
p(I-4)-D-anhydroglucose (pyranose) glycosidically linked forming microfibrils 




insoluble glucose. Being a neutral polysaccharide that tends to self-associate 
(Reviewed by Morris, 2001) as a result it has a very low solubility (low water 
holding capacity) (Reviewed by Aspinall et al., 1967; Reviewed by Zecher and 
Gerrish, 1999). This was shown for our purified cellulose using the Englyst method 
and image analysis. Image analysis revealed that after one hours incubation of 
cellulose in water there were no solubilisation of the cellulose fibres, suggesting the 
cellulose fibres are insoluble. 
Cellulose is only partially digested by the human body (Reviewed by Zecher and 
Gerrish, 1999) and is fermented very slowly throughout the colon. The purified 
cellulose in this study was virtually unfermented and the rate of fermentation was 
very slow during the 24 hour fermentation period. Cellulose produced very low 
levels of SCFAs with a SCFA profile of A>P>B, thus in this case producing 
proportionally more propionate than butyrate. Previously cellulose was shown to 
ferment under anaerobic conditions by bacteria to produce methane and fatty acids 
(Reviewed by Aspinall et al., 1967). Purified cellulose has been shown to be 
virtually indigestible, although cellulose within whole foods is digested more readily 
within the gastrointestinal tract (Reviewed by Wolever 1995). The ordered packing 
of cellulose confers resistance to enzymatic attack thus limiting 
degredation/fermentation via colonic microflora (Reviewed by Aspinall et al., 1967; 
Reviewed by Alberts et al., 1994; Reviewed by Zecher and Gerrish, 1999; Reviewed 
by Morris, 2001). Thus the level of SCFAs produced would be minimal, although 
would probably be consistently produced throughout the proximal and distal colon. 
The lack of SCFAs may explain why rats fed on cellulose or fibre deficient diet had 
evidence of little villus maturation, i. e. no ridged morphology, with cellulose found 
to have a lower cell turnover and migration up the crypt (Reviewed by Cassidy and 
Fitzpatrick, 1995). The angles within these pyranose rings affect the fibres 
conformation, , yhich in turn affects fermentation (Reviewed by Morris, 2001). The 
differences in the fermentation of cellulose poly-o-D-Glucose and resistant starch 
poly-cc-D-Glucose is its conformation, i. e. axial versus equatorial, and due to its 
packing, for example cellulose is more resistant to enzymatic attack resulting in 
limited degradation during fermentation because of its ordered packing (Reviewed 




fermented, it has been shown to increase stool weight, decreasing transit time, by its 
ability to retain water. Cellulose has previously been shown to produce 
proportionally higher levels of butyrate (Reviewed by Blackwood et al., 2000), 
which have a number of potential health benefits but this was not shown in this 
study. 
3.6.1.4 Starch 
Starch is the reserve food material of most plants and is one of the principal 
components of the diet (Reviewed by Aspinall et al., 1967). Starch is made up of 
poly-a-(1-4)-D-Glucose (or a-(1-3)-D-Glucose the branches in arnylopectin) 
(pyranose rings), which forms non-parallel buckled ribbons forming coaxial double 
helices (Reviewed by Aspinall et al., 1967; Reviewed by Morris, 2001). It is a 
neutral Polysaccharide that tends to self-associate (Reviewed by Morris, 2001) 
making it insoluble. Starch is made up of glucose either amylose or amylopectin in 
origin, and proportions of these may vary (Reviewed by Aspinall et al., 1967). 
Starch granules contain densely packed assemblies of ordered (double helical) 
amylopectin, together with disordered amylose (Reviewed by Morris, 2001). Starch 
in the form of amylose, a storage polysaccharide, tends to adopt a wide helical 
conformation (Reviewed by Blackwood et al., 2000). Our resistant starch was of 
amylose origin and shown to have a very low level (0.715%) of NSP as expected, 
63.5% of which is soluble glucose, 36.5% of which is insoluble glucose. This 
glucose could be residual resistant starch after incomplete degradation during the 
Englyst procedure. Thus resistant starch residue was primarily soluble with a 
solubility ratio of 1 . 75: 1. 
The degradation of starch within the gastrointestinal tract depends on its chain 
conformation and packing which is dependent on any pre-processing that it may have 
been subjected too (Reviewed by Morris, 2001). Amylose is more readily digested 
(Reviewed by Aspinall et al., 1967). Starch can be categorised into three main 
categories; the first is the rapidly digested starch, which is digested in the small 
intestine, the second group is the starch, which is digested slowly in the small 




composed of amylose granules (thus probably RS2 type), was rapidly fermented with 
fermentation slowing at 24 hours and producing a ratio of SCFA production of 
A>B>P, thus resistant starch was shown to be a large producer of butyrate. Rice 
starch (the main constituent of the basal diet) was also rapidly fermented with 
fermentation slowing at 24 hours. Initially the rice starch was shown to produce high 
levels of butyrate giving a ratio of A>B>P, but after 24 hours butyrate production 
dropped giving a ratio of A>P>B, although proportionally a high producer of 
butyrate compared to ispaghula husk. The majority of starch reaching the colon is 
fermented in the colon, the extent varying on the fermentative capacity of the colonic 
microflora (Reviewed by Jenkins and Kendall, 2000), as for the other fibres. 
Prolonged feeding of rats with potato starch has been shown to result in an increase 
in butyrate within the caecurn and towards the distal colon, and levels increased over 
time revealing an adaptive process of SCFA production by the colonic mucosa (Le 
Blay et al., 1999). 
3.6.2 The health benefits of dietary fibres and their use in disease states. 
Dietary fibre is thought to have a wide range of properties that influence a number of 
prevailing western diseases. Diet gives clues to the aetiology of many of the life 
style diseases, such as colon cancer and heart disease (Reviewed by Kritchevsky, 
2001). Metabolic affects of fibres include reducing obesity (bringing about quicker 
satiety and changing nutrient absorption), gallstones (through reducing cholesterol 
saturation and possibly affecting the bile acid pool), diabetes (work carried out by 
Jenkins and Anderson found fibres to help alleviate symptoms by normalising 
glucose tolerance and plasma insulin levels), coronary heart disease and colon cancer 
(Reviewed by Kritchevsky, 2001). 
3.6.2.1 Weight management. 
Dietary fibre has a number of benefits to health including weight management 
(Reviewed by Stephen, 1995). Dietary fibre helps bring about quicker satiety, 
delayed gastric emptying, changing nutrient absorption (Harmuth-Hoene and 
Schelenz, 1980), gastrointestinal hormones, ileal break and caloric excretion 
(Reviewed by Stephen, 1995). Fibres, especially bulking fibres such as ispaghula 
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husk, help with weight management due to a quicker satiety being reached along 
with the fact that they are low calorie foods. Determinants of obesity include calorie 
intake and calorie expenditure (including physical activity) with energy balance 
being relevant to a number of disease processes including colorectal cancer. High 
intake of calorific foods (inc starches and refined cereals) may favour 
hyperinsulinemia and insulin resistance, with a possible increase in activity of IGF-I 
(Reviewed by Gerber and Corpet, 1999). Thus weight management will also 
indirectly counteract a number of other conditions. 
3.6.2.2 Cardiovascular Disease - Cholesterol metabolism. 
It is now established that insoluble fibres, such as cellulose, do not influence serum 
lipids, whereas soluble fibres, pectin and psyllium (ispaghula husk), exert a 
hypocholesterolaemic effect'(Reviewed by Reiser, 1987; Reviewed by Anderson, 
1995; Gallaher and Hassel, 1995; Reviewed by Graham, 1996; Reviewed by 
Kritchevsky, 2001). Bile is produced in the liver, stored by the gallbladder, secreted 
into the small intestine via bile ducts when needed for digestion (Reviewed by Miller 
and Keane, 1987). Bile helps in alkalinising the intestinal contents and plays a role 
in the emulsification, absorption, and digestion of fat. The chief constituents are 
conjugated bile salts, cholesterol, phospholipid, bilirubin, and electrolytes (Reviewed 
by Miller and Keane, 1987). Bile acids are steroid acids derived from cholesterol; 
they are classified as primary, those synthesised by the liver, e. g. cholic and 
chenodeoxycholic acid, or secondary, those produced from primary bile acids by 
intestinal bacteria and returned to the liver by the enterohepatic circulation, e. g. 
deoxycholic and lithocholic acid (Reviewed by Miller and Keane, 1987). These bile 
acids affect a number of other disease processes including gallstones and colorectal 
cancer development. 
Low glycaemic foods are predictors of cardiovascular disease, two studies have 
shown that the lower the glycaemic index of the food the higher the high density 
lipoprotein (HDL) (transports cholesterol out of the body) cholesterol suggesting 
they are protective (Reviewed by Wolever, 1995; Reviewed by Jenkins and Kendall, 
2000). The mechanisms by which soluble fibres exert their effects is due to the 




absorption of cholesterol and possibly by influencing bile acid metabolism 
(Reviewed by Reiser, 1987; Gallaher and Hassel, 1995; Reviewed by Kritchevsky, 
2001). The data suggests that soluble fibres may lower serum lipid levels, but a 
high-fibre diet itself may afford protection against cardiovascular heart disease 
(Reviewed by Kritchevsky, 2001). There appears to be a positive association 
between slow releasing carbohydrates, reduced insulin levels, higher HDL 
cholesterol concentrations, and reduced diabetes and cardiovascular disease risks 
(Reviewed by Jenkins and Kendall, 2000) and resistant starch has been shown to 
achieve this. Fibres have been shown to bind cholesterol and bile acids with 
differing affinities, for example cellulose has been shown to be a poor binder of bile 
acids, whereas ispaghula husk has been shown to bind certain bile acids (Reviewed 
by Kritchevsky, 1995; Reviewed by Blackwood et al., 2000) and increase the level 
of lipid output within faeces, when compared to wheat bran (Nyman and Asp, 1985). 
Altogether fibres reduce the appearance of cholesterol in the blood and tissues 
resulting in the increased excretion of neutral and acidic steroids (Reviewed by 
Kritchevsky, 1995). The conversion of cholesterol to bile acids occurs when 
hydroxylation is at the 7-a position, which is interrelated to the activity of HMG- 
CoA reductase, a key step in cholesterol biosynthesis (Reviewed by Kritchevsky, 
1995). Fibres have been shown to affect the activity of these enzymes, in a rat 
experimental model cellulose resulted in elevation of 7a-hydroxylation and the 
reduction of HMG-CoA (3-hydroxy-3methylglutaryl coenzyme A) reductase activity 
(Reviewed by Kritchevsky, 1995). There is an important physiological relationship 
between dietary fibre, daily bile acid excretion, faecal bile acid concentrations and 
cardiovascular disease and colon cancer (Reviewed by Story, 1995). Some dietary 
fibres lower cholesterol levels and result in an increase in bile acid excretion but not 
all do both like ispaghula husk (Reviewed Story, 1995). Ispaghula husk has been 
proposed as having potentially wide use as a prophylactic in the treatment of 
coronary heart disease, with oral intake of ispaghula husk resulting in the lowering of 
total serum cholesterol and serum low density lipoproteins (LDL) in humans 
(Reviewed by Dettmar, 1996). Pectin's ability to lower cholesterol is thought to 
occur by a number of mechanisms including viscosity (Gallaher and Hassel, 1995) 
decreasing cholesterol absorption, its ability to increase HDL levels accompanied by 




2001). The production of SCFAs (particularly propionate and butyrate) may also 
influence hepatic cholesterol synthesis (Reviewed Behall, 1997) and bile acid 
metabolism (Reviewed by Ink and Hurt, 1987; Reviewed by Kritchevsky, 2001). 
Pectin binds strongly to a number of cations due to its negative charge using 
electrostatic forces and also to a number of other particles non-specifically including 
bile acids and proteins (Reviewed by Eastwood, 1995). Thus pectin exerts beneficial 
effects on cholesterol metabolism and lipoprotein levels (Reviewed by May, 1999). 
All viscous polysaccharides have been shown to decrease small bowel transit and 
thus slow down nutrient absorption (Reviewed by Blackwood et al., 2000), including 
ispaghula husk. Thus a number of dietary fibres may help in the prevention of 
cardiovascular disease. Insulin appears to also affect cholesterol metabolism, 
Ludwig (1999) study (Reviewed by Kritchevsky, 2001) concluded that high fibre 
diets might protect against obesity and cardiovascular disease by lowering insulin 
levels (Reviewed by Jenkins and Kendall, 2000; Reviewed by Kritchevsky, 2001). 
Other diet constituents, such as Vitamin E, are inversely related to the risk of death 
from coronary heart disease (Reviewed by Rodgers, 1997). 
3.6.2.3 Diabetes - Glucose metabolism and Insulin response. 
Insulin is a major fuel regulating hormone, secreted into the blood in response to a 
rise in concentration of blood glucose and amino acids. Insulin is secreted not only 
in the presence of glucose and amino acids but also in response to the gut hormones 
secretin, pancreozymin and gastrin, to help maintain glucose levels. Insulin's main 
function is through the regulation of glycaemic control; regulating postpandrial 
glucose levels possibly by delayed gastric emptying and delayed glucose absorption 
(Reviewed by Miller and Keane, 1987). 
Low glycaemic foods have been shown to reduce the risk of type 2 diabetes 
(Reviewed by Jenkins and Kendall, 2000). Type 2 (95%) or non-insulin-dependent 
diabetes mellitus (NIDDM) is the result of inappropriate insulin secretion, such as a 
delayed response to glucose load or an insufficient quantity (Reviewed by Miller and 
Keane, 1987). There is a strong association between obesity and NIDDM, 80% 
NIDDM are obese leading a sedentary (lack of physical exercise) and high calorie 
life (Reviewed by Miller and Keane, 1987). Increasing physical exercise activity can 
151 
Clo apter 3 
Fibre Characterlsallon 
help normalise blood glucose and lipid levels, possibly a mechanism by which 
physical exercise protects against colorectal. cancer as type 2 diabetes increases the 
risk of developing colorectal cancer (Reviewed by Bruce et al., 2000). Diet is a part 
of the control of diabetes and intake is adjusted to make sure blood glucose and 
serum cholesterol are kept within acceptable limits. The introduction of certain 
carbohydrates to maintain blood glucose response, delaying postprandial rise in 
glucose, with dietary fibre reducing carbohydrate absorption and slowing gastric 
emptying (Reviewed by Reiser, 1987; Reviewed by Spiller, 1999). High fibre foods 
are thought to influence glucose levels in two ways; firstly some fibres result in a 
reduction in the rate of absorption, which in turn affects systemic metabolism; 
secondly also provides a carbohydrate source for fermentation by intestinal bacteria 
(Reviewed by Reiser, 1987; Reviewed by Wolever 1995). The viscous 
polysaccharide pectin has been shown to reduce glucose absorption helping in the 
management of type II diabetes mellitus (DM) (Reviewed by Reiser, 1987; 
Reviewed by Wolever 1995). The reduction of blood glucose and lipid control in 
diabetics seem to depend on whether a fibre is viscous (Reviewed by Wolever 1995; 
Reviewed by Spiller, 1999), not only in water but also during transit through the 
gastrointestinal tract. There are fibres that maintain their viscosity throughout the 
gastrointestinal tract including ispaghula husk (Reviewed by Wolever 1995). High 
viscosity associated with soluble fibres is often given as the cause of their effect on 
glucose and lipid metabolism (Reviewed by Blackwood et al., 2000). A stronger 
link with low glycaernic index foods and a reduction of blood glucose and lipids has 
been found (Reviewed by Wolever 1995). Soluble fibres such as ispaghula and 
pectin increase the viscosity of the intestinal contents, reducing the rate of absorption 
of bile acids, glucose and nutrients (Reviewed by Jenkins et al, 1995) thus allowing 
their absorption along a greater length of the small intestine (Reviewed by 
Blackwood et al., 2000). Fibre supplemented diets have also been shown to result in 
a reduction in insulin levels within rats (Ghatei et al., 1997). Insulin resistance has 
also been associated with increased risk of type 2 diabetes and colon cancer, with it 
providing a link between diet and colon cancer risk (Reviewed by Bruce et al., 
2000). 
Ispaghula husk has potential as a prophylactic in the treatment of type II diabetes by 
reducing the rate of glucose uptake (Reviewed by Dettmar, 1996). Pectin, a low 
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glycaemic index food reduces the risk of developing diabetes by decreasing 
postprandial insulin levels. In the control of diabetes it has been suggested by Jenkins 
that gelling agents such as pectin form a matrix trapping the glucose preventing them 
from being absorbed in the small bowel (Reviewed by Kritchevsky, 2001). There 
also appears to be a positive association between slow releasing carbohydrates, 
reduced insulin levels, higher HDL cholesterol concentrations, and reduced diabetes 
(Type II) and cardiovascular disease risks. Physiological effects of resistant starch 
include their effects on postprandial glycaemic index in relation to diabetes 
(Reviewed by Jenkins and Kendall, 2000). 
3.6.2.4 Large Bowel Disorders. 
Burkitt was the first to propose the link between fibre intake and susceptibility to 
cancer of the *colon and rectum (Reviewed by Kritchevsky, 2001). Vegetables have 
the highest fibre content per Kcal and in rural Uganda, where the fibre hypothesis 
was first developed by Burkitt and Trowell, vegetables contribute over 90% of fibre 
intake (Reviewed Wolever and Jenkins, 1997). A diet rich in plant foods contains a 
number of Possible anti-carcinogenic phytochernicals which may augment fibre 
action, exert a specific action of their own, or even antagonize the action of other 
food components (Reviewed by Kritchevsky, 2001). Colon cancer is a disease of 
excess, over nutrition, which is a symptom of westemisation/industrialisation, 
resulting in an increase intake of refined carbohydrates but also fast foods, this 
accompanied by a decline in the level of physical exercise has attributed to an 
increase in obesity (loss of energy balance) and thus as a possible consequence 
colonic cancer development. The link between weight and cancer development has 
been shown through a number of studies where a clear association between obesity 
and an excess risk of cancer development was found (Reviewed by Hill, 1999a). 
Obesity (energy imbalance) is positively associated with colorectal adenomas and 
cancer risk, with several determinants of obesity being related to colorectal cancer 
risk (Reviewed by Stephen, 1995; Reviewed by Gerber and Corpet, 1999). 
Structural features of dietary fibre may influence binding of bile acids and inorganic 
ions and potential carcinogens (Reviewed by Blackwood et al., 2000; Reviewed by 
Kritchevsky, 2001). Bulking may increase the excretion of those substances trapped 
in the faecal mass (Reviewed by Kritchevsky, 2001). Water immobilisation by fibres 
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also affects their properties; viscous polysaccharides have been shown to slow gastric 
emptying and retard the absorption in the jejunum and ileum (Reviewed Eastwood, 
1995; Reviewed by Blackwood et al., 2000; Reviewed by Kritchevsky, 2001), 
influencing enzyme activity, facilitates fermentation and influences stool weight. 
This will also affect intestinal and colonic muscle activity, metabolic turnover rate of 
absorbed nutrients and endocrine hormone activity (Reviewed Eastwood, 1995). 
Determinants of obesity include calorie intake and calorie expenditure (including 
physical activity) with the proposal that an energy balance is more relevant to colon 
carcinogenesis than calorie intake itself (Reviewed by Gerber and Corpet, 1999). 
Type II diabetes and cardiovascular disease in turn also affects colorectal cancer risk 
(Reviewed by Jenkins and Kendall, 2000). Low glycaemic foods, such as certain 
fibres, have been shown to reduce the risk of type 2 diabetes. Type 2 diabetes has in 
turn been related to a higher risk of colon cancer especially colon cancer deaths. 
Refer to section 1.4 fof more detailed information on the role of fibre in colorectal 
cancer development. 
The majority of diseases that occur in the human large intestine are of unknown 
aetiology, but diet, especially dietary fibre has been implicated in having a role. The 
mechanical action of dietary fibre includes influencing stool weight resulting in the 
relief of constipation and diverticular disease (Reviewed by Cummings 1994; 
Reviewed by Kritchevsky, 2001). Painter and Burkitt proposed that an absence of 
dietary fibre was actually a cause of diverticulosis and considerable supporting data 
has accumulated suggesting fibre therapy improved symptoms (Reviewed by Lembo, 
1998). Mechanical action of dietary fibre by influencing stool weight results in the 
relief of constipation and diverticular disease, the effects on diverticular disease 
shown by Painter (Reviewed by Dwyer et al., 1978; Reviewed by Cummings, 1994; 
Reviewed by Kritchevsky, 2001). Constipation is an over working of faccal matter 
resulting in decreased water content and hardening of stool, common causes include 
a lack of fluids, lack of physical activity and disease processes. Mild constipation 
can be easily relieved with fibre (Reviewed by Lembo, 1998). Dietary fibre relieves 
constipation by softening stools, regulating and shortening transit time, increasing 
bulk and water holding capacity; increased propulsion resulting in removal of the 
blockage. Diarrhoea is the formation of watery stools usually as a result of an Na/K 




electrolytes, increases bacterial mass re-establishing the microflora, provides a 
structure (especially those not fermented, generally the insoluble fibres) and the 
production of SCFAs through fermentation also help regulate water and electrolyte 
absorption (Reviewed by Lembo, 1998). Butyrate intracolonic infusions have been 
shown to have beneficial effects on diversion colitis enhancing morphology and 
healing, with similar effects being shown in distal. ulcerative colitis (Reviewed by 
Rombeau. and Roth, 1995). Diabetes Mellitus itself has been shown to affect the 
peripheral nerves of the lower extremities and autonomic nervous system resulting in 
delayed gastric emptying, diarrhoea and constipation (Reviewed by Miller and 
Keane, 1987). 
The majority of diseases that occur in the human large intestine are of unknown 
aetiology, but bacteria have been implicated either as causative agents or 
maintenance factors involved in many colonic disorders. Antibiotic associated 
colitis, inflammatory bowel disease (IBD) and colon cancer are all been thought to 
have an aetiology connected with the activities of the gut flora (Reviewed by Gibson 
and Macfarlane, 1994). Studies within patients with diarrhoea prominent irritable 
bowel syndrome have shown that the colonic bacterial flora produce different SCFA 
patterns (Treem et al., 1996). Epidemiological studies have also found an 
association with colorectal cancer with lower faecal pH being associated with 
reduced risk (Reviewed by Lupton, 1995). Bacteria can also have a beneficial role 
with probiotics being shown to be an effective treatment of ulcerative colitis via 
SCFA production particularly butyrate (Reviewed by Gibson and Macfarlane, 1994). 
Both food and insulin have been shown to stimulate ornithine decarboxylase (ODC) 
intestinal activity, which is one of the earliest biochemical parameters associated 
with cellular turnover and development (Reviewed by Cassidy and Fitzpatrick, 
1995). Diet has been shown to influence colonic morphology in rats, resulting in a 
physiological adaptation of the colonic epithelium (Reviewed by Cassidy and 
Fitzpatrick, 1995; Reviewed by Behall, 1997). 
Ispaghula husk has traditionally been used in India for the treatment of chronic 
constipation, dysentery, and inflammation in the gastrointestinal and urinogenital 
tracts. Ispaghula husk has many therapeutic actions and is a commonly used 
prophylatic in a number of large bowel disorders (Kennedy et al., 1979; Sandhu et 
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al., 1981; Reviewed by Dettmar, 1996). Ispaghula husk is an effective stool bulking 
treatment for constipation and diaohrrea (Fybogelo and Metamucilo) (Reviewed by 
BeMiller, 1993; Reviewed by Dettmar, 1996; Reviewed by Blackwood et al., 2000) 
and in the treatment of diverticular disease (Kennedy et al., 1979; Sandhu et al., 
1981; Thorburn et al., 1992). Davies et al., 1998 showed that ispaghula husk 
treatment helped relieve premenstrual constipation type symptoms. This is due to its 
water holding capacity and subsequent viscous nature providing a laxative effect 
(Sandhu et al., 198 1; Reviewed by Blackwood et al., 2000). Psyllium gel can inhibit 
pancreatic amylase activity; with no effect on itself and it may also inhibit lipase in 
duodenal juice, but not phospholipase. It can also bind ferrous ions, thus lowering 
iron absorption (Reviewed by BeMiller, 1993) and can bind bile acids resulting in an 
increase in the excretion of bile salts (Reviewed by BeMiller, 1993; Reviewed by 
Blackwood et al., 2000; Reviewed by Kritchevsky, 2001). The increased viscosity of 
both stomach and small bowel contents may also influence bile acid metabolism 
(Reviewed by Kritchevsky, 2001). Ispaghula is an effective treatment in 
diverticulitis disease (Sandhu et al., 1981); combined with mebevrin (an 
antispasmodic) it is an effective treatment of irritable bowel syndrome (M. Havler, 
ReckittBenckiser, personal communication; Reviewed by Dettmar, 1996). The 
dietary fibre ispaghula husk has also been implicated in relieving IBS symptoms, 
although maybe due to a placebo effect (Longstreth et al., 1981). It has been 
proposed as a possible prebiotic, protecting against the development of colorectal 
cancer although ispaghula husk has been shown to increase the number of DMH 
turnours, but only in male mice (Toth, 1984). Fybogel'5 comes in a variety of types, 
the most promising being Fybogel'5 lemon, as it provides both a fibre but also 
contain curcumin. Ispaghula may also cause epithelial cell loss and muscle 
hypertrophy in the jejunum. and ileum and thinning the colonic wall after prolonged 
feeding (Reviewed by BeMiller, 1993). Ispaghula has also been shown to affect the 
enzyme activity of P-galactosidase. 
Pectin's form zig-zag chains bearing a negative charge and are found in association 
with cations such as Ca2+ (Reviewed by May, 1999; Reviewed by Morris, 2001) with 
some pectins being calcium sensitive (Reviewed by May, 1999). Ca2+ has been 




negative charge means it is able to complex with toxic heavy metals and has been 
used to promote wound healing (Reviewed by May, 1999). Cellulose has previously 
been shown to result in damage to colonic folds, as well as a lack of maturation of 
the colonic mucosa, and a corresponding decrease in proliferation and increase in cell 
turnover time (hypoplastic state). Fibre deficient diets have also been shown to 
result in a state of hypoplasia in the colon but a possible hyperplastic state in the 
small intestine. It has been proposed that cellulose results in a decrease in cell 
turnover, whereas pectin has previously been shown to result in an increase in cell 
turnover, thus in fruit and vegetables a balance may be achieved with them 
containing both cellulose and pectin (Reviewed by Cassidy and Fitzpatrick, 1995). 
Large amounts of resistant starch in the diet may also impair the colonic digestion of 
NSP (Reviewed by Hill, 1997b). Fermentation of resistant starch not only produces 
more butyric acid but also lowers faecal pH and increases faecal bulk (Reviewed by 
Jenkins and Kendall, 2000; Ranhotra 2001), although is less effective at stool 
bulking than NSP (Reviewed by Topping and Clifton, 2001). Resistant starch has 
been shown to increase stool bulk, to increase the molar ratio of butyrate and dilute 
faecal bile acids (Reviewed by Jenkins and Kendall, 2000). High levels of resistant 
starch has a positive association with faecal NH3 concentrations along with reduced 
bile acid output and a decrease in bile acid concentration (Reviewed by Jenkins and 
Kendall, 2000). A number of studies have reported no physiological benefits and a 
mouse study using APC 1638N mice found resistant starch resulted in an increase in 
tumours (Reviewed by Jenkins and Kendall, 2000). 
Figure 3.17 provides a schematic representation of the role of diet, particularly 
dietary fibre in health and disease, referred to in the above literature. 
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Chapter Four 
Characterisation of the 1,2-dimethylhydrazine Balb/c mouse model. 
4.1 Introduction. 
1,2-dimethylhydrazine (DMH) and its related compound azoxymethane (AOM) have 
become the most widely used colonic carcinogen in experimental animals because of 
their chemical stability, the high yield of colon cancers and the short latency period. 
DMH and AOM at a concentration of 10-20mg/Kg body weights have been shown to 
produce colonic adenomas and adenocarcinomas in rats and mice, with nearly 100% 
incidence rate (Moorghen, 1992). DMH is a specific colon carcinogen that is widely 
used to study chemically induced colonic cancer (Chang, 1978; Reviewed by Rogers 
and Nauss, 1985; Reviewed by Klurfeld, 1995; Zhurkov et al., 1996; Jackson et al., 
1999) and provides a useful model for studying early carcinogenesis. Previously 
chronic administration of DMH has been shown to result in morphological changes 
similar to those observed in human adenomatous polyposis (Chang, 1980; Carter et 
al., 1994; Moorghen et al., 1998; Jackson et al., 1999). The morphological changes 
begin with hyperplasia (Chang, 1978; Moorghen et al., 1998) followed by dysplastic 
foci (microadenomatas) that grow into macroscopic sessile polyps (adenomas), 
which can become invasive (invasive adenocarcinoma) (Carter et al., 1994; 
Moorghen et aL, 1998). 
Metabolites of DMH (Figure 1.8, p60); methyldiazonium. (Moorghen, 1992), 
methylazoxymethanol (MAM) (Reviewed by Sunter, 1980) or methylcarboniurn ion 
(Reviewed by Klurfeld, 1995), are thought to be DNA alkylating agents (Reviewed 
by Sunter, 1980; Moorghen, 1992; Reviewed by Klurfeld 1995). DMH has been 
shown to result in the formation of 06. Methylguanine (Jackson et al., 2000) however 
methylation of the colonic epithelial cell DNA is not by itself sufficient to explain 
the high yield of colonic tumours (Moorghen, 1992; Papanikolaou et al., 1998). A 
number of groups have researched the effects of the carcinogen (AOM, DMH or 
MAM) on various genes and proteins that have been found to be mutated or their 
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expression altered within human colorectal cancer (Jacoby et al., 1991; Maltzman et 
al., 1997; Rudzki et al., 1997; Sheng et al., 1998; Takahashi et al., 1998; Jackson et 
al., 1999; Takahashi et al., 2000a; Takahashi et aL, 2000b; Endo et al., 2001; 
Koesters et al., 2001; Suzui et al., 2001; Kishimoto et al., 2002; Yamada et al., 
2003). The genetic changes found during human colorectal cancer development are 
shown in Figure 1.4 (p9) (Reviewed by Kinzler and Vogelstein, 1996). The first 
genetic change involves the turnour suppressor gene APC, which is found mutated in 
80-85% of all colorectal. cancers (Reviewed by Nakamura, 1997). APC binds P- 
catenin (Rubinfeld et al., 1993; Su et aL, 1993) and functions to regulate P-catenin 
levels within the cell by targeting it for degradation, when in a complex with GSK- 
3p and Axin (Fagotto et al., 1991; Reviewed by Moon and Miller, 1997; Reviewed 
by Peifer, 1997; Reviewed by Ben Ze've, 1997; Reviewed by Gordon, 1998; Ikeda et 
al., 1998; Kishida et al., 1998; Spink et al., 2000). Interestingly, P-catenin mutations 
are also found within colorectal. turnours with the most common mutation found 
within the human gene affects the protein's serine and threonine residues that are 
targeted by GSK-3p (Ikeda et al., 1998; Kishida et al., 1998; MUller et al., 1998). P- 
catenin, y-catenin, pl20(') and a-catenin are involved in a number of cellular 
process namely cell adhesion and cell signaling (Reviewed by Barth et al., 1997b). 
P-catenin, y-catenin and p120(ct) all bind to E-cadherin with cc-catenin linking this 
complex to the actin cytoskeleton to form functional adhesive complexes (Peifer et 
al., 1992; Nagafuchi et al., 1994; Reviewed by Jawhari and Pignatelli, 1997; 
Reviewed by Lewis et al., 1997; Reviewed by Pignatelli, 1998). P-catenin and y- 
catenin have also been shown to be involved in the Wnt-l signaling pathway 
(Reviewed by Miller and Moon, 1996; Reviewed by Moon and Miller, 1997; Morin 
et al., 1997a; Reviewed by Nusse, 1997). Activating mutations in P-catenin, loss of 
function mutations in APC or activation of the WNT-1 pathway results in 
cytoplasmic accumulation and nuclear translocation of P-catenin where it associates 
with the transcription factors LEF and TCF (Behr ens et al., 1996; Korinek et al., 
1997) activating P-catenin-Tcf signaling (Morin et al., 1997a). Previous studies 
revealed AOM, a metabolite of DMH, resulted in a mutation of the GSK-3p 
consensus motif of P-catenin rats and ICR mice (Takahashi et al., 1998; Takahashi et 
al., 2000b). Other studies have also found over-expression and nuclear localization 
of p-catenin within AOM induced rat colonic turnours (Sheng et al., 1998). Studies 
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have also revealed a reduction in wild type APC expression within AOM induced 
mouse colonic turnours (Maltzman et al., 1997), AOM was also found to reduce APC 
mRNA expression levels in the rat colon (Kishimoto et al., 2002). Investigations 
using DMH induced turnours in the rat colon found APC mutations in the region 
homologous to the human mutational cluster region in 6% of turnours (Endo et al., 
2001). The colon has a rapid cell turnover and a disruption in its natural homeostasis 
can result in cancer development (Reviewed by Kinzler and Vogelstein, 1996; 
Reviewed Wasan and Goodlad, 1996; Reviewed by Jawhari et al., 1997a). E- 
cadherin, P-catenin and APC all play a fundamental role in the regulation of the 
normal colon with disruptions sufficient for colorectal cancer development 
(Reviewed by llyas and Thomlinson, 1997). 
4.2 Aim. 
To characterise the expression of the E-cadherin/catenin complex within Balb/c mice 
colonic tissues treated with 1,2-dimethylhydrazine, a colonic carcinogen. 
4.3 Objectives. 
1. To examine the expression and cellular localisation of the adhesion molecules E. 
cadherin, a-catenin, 0- catenin, y-catenin and pl2o in the non-dysplastic and 
dysplastic tissues of Balb/c mice exposed to the carcinogen 1,2- 
dimethy1hydrazine. 
2. To carry out mutational analysis on exon 3 of the P-catenin gene, which contains 
the GSK-3p consensus sequence. 
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4.4 Methodology. 
1,2-dimethylhydrazine (DMH) was subcutaneously injected into rodents, female 
Balb/c mice were chosen in this study due to their resilience to liver toxicity caused 
by DMH administration whilst being susceptible to its carcinogenic effects, 
producing distal colonic turnours (Moorghen et al., 1998). After 17 weeks of 
exposure to the carcinogen, as discussed in section 2.2, the mice were sacrificed, 
their colons removed/excised, fixed in carnoys for 3 hours followed by formalin 
fixation. The colons were pinned out on corkboard serosal side down before fixation 
to ease visualisation of nodules. Using a dissecting microscope the nodules along 
with the surrounding tissue were removed by Dr M. Moorghen, Jyoti Gupta and 
Emma Tucker and placed in formalin for paraffin embedding carried out by Jenny 
Baker and Joy Code. Four-micrometer transverse sections were stained with 
haernatoxylin and eosin (H&E), with 3-6 sections per slide. Following H&E 
confirmation of turnours, 40 turnours for immunohistochernical analysis were 
selected, 10 from each feeding study group (refer to section 5). Tumours were 
stained for E-cadherin and the catenins (a-, P-, y-) using indirect 
immunchistochernical methods, described in section 2.3. The tissues were then 
scored for cytoplasmic and membranous immunoreactivity using the following 
scoring system: - 3= greater than 90% of epithelial cells showed positive expression, 
2= 90-50% of epithelial cells were positive, 1= less than 50% of epithelial cells 
were positive, with nuclear localisation marked as present or absent. 
Preliminary studies carried out using archival 1,2-dimethylhydrazine tissues revealed 
nuclear localisation of P-catenin suggesting a mutation in either fl-catenin or APC 
gene or activation of the Wnt-I pathway. Takahashi et al. (1998,2000a) showed that 
the metabolite of DMH, AOM results in a mutation in the GSK-3p consensus 
sequence of P-catenin in a rat model, thus mutational analysis of P-catenin was 
carried out. PCR was used to amplify up DNA extracted from the DMH mouse 
colonic tissues, incorporating primers designed by Takahashi et al. (1998,2000a). 
Attempts were made at amplifying DNA from both paraffin and frozen tissues. 
Paraffin embedded tumours were firstly stained for P-catenin to determine the 
presence or absence of nuclear localisation. Those with nuclear staining were chosen 
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for mutational analysis along with a control group that were not exposed to the 
carcinogen DMH. Tissue lysates were made using protocol described in section 
2.4.2. Frozen tissues were also retained from the experiment, 1 mouse from each 
group plus a control non-DMH treated mouse. For the frozen tissues, sections from 
the distal colon were removed, as nodules were not easily visible in frozen tissues the 
lysates were made from sections of the distal colon using protocol described in 
section 2.4.2. A range of conditions were applied to amplify the DNA involving 
altering the number of cycles (40 to 50 cycles), varying the annealing temperature 
from 501C to 58C, and applying the conditions used successfully by Takahashi et 
al. (2000a). This was unsuccessful in the paraffin embedded tissues but achieved in 
the frozen tissues (Fig 4.7). DNA from the frozen tissues was then amplified using 
the protocol described in section 2.4. Mutation detection was carried out using single 
strand conformational polymorphism (SSCP) techniques (section 2.4) and sequence 
analysis was used to confirm and reveal the type of mutations. Sequence data was 
analysed using websites (Blast search Genebank data base at ncbi, 
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4.5 Results. 
4.5.1 Examination of the expression and cellular localisation of the E-cadherin 
and catenin complex by immunohistochemistry. 
4.5.1.1 Increase in cytoplasmic expression and nuclear localisation of fl-catenin in 
colonic dysplastic mucosa ofBalb1c mice administered with DMH. 
Within the non-dysplastic tissues over 90% of the colonic epithelial cells were 
positive for P-catenin expression at the cell membrane within 33 of the 41 colonic 
tissues examined (Figure 4.1 and 4.5). The non-dysplastic tissues also revealed areas 
of cytoplasmic P-catenin expression, although this expression was found to be 
heterogeneous with 24 out of the 41 tissues having areas of less than 50% of the 
epithelial cells being positive. No nuclear expression for P-catenin was observed 
within the non-dysplastic tissues. The dysplastic tissues revealed increased 
membranous and cytoplasmic P-catenin immunoreactivity with over 90% of 
epithelial cells being positive for P catenin in the majority of tissues (39/41 and 
38/41 scored 3, respectively). Within these dysplastic tissues focal and scattered 
nuclear expression was also observed in 14/41 tissues. Thus when comparing the 
non-dysplastic tissues with the dysplastic tissues there was an increase in 
cytoplasmic and focal nuclear expression for P-catenin within the dysplastic areas, an 
increase in immunoreactivity was also noted (Fig. 4.1) but not quantified. 
4.5.1.2 Cytoplasmic E-cadherin cellular localisation is not associated with reduced 
membranous expression in colonic dysplastic mucosafrom mice administered with 
DMH. 
Within the non-dysplastic tissues over 90% of epithelial cells were positive for E- 
cadherin membrane expression within the majority of the tissues (39 out of 41 tissues 
scored 3) (Fig. 4.2 and 4.5). Cytoplasmic expression showed heterogeneity with 
over 
164 
Figure 4. IA. Representative 192-dimethylhydrazine mouse colonic 
tissue section showing P-catenin localisation and expression in 
non-dysplastic (X) and dysplastic (Y) tissues (x20 Obj). B. Area of 
dysplasia with increased membranous, cytoplasmic and focal 





Non-dysplastic tissues revealed 0-catenin expression at the membrane with areas 
of cytoplasmic expression but no nuclear expression. Dysplastic tissues revealed 
increased membranous and cytoplasmic P-catenin immunoreactivity with focal 
nuclear localisation. Thus within the dysplastic tissues there was an increase in 
cytoplasmic and focal nuclear localisation for 0-catenin when compared to the 
non-dysplastic tissues. An apparent increase in P-catenin immunoreactivity was 
also noted. 
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50% of the epithelial cells being positive for E-cadherin in some tissues (23/41 
scored 2) the remainder of tissues having lower expression levels. There was no 
nuclear E-cadherin expression within the non-dysplastic tissues (0/41). Over9O%of 
epithelial cells were positive for E-cadherin membrane expression within the 
dysplastic tissues suggesting membrane expression was maintained (39/41 scored 3). 
This was accompanied by an increase in cytoplasmic expression with 90% of the 
epithelial cells being positive in the majority of tissues (32/41 scored 3) but no 
nuclear localisation (0/41) was observed. Thus the results show an increase in 
cytoplasmic expression for E-Cadherin within the dysplastic tissues (Fig. 4.2). 
4.5.1.3 Increase in a-catenin andp. 120 cytoplasmic expression in dysplastic colonic 
mucosa is not associated with nuclear localisation. 
Expression of a-catenin (Figure 4.3 and 4.5) within the non-dysplastic colonic 
tissues revealed membranous expression in over 90% of all colonic epithelial cells 
within all tissue examined (40/40 scored 3). Over 50% of epithelial cells were 
positive for a-catenin within the cytoplasm in the majority of these tissues (35/40 
scored 2) and no nuclear expression 0/41 was observed. Within the dysplastic areas 
of these colonic tissues there was maintenance of membrane expression, with 90% of 
epithelial cells being positive for membrane expression in all tissues examined 
(40/40 scored 3). This was accompanied by an increase in cytoplasmic localisation 
with 90% of the cells positively expressing a-catenin in the majority of tissues 
(29/40 scored 3), although there was some heterogeneity. There was no nuclear 
expression of cc-catenin within these dysplastic tissues. Thus within the dysplastic 
tissues cc-catenin expression was shown to be maintained at the membrane and 
increase within the cytoplasm. 
Expression of p120 (Figure 4.4 and 4.5) within the non-dysplastic areas of the 
colonic tissues revealed membranous expression in 90% of epithelial cells for the 
majority of tissues (39/41 scored 3), expression was throughout the crypt, although 
greatest at the mid to top point of the crypt. Some cytoplasmic expression was 
observed with 23/41 of 
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Figure 4.2A. Representative 192-dimethylhydrazine mouse colonic 
tissue section showing E-cadherin localisation and expression in 
non-dysplastic (X) and dysplastic (Y) tissues (x20 Obj). B. Area of 
dysplasia with increased membranous, cytoplasmic but no focal 
nuclear localisation (Z) (x40 Obj). 
" .' 
Non-dysplastic tissues showed that for E-cadherin membranous expression was 
over 90% of the majority of tissues with evidence of cytoplasmic expression in 
areas but there was no nuclear expression. Within the Dysplastic tissues 
membrane expression was maintained accompanied by an increase in cytoplasmic 
localisation but with no nuclear localisation. The results show an increase in 
cytoplasmic localisation of E-Cadherin in the dysplastic tissues. Increased 
immunoreactivity within dysplastic tissue for E-cadherin was also noted. 
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Figure 4.3A. Representative 1,2-dimethylhydrazine treated mouse 
colonic tissue section showing cc-catenin localisation and 
expression in non-dysplastic (X) and dysplastic (Y) tissues (x20 
Obj). B. Area of dysplasia with increased membranous, 
cytoplasmic but no nuclear expression (x40 Obj). 
" "" 1 
". -"' 
Alpha catenin expression within the non-dysplastic tissues revealed membranous 
expression in all tissue with cytoplasmic localisation found in some of these 
tissues with no nuclear expression. Dysplastic tissues revealed membranous 
expression in over 90% of all colonocytes within the dysplastic tissues with an 
increase in cytoplasmic localisation but with no nuclear localisation. Thus within 
the dysplastic tissues cc-catenin localisation was shown to increase within the 
cytoplasm. 
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Figure 4.4A. Representative 1,2-dimethylhydrazine treated mouse 
colonic tissue section showing p120 localisation and expression in 
non-dysplastic (X) and dysplastic (Y) tissues (x20 Obj). B. Area of 
dysplasia with increased membranous, cytoplasmic but no nuclear 
expression (x40 Obj). 
p120 localisation within the non-dysplastic tissues revealed membranous expression 
with some cytoplasmic localisation but with no nuclear localisation. Within the 
dysplastic tissues there was maintenance of membrane expression with an increase in 
cytoplasmic localisation but with no nuclear expression. Thus in the dysplastic 
tissues p120 localisation was shown to increase within the cytoplasm. 
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Figure 4.5 Expression of cc-, P-catenins, pl2o(ctn) and E-cadherin within 
the 1,2-dimethyl -hydrazine mouse colonic tissues as determined by 
immunohistochemistry. 
Non-dysplastic tissue Dysplastic tissue 
Me mbrane Cy toplasm Nucleus Me mbrane Cy toplas Nucleus 
S No. S No. S No. S No. S No. S No. 
Beta-catenin 3 33/41 1 24/41 0 41/41 3 39/41 3 38/41 F 14/41 
E-cadherin 3 39/41 2 23/41 
1 
0 41/41 3 39/41 3 32/411 0 0/41 
Alpha-caten 3 40/40 , 




3. 40/40 3 29/401 0 0/41 
pl20(ctn) 
t31 




3 28/41 01 
r/4i 
Key: - S, Score; No., number of tissues with the score shown. Scoring system used 3= greater 
than 90% of epithelial cells showed positive expression, 2= 90-50% of epithelial 
cells were positive, I= less than 50% of epithelial cells were positive, with nuclear 
localisation marked as present (F) or absent (0). 
The average scores from the immunohistochemical analysis of the 1,2 
dimethy1hydrazine mouse colonic tissues revealed an interesting pattern for the 
catenins and E-cadherin with the dysplastic tissues being associated with an increase in 
cytoplasmic localisation. The tissues were scored as outlined in section 4.4. The Non- 
dysplastic tissues revealed that for P-catenin, cc-catenin, p120 and E-cadherin there was 
expression at the cell membrane within over 90% of the colonic epithelial cells 
examined (33/41,40/40,39/40 and 39/41 scored 3 respectively) with heterogenous 
cytoplasmic localisation. There was no nuclear expression for P-catenin, CC-catenin, 
p120 and E-cadherin. The dysplastic tissues revealed an increase in membranous P- 
catenin localisation (39/41 scored 3) accompanied with the maintenance of Ot-catenin, 
p120 and E-cadherin expression at the cell membrane. Significantly there was an 
increase in cytoplasmic localisation for P-catenin, a-catenin, p 120 and E-cadherin, with 
over 90% of the epithelial cells expressing cytoplasmic catenins and cadherin. For 0- 
catenin this increase in cytoplasmic expression was also accompanied by focal nuclear 
localisation within 14 of 41 dysplastic tissues. For cc-catenin, p120 and E-cadherin 
nuclear localisation was not observed within the dysplastic tissues. 
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tissues having over 50% (but less than 90%) epithelial cells positive for p120. As for 
a-catenin and E-cadherin there was no nuclear expression (0/41) within the non- 
dysplastic tissues. Within the dysplastic colonic tissues there was maintenance of 
p120 membrane expression (39/41 scored 3), as for a-catenin, accompanied by an 
increase in cytoplasmic expression with over 90% of epithelial cells being positive 
for pl20(cn) within 28 out of 41 tissues but with no nuclear expression (0/41), as for 
a-catenin and E-cadherin. Thus in the dysplastic areas of the DMH mouse tissues 
p 120 expression was shown to increase within the cytoplasm. 
4.5.1.4 ý-catenin expression in the intestinal mucosa of Balb1c mice exposed to the 
carcinogen 1,2-dimethylhydrazine. 
The expression of y-catenin within the colonic epithelial tissues was very 
heterogeneous in nature. Tissues ranged from being completely negative in both the 
non-dysplastic and dysplastic tissues (9 out of 39) to having heterogeneous 
expression within either the non-dysplastic, dysplastic tissues or both. There was no 
consistent pattern of expression observed except that in all cases epithelial cells 
expressed very low levels of y-catenin. Only a few areas of focal expression were 
observed including membranous or diffused cytoplasmic expression. For all tissue 
samples there was no nuclear y-catenin expression within both the non-dysplastic or 
dysplastic epithelium (0/41). 
4.5.2 Expression of fl-catenin and a-catenin by western blotting. 
Figure 4.6 confirmed that the antibodies P- and a-catenin used in this study were 
specific for the proteins being examined. It also confirmed that there is low 
coexpression of y-catenin in wild type or DMH treated colonic mouse tissue. The 
aim of this experiment was to confirm the P-catenin expression observed by the 
immunohistochernical technique. This proved complex due to the difficulties in 
identifying dysplastic regions from frozen tissue sections stained with haernatoxylin 
and 
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Figure 4.6 Expression of 0- and (x-catenin by western blotting. 
is 11 2S 21 5S 51 IIS III 
OWvul» m 40 
mmmowft"ý 
IS 11 2S 21 5S 51 1 IS III 
is 11 2S 21 5S 51 IIS III 
P-catenin I 
cc-catenin I 
(A) 0-catenin (N=4), (B) a-catenin (N=I) and (C) y-catenin (N=I) expression in 
wild-type Balb/c mice (1) and DMH treated Balb/c mice (2,5 and 11) 
examining both the soluble (S) and insoluble (1) fractions. The western blots (A 
and B) show that the antibodies used were specific for their target proteins p 
-catenin and a-catenin in the DMH treated Balb/c mouse colonic tissues in both 
the soluble and insoluble fractions. Western blot C reveals no significant levels 
of y-catenin expression within the mouse colonic tissue. 
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eosin. However, the western blotting results suggest that total P-catenin expression 
levels maybe increased in the tissues from the DMH treated mice when compared to 
the wild type Balb/c mice. The increase in P-catenin expression appeared to be 
localised within the soluble fraction, suggesting an increase in P-catenin associated 
with the cell membrane or cytoplasm. No apparent increase in the insoluble fraction 
(for example the actin cytoskeleton associated P-catenin pool) was identified. 
4.5.3 Mutation analysis of exon 3 of the 0-catenin gene. 
Having shown cytoplasmic and focal nuclear localisation of P-catenin within the 
dysplastic tissues it was interesting to examine P-catenin for possible mutations. 
PCR primers were used to amplify P-catenin exon 3, containing the GSK-3P 
consensus sequence (phosphorylation sites) and a product length of 123bp was 
produced. Figure 4.7 shows the successful amplification of the GSK-3P consensus 
sequence of P-catenin. Figure 4.8 gives examples of SSCP mutational analysis of this 
PCR amplified P-catenin sequence showing band shifts in three of four DMH tissue 
samples, suggesting a possible mutation within this region. Sequence analysis failed 
to confirm the presence of a mutation (figure 4.10). 
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Figure 4.7 PCR amplification of beta-catenin from frozen distal 




Figure 4.8 SSCP revealing possible beta-catenin mutations in 3 
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Fig 4.9 DNA sequences from wild-type and DMH-treated mouse 
colonic tissue for exon 3 of the fl-catenin gene. 
A. Wild type (Group 1) Forward primer. 
Query: 5 catggagccgggacagaaaa-ctgctgtcagccactgggnageagcagtcttacttggat 63 
Sbjct: 136 catggagcc-ggacagaaaagctgctgtcagccact-ggcagcagcagtcttacftggat 193 
Query: 64 tctgggaatccaftctggtgccaccaccacagctccttccctgagtggcaagggcaaccc 123 
Sbjct: 194 tct-ggaatccaftctggtgccaccaccacagctccttccctgagtggcaagggcaaccc 252 
Query: 124 tgaggaagaagatgttgacacctcccaagtcctttatgaatgggagcaaggcttttccca 183 
Sbjct: 253 tgaggaagaagatgttgacacctcccaagtcctttatgaatgggagcaaggcttttccc-311 
Query: 184 agtccttcacgcaagagcangtagc 208 
Sbjct: 312 agtccttcacgcaagagcaagtagc 336 
B. DMH treated (Group 5) Forward primer. 
Query: 5 catngagcgggacagaaaa-ctgctgtcagncactgggnagcagcagtcttacttgggat 63 
Sbict: 136 catggagccggacagaaaagctgctgtcagccact-ggcagcagcagtcttacft-ggat 193 
Query: 64 tctgggaatccattctgggtgccaccaccacagctccftccctgagtggcaagggcaacc 123 
Sb ct: 194 tct-ggaatccattct-ggtgccaccaccacagctccftccctgagtggcaagggcaacc 251 
Query: 124 ctgaggaagaagatgttgacacctcccaagtcctttatgaatgggagcaaggcttttccc 183 
Sbjct: 252 ctgaggaagaagatgttgacacctcccaagtcctttatgaatgggagcaaggcttttccc3lI 
Query: 184 agtccftcacgcaagagcangtagc 208 
Sbjct: 312 agtccttcacgcaagagcaagtagc 336 
Comparison of the direct sequences of non-DMH (wild type) and DMH treated mice 
PCR product failed to reveal a mutation within exon 3 of the P-catenin gene, which 
contained the GSK-3P consensus sequence. 
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4.6 Discussion. 
In humans the development of colorectal cancer has been well studied, and the 
genetic steps involved in the adenoma to carcinoma sequence have been elucidated 
(Reviewed by Fearon and Vogelstein, 1990; Reviewed by White, 1998). The first 
genetic alteration (as discussed in section 1.2) in the multistep process of colorectal 
cancer, in inherited (familial adenomatous polyposis coli) and sporadic turnours, is 
the loss of APC (Reviewed by Fearon and Vogelstein, 1990; Reviewed by Kinzler 
and Vogelstein, 1996; Reviewed by White, 1998; Reviewed by Fearnhead et al., 
2001) with 80-85% of adenomas carrying an APC mutation (Reviewed by 
Nakamura, 1997). The APC gene is located on chromosome Sq2l-22 and codes for 
a3 10 Kd protein (Reviewed by Moon and Miller, 1997; Mulkens et al., 199 8), being 
described as a 'gatekeeper' gene directly regulating the growth of tumours by 
inhibiting growth and/or promoting death (Reviewed by Kinzler and Vogelstein, 
1996; Reviewed by Morin et al., 1997b; Morin et al., 1997a; Reviewed by Kinzler 
and Vogelstein, 1998; Mulkens et al., 1998). APC is a cytoplasmic protein with 
multiple functional domains (Reviewed by Moon and Miller, 1997) and is found in 
association with both )r-catenin and P-catenin (Rubinfeld et al., 1993; Su et al., 1993; 
Reviewed by Barth et al, 1997b; Reviewed by Jawhari et al., 1997a). APC is 
thought to function by controlling the cytoplasmic levels of P-catenin in association 
with GSK-3P and axin (Reviewed by Moon and Miller, 1997; Reviewed by Peifer, 
1997; Reviewed by Ben Ze've, 1997; Reviewed by Gordon, 1998; Ikeda et al., 1998; 
Kishida et al., 1998; Fagotto et al., 1999; Spink et al., 2000). Interestingly Samowitz 
et al. (1999) have reported that fl-catenin mutations are more frequently found in 
small colorectal adenoma than in larger adenomas and invasive carcinomas. In 
contrast APC mutations within the mutational cluster region (MCR) has been 
associated with a greater number of adenoma development and tend to be associated 
with larger adenomas (Mulkens et al., 1998). This suggests that APC and Acatenin 
mutations are not functionally equivalent and that the APC gene may have other 
functions inhibiting tumourigenesis. 
The disruption of catenin functions have been shown to occur through a number of 
genetic and epigenetic factors along with changes in associated proteins. Mutations 
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involving APC resulting in a truncated protein that can no longer degrade P-catenin 
(Rubinfeld et al., 1996; Reviewed by Moon and Miller, 1997; Reviewed Fearnhead 
et al., 2001), leading to an increase in cytoplasmic P-catenin levels and subsequent 
nuclear translocation. Stabilization and accumulation of cytoplasmic P-catemn as a 
result of mutations in either the APC (loss of function) or fl-catenin (CTNNBI, gain 
of function) genes are causatively associated with colon carcinogenesis (Rubinfeld et 
al., 1996; Takahashi et al., 1998; Reviewed by Moon and Miller, 1997; Akiyama et 
al., 2000; Reviewed Fearnhead et al., 2001). The characterisation of mutations, 
outside of those within APC are not well defined and are relatively rare. Changes in 
cellular expression of the catenins, largely a reduction in membranous staining 
associated with increased cytoplasmic and nuclear staining (for P-catenin) suggests 
that they play a fundamental role in cancer development (Hao et al., 1997). These 
factors all suggest that loss of catenin function either directly or indirectly results in 
cancer development. 
In humans P-catenin expression in the normal non-dysplastic tissue is associated with 
the cell membranes, but in adenoma and carcinoma tissues there is reduced P-catenin 
membrane expression, which is accompanied by an increase in cytoplasmic and 
nuclear expression correlating with the progression from adenomas to carcinomas 
(Takayama et al., 1996; Hao et al., 1997). Activating mutations in the P-catenin 
gene are thought to be responsible for the excessive P-catenin signaling involved in 
the majority of carcinogen induced colonic carcinomas (Yamada et al., 2000). 
Yamada et al. (2000) found that P-catenin signaling may be involved in the initial 
stage, aberrant crypt foci, of colon carcinogenesis in azoxymethane treated male 
F344 rats. Analysis of aberrant crypt foci (ACF) within DMH-induced colon 
carcinogenesis in Fischer 344 rats found that in about 9% of the ACF, P-catenin was 
overexpressed not only on the cell membrane but also in the cytoplasm (Furihata et 
al., 2002). These findings suggest that immunohistochemical staining of ACF for P- 
catenin can evaluate the malignant potential of ACF (Furihata et al., 2002). A 
further study revealed that crypts where P-catenin has accumulated are truly 
premalignant lesions of colon cancer, and are independent of aberrant crypt foci 
(ACF) (Yamada et al., 2001a). In all of the cancer cells induced by DMH in rats, P. 
catenin was overexpressed in the nucleus (Furihata et al., 2002). In the 
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azoxymethane (AOM) treated rats, overexpression and nuclear localization of P- 
catenin was observed in all adenomas (Sheng et al., 1998). P-catenin cellular 
localization within azoxymethane (AOM) treated rats and mice revealed alterations 
in the cellular localization of P-catenin, within the dysplastic tissues P-catenin was 
expressed within the cytoplasm and nucleus, whereas in normal tissues it was 
expressed at the cell membrane (Takahashi et al., 1998 and 2000a). In our DMH 
mouse model we found similar P-catenin expression within the non-dysplastic tissues 
when compared to the cellular localisation in human colonic mucosa. Within the 
dysplastic tissues there were also similarities with an increase in cytoplasmic 
expression and focal nuclear staining for P-catenin, but this was accompanied by 
maintenance of membrane expression, suggesting a possible difference in P-catenin 
activation as it does not appear to interfere with E-cadherin/p-catenin interactions. 
The focal nuclear expression shown for P-catenin could possibly be the result of a 
number of possible genetic (APC or fl-catenin mutation) and epigenetic factors 
(tyrosine phosphorylation). Mutations within the GSK-3P consensus sequence 
allows P-catenin to escape from the proteosomal degradation with subsequent 
accumulation in the cytoplasm and translocation into the nucleus. Mutations in APC 
or WNT-1 activation would also result in this cytoplasmic accumulation, APC no 
longer being able to target it for degradation, and inappropriate activation of WNT 
would result in the inactivation of GSK-3p. The nuclear localization of P-catenin is 
a common event in colorectal tumourigenesis (Sheng et al., 1998). SSCP mutational 
analysis of this DMH mouse model revealed a possible mutation within the GSK-3P 
consensus sequence of fl-catenin. Sequence analysis failed to confirm a mutation, 
but this could be due to the differences in sensitivities of the different procedures, 
with SSCP being highly sensitive, or inaccuracies during PCR amplification. 
Takahashi et al. (2000a) revealed a P-catenin mutation in mice using the carcinogen 
AOM, a metabolite of DMH subsequent examinations of the colonic tissues induced 
by AOM in mice and rats revealed a mutation in the GSK-3P consensus motif 
(Takahashi et al., 1998 and 2000a). Yamada et al. (2003) used Male F344 rats 
receiving subcutaneous injections of azoxymethane (15 mg/kg body weight) 
mutations in the exon 3 of fl-catenin gene were detected in 22 of 56 early lesions 
(39.3%) (16 weeks old) and 21 of 37 colon cancers (56.81/o) (46 weeks old). The 
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results of this study (Yamada et al., 2003) provided evidence for the first time that a 
fl-catenin mutation was selected for during colon carcinogenesis (Yamada et aL, 
2003). 
DMH induced colonic tumors in the rat contain mutations in 0-catcnin but the pattern 
of mutation differs from that found in human colon cancers (Blum et aL, 2001; 
Kocstcrs et aL, 2001). In both humans and rodents, mutations affect the glycogen 
synthase kinase-30 consensus region of P-catenin, but within different codons (Blum 
et aL; 2001; Koesters et aL, 2001). The majority of studies tend to use relatively 
short-term treatments with carcinogen thus Koesters et aL (2001) investigated the 
mutational spectrum of the P-catenin gene in rat colon tumors induced by long-term 
(20 weeks) DMH-treatment. There were P-catenin mutations in 12 of 33 (36%) 
tumours with only one of the P-catenin mutations found to affect the previously 
implicated codon 33 cluster region, whereas 11 of 12 (>90%) mutations within codon 
4 1, resulting in a similar mutation pattern to that observed in humans (Koesters et aL, 
2001). 
The role of APC in azoxymethane (AOM) induced colorectal tumors has been 
investigated in mice (Maltzman et al., 1997). Using an antibody that recognizes the 
carboxy terminus of APC studies revealed that AOM-induced adenomas and 
carcinomas were negative for APC, suggesting the loss of wild type APC. This 
reflected the observations within MIN mouse colonic adenomas, which are known to 
have a APC mutation. Thus within the AOM-induced murine model of colorectal 
cancer there is a loss of wild-type APC protein within the colonic tumours, 
suggesting that alterations in expression of the tumor suppressor gene commonly 
mutated in human colon cancer, is also involved in this animal model of colon cancer 
(Maltzman et al., 1997). APC mutations where found in the region homologous to 
the human mutation cluster region, but these were observed in only 6% of tumors 
induced in the rat colon by the administration of DMH (Endo et al., 2001). Previous 
studies have indicated the incidence of APC mutations'amongst AOM-induced 
tumors to be 15% or less (Sheng et al., 1998). APC has been implicated in cell 
signaling (Vleminckx et al., 1997) by its regulation of P-catenin levels within the 
cell. Investigations have shown that APC contains highly conserved nuclear export 
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signals that enable it to exit from the nucleus (Rosin-Arbesfeld et aL, 2000). Cancer 
cells containing a mutant APC results in P-catenin accumulating within the nucleus 
(Rosin-Arbesfeld et aL, 2000). The APC export signals confer efficient nuclear 
export and are critical for the function of APC in reducing the transcriptional activity 
of P-catenin (Rosin-Arbesfeld et aL, 2003). 
Mutation of either the APC or the fl-catenin (CTNNBI) genes results in nuclear 
accumulation of P-catenin and leads to activation of Tcf-4/Lef-I dependent 
transcription and upregulation of target genes including c-myc (He et al., 1998), 
cyclin DI (Shtutman et al., 1999), PPARS (He et al., 1999), matrix 
metalloproteinases (MMP) (Crawford et al., 1999), CD44 (Wielenga et al., 1999), 
uPAR (Mann et al., 1999) and cox-2 (Howe et al., 1999) which are important in 
tumourigenesis. Activating mutations in the fl-catenin gene are thought to be 
responsible for the excessive P-catenin signaling involved in the majority of 
carcinogen induced colonic carcinomas. Rats exposed to AOM for 4 weeks resulted 
in an increase in COX-2 and c-myc mRNA expression along with a decrease in APC 
mRNA expression within the rats treated with AOM, along with a K-ras mutation 
within ACF consisting of 4 or more crypts (Kishimoto et al., 2002). Previous studies 
carried out by Jackson et al. (1999) failed to detect any K-ras gene mutations within 
DMH induced tumours in SWR mice. DMH and 0.001% chlorophyllin induced 
tumours containing P-catenin mutations that also had marked over-expression of 
cyclin DI, c-myc and c-jun mRNA and c-Myc and c-Jun proteins (P-catenin/TCF 
target genes) were strongly elevated compared with tumors containing wild-type p- 
catenin (Blum et al., 2001). Thus the majority of tumours induced by DMH and 
AOM select for P-catenin mutations, having a low level of APC mutations, but both 
could result in the same end with an increase in P-catenin nuclear localization and 
catenin/Tcf-4 target gene transcription. 
In normal appearing colonic mucosa AOM has been shown to induce apoptosis, 
possibly to eliminate cells damaged by AOM administration and this was 
accompanied by an elevation in cell proliferation (Kishimoto et aL, 2002). The 
PCNA-LI in the ACF showing normal P-catenin expression pattern with that in the 
ACF showing abnormal P-catenin expression pattern was examined; there was no 
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significant difference of the PCNA-LI in these two different types of ACF (Furihata 
et al., 2002), suggesting P-catenin overexpression does not play a role in 
proliferation. These results also suggest that the activation of P-catenin signaling 
pathway is not only an initiating event, but also plays a pivotal role in the promotion 
stage of colorectal carcinogenesis (Yamada et aL, 2003). 
Loss of E-cadherin-mediated adhesion appears to be a fundamental aspect of the 
neoplastic process allowing cells to escape normal growth control signals resulting in 
increased cell proliferation, loss of differentiation and an increase in invasion (Frixen 
et al., 1991; Nigarn et al., 1993; Reviewed by Barth et al., 1997b; Reviewed by 
Jankowski et al., 1997; Reviewed by Jawhari et al., 1997a; Guilford et al., 1998; 
Reviewed Semb and Christofori, 1998; Gofuku et al., 1999; Jawhari et al., 1999). 
Mutations in E-cadherin, P-catenin, a-catenin and y- catenin and the activation of 
several receptor tyrosine kinases (EGFR and c-MET, resulting in catenin 
phosphorylation) have all been shown to result in the perturbation of cellular 
adhesion (Behrens et al., 1993; Reviewed by Jankowski et al., 1997; Guilford et al., 
1998). E-cadherin has also been found to localize in the cytoplasm of intestinal 
turnours derived from transgenic APC mice and FAP patients (Sloncova et al., 2001). 
a-catenin has been shown to be reduced or absent in a number of primary turnours of 
the oesophagus, stomach and colon, with E-Cadherin mediated adhesion being 
abrogated by down-regulation of ot-catenin (Shiozaki et al., 1994; Reviewed 
Shiozaki et al., 1996; Ghadirni et al., 1999). Reduced p120 expression has also been 
observed in 20% of adenomatous polyps, with loss of membranous p120 expression 
correlating with reduced E-Cadherin expression. Decreased expression of p120 was 
also found to correlate with the larger tumour size (Skoudy et al., 1996). 
In human normal colorectal epithelial. cells E-cadherin results in membranous 
staining at the adherens junctions, with changes in immunoreactivity and cellular 
localization within adenomas and carcinomas (Sloncova et al., 2001). A decrease in 
E-cadherin expression has been found associated with poorly differentiated 
adenocarcinomas (Nigam et al., 1993) and adenomas (Valizadeh et al., 1997). These 
changes in E-cadherin expression correlated to turnour size, histopathology, growth 
patterns and the degree of dysplasia (Dorudi et al., 1993; Gagliardi et al., 1995). 
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Loss of E-cadherin expression was not observed within the DMH mouse model but 
this may be explained by the fact that this is an early stage model with low levels of 
invasive adenocarcinomas, the majority of tissues being examined being adenomas. 
In normal human epithelium a-catenin is strongly expressed and is required for 
stable E-cadherin mediated cell adhesion (Shiozaki et al., 1994; Imamura et al., 
1999). In normal human epithelium a-catenin is strongly expressed but is reduced or 
absent in a number of primary turnours of the oesophagus, stomach and colon 
(Shiozaki et al., 1994). Skoudy et al. (1996) also reported altered cc-catenin 
expression in human colorectal cancer. Within the DMH mouse model there were 
similarities with human a-catenin expression within the non-dysplastic tissues but 
differences within the dysplastic tissues as membrane expression was maintained and 
cytoplasmic localisation was increased not reduced as for humans. This could be due 
to the stage reached within the adenoma to carcinoma sequence, with the DMH 
mouse model being an early model of colon cancer development, and the fact that E- 
cadherin expression is maintained. 
in human normal colon p120-catenin is present in the crypt and surface epithelium 
with cells showing reactivity in both the membrane and cytosol (Skoudy et al., 
1996), with staining intensity being greatest in proliferating crypt cells (Valizadeh et 
al., 1997). Reduced expression of p120 was observed in 20% of adenomatous 
polyps, with loss of membranous p120 expression correlating with reduced E- 
cadherin expression. Decreased expression of p120 was found to correlate with the 
larger turnours (Skoudy et al., 1996). In the DMH mouse model there are similarities 
in expression, the main difference being that expression is maintained within the 
dysplastic tissues, this could be due to the fact that E-cadherin expression is 
maintained within this model. Although in our study we found an increased 
cytoplasmic localisation of p120 in dysplastic mucosa the overall expression and the 
association with E-cadherin was maintained. 
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4.7 Conclusion 
The increased cytoplasmic expression for the catenins and E-cadherin within the 
dysplastic tissues suggests disruption in catenin regulation. P-catenin was found to 
be localised within the cytoplasm and the nucleus, along with maintenance at the cell 
membrane, within the dysplastic tissues. Within the non-dysplastic epithelium it was 
found to be primarily expressed at the epithelial cell membranes. Expression 
patterns for a-catenin, p120, and E-cadherin were similar to P-catenin with increased 
membranous and cytoplasmic immunoreactivity in dysplastic tissues, although no 
nuclear staining -A-as observedL Alterations in P-catenin expression and localisation 
in DMH mice are similar to those changes seen in human sporadic, familial and 
BNPCC derived colorectal tumours (Herter et al., 1999; Miyaki et al., 1999; 
Akiyarna et al., 2000; Fukushima et al., 200 1) and the MIN mouse (McEntee et al., 
1999) (Figure 4.10). Further observations in the mouse have revealed that the 
changes observed have many similarities with the morphological changes observed 
in human adenomatous; polyposis (Reviewed by Sunter, 1980; Reviewed by Rogers 
and Nauss, 1985; Carter et al., 1994; Moorghen et al., 1998) and has been proposed 
as a good model for studying early changes during tumourigenesis (Chang et al., 
1980). Therefore this chemically induced model of carcinogenesis appears to be 
useful for studying the abnormalities of the cadherin/catenins pathway at the early 
stages of tumour development. Brown et al. (2001) has used this DMH model to 
examine the effects of non-steriodal anti-inflammatory drugs (NSAIDs) on P-catenin 
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The effects of dietary fibre on the development of 1,2- 
dimethy1hydrazine, induced colorectal. tumours in female Balb/c 
mice. 
5.1 Introduction. 
Diet plays an important role in the development of human epithelial cancers 
including colorectal cancer with the proposal that dietary fibre may be protective 
against its development (Reviewed by Hill, 1997a; Reviewed by Cummings and 
Bingham, 1998; Reviewed by Bingham, 1999). Dietary intervention potentially 
provides a way to prevent certain diseases of the western world. Subsequent reports 
suggest the contrary and that 'fibre supplemented foods may damage your health' 
(Reviewed Wasan and Goodlad, 1996). Thus it is important to study the impact of 
dietary fibres; fibre supplements are being used in the treatment of a number of 
ailments (refer to section 3.6) and are found in everyday foods including high fibre 
bread (cellulose; Reviewed by Harris and Ferguson, 1993), Jams (pectin; Reviewed 
by Harris and Ferguson, 1993) and cereals (Plantago ovata; Reviewed by Leeds, 
1999). 
Animal studies help distinguish between different relevant factors and to understand 
the underlying mechanisms (Reviewed by Gerber and Corpet, 1999). Previous fibre 
studies in animals have had varying results ranging from protection, no effect, to 
enhancement of colorectal. cancer, for all fibres (Reviewed by Jacobs, 1990; 
Reviewed by Klurfeld, 1990; Reviewed by Harris and Ferguson, 1993). On balance 
soluble fibres, such as pectin, appear to be less protective than insoluble fibres 
(Reviewed by Harris and Ferguson, 1993). A number of protective mechanisms for 
fibres against the development of colorectal. cancer have been proposed (Reviewed 
Harris and Ferguson, 1993; Reviewed by Key et al., 2002) (sections 1.4,1.5 and 3.6) 




dietary fibres are not consumed in isolation or as individual fibres it is necessary to 
isolate the potential effects of individual fibres. 
To determine the biological effects of the fibres a number of parameters were 
explored. In this study colonic epithelial cell homeostasis, keeping a balance 
between proliferation and apoptosis was investigated by examining the effects of 
fibres on cell proliferation within the colonic crypt. As luminal contents are in 
contact with the colonic epithelium it could have profound effects on these 
parameters, thus affecting patterns of growth, differentiation and apoptosis (Hague et 
al., 1995). The expression of the adhesion molecules, E-cadherin and the catenins 
(a-, p-q-) and p120 (section 1.3) were examined due to their role in growth, 
differentiation and apoptosis of colonic epithelium and disruption in their functions 
leads to colorectal cancer development. P-catenin regulation is altered in a large 
number of colorectal tumours, as a result of loss of function mutations in APC, gain 
of function mutations within P-catenin and activation of Wnt-I (section 1.3). 
5.2 Aim. 
The aim of this study was to determine the effects of the dietary fibres: Ispaghula 
husk, pectin and cellulose on the development of 1,2-dimethylhydrazine induced 





This model examined the effects of fibre supplements on the development of 
chemically (1,2-dimethylhydrazine) induced colorectal cancer. 
1. The mice were examined for macroscopic nodule formation, followed by 
excision of these nodules. 
2. Microscopic confirmation of nodules as adenoma/adenocarcinomas using 
histological examination with further microscopic examination for 
microadenoma. numbers (adenoma prelesions). 
3. Tumour number, size and distribution were determined. 
The following effects of these dietary fibres on epithelial cells within the colonic 
tissues were examined. 
Proliferation was examined using flash-labelling with bromodeoxyuridine, 
(BrdU), and 
2. the expression of E-cadherin/catenin complex was examined within the non- 
dysplastic and dysplastic tissues of the colon by immunohistochernistry. 
5.4 Study design. 
The 1,2-dimethylhydrazine model using female Balb/c mice examined the effects of 
fibre supplements on tumour development. The mice were received at two weeks of 
age and acclimatised for I week on normal RM I diet (section 2.2). The mice were 
fed on sample diets for I week prior to administration of 1,2-dimethylhydrazine 
injections. The experimental diets were initially fed in pellet form but were 
subsequently abandoned for a powdered form as pelletting of these diets made them 
inedible. New ideas have recently come to light involving making biscuits so that 
food intake can be monitored (lain Brownlee, Newcastle University, Personal 
communication). The mice were continuously monitored for weight changes (Fig 
5.1) and initially for water and food intake. Food intake monitoring was abandoned 
due to the nature of the food, thus the mice were allowed access ad libitum. 
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Tissues were collected, fixed and examined for nodule number, size and distribution 
(section 2.2.2). Nodules (Fig 2.2 section 2.2), were excised along with surrounding 
non-dysplastic tissue and placed in fresh formalin, performed by Dr M. Moorghen, 
Dr J. Gupta and E. Tucker. These tissues were then processed, dehydrated in alcohol 
and histoclear and embedded in paraffin by J. Baker, J. Code and E. Tucker. J. 
Baker and J. Code then stained serial sections with haematoxylin and eosin for 
histological examination of the macroscopic nodules carried out by E. Tucker and 
Professor M. Pignatelli, E. Tucker and Dr J. Gupta performed microadenoma 
analysis. 
E-cadherin and catenin expression was determined in 20 tumours from each of the 
fibre supplemented groups basal, ispaghula husk, pectin and cellulose diets. These 
sections were scored (2-3.2) and the four groups compared. 
Bromodeoxyuridine (BrdU) detection via immunohistochernical methods is a 
powerful tool to study the cytokinetics of normal and neoplastic cells. 
Bromodeoxyuridine (BrdU) is a thymidine analogue that is specifically incorporated 
into DNA during S-phase of cell cycle and thus is expressed in the nuclei of 
proliferating cells (Coulter website; Chemicon International website) and at low 
concentrations will not block cell division (Ulrike Heberlein website). In vivo 
labelling of tumour cells with BrdU and its subsequent detection of incorporation 
with specific anti-BrdU monoclonal antibodies provides an accurate and 
comprehensive method for quantifying DNA synthesis (Chemicon International 
website). Thus to study the effects of these fibres on the proliferation of the colonic 
epithelium, mice were injected with Bromodeoxyuridine (BrdU) intraperitoneal QP) 
one hour prior to sacrifice. The BrdU labelling index was determined (section 2.2.4), 
to achieve this the left side of 50 (where possible) relatively normal hyperplastic 





5.5.1 The feeding study was monitored in terms of weight, faecal matter and 
di etary constituents. 
During the duration of the experiment the weight (Figure 5.1) was continuously 
monitored with food intake being allowed ad libitum. Observations of the effects of 
fibre on defecation (Figure 5.2) revealed that the basal diet (fibre deficient) resulted 
in faecal matter that were similar in colour to the control mice but the faecal matter 
appeared to be more solid and this was accompanied by reduction in volume 
(although this was not specifically measured). Cellulose resulted in faecal pellets 
that were well formed, very similar to the control, although were white in colour 
elucidating the role of crude fibre in forming faeces (cellulose is white). Pectin 
resulted in softer, darker and stickier faeces with ispaghula resulting in long string 
like faeces, which could have been the result of mucilage formation from the 
ispaghula husk. The level of fibre within the basal diet, along with the energy 
content was examined (Table 5.1) by special dietary services (SDS, Witham, Essex). 
The basal diet was found to have a very low level of crude fibre and NSP, so 
represented essentially a fibre free diet. The constituents of the basal diet and the 
fibre supplemented diets (Table 5.2) were also provided by special dietary services 
(SDS, Witham, Essex) and revealed that there were slight differences between the 
basal diets and the fibre supplemented diets. The basal diet contained a higher level 
of sucrose and rice starch than the fibre supplemented basal diets, this was to 
compensate for the lack of fibre within this diet. The basal diets supplemented with 




Fig 5.1 Average weight gain in female Balb/c mice fed various fibre 
supplemented diets and injected with 1,2-dimethylhydrazine mice 
over the first eight weeks. 
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Key: Group 1 wild type mice fed on a basal diet, Groups 2,3 and 4 DMH treated mice fed 
on a ispaghula husk supplemented diet, Groups 5,6 and 7 and 15 DMH treated mice fed on 
a pectin supplemented diet, Groups 8,9 and 10 DMH treated mice fed on a cellulose 
supplemented diet, Groups 11,12 and 13 DMH treated mice fed on a basal diet and Group 
14 fed on RM 1. 
A graphic representation of the average increase in weight for the Balb/c mice groups 
fed on different fibre supplemented diets over the first eight week period. The graph 
revealed an initial decrease in weight at week two this was probably due to 
acclimatisation to the new surroundings and diets. The graph showed from week two 




Fig 5.2 Faecal matter obtained from female Balb/c mice fed on the 
different diets, basal and basal diet supplemented with ispaghula 
husk, pectin and cellulose. 
fj 
Key: A- Normal mice on RMI, B- Basal diet, C- cellulose diet, D- Pectin diet, E- Ispaghula husk 
supplemented diets. 
A pictorial representation of the changes observed in faecal material collected from 
the Balb/c mice fed on the diets, RM I, Basal, and the fibre supplemented basal diets, 
ispaghula husk, pectin and cellulose. The effects of the individual fibre on faecal 
defecation was clearly seen, those on basal diet (B) (fibre deficient) resulted in faecal 
matter that were similar in size and colour to the control mice fed on a standard RM I 
diet (A), although appeared to be harder and less frequently produced, although this 
was not measured (SDS, Witham Essex). Cellulose (C) resulted in faecal matter 
similar in size and constitution to the control mice but reflected the white colour 
attributable to the cellulose. Pectin (D) resulted in darker faecal matter and from 
observations they were also sticky in nature with ispaghula husk (E) resulting in long 
string like faeces a possible result of the mucilage form of ispaghula husk when it is 




Table 5.1 A) Fibre content B) Energy content of the Basal diet (Fibre 
Deficient diet) as determined by the manufacture special dietary 
services (SDS, Witham, Essex). 
A 
Fibre content % 
Crude Fibre 0.38 
Total Dietary Fibre 1.13 







Gross Energy 16.41 
Digestible Energy 15.75 
Metabolised Energy 14.32 
Table A showed that the basal diet contained a very low level of crude fibre (lignin) 
and dietary fibre (NSP) but contained a high level of starch and sugar contents, 
33.01% and 35.55% respectively. Table B represents the gross energy (total), 
digestible energy (gross energy of the food less the gross energy within the faecal 
matter) and the metabolised energy (digestible energy of the food less the energy 





Table 5.2 Formulation of the different fibre supplemented diets; 
basal (FDD), ispaghula husk, pectin and cellulose; as determined by 
the manufacture special dietary services (SDS, Witham, Essex). 
Diet 
Ingredients Basalffiýjý Ispaghula Pectin Cellulose 
Proteins ')0 Ca casemate - 20 20 
Energy Sucrose 32.5 25.5 25.5 25.5 
Soya Oil 5 5 5 5 
Carbohydrate Rice Starch 37.5 32.5 32.5 32.5 
Fibre Ispaghula 0 14.5 0 0 
Pectin 0 0 14.5 0 
Cellulose 0 0 0 14.5 
Supplement Vit/Min 5 5 5 5 
The diets manufactured by SDS varied in their sucrose, rice starch and fibre contents. 
Within the fibre supplemented diets the fibre supplements accounted for 14.5% of 
the diet. In the basal diet, where no fibre was added, there was an accompanied 
increase in both sucrose (from 25.5% to 32.5%) and rice starch (32.5% to 37.5%) 
levels. The protein, soya oil and vitamin and mineral supplement content were equal 




5.5.2 Macroscopic analysis of nodules induced by the administration of 1,2- 
dimethy1hydrazine within the colonic tissues of Balb/c mice treated with various 
fibre supplemented diets. 
Figures 5.3,5.4,5.5, and 5.6 represent the macroscopic findings from this study. 
The macroscopic results revealed that those mice fed on a basal diet supplemented 
with 14.5% pectin had the greatest macroscopic nodule incidence (fig. 5.3), although 
the overall difference between diets was not statistically significantly different 
(*CHI-squared test p=0.203), nodule number (fig. 5.4) and total nodule burden 
(fig. 5.5). For all the fibre fed groups; ispaghula husk, pectin and cellulose, and the 
fibre deficient group, the majority of these nodules found were in the distal colon 
(fig. 5.6). Interestingly, although cellulose did not result in an increase in nodule 
number, compared to the control, there was an increase in nodule size suggesting that 
cellulose 'enhanced the progression of nodule development, although there was no 
significant difference in turnour burden from the control. These macroscopic 
findings suggested that the addition of pectin to the basal diet increased nodule 
initiation, development and progression within the DMH mouse model. 
5.5.3 Microscopic analysis of tumours induced by the administration of 1,2. 
dimethy1hydrazine within the colonic tissues of Balb/c mice treated with various 
fibre supplemented diets. 
Histological confirmation of nodules identified macroscopically was achieved using 
light microscopy of tissue sections stained with haernatoxylin and eosin (H&E). The 
majority of nodules were confirmed as being dysplastic epithelium 67.6%, 75%, 
87.9% and 59.6% for the basal, ispaghula, pectin and cellulose diets respectively 
(figure 5.7). The remainder were either lymphoid aggregates, mucosal folds or of an 





Figure 5.3 Incidence of nodule development in 1,2- 
dimethy1hydrazine female Balb/c mice fed on various diets; basal 
and the basal diet supplemented either with ispaghula husk, pectin 
or cellulose. 
- No. of Mice Basal Ispaghula Pectin Cellulose 
Nodule 16 16 21 17 
No Nodule 10 838 
Total No. of mice 26 24 24 25 
% with Nodules 61.5 66.7 87.5 68 
Percentage of female Balb/C mice that developed macroscopic 1,2- 
dimethy1hydrazine induced nodules within the different dietary groups. A higher 
incidence of nodule development was observed within the pectin supplemented 
group when compared to the basal (control) group, although there was no statistically 
significant overall difference in nodule incidence between the diets (CHI-squared test 
P=0.203*). 
* statistical analysis performed by J. Sykes, ReckittBenckiser Healthcare Limited, Hull. 
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Fig 5.4 Total number of macroscopic nodules found within the 
colons of 1,2-dimethylhydrazine treated female Balb/c mice on 
various dietary fibre supplemented diets. 
Total Nodule number in 1,2-dimethylhhydrazine female balb/c on 











umber of mice on each diet; Basal N= 26, ispaghula husk N= 24, pectin N=24, cellulose N=25. 
This graphic representation of total nodule number revealed that the pectin 
supplemented basal diet resulted in an increase in the number of macroscopic 
nodules fon-ned by the carcinogen 1,2-dimthylhydrazine in female Balb/c mice. The 
graph revealed ispaghula husk supplemented basal diet also resulted in a slight 
increase in the number of macroscopic nodules formed by 1,2-dimethylhydrazine in 
comparison to the diet supplemented with cellulose and the basal diet that contained 
no additional fibre. Thus the basal diet and the cellulose supplemented basal diet 
resulted in the lowest number of tumours. Thus the fibres appeared to influence 
nodule development to different extents, with the fibre free diet (basal) diet resulting 




Figure 5.5 Total macroscopic nodule burden formed within the 
colons of 1,2-dimethylhydrazine treated female Balb/c mice on 
various dietary fibre supplemented diets. 
Total Nodule Burden seen in 1,2-dimethylhydrazine Balb/C mice 











I Total number of mice on each diet; Basal N= 26, ispaghula husk N= 24, pectin N=24, cellulose N=25. I 
The total nodule burden found in each mouse in each of the fibre-supplemented 
groups was calculated using the formula explained in section 2.4 (Page 14). The 
graph shows that both the pectin and cellulose fibre supplemented basal diets 
resulted in a greater tumour burden, with pectin being statistically significantly 
different to the control. (*Chi-square -p <0.001 - evidence of overall difference 
between treatments; ANOVA - P<0.0001 - evidence of an overall difference 
between treatments; Wilcoxon Rank Sums - p=0.0004 again proving an overall 
difference). Cellulose, which was also shown to increase nodule burden was found 
not to be statistically significantly different from control. 




Figure 5.6 Represents the nodule distribution within the colon in 1,2- 
dimethy1hydrazine female Balb/c mice fed on various fibre- 
supplemented diets. 
Nodule Distribution in 1,2-dimethylhydrazine female Balb/c mice fed on 
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I Total number of mice on each diet; Basal N= 26, ispaghula husk N= 24, pectin N=24, cellulose N=25. I 
Nodule distribution was detennined, locating them in one of four quadrants; D= 
Distal, DM = Distal Middle, P= Proximal, PM = Proximal Middle (fig 2.1, section 
2.2). The graph shows that for all groups the majority of nodules were found within 
the distal colon. Nodules of the proximal region were also found in the cellulose, 
pectin and ispaghula husk fibre groups. 
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Figure 5.7 Percentage of macroscopic nodules confirmed as 
microscopic tumours within the 1,2-dimethylhydrazine female 
Balb/c mice fed on various fibre supplemented diets. 
Total Basal Ispaghula Pectin Cellulose 
Macro 
. 37 64 140 47 
Micro 25 48 123 28 
67.6% 75% 87.9% 59.6% 
Irotal. number of mice on each diet; Basal N= 26, ispaghula husk N= 24, pectin N=24, cellulose N=25.1 
The percentage of macroscopic nodules confirmed as microscopic turnours showed 
that the majority of nodules formed within the pectin fibre supplemented diet group 
were turnours (87.9%). Within the other fibre supplemented groups, basal (no fibre), 





Figure 5.8 Classification of the macroscopic nodules formed in the 










Microscopic analysis of Macroscopic nodules from the 1,2- 
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Classification of macroscopic nodules confirmed that the majority were tumours in 
all fibre-supplemented groups, particularly the pectin-supplemented group. The 
remaining macroscopic nodules were found to be lymphoid aggregates or were of 




basal diet resulted in the greatest incidence of tumour development within the DMH 
mice (figure 5.9). Tumour incidence was statistically significantly higher for those 
mice fed on the diet supplemented pectin when compared with those fed on the basal 
diet (*CHI-squared test p=0.004). The analysis of microadenoma numbers also 
suggested that the pectin supplemented basal diet increased the rate of initiation of 
tumour development when compared to the basal diet alone, although there was no 
statistically significant overall difference between the different dietary groups 
(*ANOVA p=0.1483) (Figure 5.13). The pectin supplemented diet was found to 
result in an increase in tumour number (Figure 5.10), although there was no 
statistically significant overall difference in total tumour number between the 
different diets (*ANOVA p=0.1577) because of the large variation between groups 
within each diet. Pectin also appeared to increase the total tumour burden (Figure 
5.11) (and average tumour burden per mouse, results not sown) when compared to 
the basal diet alone, although again there was no overall statistically significant 
difference between the diets (ANOVA p=0.1506) due to the large variations between 
the groups within each diet. The increase in tumour numbers and size suggests 
pectin also increased the rate of tumour development. The ispaghula husk 
supplemented basal diet was shown to result in an increase in tumour number, but 
this was not significantly different to the basal diet alone (figure 5.10). The 
isPaghula husk supplemented diet appeared to have a similar tumour burden to the 
basal diet (figure 5.11), thus it appeared that ispaghula husk resulted in a greater 
tumour initiation but that these tumours developed at a slower rate. The cellulose 
supplemented basal diet appeared to result in a similar number of tumours to the 
basal diet alone (figure 5.10), although the cellulose diet resulted in a larger total 
turnour burden (figure 5.11), suggesting that cellulose may have had little effect on 
tumour initiation but those tumours that did develop were larger in size. The 
majority of tumours were found in the distal colon (figure 5.12) only the pectin 
supplemented dietary group had any tumours confirmed in the proximal and 
proximal middle sections of the colon (figure 2.1, section 2-2). These results suggest 
that the type of fibre affected the rate of tumour initiation and development of 1,2- 




Figure 5.9 Percentage of female Balb/c mice that developed 1,2- 
dimethy1hydrazine induced tumours, fed on various fibre 
supplemented diets. 
No. of mice Basal I Ispaghula Pectin Cellulose 
Tumours 10 15 19 12 
No Turnours 16 9 5 13 
Total 26 24 24 25 
ý/o 
with turnours 38.5 62.5 79.2 41.4 
This table revealed that a higher incidence of tumour development occurred within 
the pectin supplemented group after induction by 1,2-dimethylhydrazine when 
compared to the basal (control) group (and the other fibre supplemented groups). 
There was a statistically significant overall difference in tumour incidence between 
the different fibre supplemented diets (*CHI-squared test p=0.023). Tumour 
incidence was statistically significantly higher for those mice fed on the diet 
supplemented pectin when compared with those fed on the basal diet (*CHI-squared 
test p=0.004). There was no statistically significant difference in tumour incidence 
between the ispaghula husk and basal diet (*CHI-squared test p=0.089). There was 
no statistically significant difference in tumour incidence between the cellulose and 
basal diet (*CHI-squared test p=0.492). 





Figure 5.10 Total number of tumours induced by 1,2- 
dimethy1hydrazine in female Balb/c mice on various fibre- 
supplemented diets. 
Total Tumour Number in 1,2-dimethylhydrazine female Balb/c 










Total number of mice on each diet; Basal N= 26, ispaghula husk N= 24, pectin N=24, cellulose N=25. 
The total number of tumours induced by 1,2-dimethylhydrazine in female Balb/c 
mice appeared to be greater in those mice fed a pectin supplemented basal diet. 
Ispaghula husk supplementation of the basal diet also appeared to promote tumour 
development, but to a lesser extent than that of pectin, when compared to the basal 
diet findings. Cellulose supplementation of the basal diet appeared to have little 
effect on tumour development, resulting in a similar number of turnours as the basal 
diet alone. There was no statistically significant overall difference in total tumour 
number between the different diets (*ANOVA p=0.1577) because of the large 
variation between groups treated with the same dietary fibre supplement diet. 




Figure 5.11 Total tumour burden found in 1,2-dimethylhydrazine 
treated female Balb/c mice on various fibre-supplemented diets. 
Total Tumour burden in 1,2-dimethylhydrazine female balb/c mice 











I Total number of mice on each diet; Basal N= 26, ispaghula husk N= 24, pectin N=24, cellulose N=25. 
The pectin supplemented basal diet increased turnour burden within the colon when 
compared to the other fibre groups. This suggested that pectin not only increased the 
number of tumours but also increased the size (as suggested by the average tumour 
burden per mouse, results not shown). Cellulose supplementation of the basal diet 
also revealed a greater turnour burden, this is interesting as the number of tumours 
formed were relatively small suggesting that although fewer tumours were formed 
they were bigger in size. There was no statistically significant overall difference in 
turnour burden between the different diets (*ANOVA p=O. 1506) because of the large 
variation between groups treated with the same dietary fibre supplemented diet. 




Figure 5.12 Tumour distribution within 1,2-dimethylhydrazine 
treated female Blab/c mice fed on various fibre-supplemented diets. 
Distribution of microscopically confirmed tumours within Balb/c 
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0 Proximal 
0 Proximal Middle 
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0 Distal 
Total number of mice on each diet; Basal N= 26, ispaghula husk N= 24, pectin N=24, cellulose N=25. 
Tumour distribution within 1,2-dimethylhydrazine treated mice revealed that the 
majority of the tumours formed, within all fibre supplemented groups, were primarily 
within the distal colon. Only those mice fed on the pectin supplemented basal diet 




Figure 5.13 Average microadenoma number in 1,2- 
dimethy1hydrazine treated female Balb/c mice fed on different fibre 
supplemented diets. 
Average number of Microadenomas formed within 1,2- 
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The average number of microadenomas formed, prelesions to adenoma development, 
was greatest within the pectin supplemented basal diet, followed by the cellulose 
supplemented basal diet, which was interesting as cellulose had the lowest number of 
turnours. The basal diet had the lowest number of microadenomas. There was no 
statistically significant overall difference in microadenoma number between the 
different diets (*ANOVA pý0.1483) because of the large variation between groups 
treated with the same dietary fibre supplemented diet. 




5.5.4 Addition of dietary fibres to the basal diet increased the number of cells 
undergoing DNA replication suggesting an increase in cell proliferation within 
the crypt. 
The bromodeoxyuridine-labelling index (BrdU-LI; Figure 5.14) revealed that the 
pectin supplemented basal diet appeared to result in an increase in the number of 
cells replicating their DNA. This suggested that pectin increased the proliferation 
within the colonic crypt. There was no significant difference between the basal diet 
and the diets supplemented with ispaghula husk or cellulose due to the large standard 
variation for the number of BrdU immunoreactive cells within the basal diet group. 
Overall it was shown that there was no statistically significant overall difference in 
BrdU-LI between the diets (*ANOVA p=0.0641) this was due to the variation 
between the two mice within each dietary group. There was also no significant 
difference (*ANOVA p=0.1835) in crypt length between the fibre supplemented 
diets and the basal diet (due to the large standard variation) (figure 5.15a), and the 
large variations between the two mice studied within each dietary group, particularly 
between those mice on the basal diet. The increase, although not significant, in 
proliferation by the pectin group together with the finding that there were no 
significant difference in crypt length may indicate that there is an alteration in the 
level of apoptosis within the crypt. 
5.5.5 The basal diet that was deficient in fibre resulted in the lowest tumour 
incidence, tumour number and tumour burden induced by 1,2- 
dimethylhydrazine. 
The DMH mice fed on the basal diet, a diet deficient of fibre, resulted in the lowest 
tumour incidence (figure 5.9 and figure 5.13), tumour number (figure 5.10) and total 
tumour burden (figure 5.11). There were some discrepancy as to whether the basal 
diet was strictly fibre deficient as the fibre was replaced with rice starch. Rice starch 




Figure 5.14 Effects of various fibre supplemented diets on the 
number of colonic cells in S phase as determined by flash-labelling 
with BrdU within 1,2-dimethylhydrazine treated female Balb/c mice. 
Average number of bromodeoxyuridine positive cells 
6 
5 
Average number of BRDU positive cells within the colonic crypt of 






Fibre supplemented diet 
Bromodeoxyuricline labelling index 
BRDU-Ll for 1,2-dimethylhydrazine female Balb/C mice fed on 









I For each group N=2, n=50 each, except for one mouse within the basal where n=36 
I 
The average number of (A) BrdU positive cells and the (B) BrdU labelling index was 
greatest in the pectin supplemented basal diet, suggesting that pectin resulted in an 
increase in the number of cells in S phase, as determined by flash-labelling with 
bromodeoxyuridine. There was no statistically significant overall difference in 
BrdU-Ll between the diets (*ANOVA p=0.0641) due to the variation between the 
two mice, particularly those fed the basal diet. 
*Statistical analysis performed by J. Sykes, Reckittl3enckiser Healthcare Ltd, Hull, UK 
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Figure 5.15a The effects of various fibre-supplemented diets on the 
average colonic crypt length in 1,2-dimethylhydrazine treated 
female Balb/c mice. 
The effect of various fibre supplemented diets on the average 













Fibre supplemented diet 
h group N=2, n=50 each, except for one mouse within the basal where n=36 
Comparison of the four fibre supplemented diets suggested that there was no 
difference between the groups in terms of crypt length due to the large standard 
deviations. The average crypt length appears to be greater within the pectin 
supplemented basal diet group and lowest in the basal diet group. There was no 
statistically significant overall difference in crypt length between all the fibre- 
supplemented diets (*ANOVA p=0.1835) this was because of the large mouse to 
mouse variation, particularly within the basal diet. 
*Statistical analysis perfonned by J. Sykes, Reckittl3enckiser Healthcare Ltd, Hull, UK 
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Figure 5.14b Representative light micrographs of colonic epithelium 
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Key :-A, Basal; B, Ispaghula Husk; C, Pectin; D, Cellulose 
Representative light micrograph pictures of colonic epithelium from DMH treated 
Balb/c mice fed on either a basal diet (A), ispaghula husk supplemented basal diet (B), 
pectin supplemented basal diet (C) or a cellulose supplemented basal diet (D), stained 




Resistant starch has been shown to reach the large intestine with the small bowel not 
being 100% efficient in humans (Reviewed by Hill, 1997c). The mice fed on the 
basal diet also exhibited smaller caecums and a thinner colonic mucosa (general 
observations). This could be explained by the fact that mice are caecal fermenters 
(Reviewed by Van Soest, 1995) thus the lack of fibre would result in a decrease (or 
no increase) in the size of the caecum and a thinning of the mucosa due to a lack of 
SCFA production, also indicating that the rice starch contained only a small fraction 
of resistant starch. Goodlad and Wright (1990) suggested that fibre free diets were 
associated with disuse atrophy of the distal ileum and the colon. They suggested that 
fermented fibre, but not inert bulk, could restore intestinal proliferation possibly due 
to SCFA release by microflora directly effecting luminal nutrition or luminal 
workload (Reviewed by Goodlad and Wright, 1990). The basal diet was shown to 
have the lowest proliferation indices (figure 5.15), which again suggests a low level 
of fibre (resistant starch) within this diet. This may indicate why the basal diet was 
associated with the lowest tumour development, suggesting proliferation may be 
linked to the increased development of colonic turnours, although it must be noted 
that there was no statistically significant difference between the different fibre diets 
(*ANOVA P=0.064 1). 
5.5.6 Dietary fibres appeared to have no significant effect on P-catenin, a- 
catenin, p120 and E-cadherin protein expression within normal and dysplastic 
epithelium of 1,2-dimethylhydrazine administered mice. 
The non-dysplastic and dysplastic tissues of the DMH mouse model were scored for 
membranous, cytoplasmic and nuclear expression (refer to 5.4) and revealed an 
increase in cytoplasmic expression of P-catenin, a-catenin, p120 and E-cadherin, 
along with focal nuclear localisation of P-catenin within 30 of the 81 tissues 
examined. The basal diet and the basal diet supplemented with the fibres ispaghula 
husk, pectin, cellulose appeared to have little effect on P-catenin, ot-catenin, p120 or 






Figure 5.16 The effect of the dietary fibres Ispaghula husk, Pectin 
and Cellulose on (A) 0-catenin, (B) E-cadherin, (C) cc-catenin and 
(D) p120 expression in the 1,2-dimethylhydrazine mouse model of 
colorectal cancer. 
A. 
Non-dysplastic tissue Dysplastic tissue 7 
Memb SD Cyto SD Nuc Memb SD Cyto SD Nuc N 
Basal 2.75 0.44 1.5 0.52 0 3 0 2.95 0.22 8 20 
Ispaghula 2.65 0.49 1.35 0.49 0 3 0 3 0 10 20 
Pectin 2.71 0.56 1.71 0.56 0 2.95 0.22 2.95 0.22 6 21 
Cellulose 2.75 0.44 1.5 0.52 0 2.9 0.31 2.9 0.45 6 20 
B. 
C. 
Non-dysplastic tissue Dysplastic tissue -1 
Memb SD Cyto SD Nuc Memb SD Cyto SD I Nuc N 
Basal 2.74 0.45 1.63 0.6 0 2.84 0.37 2.79 0.54 0 19 
Ispaghula 2.75 0.44 1.4 0.5 0 2.9 0.31 2.85 0.37 0 20 
Pectin 2.86 0.36 1.57 0.6 0 2.76 0.44 2.52 0.51 0 21 
Cellulose 2.45 0.51 1.55 0.6 0 2.55 0.69 2.45 0.83 0 20 
Non-dysplastic tissue Dysplastic tissue 
Memb SD Cyto SD Nuc Memb I SD Cyto SD Nuc N 
Basal 3 0 2.06 0.56 0 3 0 2.89 0.33 0 17 
Ispaghula 2.95 0.23 2.05 0.4 0 3 0 2.95 0.23 0 19 










Non-dysplastic tissue Dysplastic tissue 
Memb SD Cyto SD I Nuc Memb SD - Cyto [ SD Nuc N 
Basal 2.68 0.48 1.68 0.58 0 2.89 0.32 2.74 0.45 0 19 
Ispaghula 2.56 0.62 1.89 0.1 32 0 3 0 2.78 0.43 0 18 
Pectin 2.81 0.4 1.71 0.64 0 2.81 0.51 2.76 0.54 0 21 
-(Ilulose Dýeýllulose 2.61 0.61 
1 




2.67 0.4-9 1 o1 18 
The tables show that the different fibre supplemented diets, basal, ispaghula, pectin and cellulose 
resulted in no obvious difference in (A) 0- catenin, (B) E-cadherin, (C) oc-catenin and (D) p120 




The dietary fibres also appeared to have little effect on the level of P- catenin nuclear 
localisation (figure 5.16). This may have been due to the fact that a small number of 
tissues (N=20) were examined within each fibre group. 
5.6 Discussion. 
Through the proposed multistep process of colorectal cancer, it is believed that by 
preventing the growth of adenomas in the colon and the rectum this will prevent the 
development of colorectal cancer (Reviewed by Byers, 2000). Thus the DMH model 
was used to examine whether the supplementation of a basal diet, primarily deficient 
in fibre, with dietary fibres resulted in a decreased incidence of tumour development. 
The study asked the question as to whether dietary fibre plays a role in the 
progression or prevention of tumour development after its initiation and promotion 
by the carcinogen 1,2-dimethylhydrazine. 
5.6.1 The potential protective or causative mechanisms of dietary ribres on colon 
cancer development. 
5.6.1.1 Bulking effects ofFibres. 
This model involved the subcutaneous injection of a carcinogen, thus could not 
answer the question whether the bulking effect of fibre (by diluting down the 
carcinogen and decreasing transit time) played a role in preventing cancer 
development. If the carcinogen was secreted in the bile (Reviewed by Pozharisski et 
aL, 1979) then the fibres would affect the carcinogens actions, for example ispaghula 
husk, which is a bulking fibre would reduce the contact of the carcinogen with the 
colonic epithelium and result in its dilution, whereas pectin has little bulking effect 
thus could not elicit these actions. The basal diet results suggested that bulking is not 
the mechanism of action of the fibre in tumour development as the basal diet 
contained little fibre and thus would not elicit a bulking mechanism. The carcinogen 
is thought to act via the blood stream, rather than being extruded with the bile, with 
the active metabolites targeting the bottom of the crypt (Reviewed by Sunter, 1980) 




Hill, London Reckift Benckiser conference personal communication). Bulking 
effects, in terms of bowel transit have also been shown to alter stool SCFA 
concentrations including butyrate and distal. colonic pH. Increasing the rate of 
intestinal transit was shown to increase butyrate concentrations in the distal colon 
(Lewis and Heaton, 1997). Butyrate production has been shown to protect against 
DMH induced turnourigenesis in vivo (McIntyre et al., 1993; Avivi-Green et al., 
200a). 
5.6.1.2 Fermentation. 
The findings from this study posed the question as to why pectin enhanced tumour 
development. Pectin is fermented readily, if not completely, in the caecurn 
producing high levels of intracolonic short chain fatty acids (SCFA) levels (Avivi- 
Green et al., *2000b) and this could have many implications. Fermentation of pectin 
in the caecum (lowering in pH observed by Cameron et al., 2000) could have 
potentially lowered the SCFA concentration within the distal. colon, as the majority 
of the SCFA production would have been within the caecurn or proximal colon. This 
would have influenced the availability of energy for colonocytes and the pH of the 
colonic lumen. Although Avivi-Green et al. (2000a) suggest that pectin produce 
high levels of intracolonic levels of butyrate and that pectin and butyrate infusions 
resulted in a decrease in the number of aberrant crypt foci (ACF) induced by DMH, 
which theoretically is in contrast to our findings, although ACF numbers were not 
determined in this study. SCFAs result in a lowering in pH within the colon, which 
has many implications on enzyme activity and bile acid solubility. If the SCFA 
levels decreased, the pH would increase, and would subsequently affect primary bile 
acid levels and their conversion to secondary bile acids by influencing the activity of 
the enzyme involved, 7-cc-dehydroxylase (section 5.5.1.4) (Reviewed by Ink and 
Hurt, 1987). Lipids themselves have been shown to stimulate proliferation within 
the small intestine, although in the presence of bacteria had little effect on colonic 
proliferation (Pell et al., 1995). pH has been shown to affect cell proliferation with 
an increase in the environments acidity being associated with an 
increase in 
proliferation. If pectin is fermented rapidly within the caecum. an 
increase in pH 
within the distal colon is unlikely to be the cause of the 
increased proliferation within 
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the colonic epithelial cells. Another study has shown pectin to result in an increase 
in markers of apoptosis within the colon (Avivi-Green et al., 2000a), which could 
elicit the increase in proliferation to help maintain a balance within the colon, colonic 
homeostasis. Our findings are similar to those of Jacobs and Lupton (1986) where 
they found that pectin resulted in 5 times the number of adenomas than the fibre free 
diet, showing that it was also the greatest stimulus for cell proliferation and that a 
lower luminal pH was associated with the greater tumour number (Jacobs and 
Lupton, 1986). 
SCFAs, such as butyrate, have previously been shown by Medina et al. (1998) to 
inhibit 1,2-dimethylhydrazine induced cancer development in rats. Weaver et al. 
(1996) also showed that in rats treated with azoxymethane (AOM), butyrate was 
protective, whereas propionate was thought to enhance tumour development. Slow 
release pellets within F344 male mice administered with AOM have been shown to 
increase apoptosis without affecting ACF or proliferation within colonic tissues 
(Caderni et al., 1998). The protective effects of butyrate have also been shown in 
vitro (section 1.3), thus the SCFA profile produced by these dietary fibres is 
important. In freshly isolated rat colonic cells both butyrate and acetate were shown 
to reduce the induction of DNA damage by H202 (oxidative stress), whereas 
propionate was ineffective (Abrahamse et al., 1999). A number of studies have 
shown that when fermented different fibres produced different levels of the three 
main SCFAs, butyrate, acetate and propionate (section 3) (Thomsen et al., 1984; 
Edwards and Eastwood, 1992; Marteau et al., 1994; Reviewed by Edwards, 1995). 
Interestingly, Clausen et al. (199 1) also showed that the ratio of butyrate production 
to total SCFA production from fibre was reduced in patients with colonic cancer and 
adenomas compared to healthy controls. Interestingly physiological mixtures of 
SCFAs representing that for pectin, acetate, propionate and butyrate ratio of 41: 21: 38 
respectively, were shown not have significant antigenotoxic effects 
(oxidative stress) 
(Abrahamse et al., 1999). A study examining the effects of resistant starch and 
cellulose on DMH induced colonic tumours within rats 
found that resistant starch 
resulted in an increase in buyrate concentration 
but did not inhibit colonic 
carcinogenesis (Sakamoto et al., 1996). 
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5.6.1.3 Microflora 
It has been proposed that different fibres select for different microflora within the 
hindgut, resulting in changes in microbial metabolism (Costa et al., 1989). This 
alteration of microflora will in turn affect their ability to ferment other dietary fibres 
(Monsma and Marlett, 1996). Narushima et al. (1998) results indicated that 
intestinal bacteria could substantially modify colorectal tumourigenesis induced by 
DMH. Further studies also showed the role of microflora in DMH induced tumour 
development, germfree mice had a greater incidence of tumour development than 
conventionalised mice but they were smaller in size (Horie at al., 1999a). This could 
be suggestive that microflora helps to slow down the initiation but increases rate of 
progression (possibly due to SCFA induction increased proliferation in vivo, or any 
effect of chemical conversion i. e. maybe it slows down the decomposition rate of 
MAM to methydiazonium thus Slowing down initiation). The effect of a number of 
individual intestinal bacteria on DMH induced colorectal adenoma formation has 
been examined by developing gnotobiotic mice. The incidence of adenoma 
formation in gnotobiotic mice with Mitsuokella multiacida, Clostridium butyricum, 
Bij1dobacterium longhum, Clostridium paraputrificum, Escherichia coli and 
Lactobacillus addophilus was 68%, 68%, 63%, 50%, 50% and 30% respectively 
(Horie et al., 1999a), suggesting bacteria influenced tumour development. There are 
a number of proposed mechanisms as to how these bacteria influenced tumour 
incidence, for example the effects of Lacidophilus may be mediated by faecal pH 
and the effects of Cl. paraputrificum and C1. butyricum may be through the 
deconjugation of bile acids (refer to section 5.5.1.4) (Horie et al., 1999a). Horie et 
al. (1999b) developed gnotobiotic mice each with a single species of intestinal 
bacteria to look at the effects on DMH induced colorectal cancer. The incidence of 
adenoma formation in gnotobiotic mice with Lactobacillus addophilus, gnotobiotic 
mice with Ecoll and germ-free mice were 30,50 and 74% respectively. Probiotics 
(viable microbial dietary supplement which benefits the host through its effects 
within the intestinal tract) have been shown to have an inhibitory effect on the 
development of aberrant crypts and tumours in animal models (Reviewed by Brady 
et al., 2000) again suggesting that microflora influences turnour development. This 




carcinogenesis, thus pectin could result in changes in the microflora of the gut that 
modify the colorectal, cancer induced by DMH. 
5.6.1.4 Bile Acids. 
Unconjugated bile acids have been shown to be tumour promoters (Bayerdorffer et 
al., 1995), and the presence of these bile acids in the intestinal tissues is regulated by 
dietary factors (Weisburger et al., 1977; Mahmoud et al., 1999). Influence of diet 
can be seen through their fermentation resulting in changes in pH within the colonic 
lumen. Increases in pH can theoretically result in the release of primary bile acids 
due to changes in their solubility, and loss of fibre as bulk could also result in the 
same end. This release of primary bile acids potentially results in their increased 
conversion to secondary bile acids, which have been shown to be involved in 
colorectal cancer development (Reviewed'by Harris and Ferguson, 1993; Reviewed 
by Chaplin 1998). The increase in pH affects the enzyme activity of 7-oc- 
dehydroxylase with a decrease in pH reducing the activity of this enzyme, an enzyme 
involved in the conversion of primary bile acids into secondary bile acids. Pectin is 
fermented rapidly in the caecurn thus would result in a dramatic lowering of pH in 
the proximal colon inhibiting the enzyme 7-cc-dehydroxylase (Reviewed by Ink and 
Hurt, 1987) but this would also result in the release of primary bile acids due to a 
loss of bulking. pH would increase as the bile acids move along the colon and the 
level of SCFAs would decrease, thus the activity of the enzyme would increase 
particularly in the distal colon. Whereas ispaghula husk has been shown to bind 
primary bile acids and as it is fermented relatively slowly would result in a steady 
release of SCFAs keeping the pH low and the concentration of primary bile acids 
low possibly resulting in a reduced production of secondary bile acids. Dietary 
fibres such as ispaghula husk have already been shown to affect bile acid 
concentrations by lowering faecal lithocholic and isolithocholic acids (Chaplin et al., 
2000). Interestingly, Furukawa et al. (1995) showed that the dietary fibre yugao- 
melon suppresses DMH induced colonic tumours 
in mice by lowering bile acid 
concentration and pH within the colon, thus bile acids could play a role 
in DMH 
induced turnour pathology. Kozoni et al. (2000) looked at the biological effects 




human and experimental cancers, in DMH treated mice. They found that DMH on 
its own increased apoptosis and so did LCA but LCA and DMH together resulted in 
a decrease in apoptosis. They also showed that DMH and LCA on their own resulted 
in an increase in proliferation but together resulted in a shift in proliferation site. 
Thus this suggests that LCA, in the presence of a chemical carcinogen, alters the 
colonic homeostasis resulting in turnour formation (Kozoni et al., 2000). Bile 
acids/salts have also been shown to induce apoptosis in vitro in colon cancer cell 
lines (Schlottman et al., 2000). 
5.6.1.5 Colonic homeostasis 
Diet (fibre) and the products of its fermentation, the SCFAs, have already been 
shown to stimulate intestinal proliferation (Jacobs and Lupton, 1984; Reviewed by 
Jacobs, 1988; Goodlad et al., 1989; Goodlad et al., 1995; Reviewed by Goodlad and 
Wright, 1990; Reviewed by Wasan and Goodlad, 1996). Pectin (via non-specific 
irritation), the products of its fermentation (Ichikawa and Sakata, 1998; Reviewed by 
Wasan and Goodlad, 1996) could affect the natural homeostasis of the colon by 
altering the balance between cell proliferation, differentiation and apoptosis. DMH 
itself increases proliferation and alters the distribution of proliferating and apoptotic 
cells within colon crypts early in carcinogenesis (Richards, 1977; Baril et al., 1990; 
Barnes et al., 1999; Carter et al., 1994), and studies using AOM have found that 
colonocyte energy metabolism (depressed butyrate metabolism) also differs with 
further changes during tumourigenesis (Zhang et al., 1998). Edwards et al. (1992) 
showed that a long-term high fibre diet was associated with an 
increase in cellular 
proliferation in the proximal but not the distal colon of rats. Robblee et al. (1989) 
has previously shown an increased labelling index with pectin compared to cellulose 
thus suggesting an increase in cell proliferation. Ispaghula husk in the form of 
Metamucil has also been shown to increase proliferation when compared to cellulose 
in rats (Calvert et al., 1985). Zhang and Lupton (1994) 
found that the production of 
SCFAs through the fermentation of fibre (cellulose, pectin or oat bran) stimulated 
caecal cell proliferation but not in colonic cells within the 
distal colon and proposed 
that other factors may influence proliferation within distal colonocytes. Changes in 
apoptosis have also been 
involved in tumour development by unbalancing colonic 




caspase 1 activity and increased cleaved poly (ADP-ribose) polymerase (PARP). 
The caspases have been shown to play a fundamental role in apoptosis; caspase I 
(ICE) belongs to a subfamily of caspases who are predominantly involved in the 
control of inflammation (Reviewed by Earnshaw et al., 1999) although it has been 
implicated in initiating the apoptotic pathway (Avivi-Green et al., 2000a). Caspase I 
has also been shown to be involved in the cleavage of P-catenin (Fukuda, 1999) and 
caspase 3 cleaves E-cadherin during apoptosis (Steinhusen et al., 2001). PARP is a 
DNA repair enzyme that is cleaved during the initial phases of apoptosis, thus an 
increase would suggest that there has been an increase in apoptosis (Avivi-Green et 
al., 2000a). A pectin supplemented basal diet was shown to increase the 
proliferation (Figure 5.15) of colonic epithelial cells in 1,2-dimethylhydrazine treated 
female Balb/c mice. This increase was not accompanied by a significant increase in 
crypt length (figure 5.14) this could be due to an increase in apoptosis as shown 
previously (Avivi-Green et al., 2000a). The increase in proliferation as a result of 
pectin supplementation could also elucidate the increase in tumour development in 
terms of initiation and progression. Although Chang et al. (1997) suggest that 
measurements of differentiation and apoptosis may have a greater prognostic value to 
detect dietary effects on tumour incidence than proliferation. 
5.6.1.6 Changes in gene andprotein expression. 
Pectin could also result in changes in gene or protein expression. Other dietary 
factors, including the SCFAs, have been shown to affect a number of proteins in 
terms of their expression levels. Tappenden and McBumey (1998) showed that 
systemic SCFAs increase plasma GLP-2 (Glucagon-like peptide-2) and ileal 
proglucagon mRNA, GLUT 2 expression, c-myc, c-jun and c-fos expression in vivo. 
Although in vitro butyrate has been shown to downregulate C-myc protein levels 
(Basson et al., 1998). Pectin could result in changes in enzyme activity such as 7-Cc- 
dehydroxylase, which converts primary bile acids into secondary bile acids. Other 
dietary factors such as morin (a flavonoid) have also been shown to affect enzyme 
activity such as Glutathione S-transferase and quinone reductase (Tanaka et al., 
1999). Mahmoud etaL (1999) found that the bile acid chenodeoxycholate resulted in 




tissues respectively, in the multiple intestinal neoplasia (MIN) mice. Mei et al. 
(1999) also showed that cells containing a mutant APC express higher levels of 
PGHS-Z mRNA and protein thus increasing PGE2 production. This was found to 
correlate with the formation of P-catenin-Lef-I complexes. Hormone levels may 
also play a role as suggested by the differences of tumour incidence between sexes 
(Reviewed by Pozharisski et al., 1979). For example Toth et al. (1984) examined the 
effects of metarnucil (ispaghula husk) on the development of tumours in DMH 
treated Swiss mice. Tley found that the administration of metamucil enhanced the 
appearance of colonic tumours in males only. Psyllium (ispaghula husk) was shown 
to protect against colorectal cancer when tumours were induced in rats by gastric 
intubation (Roberts-Andersen et al., 1987) this suggests that ispaghula may protect 
against colorectal cancer by diluting down the carcinogen. Alabaster et al. (1993) 
showed that in F-344 rats psyllium (ispaghula husk) could protect against AOM 
induced colon cancer promoted by high fat diets, and this effect was enhanced when 
in combination with wheat bran. Fibres have also been shown to modulated bacterial 
p-glucuronidase activity, with guar gum resulting in lower levels of activity than 
pectin, although this was not thought to be related to tumour number (Bauer et aL, 
1981). Psyllium (ispaghula husk) has also been shown to have lower levels of P- 
glucuronidase than cellulose (Costa et aL, 1989b) and wheat bran (Leng-Peschlow, 
1991). Thus, pectin could result in changes in gene and protein expression either 
directly or indirectly by the production of SCFAs or changes in bile acid 
concentrations. In this study the different fibres, ispaghula husk, pectin, cellulose 
and the basal diet, had little effect on P-catenin, cc-catenin, p120 or E-cadherin 
cellular localization. 
5.6.1.7 Immune responses 
Fibres may also affect the gut associated lymphoid tissue (GALT) of the colonic 
rnucosa. Within this study lymphoid aggregates were generally observed associated 
with dysplastic tissue. Exposure of Balb/c mice to 
DMH has been shown to 
stimulate an immune response (Tendler et al., 2000). 
Although Madar et al. (1998) 
found that in the ileum of rats exposed to the carcinogen DMII/AMO, the carcinogen 
even at low levels inhibited lymphoid system 




showed that gnotobiotic mice with Lacidopilus resulted in a decrease in DMH 
induced tumours. The protective effects of Laddophilus are thought to be due to 
activation of extrathymic T cells in the liver and granulocytes in the colonic mucosa. 
The SCFAs also affect the immune response (ref to section 1.5.5). 
5.6.2 Other dietary intervention studies and the biological effects. 
Other studies have looked at the biological effects of a number of dietary factors. 
Epidemiological studies have consistently indicated that the consumption of fruits 
and vegetables lower cancer risk in humans and suggest certain dietary constituents 
may be effective in preventing colorectal cancer (Mahmoud et al., 2000). This has 
lead to a number of groups studying the effects of a number of different dietary 
factors in rodent models. Many of these studies have examined changes in the 
colonic homeostasis and the effects on a number of important genes and proteins, 
such as P-catenin, in the development of colorectal cancer. Taniyama et al. (2000) 
showed that 24R, 25-dihydroxyvitamin D3 decreased the number of tumours present 
in rat colonic mucosa. The decrease in tumour number was accompanied by a 
decrease in the bromodeoxyuridine (BrdU) labelling index suggesting a decrease in 
proliferation. Tanaka et al. (1999) found that the flavonoid, morin, also resulted in a 
decrease in tumour incidence (AMO treated rats) with changes in the expression of a 
number of proteins. These changes included a decrease in proliferating cell nuclear 
antigen (PCNA) in aberrant crypt foci (ACF) and an increase in Glutathione S. 
transferase (involved in the production of leukotrienes by the immune system, part of 
the aracadonic acid metabolic pathway) and quinone reductase. Bartsch el al. (1999) 
review the findings that a high intake of certain dietary polyunsaturated fatty acids 
(PUFAs) promotes several stages of mammary and colon cancer from an increase in 
oxidative DNA damage and changes in cell proliferation and hormone levels and 
catabolism. In contrast the fish oil derived w-3 fatty acids seem to protect against 
cancer development by influencing the activity of enzymes and proteins involvcd in 
intracellular signalling and ultimately cell proliferation. In the MIN mouse, 
Mahmoud et al. (1999) examined the effects of chenodeoxycholate (unconjugatcd 
bile acid) on tumour incidence and found an increase in the number of duodenal 




cells and an increase in Prostaglandin E2 (PGE2, ) a product of the arachidonic acid 
pathway involving cyclooxygenase (COX) in duodenal tissue, suggesting that bile 
acids contribute to tumour formation where there is an APC mutation. Rao et al. 
(2000) showed that 1,4-phenylene bis (methylene) selenocyanate (P-XSC) also has 
antiturnour activity and appears to involve the modulation of P-catenin expression 
and COX-2 activity. NSAIDs modulate COX-2 activity and epidemiological 
evidence suggests that NSAIDs protect against colon cancer development (Reviewed 
by Choi and Mason, 1998). High doses of asprin (NSAID) have been shown to 
reduce tumour formation in MIN mice (Barnes and Lee, 1998). Moorghen et al. 
(1998) showed that the NSAID sulindac had a marked inhibitory effect on the 
development of colonic turnours in mice treated with the carcinogen DMIL Sulindac 
was shown to increase cell proliferation (BrdU index), which may be secondary to 
the loss of crypt epithelial cells by apoptosis induced by sulindac. Sulindac was also 
shown to reduce the number and *volume of turnours with DMH treated rats 
(Sprague-Dawley), this was found to be independent of cyclooxygenase inhibition 
but possibly due to the increase in apoptosis observed, although in contrast to 
Moorghen et al. (1998) a reduction in proliferation (Brd-U) was also observed 
(Brown et al., 2001). Interestingly Kishimoto et al. (2000) found that sulindac also 
resulted in an increase in APC mRNA in AOM treated rat colonic mucosa. The Cox. 
2 inhibitor celecoxib resulted in the suppression of occurrence and advancement of 
crypts overexpressing P-catenin, suggested to be premalignant lesions, induced by 
AOM within F344 rats (Yamada et al., 2001b). The relationship between P-catcnin 
and Bcl-2 expression in sulindac induced regression of intestinal tumours in MIN 
mice was examined by McEntee et al. (1999). They found that in this model there 
was a decrease in the expression of P-catenin with Bcl-2 conferring resistance to 
these effects. Ishizuka and Kasai (1997) found that rats treated with DMII and fed 
on a diet deficient of fibre resulted in a significant increase in the PCNA-LI 
(proliferating cell nuclear antigen-labelling index) of the distal colon and rectum. 
They found that the ingestion of wheat bran diminished this increase in PCNA-LI. 
Cameron et al. (1997) found that lignin supplementation has good bulking 
characteristics, and had a significant effect on several factors that have previously 
been linked to reduction of colon cancer risk, but the consumption of high levels of 
lignin did not decrease the risk for colon carcinogenesis. Within the colon of DMII 
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induced ACF in mice found a protective effect of carotenoids and curcurnins (Kim et 
al., 1998). Mahmoud et al. (2000) has also shown that the plant phenolics decrease 
intestinal turriours in an animal model of familial adenomatous polyposis coli (FAP). 
They examined the effects of caffeic acid phenethyl ester (CAPE), curcumin, 
quercetin and rutin. They found that only CAPE and curcumin resulted in a decrease 
in tumour development and this was associated with an increase in entcrocyte 
apoptosis and proliferation and a decrease in 0-catenin expression in enterocytes. 
Thus suggesting that CAPE and curcumin suppresses APC associated intestinal 
carcinogenesis. Mikhailowski et al. (1998) looked at TGF-01, a cytokine known to 
play a key role in the control of cell growth inhibiting human and rodent epithclial 
cell proliferation. They found that in vivo TGF-P 1 markedly inhibited colonic ACF 
formation and significantly reduced colonic turnour formation and size. 
5.6.3 Animal studies 
The findings from these dietary studies, especially those looking into fibre, reviewed 
by Jacobs (1990) and Klurfeld (1990), vary considerably. This could be attributed to 
a number of factors such as the use of different animal models with varying genetic 
background, the age, sex, strain of the animal, the dosage of dietary supplement, 
carcinogen administration site, all of which can effect the results (Reviewed by 
Bingham, 1990; Reviewed by Pozharisski et al., 1979). Rats and mice are very 
popular experimental animals for studying human nutrition (Reviewed by Van Soest, 
1995). However, these models have many disadvantages especially when it comes to 
studying dietary fibre. Firstly they are smaller, have inferior fermentation capacities 
with their main site of fermentation being in the caecum. whereas in humans it is the 
colon. They are also coprophagous, which can confound results (Reviewed by Van 
Soest, 1995). Although tumours, are produced mainly in the descending colon and 
rectum in rodents after administration of DMH, the mode of tumour formation 
appears to be species specific: the neoplasms isolated in the rat are border-based but 
widespread in the mouse (Chang, 1980). Thus the mouse appears to be the better 
experimental model with which to analyse the pathogenesis of multiple adcnomas 




differ in some way or other; there is no species that behaves exactly like humans 
(Reviewed by Van Soest, 1995). 
Further problems with the DMH model include the unknown genetic background 
with the possibility of a non-uniform genetic background as with all carcinogen- 
based models. It has previously been shown that the active metabolite of DMH and 
AOM is MAM, which, in the case of AOM, has been shown to cause mutation in the 
GSK-3P consensus motif of P-catenin (Takahashi et aL, 1998 and 2000). This was 
implied by the finding that within microadenomas there is an over expression and 
redistribution of P-catenin to the cytoplasm and nucleus, suggesting a disruption in 
the regulation of P-catenin expression. Although this model has many histological 
changes that are seen in humans the initial stages of DMH induced colorcctal cancer 
in rodents involve hyperplasia, which is not seen in humans. The microflora. in 
munne species is likely to be different to humans thus there are a number of 
problems with these models. Another problem with this model was the use of a 
carcinogen that is not usually found in the human diet (Reviewed by Harris and 
Ferguson, 1993) along with fibres that are not usually found in a murine diet. 
Although Pozharisski (1975) reports that 1,1-dimethylhydrazine occurs in tobacco 
and methy1hydrazine is found in edible mushroom (Gyromilra esculenta), thus 
hydrazines may be a suspect in the aetiology of colon cancer. 
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Chapter 6 
Examination of the effects of SCFAs and dietary fibres on colonic 
cell homeostasis and the expression and cellular localisation of 0- 
catenin. 
6.1 Introduction 
The aim of this chapter was to elucidate the biological mechanisms behind the in 
vivo responses to luminal factors using in vitro techniques. Within the in vivo study, 
pectin was shown to increase turnour development in terms of tumour incidence, 
number and burden (size), and this was accompanied by an increase in the number of 
cells undergoing DNA replication suggesting an increase in proliferation within the 
colonic tissues. Using an in vitro system of colonic epithelial cells, of adenoma and 
carcinoma origin, the role of the dietary fibres pectin, ispaghula husk, cellulose and 
rice starch and their associated short chain fatty acids, butyrate, acetate and 
propionate on colonic cell homeostasis and protein expression was examined. 
Colonic homeostasis is an important factor in the development of colorectal cancer. 
Colonic homeostasis is the result of a balance between cell growth and cell death 
with colorectal cancer occurring when one of these processes is disrupted. Escaping 
one of the controlling mechanisms of colonic homeostasis results in an increase in 
cell proliferation and/or a loss of cell apoptosis results in the clonal expansion of 
abnormal cells. Perturbation of the cadhcrin/catenin complex, important in the 
regulation of a number of cellular processes, results in changes in intcrcellular 
adhesion and cell transformation (Valizadeh et al, 1997; Guilford, 1998). APC has a 
diverse functionality within the cell and is particularly important in regulating lcvcls 
of P-catcnin within the cell (Reviewed by Moon and Miller, 1997; Revicwcd by 
Morin et al., 1997; Reviewed by Ben-Ze'ev and Geiger, 1998; Rcviewcd by Gordon, 
1998; Reviewed by White, 1998). 'Gain of function' mutations in P-catenin or Ioss 
of function' mutations in APC have been shown to result in an ovcrcxprcssion and 
change of cellular localisation of P-catcnin, from the membrane to the cytoplasm and 
nucleus, within colonic dysplastic tissues (Rubinfeld et al., 1996; Takahashi el al., 
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1998; Lamlurn et al., 2000; Reviewed by Fearnhead et al., 2001). The nuclear 
translocation of P-catenin and the association with the transcription factors Tcf- 
4/Lef-I have been shown to result in the expression of a number of genes important 
in colonic homeostasis and colorectal cancer development including c-myc and 
cyclin-DI (He et al., 1998; Shtutman et al., 1999). Tbus E-cadherin, P-catenin and 
APC all play a fundamental role in the regulation of the normal colon with 
disruptions playing a role in colorectal cancer development. 
The effects of fibres in vitro have yet to be studied, but the effects of other luminal 
factors have been studied particularly the short chain fatty acids acetate, propionate 
and butyrate. These SCFA's profoundly alter the milieu of the colon and have a 
wide range of biological effects. The SCFA butyrate has been the most extensively 
studied in vitro and revealed a number of biological effects including those involved 
in colonic homeostasis, being powerful promoters of differentiation, apoptosis and 
cell migration (Sakata and Yajima, 1984; Hague et al, 1995; Wilson and Gibson, 
1997; Basson and Sgambati, 1998; Wang and Friedman, 1998; Tappenden and 
McBurney, 1998; Bordonaro et al, 1999; Siavostian et al, 2000), inhibition of growth 
(Archer et al, 1998a), membrane synthesis and sodium absorption of colonocytes 
(Schwartz et al. 1998) and changes in gene and protein expression (Archer et al., 
1998a; Litvak et al., 1998; Coradini et al., 2000; Siavoshian et al., 2000; Ltlhrs et al., 
2002; Menzel et al., 2002). 
6.2 Aims 
To identify the biological mechanisms responsible for the effects seen In vivo, using 
in vitro techniques. 
To examine the effects of luminal factors (fibres and SCFAs) on a number of 
parainctcrs of colonic homcostasis and cadhcrin/catenin protcin cxpression in human 
and murine colonic epithelial cell lines. 
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6.3 Methodology 
A panel of previously characterised human colon carcinoma cell lines HT29, 
HCT116, LS174T, and SW1222, the adenoma cell line RG/C2 and a murine rectal 
carcinoma cell line CMT-93 were used in these experiments. The cell lines were 
chosen due to their different genetic makeup with some containing APC mutations 
(HT'29 and SW 1222), others containing known P -catenin mutations (HCT 116) and 
one with E-cadherin mutation (LS174T). The remaining cell lines, RG/C2 and 
CMT-93, remain to be characterised as they have unknown quantities in their genetic 
make up. Immunocytochernistry along with mutational analysis (PCR, SSCP and 
sequence analysis) were used to determine the P-catenin status of LS174T and 
RG/C2 cell lines. This work was carried out with the help of Nari Janghra who 
performed the SSCP and sequence analysis used within this thesis for the cell line 
LS174T. Western blotting, immunocytochernistry and immunofluoresence were 
used to examine protein expression. Proliferation was measured using cell counts in 
all cell lines and confirmed using the MIB-1 antibody, which determines Ki-67 
expression, for the cell lines HT29 and SW1222. Other studies were originally 
undertaken to determine total cell numbers and possible cell adhesive properties after 
treatment with various dietary fibres and SCFAS using colorimetric assays using a 
microtitre plate and an ELISA plate reader. The colourimetric substrates used were 
trypan blue and the tetrazoliurn salt MTT (3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyltetrzoliumbromide). These studies were unsuccessful; firstly due to the false 
positive results obtained with trypan blue coupled with solubilisation of the cell 
membrane by SDS (Sodium dodecylsulfate), with ispaghula husk. Ispaghula husk 
appeared to bind trypan blue thus further methods were explored. MTT was then 
employed to determine cell numbers, by measuring mitochondrial activity, but 
problems arose with MTT crystal solubilisation. Different methods for solublising 
MTT tetrazoliurn salts were examined, the solvent Dimcthyl Sulphoxidc (DMSO) 
together with a glycine buffer and acidified (HCI) Triton-X, but neither of tile 
methods were successful. In hindsight these techniques, if they had been successful, 
may have had confounding results as both could result in the measurement of 
apoptotic cells. Apoptosis was measured using anncxin-V binding and floating cell 
numbers were also examined but due to the nature of the fibres these counts gave 
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inconsistent results. This was due to the difficulties in distinguishing between 
apoptotic cells and fibre residue along with the mucilaginous nature of ispaghula 
husk restricting the ability of suspending the cells. 
Initial problems arose with the sterility of the fibres used in the in vitro experiments. 
The dietary fibres used within this study were not sterile, for example ispaghula husk 
was obtained after sterilisation at IOKgreys of gamma-irradiation, this did not render 
the fibre sterile as they still resulted in microbial counts including fungal spores (M. 
Havler, personal communication). This posed the possibility of a lack of usability, 
along with a number of sterilisation procedures being ruled out as they changed the 
properties of fibres. An example of this was the finding that y-irradiation of 
ispaghula husk resulted in changes in properties including waterholding capacity thus 
would not be representative of the ispaghula husk used in the study (M. Havler, 
ReckittBenckise'r Healthcare Ltd, and S. Al Assaf, North East Wlaes Institute, 
Wrexam, personal communication, ). To keep the problem of sterility to a minimum, 
antibiotics within the cell culture medium along with the use of minimal incubation 
times and a low percentage of fibres were adopted. 
Original studies on protein expression using western blotting techniques used protein 
assays to determine equal loading. These studies revealed that aflcr butyratc 
treatment equal loading could not be achieved using protein assays (BioRad 
Laboratories, Protein assay kit). This was most likely due to the induction of 
differentiation by butyrate, resulting in the production of glycoprotcins. This 
resulted in the alteration of protocol to incorporate equal cell numbers rather than 
cellular protein levels. 
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6.4 Results 
6.4.1 The effects of the SCFAs (butyrate, acetate, propionate) and various ribres 
(ispaghula, pectin, cellulose and rice starch) on the proliferation of a number of 
carcinoma and adenoma cell lines. 
The results from this study revealed that in the carcinoma cell lines HCTI 16 (Figure 
6.1), HT29 (Figure 6.2), SW1222 (Figure 6.3), LS174T (Figure 6.4), the adenoma 
cell line RG/C2 (figure 6.5) and the murine rectal carcinoma cell line CMT-93 
(Figure 6.6) that 4mM butyrate and to a lesser extent I OmM propionate resulted in a 
reduction in total cell number over a 72 hour period. The difference in total cell 
numbers at 72 hours with butyrate and propionate treatment was only shown to be 
stastically significantly different to the control in the cell lines HCTI 16 (Student T. 
test p=0.008 and p=0.009 respectively) and LS174T (Student T-test p=0.037 and 
p=0.031 respectively). The reduction in total cell numbers suggested a decrease in 
proliferation and possibly the induction of growth arrest. The carcinoma cell line 
HT'29 appeared to be less susceptible to the effects of butyrate and propionate 
(Figure 6.2) but this result is inconclusive. The inhibition of proliferation by the 
SCFAs butyrate and propionate in the carcinoma derived cell lines 11729 (figure 6.7) 
and SW1222 (figure 6.8) were confirmed using ki-67 nuclear expression. These 
results revealed that in the cell line SW1222 cell numbers after butyrate treatment 
was shown to be statistically significantly different to the control at concentrations of 
ImM, 2mM and 4mM (Student T-test p=0.0006, p=0.0001 and P=0.0004 
respectively). This was also shown for treatment with propionate at concentrations 
of 3mM, 6mM and lOmM there was a statistically significant difference in ki-67 
expression when compared to the control (Student T-test p=0.001, P=0.0007 and 
p=0.00008 respectively). For the cell line HT29 a statistically significant differcncc 
in ki-67 expression from the control was only observed at a concentration of 4mM 
for butyrate and 10 mM for propionate (Student T-test p=0.02 and P=0.04 
respectively). Thus these findings suggested that both butyratc and propionate 
treatment resulted in a reduction in cell proliferation. The fibres, ispaghula husk, 
pectin, cellulose and rice starch appeared to have little effect on total cell numbers at 
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Figure 6.1. The SCFAs butyrate and propionate reduced total cell 
number in the colonic epithelial cell line HCT116 (p23). 
















The graph revealed that the short chain fatty acids butyrate and propionate reduced 
total cell numbers by inhibited cell proliferation (reducing cell growth, causing 
growth arrest) or induced apoptosis when compared to the control. Both Butyrate 
and propionate were shown to be significantly different to the control at 72 hours 
(Student T-test p=0.008 and p=0.009 respectively). The remaining short chain fatty 
acid acetate along with the fibres: pectin, ispaghula, cellulose and rice/resistant starch 
have little effect on total cell numbers when compared to control (From one 
independent study N=I) (Student T-test p>0.05). 
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Figure 6.2. The SCFAs butyrate and propionate reduced total cell 
numbers in the colonic epithelial cell line HT29 (p186). 
Total cell number for HT29 after treatment with fibre and 


















The graph revealed that the short chain fatty acids butyrate and propionate reduced 
total cell numbers by inhibited cell proliferation (reducing cell growth, causing 
growth arrest) or increased cell apoptosis compared to the control. This was found 
not to be significantly different to the control at 72 hours (Student T-test p=0.1.67 
and p=0.462) for butyrate and propionate respectively. The remaining short chain 
fatty acid acetate along with the fibres: pectin, ispaghula, cellulose and rice/resistant 
starch had little effect on total cell numbers when compared to control (Results 
representative of findings from one independent study N= 1) (Student T-test p>0. I). 
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Figure 6.3. The SCFAs butyrate and propionate reduced total cell 
number in the colonic epithelial cell line SW1222 (p119). 
Total cell number for SW1222 cells after treatment with 
various fibres and their associated SCFAs 
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The graph revealed that the short chain fatty acids butyrate and propionate reduced 
total cell numbers by inhibited cell proliferation (reducing cell growth, causing 
growth arrest) or increased apoptosis compared to the control. This was found not to 
be significantly different to the control at 72 hours (Student T-test p=0.137 and 
p=0.148) for butyrate and propionate respectively. The remaining short chain fatty 
acid acetate along with the fibres: pectin, ispaghula, cellulose and rice/resistant starch 
had little effect on total cell numbers when compared to control (Representative 
results from two independent studies N=2) (Student T-test p>0.3). 
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Figure 6.4. The SCFAs butyrate and propionate reduced total cell 
numbers in the colonic epithelial cell line LS174T (p40). 
Total cell number for LSI 74T cells after treatment with 















The graph revealed that the short chain fatty acids butyrate and propionate reduced 
total cell numbers by inhibited cell proliferation (reducing cell growth, causing 
growth arrest) or increased apoptosis compared to the control. Both Butyrate and 
propionate were shown to be significantly different to the control at 72 hours 
(Student T-test p=0.037 and p=0.03 respectively). The remaining short chain fatty 
acid acetate along with the fibres: pectin, ispaghula, cellulose and rice/resistant starch 
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Figure 6.5. The SCFAs butyrate and propionate reduced total cell 
numbers in the colonic epithelial cell line RG/C2 (p42). 
Total cell number for RG/C2 cells after treatment with 
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The graph revealed that the short chain fatty acids butyrate and propionate reduced 
total cell numbers by inhibited cell proliferation (reducing cell growth, causing 
growth arrest) or increased apoptosis compared to the control. This was found not to 
be significantly different to the control at 72 hours (Student T-test p=0.07 and p=0.2) 
for butyrate and propionate respectively. The remaining short chain fatty acid 
acetate along with the fibres: pectin, ispaghula, cellulose and rice/resistant starch had 
no obvious effect on total cell numbers when compared to control at 72 hours (N=I) 
(Student T-test p>0.2). 
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Figure 6.6. The SCFAs butyrate and propionate reduced total cell 
number in the colonic epithelial cell line CMT-93 (p5). 
Total cell number for CMT-93 cell line during treatment 
with various fibres and their associated SCFAs 
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The graph revealed that the short chain fatty acids butyrate and propionate reduced 
total cell numbers by inhibited cell proliferation (reducing cell growth, causing 
growth arrest) or increased apoptosis compared to the control. This was found not to 
be significantly different to the control at 72 hours (Student T-test p=0.097 and 
p=O. 117) for butyrate and propionate respectively, this could possibly due to the 
large variation within the control. The remaining short chain fatty acid acetate along 
with the fibres: pectin, ispaghula, cellulose and rice/resistant starch had little effect 
on total cell numbers when compared to control (N=2) and were shown to have no 
significant difference to the control at 72 hours (Student T-test p>0.5). 
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Figure 6.7 Histograms showing the effects of SCFA 
treatment on cellular proliferation as determined by the 
expression of r. 1-67 in the carcinoma cell line HT29 (p 176). 
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The histograms revealed that both butyrate and propionate resulted in a reduction in Kl- 
67 expression which suggested they resulted in a reduction in cell turnover. This was 
shown to be statistically significant different from the control at a concentration of 
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Figure 6.8 Histograms representing the effects of SCFA 
treatment on cellular proliferation as determined by the 
expression of id-67 in the carcinoma cell line SW1222 
(p107). 
SW1222 Treated with Sodium Butyrate 
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The histograms revealed that both butyrate and propionate resulted in a reduction in Icl- 
67 expression which suggested they resulted in a reduction in cell turnover. This was 
shown to be statistically significant different from the control for all concentrations of 
butyrate and propionate (Student T-testp<0.001). There were also differences observed 
at 6mM and l5mM concentrations of acetate (Student T-test p<0.05). 
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a concentration of 0.1% in any of the carcinoma or adenoma derived cell lines 
(Student T-test p>0.05), although this does not concisely prove that there was no 
alteration in cell proliferation. Using ki-67 expression acetate was shown to case a 
significant difference in ki-67 expression compared to the control at concentration of 
6mM and l5mM (Student T-test p=0.037 and p=0.022 respectively) within the 
colonic carcinoma cell line SW1222, although this result is inconclusive because it is 
from one independent experiment. 
6.4.2 The characterisation of the cell lines LS1 74T and RGIC2 for a exon 3 fl- 
catenin gene mutation. 
P-catenin was found to be expressed within both LS 174T and RG/C2 cell line (figure 
6.9). In LS 174T cells P-catenin was expressed within the cytoplasm accompanied by 
possible nuclear expression. The absence of any membranous expression within the 
LS I 74T cell line was consistent with the finding that LS I 74T lacks expression of E- 
cadherin (Efstathiou et al., 1999). Within the cell line RG/C2, P-catenin expression 
was localised at the cell membrane and c ytoplasm, with possible nuclear localisation, 
however this was not confirmed. This was found using both immunocytochernistry 
(ICC) (N=I, N=2 respectively) and collagen gels (N=1), these results together 
suggested a possible disruption in P-catenin regulation either through an APC 
mutation or a P-catenin mutation. LS174T and RG/C2 have previously been shown 
to have wild type APC (Ref; Chris Paraskeva personal communication respectively) 
thus the status of the P-catenin gene was examined. Amplification products of exon 
3 of the P-catenin gene showed a band shift in the carcinoma cell line LS174T but 
not in the adenoma cell line RG/C2 (Figure 6.10). This suggested that there was a 
mutation within exon 3 of the P-catenin gene in the LS174T cell line, a result which 
was confirmed using sequence analysis of the gene product (Figure 6.11), revealing a 
C to T point mutation. The lack of a band shift for the cell line RG/C2 suggested no 
such mutation in exon 3, which was confirmed by sequence analysis (Figure 6.12). 
These results suggest that the cell line RG/C2 may not exhibit nuclear localisation, 
carry a mutation in the P-catenin gene or may affect another exon that has not been 
studied, or another possible mechanism that results in the deregulation of P-catenin. 
Further experiments are required to determine whether P-catenin is expressed within 
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Figure 6.9 Expression of P-catenin in LS174T (p18) and RG/C2 (p46) 
growing as a monolayer (1) and in a 3D collagen gel (2). 
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For LS174T ICC (1) revealed cytoplasmic and possible nuclear expression (A), the 
accompanying 3D collagen gels also revealed this pattern of expression at 5 days (C) 
and I week (E), although there appeared to be no nuclear localisation within the cells 
grown in collagen. For RG/C2 ICC (2) revealed membranous, cytoplasmic coupled with 
possible nuclear localisation and the collagen gels (B) after I week (D) and 2 weeks (F). 
(LS I 74T N=I; RG/C2 N=2 (ICQ and N=I) (x40 Objective plus telescopic zoom). 
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Figure 6.10 SSCP on four different cell lines revealing a P-catenin 
mutation in LS174T cell line. 
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Key: - A= LS I 74T, B= RG/C2, C= AA/C 1, D= HT29, M=Marker 
The SSCP revealed a possible mutation in exon 3 of the fl-catenin gene within the 
cell line LS I 74T (A) as there is a clear band shift seen. No band shift was found 
in the cell line RG/C2 (B) suggesting an absence of a mutation in exon 3 of the A 
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Figure 6.11 Sequence analysis of LS174T (p2l) for exon 3 of the 
catenin gene. 
LS174T Forward 
Query: 84 gttagtcactggcagcaacagtcttacctggactctggaatccaftctggtgccactacc 143 
Sbjct: 867 gttagtcactggcagcaacagtcttacctggactctggaatccaftctggtgccactacc 926 
Query: 144 acagctccttftctgagtggtaaaggcaatcctgaggaagaggatgtggatacctcccaa 203 
Sbjct: 927 acagctccttctctgagtggtaaaggcaatcctgaggaagaggatgtggatacctcccaa 986 
Query: 204 gtcctgtatgagtgggaacagggattttctcagtccttcactcaagaacaagtagctggt 263 
Sbjct: 987 gtcctgtatgagtgggaacagggattttctcagtccttcactcaagaacaagtagctggt 1046 
LS174T Reverse 
Query: 85 ggacttgggaggtatccacatcctcttcctcaggattgcctttaccactcagaaaaggag 144 
Sbjct: 990 ggacttgggaggtatccacatcctcttcctcaggattgcctttaccactcagagaaggag 931 
Query: 145 ctgtggtagtggcaccagaatggattccagagtccaggtaagactgttgctgccagtgac 204 
Sbjct: 930 ctgtggtagtggcaccagaatggattccagagtccaggtaagactgttgctgccagtgac 871 
The sequence analysis for LS 174T revealed aC --- >T point mutation in exon 3 of 
the fl-catenin gene. 
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Figure 6.12 Sequence analysis of RG/C2 (p46) PCR product of exon 
3 of the fl-catenin gene. 
RG/C2 forward 
Query: 5 gtttcgtatttatagctgatttgatggagttggacatggccatgggaaccaagacagaaa 64 
Sbjct: 802 gtttcgtatttatagctgatttgatggagttggacatggccat-ggaacc-agacagaaa 859 
Query: 65 agcggctgttagtcactgggcagcaacagtcttacctggactctggaatccattctggtg 124 
Sbjct: 860 agcggctgttagtcact-ggcagcaacagtcttacctggactctggaatccattctggtg 918 
Query: 125 ccactaccacagctccttctctgagtggtaaaggcaatcctgaggaagaggatgtggata 184 
Sbjct: 919 ccactaccacagctccttctctgagtggtaaaggcaatcctgaggaagaggatgtggata 978 
Query: 185 cctcccaagtcctgtatgagtgggaacagggattttctcaagtccttcactcaagaacaa 244 
Sbjct: 979 cctcccaagtcctgtatgagtgggaacagggattttctc-agtccttcactcaagaacaa 1037 
Query: 245 gtagctggtaagagtattatttttcaftgccttactgaaagtcagaatgcag 296 
Sbjct: 1038 gtagctggtaagagtattatttttcattgccttactgaaagtcagaatgcag 1089 
RG/C2 Reverse 
Query: 22 cagctacttgttcttgantgaaggactgagaaaa-ccctgttcccactcatacaggactt 80 
Sbjct: 1044 cagctacttgttcttgagtgaaggactgagaaaatccctgttcccactcatacaggactt 985 
Query: 81 gggaggtatccacatcctcttcctcaggattgcctttaccactcagaaaagganctgtgg 140 
Sbjct: 984 gggaggtatccacatcctcttcctcaggattgcctttaccactcagagaaggagctgtgg 925 
Query: 141 tantggcaccaagaatggnttccagagtccaggtaagactgttgctgccantgnctaaca 200 
Sbjct: 924 tagtggcacca-gaatggaftccagagtccaggtaagactgttgctgccagtgactaaca 866 
Query: 201 gccgcttttctgtctggttccatggccatgtccaactccatcaaatcagctataaatacn 260 
Sbjct: 865 gccgcttttctgtctggttccatggccatgtccaactccatcaaatcagctataaatacg 806 
Query: 261 aaacagtattatcattagtagattggaaatg 291 
Sbjct: 805 aaacagtattagcattagtagattggaaatg 775 
The sequencing analysis confirmed that there was no mutation in exon 3 of the 
catenin gene in the RG/C2 colonic adenoma cell line. 
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the cytoplasm and nucleus of the RG/C2 cell line and whether RG/C2 carries a 
catenin mutation. 
6.4.3 The effects of SCFAs acetate, propionate and butyrate on fl-catenin protein 
expression. 
After 48 hours incubation of HT29, SW1222 and HCTI 16 with varying 
concentrations of the SCFAs butyrate, propionate and acetate there were no 
alterations in the total protein levels of P-catenin when examined using western 
blotting (figure 6.13 and 6.14) although for HCTI 16 this result was from one 
independent experiment thus was not conclusive. Using immunocytochemistry there 
were differential responses to butyrate in the three cell lines. Within the cell line 
HCTI 16 (figure 6.15), which has a P-catenin mutation, P-catenin localisation 
changes from membranous and cytoplasmic with an accompanied loss of 
membranous expression in the butyrate treated cells. The other SCFAs had little 
effect on cellular localisation of P-catenin in the HCTI 16 cell line, although this 
result was not conclusive as this result was from only one independent study. In the 
carcinoma cell lines HT29 (figure 6.16) and SW1222 (figure 6.17) there was little 
effect on P-catenin localisation after treatment with the SCFAs butyrate, propionate 
and acetate. Immunofluorescence using confocal microscopy confirmed the 
relocalisation of P-catenin into the cytoplasm within the HCTI 16 carcinoma derived 
cells when treated with 4mM butyrate for 48 hours (Figure 6.18). Immuoflouresence 
also confirmed that this did not occur in the carcinoma derived cell line HT29 when 
treated with 4mM butyrate for 48 hours (Figure 6.19). Using western blot analysis to 
examine the different fractions of the cell, soluble (cytoplasm and membrane) and 
the insoluble (actin cytoskeleton) fractions revealed that there was an increase in the 
soluble fraction in the HCTI 16 cells but not the HT29 cells upon treatment with 
4mM butyrate for 48 hours (Figure 6.20). This suggested that butyrate treatment 
resulted in a reduction in the amount of P-catenin associated with the actin 
cytoskeleton, although these experiments did not elucidate whether this was due to 
an increase in membranous or cytoplasmic expression. The western blotting results 
were not conclusive as they were from one independent experiment and require 
repeating. Although when taken together with the immunocytochemistry and the 
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Figure 6.13 Effect of varying concentrations of butyrate on P- 
catenin total protein expression in HT29 (p185), SW1222 (p115) 
and HCTI 16 (p34) cell lines. 
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p-catenin protein expression was determined by western blotting (SDS-PAGE). 
The blot shown is a typical example of those obtained from at least 2 
independent experiments, except for the cell line HCTI 16 (N=I). After 48 hour 
incubation of HT29, SW1222 and HCT116 with varying concentrations of 
butyrate (0,1 mM, 2mM and 4mM) there was no obvious effect on total 0-catenin 
protein expression levels. 
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Figure 6.14 The effect of varying concentrations of the 
SCFAs propionate and acetate on P-catenin protein 
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The western blots revealed that neither propionate at 3mM, 5mM or I OmM or 
acetate at 6mM, 12mM or 15mM had any effect on the total protein expression 
levels of P-catenin in the cell lines HT29 or SW1222 (N=2, although N=l for 
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Figure 6.15 Butyrate treatment of colonic carcinoma derived 
HCT116 (p23) cell line results in the relocalisation of P-catenin from 
the cell membrane to the cytoplasm (x40). 
Key: - A, Control; B, 4mM Butyrate; C, I OmM Propionate; D, 15mM Acetate. 
FICTI 16 cells were cytospun onto glass slides, fixed using 100% alcohol and frozen 
at -201C until use. Cells were then rehydrated, peroxidase was blocked using 
hydrogen peroxide, non-specific binding was blocked using goat serum, primary 
antibody was added for I hour at room temperature. This was followed by goat anti 
mouse antibody (1: 250,30 minutes), streptavidine (1: 250,30 minutes) and DAB (10 
minutes) dehydrated and mounted (N=I). (Magnification x40) 
p-catenin localisation changed from membranous in control cells to cytoplasmic in 
4mM butyrate (B) treated cells along with a number of morphological changes 
including an increase in size of the butyrate treated cells. The other SCFAs 
propionate (C) and acetate (D) had no obvious effect on the localisation of P-catenin 
when compared to control, with 0-catenin being found at the cell membrane and 
cytoplasm with the nuclei remaining negative for expression. 
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Figure 6.16 The SCFAs, butyrate, propionate and acetate, had no 
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Key: - A, Control; B, 4mM Butyrate; C, I OmM Propionate; D, 15mM Acetate 
HT29 cells were fixed using BNF, embedded in agar followed by paraffin and 
treated as tissues. Cells were rehydrated, peroxidase activity was blocked using 
hydrogen peroxide, non-specific binding was blocked using goat serum, primary 
antibody was added for I hour at room temperature. This was followed by goat anti 
mouse antibody (1: 250,30 minutes), streptavidine (1: 250,30 minutes) and DAB (10 
minutes) dehydrated and mounted (N=3). 
The luminal factors; butyrate (4mM) (B), propionate (I OmM) (C), acetate (1[3) had no 
obvious effect on the localisation of 0-catenin when compared to the control (A), 
with P-catenin being found at the cell membrane and cytoplasm with the nuclei 
remaining negative for expression. 
r. 
. 425pt q16'Qk! % a "0 " '%. 
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Figure 6.17 The SCFAs, butyrate, propionate and acetate, had no 
obvious effect on the localisation of P-catenin localisation in the cell 
line SW1222 (p113) (x40). 
SW1222 cells were fixed using BNF, embedded in agar followed by paraffin and 
treated as tissues. Cells were rehydrated, peroxidase activity was blocked using 
hydrogen peroxide, non-specific binding was blocked using goat serum, primary 
antibody was added for I hour at room temperature. This was followed by goat anti 
mouse antibody (1: 250,30 minutes), streptavidine (1: 250,30 minutes) and DAB (10 
minutes) dehydrated and mounted (N=3). 
The luminal factors; butyrate (4mM) (B), propionate (I OmM) (C), acetate (I 5mM) 
(D) had no obvious effect on the localisation of P-catenin when compared to the 
control (A), with P-catenin being found at the cell membrane and cytoplasm with the 
majority of the nuclei being negative for expression. 
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Figure 6.18 Butyrate treatment of colonic carcinoma-derived' 
HCT116 cell line results in the relocalisation of P-catenin from"thei' 
cell membrane to the cytoplasm. 
HCTI 16 cells (p32) were grown on collagen coated glass slides, and were stained 
with mouse monoclonal anti-Beta-catenin primary antibody, followed by anti-mouse 
FITC secondary antibody. The slides were mounted using Vectorshield mounting 
medium and cells were viewed under the Leica TCS-NT confocal laser scanning 
microscope with leica TCS-NT software for 2D and 3D image analysis. Results are 
representative of triplicate experiments (N=3), each looking over 5 different fields 
(Magnification x63). 
Visualisation of cells for FITC staining, Showing P-catenin localisation 
Visualisation of cells for DAPI staining, showing Nuclei 
A. Longitudinal sections. 
B. Transverse sections. 
P-catenin staining changes from predominantly membranous in control cells to an 
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Figure 6.19 Butyrate treatment of colonic carcinoma-derived HT29 
cell line has no effect on the localisation of 0-catenin. 
HT'29 cells (p 185) were grown on collagen coated glass slides, and were stained with 
mouse monoclonal anti-Beta-catenin primary antibody, followed by anti-mouse 
FITC secondary antibody. The slides were mounted using Vectorshield mounting 
medium and cells were viewed under the Leica TCS-NT confocal laser scanning 
microscope with leica TCS-NT software for 2D and 3D image analysis. Results are 
representative of triplicate experiments, each looking over 5 different fields 
(Magnification x63). 
Visualisation of cells for FITC staining, Showing P-catenin localisation 
VisuaIisation of cells for DAPI staining, showing Nuclei 
A Longitudinal sections. 
B Transverse sections. 
P-catenin staining remains unchanged in the butyrate (4mM) treated cells when 






Figure 6.20 Western blot showing an increase in soluble 0- 
catenin after treatment with 4mM Butyrate in the cell line 
HCT1 16 (P-catenin mutation) but not in the cell line HT29 (APC 
mutation). 
A 
cs Cl 2S 21 4S 41 
B 
m 
dm jý 1' «oW,. 
cs cl 2S 21 4S 41 
Key: CS, Control cells soluble fraction, CI, control cells insoluble fraction, 2S, 
2mM butyrate treated cells soluble fraction, 21,2 mM butyrate treated cells 
insoluble fraction, 4S, 4mM butyrate treated cells soluble fraction, 41,4 mM 
butyrate treated cells insoluble fraction. 
FICTI 16 (N=I) (A), HT29 (N=I) (B). The HCTI 16 cell line revealed a 
possible increase in soluble P-catenin when treated with 4mM butyrate 
(4S) compared to the control soluble fraction (CS). The cell line HT29 
revealed no obvious increase in soluble P-catenin in the cell line HT29 
after treatment with 4mM butyrate (4S) when compared to control (CS). 
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immunofluorescence (at least three independent experiments) there was an 
accumulation of P-catenin within the cytoplasm after treatment with 4mM butyrate 
for 48 hours within the cell line HCT 116. 
The effects of the fibres ispaghula husk and pectin on P-catenin expression were also 
examined using immunocytochemistry (Figure 6.2 1), which assessed protein 
expression when cells are grown as a monolayer and 3-D matrix collagen gels 
(Figure 6.22 and 6.23). The results suggested that treatment with 0.1% of each fibre 
had no effect on P-catenin cellular localisation in the cell lines HM 16 and 
SW1222. These results were inconclusive due to the fact that they were from one 
independent study. P-catenin expression was also examined within a collagen gel 
where cells can undergo glandular differentiation. Interestingly the cell line HCT 116 
after four days incubation with butyrate revealed similar expression of P-catenin with 
a possible relocalisation into the cytoplasm, but after seven days this membranous 
expression was clearly present. This could be due to a number of reasons, but it is 
thought that cells adapt to butyrate after a period of time in culture thus the effects 
could be abrogated. Alternatively this may be due to the cells undergoing 
differentiation or due to differences with growth in monolayers and 3D collagen gels. 




In vitro arperimentation 
Figure 6.21 The luminal factors pectin and ispaghula husk (two 
dietary fibres) had no obvious effect on the localisation of 0-catenin 
in the cell lines HCT116 (p23), HT29 (p175) or SW1222 (p113) (x40). 
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Key: - A, HCT 116; B, HT29; C, SW1222. 
The cells were cytospun or embedded in agar. Cells were then rehydrated , 
peroxidase were blocked using hydrogen peroxide, non-specific binding was blocked 
using goat serum, primary antibody was added for I hour at room temperature or 
over night at 41C. This was followed by goat anti-mouse antibody (1: 250,30 
minutes), streptavidine (1: 250,30 minutes) and DAB (10 minutes) dehydrated and 
mounted (N=I) (Magnifcication x40). 
The luminal factors ispaghula husk (0.1 %), pectin (0.1 %) had no obvious effect on 
the localisation of 0-catenin when compared to control with P-catenin being found at 
the cell membrane and cytoplasm with the nuclei remaining negative for expression. 
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Figure 6.22 The effect of butyrate, ispaghula husk and pectin on the 






4 Days 7 Days 
A, Control; B, Butyrate; C, Ispaghula Husk; D, Pectin. 
The luminal factors appeared to have little effect on the cellular localisation of p- 
catenin on HCTI 16 in collagen, except butyrate at day 4 appears to result in a 
possible redistribution of 0-catenin into the cytoplasm, this is not seen at day 7. 
The cells within the collagen gels treated with ispaghula husk appear to be poorly 
cohesive and disorganised (x40 Objective plus telescopic zoom). 
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Figure 6.23 Treatment of SW1222 collagen gels with butyrate, 







4 days 7 Days 
A, Control; B, Butyrate; C, Ispaghula husk; D, Pectin 
The luminal factors butyrate, ispaghula husk and pectin had very little effect on 
the cellular localisation of P-catenin in SW1222 cells, with it being found at the 
membrane and in the cytoplasm (x40 objective plus telescopic zoom). 
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6.5 Discussion 
SCFAs are rapidly absorbed by colonocytes in the large intestine giving them the 
potential to exert a number of biological effects with possible beneficial roles within 
the colon (Reviewed by Burrin and Reeds, 1997; Review Cook and Sellin, 1998). 
Dzierzewicz et al. (2002) showed that treatment of transformed Caco-2 cells with 
butyrate resulted in the loss of their malignant phenotype including reduced 
proliferation, enhanced differentiation, and stimulation of apoptosis and interleukin-8 
secretion (Dzierzewicz, et al. 2002). Investigations led to the discovery that SCFAs 
were not only involved in ion transport but also as nutrients for the colonic 
epithelium, modulators of intracellular pH, cell volume, regulators of cellular 
proliferation, differentiation and gene expression (Reviewed by Burrin and Reeds, 
1997; Review Cook and Sellin, 1998). 
This study confirmed previous findings that in vitro butyrate resulted in decreased 
colonic cell proliferation as determined by total cell numbers and 
immunocytochernistry using the MIB-I antibody which measures the level of Ki-67 
antibody. This study also revealed that propionate resulted in a decrease in 
proliferation, whereas acetate had little or no effect. Cyclin D3, p2l (mRNA and 
protein) and a reduction in cyclin DI has previously been shown to be involved in 
butyrate induced GO-GI cell cycle arrest affecting cell proliferation and 
differentiation (Archer et al., 1998a; Archer et al., 1998b; Coradini et al., 2000; 
Siavashian et al., 2000; Buecher et al., 2001). Butyrate results in histone 
hyperacetylation, being a non-competitive inhibitor of histone deacetylases, which 
changes gene transcription thus effecting gene expression (Reviewed by Cress and 
Seto, 2000). Proteolysis has also been implicated as a means by which butyrate 
modulates the expression of key proteins in the control of cell cycle, apoptosis and 
differentiation (Tan et al., 2002). Butyrate activates P-catenin-Tcf signalling, the 
mechanism of action and the consequences of this action remain unclear. Activation 
of Wnt has been associated with modulation of genes involved in cell proliferation, 
differentiation and tumour progression (Bordonaro et al., 2002). The mechanism of 
action of propionate is unclear, although it could involve similar mechanisms of 
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inducing cell cycle arrest involving possible inhibition of histone deacetylases or 
possibly modulating induced 0-catenin-Tcf-4 signalling pathways. 
The activation of the Writ signaling pathway through mutations inAPC, Acatenin or 
activation of Writ-I modulates the transcription of genes linked to proliferation, 
differentiation and tumour progression (Bordonaro et al., 2002). Mutations within 
the adenomatous polyposis coli (APQ gene have previously been shown to directly 
target the protooncogene c-myc, by elevating P-catenin-Tcf (T-cell factor) signalling 
(Wilson et al., 2002). APC has recently been shown to consist of nuclear export 
signals which have been found to regulate P-catenin-Tcf signalling. Loss of function 
mutations within APC resulting in the loss of these export signals and APCs ability 
to modulate P-catenin-Tcf signalling as well as the ability to regulate P-catenin levels 
(Rosin-Arbesfeld et al., 2000; Rosin-Arbesfeld et al., 2003). Butyrate influences P- 
catenin-Tcf dependent writ signaling stimulating P-catenin-Tcf complex formation 
and Tcf activity in vitro (Bordonaro et al., 1999; Wilson et al., 2002), in the presence 
of a membrane potential using SW620 colonic carcinoma cells (Bordonaro et al., 
1999). Butyrate induced p-catenin-Tcf complex formation and subsequent increase 
in Tcf activity was found to be independent of the down regulation caused by the 
expression of wild-type APC (Bordonaro et al., 1999). The finding that butyrate 
increased 0-catenin-Tcf-4 signalling in the presence of a membrane potential was 
interesting as butyrate is usually found in association with the dissipation of 
membrane potential (Bordonaro et al., 1999), thus this increase in Tcf-4 signalling 
could be temporary within the first 24 hours. Tcf-4 target genes include c-myc, 
cyclin DI and Tcf-I (He et al., 1998; Shtutman et al., 1999; Reviewed Barker and 
Clevers, 2000) proteins involved in cell proliferation and apoptosis. Butyrate 
treatment resulted in decreased c-myc (Taylor et al., 1992; Basson et al., 1998) and 
cyclin-D I (Coradini et al., 2000) expression, thus suggesting butyrate may not only 
increase but also modulate P-catenin-Tcf-4 target gene transcription. The down- 
regulation of c-myc by butyrate has been attributed to a transcriptional pause 
mechanism in exon 2 of the c-myc gene, thus presumably overriding the effects of 
Tcf on initiation of transcription (Bordonoaro et al., 1999b). These findings could 
explain why butyrate induced P-catenin-Tcf-4 transcription may not result in the 
transcription of all its target genes and may explain why butymte did not increase 
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proliferation. The Upregulation of P-catenin-Tcf activity by butyrate, in the absence 
of wild type APC (SW620 cells) has been associated with an increase in colonic 
epithelial cell apoptosis (Bordonaro et al., 1999), rather than proliferation or 
differentiation. After examination of a number of cell lines it was found that there 
was no correlation between the sensitivities to proliferation inhibition and the 
sensitivities to apoptosis induction by butyrate (Galfi et al., 2002) suggesting 
possible independent signaling pathways. This suggests that perhaps histone 
deacetylation was involved in the inhibition of proliferation (Galfi et al., 2002) with 
0-catenin-Tcf4 being involved in the induction of apoptosis (Bordonaro et al., 
1999). It has been suggested that APC maybe more closely linked to induction of 
differentiation (Bordonaro, et al., 1999). Further studies by Bordonaro, et al. (2002) 
have found that butyrate effects on wnt-signalling are partly due to the inhibition of 
histone deacetylases resulting in changes in DNA structure. 
Butyrate has been shown to effect the expression of a number of genes critical to 
colonic tumorigenesis (Wilson et al., 2002) (section 1.5.5), including p53, Bcl-2 and 
c-myc. Butyrate was shown to result in the upregulation of P-catenin in the colonic 
epithelial cell line MCE301 (Tabuchi et al., 2002). In this study western blotting 
(SDS-PAGE) suggested that there was no obvious change in total P-catenin 
expression in the cell lines HCT1 16, HT29 or SW1222 following 48 hour butyrate 
treatment at I mM, 2mM and 4mM concentrations. The results for HCT 116 were 
inconclusive due to a lack of repetition. Although these results were in fact 
consistent with the findings of Bordonaro et aL (2002) which revealed that treatment 
of HCT1 16 and SW620 cell lines with 5mM butyrate for 24 hours had no effect on 
total levels of P-catenin. P-catenin expression levels appeared to be unaltered by the 
addition of the SCFAs propionate and acetate, even at concentrations of lOmM and 
l5mM respectively, within the cell lines HT29 and SW1222. Thus butyrate, 
propionate and acetate did not appear to affect total protein expression of P-catenin. 
The upregulation of P-catenin was not observed in this study or that of Bordonaro et 
aL (2002), this could be due to the use of different cell lines, different techniques 
(cDNA microarrays versus western blotting over different time periods, although 48 
hours consistent in both) or could be the difference in examining genes verse protein 
expression possibly indicating a modification in translation. 
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This study revealed that butyrate at a concentration of 4mM resulted in the 
relocalisation of P-catenin into the cytoplasm in HCT116 cells, however this 
phenomenon was not observed in HT29 cells. P-catenin expression was determined 
by three techniques; immunocytochemistry, immunoflouresence confocal 
microscopy and western blotting using an antibody against the C-terminal region of 
the p-catenin protein. Different reasons could account for the cytoplasmic 
accumulation of P-catenin within HCTI 16 cell lines. The two cell lines differ in 
their genetic make up; HT29 has a wildtype fl-catenin and mutant APC whereas 
HCTI 16 cell line has a wild type APC and a heterozygous mutation in the fl-catenin 
gene (Ilyas et al., 1997; Morin et al., 1997). Difference in APC and P-catenin status 
between the two cell lines could affect P-catenin-Tcf-4 signaling and protein-protein 
interactions of P-catenin with the proteins E-cadherin, GSK-3P or APC. 
The HCT1 16 cell line is replication error positive (RER+) (Efstathiou et al., 1999) 
and has previously been shown to express full length APC (Su et al., 1993; Ilyas et 
al., 1997; Morin et al., 1997). HCT1 16 was also shown to express intact P-catenin 
as determined by western blotting, however sequence analysis revealed a mutation 
within the Acatenin gene (CTNNBI) (Morin et al., 1997). HCTI 16 had a 
heterozygous 3-bp deletion in codon 45, an inframe deletion within exon 3 within the 
fl-catenin gene (CTNNBI) (Ilyas et al., 1997; Morin et al., 1997). This mutation 
resulted in the loss of the highly conserved serine residues (Ser 
45) in a region of the 
protein that may be a target for GSK-3P (Ilyas et al., 1997; Morin et al., 1997). 
HCT1 16 has been shown to have constitutively active p-catenin-Tcf transcription 
(Morin et al., 1997). Morin et al. (1997) demonstrated that the heterozygous 0- 
catenin acts in a dominant negative fashion for mutant P-catenin that resulted in an 
increase in 0-catenin-Tcf-4 mediated transcriptional activity (Ilyas et al., 1997; 
Morin et al., 1997) and was unaffected by the presence of wild type APC (Morin et 
al., 1997). Mutagenesis experiments demonstrated that substitution of the serine 
residues in the glycogen synthase kinase 3P (GSK-30) phosphorylation consensus 
motif of P-catenin inhibits the ubiquitination and results'in the stabilisation of the 
protein (Aberle et al., 1997). 
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Agents such as butyrate, ascribed as having chemopreventive activity for colon 
cancer and induce GO-GI cell cycle arrest, in fact also stimulate P-catenin-Tcf 
activity in vitro (Bordonaro et aL, 1999; Bordonaro et aL, 2002; Wilson et al., 2002) 
although it has been suggested that this is not accompanied by an increase in target 
gene expression (Vincan et al., 2000). Within the cell line HM 16, Bordonaro et al. 
(2002) found that butyrate resulted in a decrease in free Tcf within the cytoplasm and 
this was accompanied by an increase in P-catenin-Tcf binding to DNA, although this 
study also revealed that 5mM butyrate had little effect on the nuclear levels of p- 
catenin after 24 hours. This could partially explain the increase in cyotplasmic P- 
catenin expression found within the cell line HCTI 16. 
It is also possible that the increase in cytoplasmic localisation of P-catenin within 
HCTI 16 cell line following butyrate treatment was due to the induction of apoptosis. 
This would result in the cleavage of P-catenin and as such an increase in cytoplasmic 
P-catenin although there were no other physical signs of apoptosis were observed. p. 
catenin-Tcf-4 signalling is thought to be more associated with apoptosis (Bordonaro 
et al., 1999). The response to butyrate in terms of differentiation and apoptosis by 
HT29 is decreased during prolonged exposure (Kucerova et al., 2002). This may 
explain why, after 7 days prolonged treatment of the HCTI 16 cells in collagen, there 
appears to be no effect on P-catenin localisation with butyrate treatment although this 
could be due to a lack of repetition, so no strong conclusions could be ascertained. 
Aberle et al. (1997) revealed that the ubiquitin-dependent proteolysis system was 
involved in the regulation of P-catenin turnover. P-catenin, but not E-cadherin, p120 
and a-catenin, becomes stabilised when proteosome-mediated proteolysis was 
inhibited leading to the accumulation of multi-ubiquitinated forms of p-catenin. 
Research showed that ubiquitination of A-catenin was greatly reduced in Wnt. 
expressing cells, providing the first evidence that the ubiquitin-proteosome 
degradation pathway may act down stream of GSK-3P in the regulation of P-catenin 
(Aberle et al., 1997). Butyrate has been shown to have differing effects on 
proteosome activity depending on the protein and cell system being examined. 
Butyrate treatment resulted in alterations in the proteosome of HT-29 cells (Tan et 
al., 2002) resulting in changes in the expression of various components of the 
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ubiquitin-proteosome system (Tan et al., 2002). Butyrate did not appear to effect 
proteosome activity, although inhibition of proteosomes by other inhibitors did 
appear to increase cyclin D3 expression (Buecher et al., 2001). Butyrate was shown 
to suppress the activation of NF-O and cellular proteosome activity (Yin et al., 
2001), thus there are conflicting studies as to whether butyrate affects proteosome 
activity. A change in proteosome activity could profoundly affect the ubiquitination 
and degradation of P-catenin in HCT 116, again postulating another mechanism for 
relocalisation and accumulation of P-catenin in the cytoplasm. Modulation of 
proteosome activity was probably not the cause of cytoplasmic accumulation 
observed in this study, as there were no changes in overall P-catenin levels. Analysis 
of the glycogen synthase kinase-3p (GSK-3p) activity in several colon cancer cell 
lines suggested a correlation between comparatively low enzyme activity and 
moderate to high differentiation status. Butyrate has been shown to result in the 
phosphorylation of GSK-3P inhibiting its ability to phosphorylate target proteins 
(Tuhackova et al., 1999). GSK-3P activity was shown to decrease with butyrate 
treatment, resulting in an increase in the stabilization of P-catenin (as in wnt) 
although there was no increase in P-catenin target gene expression (Vincan et al., 
2000). The modulation of GSK-3P activity is unlikely to affect P-catenin 
cytoplasmic accumulation due to HCT116 having mutant P-catenin, which is 
resistant to GSK-3P induced degradation. 
Mutation of the second allele of HCT1 16 was shown to reduce 0-catenin-TCF/LEF 
transcription and this in turn was shown not to affect growth rate in vitro but 
adhesive functions of P-catenin (Sekine et al., 2002). Thus the relocalisation of p- 
catenin to the cytoplasm by butyrate could be due to changes in cellular adhesion. 
Wnt-I expression has been shown to result in the accumulation of P-catenin, 
plakoglobin and stabilisation and increased expression of cadherin strengthening 
cell-cell adhesion (Bradley et al., 1993; Hinck et al., 1994a). C-myc, a target gene 
for P-catenin-Tcf-4 and its associated proteins (c-Myc-1, c-Myc-2) have been shown 
to result in the upregulation of E-cadherin when simultaneously expressed (Batsche 
and Cremisi, 1999). Butyrate has also been shown to result in the upregulation of E- 
cadherin (Kucerova et al., 1999) suggesting that it is a possible target of P-catenin- 
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Tcf-4 (Reviewed by Ben-Ze'ev, 1998). Within HCTI 16 there is a heterozygous 
mutation within the E-cadherin gene with the E-cadherin protein being expressed by 
this cell line (Efstathiou et al., 1999). The mutation within HCT1 16 was shown to be 
a deleted frameshift, a single base deletion in repeat regions of exon 3 (codon 120), 
h 
11 causing a downstream premature stop codon (TGA) at codon 216 within HCTI 16 
(Efstathiou et al., 1999). The mutation within HCT 116 results in a truncation within 
the N-terminal region, the extracellular domain of the protein, which may interfere 
with the normal function of full-length E-cadherin (Efstathiou et aL, 1999). The 
steady state levels of P-catenin are partly dependent upon cadherin expression 
(Munemitsu et al., 1996). E-cadherin has been shown to be upregulated in some cell 
lines by butyrate treatment (Kucerova et al., 1999), which could possibly be due to 
the induction of differentiation. Butyrate was also shown to result in an increase in 
membrane bound P-catenin, suggesting a possible mechanism as to how butyrate 
induces cell differentiation (Vincan et aL, 2000). In HCTl 16, P-catemn 
coprecipitated with APC, E-cadherin and a-catenin (Rubinfeld et al., 1993; Su et al., 
1993; Ilyas et al., 1997). E-cadherin binds to all 12 Arm repeats within P-catenin 
(Huber and Weis, 2001). APC contains sequences homologous to the 
phosphorylated region of cadherin and is likely to bind similarly (Huber and Weis, 
2001). APC association with the catenins is consistent with the previous observation 
that APC is localised in the detergent insoluble fraction (microtubule network) (Su 
et al., 1993) although in HCTI 16 APC would be unable to elicit its degredation. The 
binding of the P-catenin to APC could account for the increase in cytoplasmic 
accumulation observed within this study although this would not account for the 
western blotting results, which suggests that APC-P-catenin interactions would be 
found within the soluble fraction. Cadherins appear to associate with similar 
amounts of a- and P-catenin whereas APC associates preferentially with P-catenin 
(Su et al., 1993). Due to the heterozygous mutation within the cell line HCTI 16, it is 
unknown whether or not E-cadherin or a-catenin complexes contain mutant protein 
(Ilyas et aL, 1997). The P-catenin mutation in the cell line HCTI 16 is found within 
exon 3, which consists of the GSK-3P consensus sequence, that lies upstream from 
the E-cadherin binding site within the p-catenin Arm repeat region so it would be 
unlikely to affect these interactions (Nusse, 2002). In HCT1 16 the mutation was in a 
region outside the Arm repeats 5 prime to the a-catenin binding site (Ilyas et al., 
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1997). O-catenin forms independent complexes with either APC or E-cadherin 
(Rubinfeld et al., 1993), E-cadherin and APC directly compete for binding to the 
internal, armadillo-like repeats of P-catenin, the NI-12-terminal domain of P-catenin 
binding to a-catenin (HUlsken et al., 1994; Reviewed Ilyas and Tomlinson., 1997). 
This leads to the conclusion that the mutation within P-catenin would not interfere 
with its interactions with E-cadherin, APC or cc-catenin. Immediately after synthesis, 
E-cadherin, P-catenin and plakoglobin cosedimented as complexes. a-catenin was 
not associated with these complexes after synthesis, but a subpopulation of ot-catenin 
joined the complex at a time coincident with the arrival of E-cadherin to the plasma 
membrane (Hinck et al., 1994b). In addition to cadherin/catenin complexes, there 
were cadherin-independent pools of catenins Present in both TX-100 soluble and 
insoluble fractions (Hinck et al., 1994b). Cadherin-p-catenin complexes were 
present in the TX- 100 soluble fraction ("inck et al., 1994b). Approximately 5 0% of 
complexes were titrated into the TX-100 insoluble fraction coincident with the 
arrival of the complexes at the plasma membrane and the assembly of cc-catenin 
(Hinck et al., 1994b). The increase in soluble pool could also be due to an increase 
in E-cadherin-p-catenin at the membrane but not linked to the actin cytoskeleton by 
a-catenin. E-cadherin expression appeared to be maintained at the cell membrane 
within the HCT1 16 (results not shown) but the increase in E-cadherin expression by 
butyrate could result in the increased transcription of the mutant E-cadherin, which 







7.1 Concluding remarks. 
Colorectal cancer is the second biggest cause of cancer mortality in the western 
world. In advanced disease the prognosis is poor and available forms of treatment 
are largely ineffective, thus there is a need to develop preventive approaches. 
Moreover there is a national strategy towards health improvement and prevention of 
disease, which includes recommendations to increase the consumption of fruit and 
vegetables (five portions a day) along with the cessation of smoking. Dennis Burkitt 
was the first to propose that dietary fibre, contained within cereals, fruit and 
vegetables, may protect against a number of prevailing diseases in the western world 
including bowel cancer. Recent studies have produced conflicting data as to whether 
dietary fibre protects against colorectal. cancer development. This study attempted to 
examine the effects of individual fibres on colonic turnourigenesis, particularly those 
used to supplement foods. Loss of function mutations within the turnour-suppressor 
gene APC occurs in 80-85% of sporadic colorectal cancers; loss of function of APC 
results in P-catenin over expression within the cytoplasm along with nuclear 
translocation. Thus this study has investigated the effects of dietary fibres on 
catenin expression and cellular localisation. 
This study has confirmed that different fibres produce different levels of SCFAs and 
at differing rates along with revealing the SCFA production for the fibres used in this 
study; ispaghula husk, pectin and cellulose. Pectin was shown to be rapidly 
fermented, which is consistent with previous findings that it is completely fermented 
in the caecurn of mice. This finding may partially explain the results that pectin 
increased the incidence and increased development of colonic turnours within the 
distal colon of mice treated with 1,2-dimethylhydrazine (DMH). Complete 
fermentation of pectin would result in the loss of bulk, which would result in the 
release of bile acids and as a consequence an increase of primary bile acids being 




processes. The release of SCFAs have previously been shown to result in an increase 
in proliferation in vivo (Goodlad et al., 1989; Goodlad et al., 1995), in the case of 
pectin the level of SCFAs reaching the distal colon would presumably be low. If this 
is not the case high levels of SCFAs could be another cause of an increase in cell 
proliferation. Pectin has also been shown to result in an increase in markers of 
apoptosis (Aviv-green et al., 2000a), so this increase in apoptosis could explain the 
increase in proliferation due to a balance of colonic homeostasis. Other constituents 
of the diet also appeared to affect fermentation, although the constituents examined 
within this study would not reach the colon so the relevance of these results are 
difficult to determine. Future studies could involve a repetition of the in vitro 
fermentation process after mimicking digestion throughout the gastrointestinal tract. 
This would be achieved by subjecting the fibres to digestion conditions found within 
the gastrointestinal tract. Replicating the conditions found within the mouth could be 
achieved by using the enzyme amylase and mechanical force reflecting mastication 
and possibly exposure to a representation of the commensal microflora. The next 
stage would involve mimicking the stomachs digestion process, which involves 
mechanical, enzymatic digestion using pepsin and acid hydrolysis (Reviewed by 
Moore and Agur, 1995). Digested food enters the small intestine where nutrients are 
absorbed and bile secreted, a process that would be difficult to mimic. The 
remaining residue would possibly reflect more accurately that which enters the large 
intestine providing a more accurate reflection of SCFA production from each dietary 
fibre. This would be particularly true for rice starch where only the portion of 
resistant starch would actually reach the large intestine dramatically altering the 
levels of SCFAs achieved. It would also give a more accurate picture of the SCFA 
profiles for the fibre supplemented diets as there are components within these diets 
that have the potential to affect fermentation within the large intestine, such as 
protein. A further extension of the analysis of the properties of dietary fibres would 
be to repeat the in vitro experiments using faecal matter obtained from normal and 
DMH-treated mice. This would reflect more accurately the fermentation patterns 
within the mouse, as there are variations in the resident bacteria within the large 
intestines of mice and humans (Interpretation from Reviewed by Holdeman et al., 
1977). Although this study may be difficult due to the small quantities of murine 
faccal matter produced, this could be overcome by making an artificial faecal slurry 




The 1,2-dimethylhydrazine (DMH) mouse model was used to examine the effects of 
the dietary fibres used as food supplements on tuniourigenesis. This is an established 
animal model of colonic turnourigenesis, which is characterised by the development 
of multiple adenomas in the large intestine which eventually progress to 
adenocarcinomas. The aim of this study was to examine alterations in the expression 
of the catenins (a-, P-catenin and pl20(")) and E-cadherin expression in colonic 
adenomas induced by DMH. P-catenin, (x-catenin, p120(c') and E-cadherin 
expression were all altered within the dysplastic epithelium of the 1,2- 
dimethy1hydrazine induced adenomas. Within the dysplastic tissues there was an 
increase in cytoplasmic catenin and cadherin localisation along with maintenance of 
membranous expression. This is different to human adenomas where relocalisation 
of P-catenin into the cytoplasm is usually associated with a loss of membranous 
expression (Hao et al., 1997). Takahashi et al. (2000) also examined P-catenin 
staining and found an increase in cytoplasmic staining and nuclear localisation but a 
decrease in P-catenin membranous expression. This difference could be due to the 
differences between the two models, including the use of a metabolite of DMH, 
AOM, and the use of different immunohistochemical techniques. Increased 
cytoplasmic and nuclear localisation of P-catenin suggests either activation of WNT- 
I or a mutation within P-catenin or APC. For P-catenin we failed to show a mutation 
within the P-catenin gene. Other studies have shown that AOM, a metabolite of 
DMH, results in a mutation of exon 3 of the P-catenin gene within a murine model 
(Takahashi et al., 2000; Yamada et al., 2003). Thus future work could include 
finding a more sensitive method to specifically amplify up the mutant P-catenin 
including real time PCR, high fidelity PCR, nesting primers or the use of more 
accurate polymerases. The PCR method used may not have been sensitive enough 
to detect single base-pair changes and any masked mutations. The techniques could 
also be improved through the use of microdissection. to reduce the contamination of 
non-dysplastic colonic tissues. 
The maintenance of E-cadherin expression and catenin expression at the cell 
membrane as well as cytoplasmic localisation is a significant finding. This could be 




properties of the proteins. E-cadherin mutations within the extracellular domain, 
exon 8 or 9, maintained E-cadherin and catenins at the cell membrane, along with an 
increase in catenins within the perinuclear region within diff-used gastric cancer cells 
(Luber et al., 2000). Tbus it would be interesting to examine E-cadherin for 
mutations within exon 8 and 9, as this may explain the unusual finding. Another 
interesting analysis would be the evaluation of dysplastic tissues for functional 
interactions within the cadherin/catenin complex using western blotting and 
immunoprecipitation. 
Another possible explanation are changes in proteosome activity with a reduction in 
proteosome activity explaining the accumulation of the catenins and cadherin within 
the cytoplasm, accompanied by their maintenance at the cell membrane. Butyrate 
has been shown to alter proteosome activity and resulting in a reduction in the 
degradation of a number of proteins (Refer to section 6.5). It could also be the result 
of changes in tyrosine phosphorylation, DMH possibly inducing proteins that result 
in the tyrosine phosphorylation of the catenins, disrupting their cellular function 
(refer to 1.3.3). Examination of the tyrosine phosphorylation status of P-catenin 
could be achieved using western blotting and the antibody 4GIO. There is also the 
possibility of changes in methylation with the carcinogen previously been shown to 
result in pro-mutagenic 06_methylguanine lesions (Reviewed by Sunter, 1980). 
The status of APC gene and the functionality of the protein could also be examined, 
as this is an important protein in the regulation of catenin levels and cellular 
localisation within the cell. APC in a complex with GSK-3P and axin have shown to 
result in the degradation of P-catenin. Loss of function mutations in APC results in 
the loss of its ability to down regulate P-catenin. APC has recently been found to 
have a highly conserved nuclear export signal, cells with mutant APC lacking these 
export signals results in P-catenin nuclear accumulation (Rosin-Arbesfeld et al., 
2000) suggesting that the ability of APC to exit from the nucleus appears to be 
critical for its turnour suppressor function (Rosin-Arbesfeld et al., 2000). The export 
signals are crucial for APCs function by reducing the transcriptional activity of p- 
catenin (Rosin-Arbesfeld et al., 2003). Thus a loss of APC function could reflect 




catenin expression at the cell membrane and the nuclear localisation of P-catenin. 
Within colonic tumours induced by either AOM or DMH within rats and mice APC 
expression has been shown to be negative, with reductions in mRNA expression and 
low levels of APC mutations (Maltzman et al., 1997; Endo et al., 2001; Kishimoto et 
aL, 2002). If the mutation within APC involves its export signals it could also 
account for the nuclear localisation of P-catenin. Mutations in APC and P-catenin 
are thought not to be the only reasons for loss of the regulation of P-catenin levels. 
A number of other complexes involved in P-catenin degradation, such as mutations 
in axin (Reviewed by Gordon, 1998; Ikeda et al, 1998) could also play a role in the 
fundamental disruption of this multiprotein complex. Mutations in GSK-3 could also 
be a significant factor with mutant GSK-3p, lacking the kinase domain, being unable 
to phosphorylate either APC or P-catenin. 
The accumulation of P-catenin within the cytoplasm leads to translocation of p- 
catenin into the nucleus where it associates with the transcription factors LEF and 
TCF (Behrens et al., 1996; Reviewed by Barth et al, 1997b; Reviewed by Jankowski 
et al, 1997; Korinek, 1997; Reviewed by Nusse, 1997; Morin et al, 1997a; Muller et 
al, 1998). P-catenin forms a complex with TCF/LEF transcription factors which 
binds to DNA and consequently activates gene transcription. The nuclear 
localisation of P-catenin could have a number of implications in terms of modulation 
of TCF signalling resulting in the transcription of a number of target genes such as c- 
myc, cyclin DI and cox-2 (He et al., 1998; Shtutman et al., 1999; Howe et al., 1999). 
Thus the modulation of gene expression of target genes of P-catenin/tcf-4 could be 
examined, along with an examination of P-catenin/TCF-4 interactions. The target 
genes c-myc (He et al., 1998), cyclin D1 (Shtutman et al., 1999) and Cox-2 (Howe et 
al., 1999) expression have been examined within similar models, for example rats 
exposed to azoxymethane (AOM) for 4 weeks were shown to have elevated Cox-2 
and c-myc mRNA expression (Kishimoto et al., 2002). 
The effect of the characterised fibres; ispaghula husk, pectin and cellulose along with 
a basal diet being relatively fibre free on tumour development were examined in a 
murine model using the complete carcinogen 1,2-dimethylhydrazine. The results 




development and progression. This included the initiation, even though DMH 
initiates tumour development the fibre pectin also seemed to increase the rate of 
initiation in terms of microadenoma number (although not significant) and turnour 
incidence (significantly when compared to the basal diet), tumour numbers (although 
not significantly) and tumour size (not significantly). The reason these experiments 
failed to prove a significant difference between the fibre-supplement groups was 
attributed to the large variation between groups on the same diet. These results are in 
keeping with previous findings that soluble fibres tend to be less protective against 
turnour development than insoluble fibres (Harris and Ferguson, 1993). The 
proposed chemopreventive effects of fibres include their bulking abilities which help 
dilute carcinogens down and decrease transit time within the colonic lumen, changes 
in bile acids and short chain fatty acids (SCFAs) along with other systemic effects 
through reduction in appetite, reduction in insulin, a reduction in glucose absorption 
helping to control type II diabetes and lowering of the risk of coronary heart disease 
(CHD) could all have an indirect effect on colorectal cancer development. Pectin 
was shown to increase (although not significantly due to the large variations ' 
between 
the mice) in the number of cells replicating their DNA as indicated by an increase in 
bromodeoxyuridine-labelling index (BrdU-LI). This increase in proliferation 
indicates a possible disruption in colonic homeostasis, through either a direct 
increase in proliferation or an increase in apoptosis; suggested by the average crypt 
lengths within each fibre supplemented group not being significantly different. 
Interestingly the lowest number of tumours, with the lowest incidence and the lowest 
level of proliferation (cells undergoing DNA replication) was in those mice fed the 
basal diet, which was fibre free. This leads to a number of possibilities but the most 
significant being the increase in proliferation being associated with the increase in 
tumour development within this model. DMH itself has been shown to increase 
proliferation and the addition of fibre may accentuate this causing a greater 
imbalance in colonic homeostasis. The disruption of catenin expression within the 
dysplastic tissues and the nuclear localisation of P-catenin could also be a 
consequence or the cause of the increase in proliferation within the dysplastic. 
Furihata et al. (2002) found that an overexpression of P-catenin was not associated 
with an increase in proliferating cell nuclear antigen-labelling index (PCNA-LI), and 




fibre supplemented diets to support this hypothesis. The finding that there was no 
obvious difference in catenin expression between the mice fed on different fibre diets 
but this could have been because of the small sample number; alternatively this could 
simply be a reflection of the limitations of immunohistochernistry. Future studies 
could involve the repetition of these experiments using different colon cancer models 
such as the MIN mouse or APC knockout mice, or supplementation of a normal diet, 
although this may not be good use of resources. Further studies within the tissues 
already obtained could involve measuring the level of apoptosis (apoptotic body 
count or use of the TUNEL immunohistochemistry) within the colonic tissues, and 
determine whether there are any significant differences between the fibres. In terms 
of exploring the possible chernopreventive properties of fibre supplements an 
extension of the examination of different types of fibre supplement on the market 
would be important. For example in this study ispaghula husk was examined, this 
fibre is the main constituent of fybogele a product used the treatment of constipation 
and diahhorea, and regulation of bowel habit. This study could be extended to 
examine the different types of fybogelo as fybogelo lemon also contains curcumin, 
with curcumin previously being shown to have possible chernopreventive properties 
(Reviewed by Choi and Mason, 1998; Anto et al., 2002). Thus it would be 
interesting to examine the effects of the two different supplement on colorectal 
cancer development and determine whether there is any synergy between the two. 
The use of an ex vivo model such as the growth of colonic biopsies in culture (organ 
culture) either human or murine in origin may provide a link between the in vivo and 
in vitro results and be a more precise representation of the in vivo system. 
The possible biological effects of the dietary fibres and the SCFAs associated with 
the fermentation of these fibres were investigated in vitro. The SCFAs butyrate and 
propionate resulted in a decrease in proliferation and an increase in apoptosis 
(Reviewed Rombeau and Roth, 1995; Hague et al., 1995; Reviewed by Cummings, 
1997; Reviewed LWus et al., 2002). The fibres were found to have no effect on total 
cell number suggesting that proliferation is unaffected by the addition of fibres. To 
extend this further, cell turnover could be examined using tritiated thymidine, which 
would help confirm whether the total cell number obtained was due to no changes in 




Examination of combinations of SCFAs would be relevant as this would more 
closely reflect the in vivo situation and would also allow for investigations into the 
interactions between different SCFAs. 
Butyrate was shown to induce relocalisation of P-catenin from the cell membrane 
into the cytoplasm within the cell line HM 16 but not HT29. The changes in P- 
catenin expression within HCTI 16 but not HT29 using butyrate could be examined 
further to determine the mechanism behind this. HM 16 has a mutant P-catenin 
whereas HT29 has a wild type p-catenin. Thus it would be important to examine 
other cell lines with mutant P-catenin or without a mutant P-catenin for example 
LS174T and SW1222 respectively. Changes in proteosome activity within the two 
different cell lines after butyrate treatment could also be examined along with the 
ubiquitination of P-catenin protein. There are conflicting studies as to whether 
butyrate affects proteosome activity, butyrate did not appear to affect proteosome 
activity when examining the effects on cyclin D3 expression (Buecher et al., 2001); 
whereas Butyrate was shown to suppress the activation of NF-KB and cellular 
proteosome activity (Yin et al., 2001); this could be the result of examination of 
different cell systems and target genes. A change in proteosome activity could 
profoundly affect the ubiquitination and degradation of P-catenin in HCT 116, again 
postulating another mechanism for relocalisation and accumulation of P-catenin in 
the cytoplasm. Changes in P-catenin transcription could also be examined with 
butyrate being a known histone deacetylase inhibitor. The Wnt signaling pathway 
modulates the transcription of genes linked to proliferation, differentiation and 
turnour progression (Bordonaro et al., 2002). Butyrate has also been shown to 
influence P-catenin-Tcf dependent Wnt signaling (Bordonaro et al., 2002). Butyrate 
induced increase in Tcf activity, which is reflected in an increase in P-catenin-Tcf 
complex formation, is independent of the down regulation caused by expression of 
wild-type APC (Bordonaro et al, 1999). Thus, butyrate and wild-type APC have 
different and independent effects on P-catenin-Tcf signalling (Bordonaro et al, 
1999). Examination of P-catenin/TCF-4 interactions could be examined. HCTI 16 
has a wild type APC with a mutant p-catenin accompanied by low levels of p. 
catenin-Tcf complexes and higher levels of free Tcf (Bordonaro et al., 2002). 




accompanied by an increase in P-catenirvTcf-4 complex formation (Bordonaro et al., 
2002). Thus the relocalisation of P-catenin into the cytoplasm could be the result of 
an increase in P-catenin-TCF complex formation. Examination of any possible 
nuclear localisation of P-catenin or changes in target gene transcription, such as c- 
myc (He et al., 1998), cyclin D1 (Shtutman et al., 1999) or cox-2 (Howe et al., 1999) 
between the 2 cell lines would be of interest with butyrate previously shown to down 
regulate c-myc protein expression within Caco-2 cells (Basson et al., 1997). This 
could be extended to examine whether propionate has a similar effect although the 
initial immunocytochemistry results suggest this is not the case. The tyrosine 
phosphorylation status of P-catenin could also be examined using western blotting 
and the antibody 4GIO. It would also be possible to examine the interaction of P- 
catenin with E-cadherin and extending the studies using the murine cell line CMT-93 
as it may give ftu-ther evidence to how the fibres affect tumour development in the 
murine model. 
The increase in cell proliferation in vivo could be attributed to the production of 
SCFA from the fermentation of the dietary fibres. This is supported by the fact that 
pectin was shown to produce the highest level of SCFAs at the fastest rate (Refer to 
3.5) and previous experiments revealing that SCFAs increase proliferation in vivo 
(Goodlad et al., 1989; Goodlad et al., 1995; Ichikawa and Sakata, 1998). SCFAs 
have also been shown to produce the biological effects in vitro, by decreasing 
proliferation, with the fibres having little effect (refer to 6.4). The reduction in 
proliferation in vitro versus the increase in proliferation in vivo brings into play the in 
vivo vs in vitro debate with the difference responses possibly relating to the 
availability of glucose and the ability of cells to metabolise butyrate (Singh et al., 
1997). The rapid fermentation of pectin within the caecum, resulting in a possible 
lowering SCFAs levels in the distal. colon, suggests that other factors maybe eliciting 






The results suggest that the DMH mouse model is a good model for studying the 
effects of chernopreventive agents on catenin expression and associated gene 
products in relation to colonic neoplasia. In this model the carcinogen acts 
systemically but the development human colorectal neoplasia could be related to 
either systemic or luminal carcinogens. Despite this difference, this model retains 
sufficient similarities to human colon cancer to allow for valid comparisons to be 
made. The original hypothesis to that dietary fibres protect against turnour 
development could not be proved. The studies revealed that in DMH-treated mice 
fibres did not protect against turnour development; the more soluble fibre pectin 
indeed resulted in a significant increase in tumour incidence with a possible increase 
in development when compared to a fibre-free diet (basal). The fibres used in this 
study: ispaghula husk, pectin and cellulose did not appear to affect p-catenin 
expression in vivo, but in vitro butyrate was shown to affect P-catenin expression in a 
cell line, which has a P-catenin mutation (HCTl 16) but not in a cell line with an 
APC mutation (HT29). 
This study revealed that individual dietary fibres were not sufficient to prevent 
against colon cancer induced by systemic carcinogens. The fact that epidemiological 
studies have revealed that fruit and vegetables have a negative effect on colon cancer 
maybe attributed to other factors such as antioxidants (vitamins) within them. 
Dietary fibre may have other chemopreventative effects on colon cancer that may not 
have been revealed by this study. Dietary fibre has a bulking effect, which reduces 
the contact of luminal carcinogens with the colonic mucosa, the carcinogen used in 
this study was systemic. Epidemiological studies revealed that high fat and red meat 
intake has been positively associated with colon cancer; dietary fibres reduce protein 
digestion, which has been associated with arnine production, which are possible 
tumour promoting compounds. Butyrate, a SCFA produced during fermentation, has 
also been proposed to be chemopreventative, the fibres used in this study did not 
appear to produce high levels of butyrate (resistant starch and rice starch excluded as 
levels of these would be minimal) apart from pectin, although the intercolonic levels 




tumours were observed. Butyrate was also found to have an unexplained effect on 
mutant P-catenin, but not wild type, which may be a finiher chemopreventative 
biological action. Dietary fibre may also protect against colon cancer indirectly, 
dietary fibres have previously been shown to help treat and prevent type II diabetes, 
which has been positively associated with an increased risk of colon cancer. 
Thus this study revealed that the dietary fibre pectin enhanced tumour development 
in this model. This suggests the supplementation of foods with excessive pectin and 
the consumption of fruit jams may not be beneficial to the colon. The clinical 
implication of these studies highlights the need for a well balanced diet and the 
adoption of the '5 a day policy' with a consumption of both fruit and vegetables 
ensuring the consumption of all their constituents, not just an increase in the 
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